id	label	authors	source_paper	year	doi	cit_score
1	healthcare workers' (hcws) attitudes and related factors towards covid-19 vaccination: a rapid systematic review	li, m; luo, y; watson, r; zheng, y; ren, jl; tang, j; chen, yh	postgraduate medical journal	2019	10.1136/postgradmedj-2021-140195	0
2	effectiveness of severe acute respiratory syndrome coronavirus 2 messenger rna vaccines for preventing coronavirus disease 2019 hospitalizations in the united states	tenforde, mw; patel, mm; ginde, aa; douin, dj; talbot, hk; casey, jd; mohr, nm; zepeski, a; gaglani, m; mcneal, t; ghamande, s; shapiro, ni; gibbs, kw; files, dc; hager, dn; shehu, a; prekker, me; erickson, hl; exline, mc; gong, mn; mohamed, a; henning, dj; steingrub, js; peltan, id; brown, sm; martin, et; monto, as; khan, a; hough, cl; busse, lw; ten lohuis, cc; duggal, a; wilson, jg; gordon, aj; qadir, n; chang, sy; mallow, c; gershengorn, hb; babcock, hm; kwon, jh; halasa, n; chappell, jd; lauring, as; grijalva, cg; rice, tw; jones, id; stubblefield, wb; baughman, a; womack, kn; lindsell, cj; hart, kw; zhu, yw; olson, sm; stephenson, m; schrag, sj; kobayashi, m; verani, jr; self, wh	clinical infectious diseases	2019	10.1093/cid/ciab687	6
3	behavioral and psychosocial factors associated with covid-19 skepticism in the united states	latkin, ca; dayton, l; moran, m; strickland, jc; collins, k	current psychology	2019	10.1007/s12144-020-01211-3	0
4	case series of thrombosis with thrombocytopenia syndrome after covid-19 vaccination-united states, december 2020 to august 2021	see, i; lale, a; marquez, p; streiff, mb; wheeler, ap; tepper, nk; woo, ej; broder, kr; edwards, km; gallego, r; geller, ai; jackson, ka; sharma, s; talaat, kr; walter, eb; akpan, ij; ortel, tl; urrutia, vc; walker, sc; yui, jc; shimabukuro, tt; mba-jonas, a; su, jr; shay, dk	annals of internal medicine	2019	10.7326/m21-4502	0
5	understanding the prevalence and associated factors of behavioral intention of covid-19 vaccination under specific scenarios combining effectiveness, safety, and cost in the hong kong chinese general population	yu, yq; lau, jtf; lau, mmc; wong, mcs; chan, pks	international journal of health policy and management	2019	10.34172/ijhpm.2021.02	1
6	adjunct immune globulin for vaccine-induced thrombotic thrombocytopenia	bourguignon, a; arnold, dm; warkentin, te; smith, jw; pannu, t; shrum, jm; al maqrashi, zaa; shroff, a; lessard, mc; blais, n; kelton, jg; nazy, i	new england journal of medicine	2019	10.1056/nejmoa2107051	0
7	predictors of the intention to receive a sars-cov-2 vaccine	meier, bp; dillard, aj; lappas, cm	journal of public health	2019	10.1093/pubmed/fdab013	1
8	repeated cross-sectional sero-monitoring of sars-cov-2 in new york city	stadlbauer, d; tan, j; jiang, kj; hernandez, mm; fabre, s; amanat, f; teo, c; arunkumar, ga; mcmahon, m; capuano, c; twyman, k; jhang, j; nowak, md; simon, v; sordillo, em; van bakel, h; krammer, f	nature	2019	10.1038/s41586-020-2912-6	1
9	the deadly coronaviruses: the 2003 sars pandemic and the 2020 novel coronavirus epidemic in china	yang, ys; peng, fj; wang, rs; guan, k; jiang, tj; xu, gg; sun, jy; chang, roe	journal of autoimmunity	2020	10.1016/j.jaut.2020.102434	12
10	acceptance of covid-19 vaccination during the covid-19 pandemic in china	wang, jh; jing, rz; lai, xz; zhang, hj; lyu, y; knoll, md; fang, h	vaccines	2020	10.3390/vaccines8030482	24
11	intention to participate in a covid-19 vaccine clinical trial and to get vaccinated against covid-19 in france during the pandemic	detoc, m; bruel, s; frappe, p; tardy, b; botelho-nevers, e; gagneux-brunon, a	vaccine	2020	10.1016/j.vaccine.2020.09.041	24
12	the pathogenicity of sars-cov-2 in hace2 transgenic mice	bao, ln; deng, w; huang, by; gao, h; liu, jn; ren, ll; wei, q; yu, p; xu, yf; qi, ff; qu, yj; li, fd; lv, q; wang, wl; xue, j; gong, sr; liu, my; wang, gp; wang, sy; song, zq; zhao, ln; liu, pp; zhao, l; ye, f; wang, hj; zhou, wm; zhu, n; zhen, w; yu, hs; zhang, xj; guo, l; chen, l; wang, ch; wang, y; wang, xm; xiao, y; sun, qm; liu, hq; zhu, fl; ma, cx; yan, lm; yang, ml; han, j; xu, wb; tan, wj; peng, xz; jin, q; wu, gz; qin, c	nature	2020	10.1038/s41586-020-2312-y	29
13	covid-19 in critically ill patients in the seattle region - case series	bhatraju, pk; ghassemieh, bj; nichols, m; kim, r; jerome, kr; nalla, ak; greninger, al; pipavath, s; wurfel, mm; evans, l; kritek, pa; west, te; luks, a; gerbino, a; dale, cr; goldman, jd; o'mahony, s; mikacenic, c	new england journal of medicine	2020	10.1056/nejmoa2004500	9
14	sars-cov-2 vaccines: status report	amanat, f; krammer, f	immunity	2020	10.1016/j.immuni.2020.03.007	47
15	establishment and validation of a pseudovirus neutralization assay for sars-cov-2	nie, jh; li, qq; wu, jj; zhao, cy; hao, h; liu, h; zhang, l; nie, ll; qin, hy; wang, m; lu, q; li, xy; sun, qy; liu, jk; fan, cf; huang, wj; xu, m; wang, yh	emerging microbes & infections	2020	10.1080/22221751.2020.1743767	23
16	a serological assay to detect sars-cov-2 seroconversion in humans	amanat, f; stadlbauer, d; strohmeier, s; nguyen, tho; chromikova, v; mcmahon, m; jiang, kj; arunkumar, ga; jurczyszak, d; polanco, j; bermudez-gonzalez, m; kleiner, g; aydillo, t; miorin, l; fierer, ds; lugo, la; kojic, em; stoever, j; liu, sth; cunningham-rundles, c; felgner, pl; moran, t; garcia-sastre, a; caplivski, d; cheng, alc; kedzierska, k; vapalahti, o; hepojoki, jm; simon, v; krammer, f	nature medicine	2020	10.1038/s41591-020-0913-5	50
17	immunoinformatics-aided identification of t cell and b cell epitopes in the surface glycoprotein of 2019-ncov	baruah, v; bose, s	journal of medical virology	2020	10.1002/jmv.25698	11
18	potential interventions for novel coronavirus in china: a systematic review	zhang, l; liu, yh	journal of medical virology	2020	10.1002/jmv.25707	10
19	covid-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics	dhama, k; sharun, k; tiwari, r; dadar, m; malik, ys; singh, kp; chaicumpa, w	human vaccines & immunotherapeutics	2020	10.1080/21645515.2020.1735227	11
20	microneedle array delivered recombinant coronavirus vaccines: immunogenicity and rapid translational development	kim, e; erdos, g; huang, sh; kenniston, tw; balmert, sc; carey, cd; raj, vs; epperly, mw; klimstra, wb; haagmans, bl; korkmaz, e; falo, ld; gambotto, a	ebiomedicine	2020	10.1016/j.ebiom.2020.102743	10
21	development of an inactivated vaccine candidate for sars-cov-2	gao, q; bao, ll; mao, hy; wang, l; xu, kw; yang, mn; li, yj; zhu, l; wang, n; lv, z; gao, h; ge, xq; kan, b; hu, yl; liu, jn; cai, f; jiang, dy; yin, yh; qin, cf; li, j; gong, xj; lou, xy; shi, w; wu, dd; zhang, hm; zhu, l; deng, w; li, yr; lu, jx; li, cg; wang, xx; yin, wd; zhang, yj; qin, c	science	2020	10.1126/science.abc1932	87
22	neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 inpatients and convalescent patients	wang, xl; guo, xh; xin, qq; pan, y; hu, yl; li, j; chu, yh; feng, ym; wang, qy	clinical infectious diseases	2020	10.1093/cid/ciaa721	11
23	safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored covid-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial	zhu, fc; li, yh; guan, xh; hou, lh; wang, wj; li, jx; wu, sp; wang, bs; wang, z; wang, l; jia, sy; jiang, hdc; wang, l; jiang, t; hu, y; gou, jb; xu, sb; xu, jj; wang, xw; wang, w; chen, w	lancet	2020	10.1016/s0140-6736(20)31208-3	69
24	coronavirus infections in children including covid-19 an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children	zimmermann, p; curtis, n	pediatric infectious disease journal	2020	10.1097/inf.0000000000002660	8
25	vaccines for covid-19: the current state of play	koirala, a; joo, yj; khatami, a; chiu, c; britton, pn	paediatric respiratory reviews	2020	10.1016/j.prrv.2020.06.010	6
26	vaccine confidence in the time of covid-19	harrison, ea; wu, jw	european journal of epidemiology	2020	10.1007/s10654-020-00634-3	15
27	the online competition between pro- and anti-vaccination views	johnson, nf; velasquez, n; restrepo, nj; leahy, r; gabriel, n; el oud, s; zheng, mz; manrique, p; wuchty, s; lupu, y	nature	2020	10.1038/s41586-020-2281-1	11
28	determinants of covid-19 vaccine acceptance in the us	malik, aa; mcfadden, sm; elharake, j; omer, sb	eclinicalmedicine	2020	10.1016/j.eclinm.2020.100495	6
29	acceptability of a covid-19 vaccine among adults in the united states: how many people would get vaccinated?	reiter, pl; pennell, ml; katz, ml	vaccine	2020	10.1016/j.vaccine.2020.08.043	35
30	syrian hamsters as a small animal model for sars-cov-2 infection and countermeasure development	imai, m; iwatsuki-horimoto, k; hatta, m; loeber, s; halfmann, pj; nakajima, n; watanabe, t; ujie, m; takahashi, k; ito, m; yamada, s; fan, sf; chiba, s; kuroda, m; guan, lz; takada, k; armbrust, t; balogh, a; furusawa, y; okuda, m; ueki, h; yasuhara, a; sakai-tagawa, y; lopes, tjs; kiso, m; yamayoshi, s; kinoshita, n; ohmagari, n; hattori, s; takeda, m; mitsuya, h; krammer, f; suzuki, t; kawaoka, y	proceedings of the national academy of sciences of the united states of	2020	10.1073/pnas.2009799117	17
31	expanded umbilical cord mesenchymal stem cells (uc-mscs) as a therapeutic strategy in managing critically ill covid-19 patients: the case for compassionate use	atluri, s; manchikanti, l; hirsch, ja	pain physician	2020		4
32	the covid-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control	helmy, ya; fawzy, m; elaswad, a; sobieh, a; kenney, sp; shehata, aa	journal of clinical medicine	2020	10.3390/jcm9041225	7
33	preliminary identification of potential vaccine targets for the covid-19 coronavirus (sars-cov-2) based on sars-cov immunological studies	ahmed, sf; quadeer, aa; mckay, mr	viruses-basel	2020	10.3390/v12030254	33
34	isolation and rapid sharing of the 2019 novel coronavirus (sar-cov-2) from the first patient diagnosed with covid-19 in australia	caly, l; druce, j; roberts, j; bond, k; tran, t; kostecki, r; yoga, y; naughton, w; taiaroa, g; seemann, t; schultz, mb; howden, bp; korman, tm; lewin, sr; williamson, da; catton, mg	medical journal of australia	2020	10.5694/mja2.50569	12
35	immunogenicity of a dna vaccine candidate for covid-19	smith, trf; patel, a; ramos, s; elwood, d; zhu, xz; yan, j; gary, en; walker, sn; schultheis, k; purwar, m; xu, zy; walters, j; bhojnagarwala, p; yang, m; chokkalingam, n; pezzoli, p; parzych, e; reuschel, el; doan, a; tursi, n; vasquez, m; choi, j; tello-ruiz, e; maricic, i; bah, ma; wu, yh; amante, d; park, dh; dia, y; ali, ar; zaidi, fi; generotti, a; kim, ky; herring, ta; reeder, s; andrade, vm; buttigieg, k; zhao, g; wu, jm; li, d; bao, ll; liu, jn; deng, w; qin, c; brown, as; khoshnejad, m; wang, ns; chu, aqln; wrapp, d; mclellan, js; muthumani, k; wang, b; carroll, mw; kim, jj; boyer, j; kulp, dw; humeau, lmpf; weiner, db; broderick, ke	nature communications	2020	10.1038/s41467-020-16505-0	34
36	an mrna vaccine against sars-cov-2-preliminary report	jackson, la; anderson, ej; rouphael, ng; roberts, pc; makhene, m; coler, rn; mccullough, mp; chappell, jd; denison, mr; stevens, lj; pruijssers, aj; mcdermott, a; flach, b; doria-rose, na; corbett, ks; morabito, km; o'dell, s; schmidt, sd; swanson, pa; padilla, m; mascola, jr; neuzil, km; bennett, h; sun, w; peters, e; makowski, m; albert, j; cross, k; buchanan, w; pikaart-tautges, r; ledgerwood, je; graham, bs; beigel, jh	new england journal of medicine	2020	10.1056/nejmoa2022483	138
37	research and development on therapeutic agents and vaccines for covid-19 and related human coronavirus diseases	liu, c; zhou, qq; li, yz; garner, lv; watkins, sp; carter, lj; smoot, j; gregg, ac; daniels, ad; jervey, s; albaiu, d	acs central science	2020	10.1021/acscentsci.0c00272	12
38	characterization of the receptor-binding domain (rbd) of 2019 novel coronavirus: implication for development of rbd protein as a viral attachment inhibitor and vaccine	tai, wb; he, l; zhang, xj; pu, j; voronin, d; jiang, sb; zhou, ys; du, ly	cellular & molecular immunology	2020	10.1038/s41423-020-0400-4	27
39	potential maternal and infant outcomes from coronavirus 2019-ncov (sars-cov-2) infecting pregnant women: lessons from sars, mers, and other human coronavirus infections	schwartz, da; graham, al	viruses-basel	2020	10.3390/v12020194	5
40	the epidemiology, diagnosis and treatment of covid-19	zhai, p; ding, yb; wu, x; long, jk; zhong, yj; li, ym	international journal of antimicrobial agents	2020	10.1016/j.ijantimicag.2020.105955	5
41	covid-19 vaccine: a comprehensive status report	kaur, sp; gupta, v	virus research	2020	10.1016/j.virusres.2020.198114	12
42	vaccine hesitancy: the next challenge in the fight against covid-19	dror, aa; eisenbach, n; taiber, s; morozov, ng; mizrachi, m; zigron, a; srouji, s; sela, e	european journal of epidemiology	2020	10.1007/s10654-020-00671-y	40
43	'vaccine hesitancy' among university students in italy during the covid-19 pandemic	barello, s; nania, t; dellafiore, f; graffigna, g; caruso, r	european journal of epidemiology	2020	10.1007/s10654-020-00670-z	14
44	acceptance of a covid-19 vaccine in southeast asia: a cross-sectional study in indonesia	harapan, h; wagner, al; yufika, a; winardi, w; anwar, s; gan, ak; setiawan, am; rajamoorthy, y; sofyan, h; mudatsir, m	frontiers in public health	2020	10.3389/fpubh.2020.00381	22
45	sars-cov-2 causing pneumonia-associated respiratory disorder (covid-19): diagnostic and proposed therapeutic options	chakraborty, c; sharma, ar; sharma, g; bhattacharya, m; lee, ss	european review for medical and pharmacological sciences	2020		4
46	current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (covid-19)	ahn, dg; shin, hj; kim, mh; lee, s; kim, hs; myoung, j; kim, bt; kim, sj	journal of microbiology and biotechnology	2020	10.4014/jmb.2003.03011	8
47	covid-19: therapeutics and their toxicities	chary, ma; barbuto, af; izadmehr, s; hayes, bd; burns, mm	journal of medical toxicology	2020	10.1007/s13181-020-00777-5	2
48	characterization of spike glycoprotein of sars-cov-2 on virus entry and its immune cross-reactivity with sars-cov	ou, xy; liu, y; lei, xb; li, p; mi, d; ren, ll; guo, l; guo, rx; chen, t; hu, jx; xiang, zc; mu, zx; chen, x; chen, jy; hu, kp; jin, q; wang, jw; qian, zh	nature communications	2020	10.1038/s41467-020-15562-9	57
49	sars-cov-2 and coronavirus disease 2019: what we know so far	rabi, fa; al zoubi, ms; kasasbeh, ga; salameh, dm; al-nasser, ad	pathogens	2020	10.3390/pathogens9030231	10
50	a human monoclonal antibody blocking sars-cov-2 infection	wang, cy; li, wt; drabek, d; okba, nma; van, r; osterhaus, adme; van kuppeveld, fjm; haagmans, bl; grosveld, f; bosch, bj	nature communications	2020	10.1038/s41467-020-16256-y	21
51	sars-cov-2 infection protects against rechallenge in rhesus macaques	chandrashekar, a; liu, jy; martinot, aj; mcmahan, k; mercado, nb; peter, l; tostanoski, lh; yu, jy; maliga, z; nekorchuk, m; busman-sahay, k; terry, m; wrijil, lm; ducat, s; martinez, dr; atyeo, c; fischinger, s; burke, js; slein, md; pessaint, l; van ry, a; greenhouse, j; taylor, t; blade, k; cook, a; finneyfrock, b; brown, r; teow, e; velasco, j; zahn, r; wegmann, f; abbink, p; bondzie, ea; dagotto, g; gebre, ms; he, x; jacob-dolan, c; kordana, n; li, zf; lifton, ma; mahrokhian, sh; maxfield, lf; nityanandam, r; nkolola, jp; schmidt, ag; miller, ad; baric, rs; alter, g; sorger, pk; estes, jd; andersen, h; lewis, mg; barouch, dh	science	2020	10.1126/science.abc4776	57
52	dna vaccine protection against sars-cov-2 in rhesus macaques	yu, jy; tostanoski, lh; peter, l; mercado, nb; mcmahan, k; mahrokhian, sh; nkolola, jp; liu, jy; li, zf; chandrashekar, a; martinez, dr; loos, c; atyeo, c; fischinger, s; burke, js; slein, md; chen, yz; zuiani, a; lelis, fjn; travers, m; habibi, s; pessaint, l; van ry, a; blade, k; brown, r; cook, a; finneyfrock, b; dodson, a; teow, e; velasco, j; zahn, r; wegmann, f; bondzie, ea; dagotto, g; gebre, ms; he, x; jacob-dolan, c; kirilova, m; kordana, n; lin, zj; maxfield, lf; nampanya, f; nityanandam, r; ventura, jd; wan, hh; cai, yf; chen, b; schmidt, ag; wesemann, dr; baric, rs; alter, g; andersen, h; lewis, mg; barouch, dh	science	2020	10.1126/science.abc6284	77
53	human neutralizing antibodies elicited by sars-cov-2 infection	ju, b; zhang, q; ge, jw; wang, rk; sun, j; ge, xy; yu, jz; shan, ss; zhou, b; song, s; tang, x; yu, jf; lan, j; yuan, j; wang, hy; zhao, jn; zhang, sy; wang, yc; shi, xl; liu, l; zhao, jc; wang, xq; zhang, z; zhang, lq	nature	2020	10.1038/s41586-020-2380-z	62
54	structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies	wrapp, d; de vlieger, d; corbett, ks; torres, gm; wang, ns; van breedam, w; roose, k; van schie, l; hoffmann, m; pohlmann, s; graham, bs; callewaert, n; schepens, b; saelens, x; mclellan, js	cell	2020	10.1016/j.cell.2020.04.031	15
55	a noncompeting pair of human neutralizing antibodies block covid-19 virus binding to its receptor ace2	wu, y; wang, fr; shen, cg; peng, wy; li, dl; zhao, c; li, zh; li, sh; bi, yh; yang, y; gong, yh; xiao, hx; fan, z; tan, sg; wu, gz; tan, wj; lu, xc; fan, cf; wang, qh; liu, yx; zhang, c; qi, jx; gao, gf; gao, f; liu, l	science	2020	10.1126/science.abc2241	47
56	a neutralizing human antibody binds to the n-terminal domain of the spike protein of sars-cov-2	chi, xy; yan, rh; zhang, j; zhang, gy; zhang, yy; hao, m; zhang, z; fan, pf; dong, yz; yang, yl; chen, zs; guo, yy; zhang, jl; li, yn; song, xh; chen, y; xia, l; fu, l; hou, lh; xu, jj; yu, cm; li, jm; zhou, q; chen, w	science	2020	10.1126/science.abc6952	55
57	an infectious cdna clone of sars-cov-2	xie, xp; muruato, a; lokugamage, kg; narayanan, k; zhang, xw; zou, j; liu, jy; schindewolf, c; bopp, ne; aguilar, pv; plante, ks; weaver, sc; makino, s; leduc, jw; menachery, vd; shi, py	cell host & microbe	2020	10.1016/j.chom.2020.04.004	32
58	targets of t cell responses to sars-cov-2 coronavirus in humans with covid-19 disease and unexposed individuals	grifoni, a; weiskopf, d; ramirez, si; mateus, j; dan, jm; moderbacher, cr; rawlings, sa; sutherland, a; premkumar, l; jadi, rs; marrama, d; de silva, am; frazier, a; carlin, af; greenbaum, ja; peters, b; krammer, f; smith, dm; crotty, s; sette, a	cell	2020	10.1016/j.cell.2020.05.015	100
59	immunogenicity and safety of a recombinant adenovirus type-5-vectored covid-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial	zhu, fc; guan, xh; li, yh; huang, jy; jiang, t; hou, lh; li, jx; yang, bf; wang, l; wang, wj; wu, sp; wang, z; wu, xh; xu, jj; zhang, z; jia, sy; wang, bs; hu, y; liu, jj; zhang, j; qian, xa; li, q; pan, hx; jiang, hdc; deng, p; gou, jb; wang, xw; wang, xh; chen, w	lancet	2020	10.1016/s0140-6736(20)31605-6	63
60	repurposing drugs, ongoing vaccine, and new therapeutic development initiatives against covid-19	saha, rp; sharma, ar; singh, mk; samanta, s; bhakta, s; mandal, s; bhattacharya, m; lee, ss; chakraborty, c	frontiers in pharmacology	2020	10.3389/fphar.2020.01258	1
61	determinants of covid-19 vaccine acceptance in saudi arabia: a web-based national survey	al-mohaithef, m; padhi, bk	journal of multidisciplinary healthcare	2020	10.2147/jmdh.s276771	19
62	perspectives on monoclonal antibody therapy as potential therapeutic intervention for coronavirus disease-19 (covid-19)	shanmugaraj, b; siriwattananon, k; wangkanont, k; phoolcharoen, w	asian pacific journal of allergy and immunology	2020	10.12932/ap-200220-0773	8
63	antibody responses to sars-cov-2 in patients with novel coronavirus disease 2019	zhao, jj; yuan, q; wang, hy; liu, w; liao, xj; su, yy; wang, x; yuan, j; li, td; li, jx; qian, s; hong, cm; wang, fx; liu, yx; wang, zq; he, q; li, zy; he, b; zhang, ty; fu, y; ge, sx; liu, l; zhang, j; xia, ns; zhang, z	clinical infectious diseases	2020	10.1093/cid/ciaa344	43
64	potent neutralizing antibodies from covid-19 patients define multiple targets of vulnerability	brouwer, pjm; caniels, tg; van der straten, k; snitselaar, jl; aldon, y; bangaru, s; torres, jl; okba, nma; claireaux, m; kerster, g; bentlage, aeh; van haaren, mm; guerra, d; burger, ja; schermer, ee; verheul, kd; van der velde, n; van der kooi, a; van schooten, j; van breemen, mj; bijl, tpl; sliepen, k; aartse, a; derking, r; bontjer, i; kootstra, na; wiersinga, wj; vidarsson, g; haagmans, bl; ward, ab; de bree, gj; sanders, rw; van gils, mj	science	2020	10.1126/science.abc5902	49
65	sars-cov-2 viral spike g614 mutation exhibits higher case fatality rate	becerra-flores, m; cardozo, t	international journal of clinical practice	2020	10.1111/ijcp.13525	9
66	coast-to-coast spread of sars-cov-2 during the early epidemic in the united states	fauver, jr; petrone, me; hodcroft, eb; shioda, k; ehrlich, hy; watts, ag; vogels, cbf; brito, af; alpert, t; muyombwe, a; razeq, j; downing, r; cheemarla, nr; wyllie, al; kalinich, cc; ott, im; quick, j; loman, nj; neugebauer, km; greninger, al; jerome, kr; roychoudhury, p; xie, h; shrestha, l; huang, ml; pitzer, ve; iwasaki, a; omer, sb; khan, k; bogoch, ii; martinello, ra; foxman, ef; landry, ml; neher, ra; ko, ai; grubaugh, nd	cell	2020	10.1016/j.cell.2020.04.021	2
67	tracking changes in sars-cov-2 spike: evidence that d614g increases infectivity of the covid-19 virus	korber, b; fischer, wm; gnanakaran, s; yoon, h; theiler, j; abfalterer, w; hengartner, n; giorgi, ee; bhattacharya, t; foley, b; hastie, km; parker, md; partridge, dg; evans, cm; freeman, tm; de silva, ti; mcdanal, c; perez, lg; tang, hl; moon-walker, a; whelan, sp; labranche, cc; saphire, eo; montefiori, dc	cell	2020	10.1016/j.cell.2020.06.043	84
68	site-specific glycan analysis of the sars-cov-2 spike	watanabe, y; allen, jd; wrapp, d; mclellan, js; crispin, m	science	2020	10.1126/science.abb9983	35
69	cross-neutralization ofsars-cov-2 by a human monoclonal sars-cov antibody	pinto, d; park, yj; beltramello, m; walls, ac; tortorici, ma; bianchi, s; jaconi, s; culap, k; zatta, f; de marco, a; peter, a; guarino, b; spreafico, r; cameroni, e; case, jb; chen, rte; havenar-daughton, c; snell, g; telenti, a; virgin, hw; lanzavecchia, a; diamond, ms; fink, k; veesler, d; corti, d	nature	2020	10.1038/s41586-020-2349-y	58
70	isolation of potent sars-cov-2 neutralizing antibodies and protection from disease in a small animal model	rogers, tf; zhao, fz; huang, dl; beutler, n; burns, a; he, wt; limbo, o; smith, c; song, g; woehl, j; yang, ll; abbott, rk; callaghan, s; garcia, e; hurtado, j; parren, m; peng, lh; ramirez, s; ricketts, j; ricciardi, mj; rawlings, sa; wu, nc; yuan, m; smith, dm; nemazee, d; teijaro, jr; voss, je; wilson, ia; andrabi, r; briney, b; landais, e; sok, d; jardine, jg; burton, dr	science	2020	10.1126/science.abc7520	31
71	rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the sars-cov-2 spike protein	zost, sj; gilchuk, p; chen, re; case, jb; reidy, jx; trivette, a; nargi, rs; sutton, re; suryadevara, n; chen, ec; binshtein, e; shrihari, s; ostrowski, m; chu, hy; didier, je; macrenaris, kw; jones, t; day, s; myers, l; lee, feh; nguyen, dc; sanz, i; martinez, dr; rothlauf, pw; bloyet, lm; whelan, spj; baric, rs; thackray, lb; diamond, ms; carnahan, rh; crowe, je	nature medicine	2020	10.1038/s41591-020-0998-x	23
72	structures of human antibodies bound to sars-cov-2 spike reveal common epitopes and recurrent features of antibodies	barnes, co; west, ap; huey-tubman, ke; hoffmann, mag; sharaf, ng; hoffman, pr; koranda, n; gristick, hb; gaebler, c; muecksch, f; lorenzi, jcc; finkin, s; hagglof, t; hurley, a; millard, kg; weisblum, y; schmidt, f; hatziioannou, t; bieniasz, pd; caskey, m; robbiani, df; nussenzweig, mc; bjorkman, pj	cell	2020	10.1016/j.cell.2020.06.025	31
73	convergent antibody responses to sars-cov-2 in convalescent individuals	robbiani, df; gaebler, c; muecksch, f; lorenzi, jcc; wang, zj; cho, a; agudelo, m; barnes, co; gazumyan, a; finkin, s; hagglof, t; oliveira, ty; viant, c; hurley, a; hoffmann, hh; millard, kg; kost, rg; cipolla, m; gordon, k; bianchini, f; chen, st; ramos, v; patel, r; dizon, j; shimeliovich, i; mendoza, p; hartweger, h; nogueira, l; pack, m; horowitz, j; schmidt, f; weisblum, y; michailidis, e; ashbrook, aw; waltari, e; pak, je; huey-tubman, ke; koranda, n; hoffman, pr; west, ap; rice, cm; hatziioannou, t; bjorkman, pj; bieniasz, pd; caskey, m; nussenzweig, mc	nature	2020	10.1038/s41586-020-2456-9	29
74	detection of sars-cov-2-specific humoral and cellular immunity in covid-19 convalescent individuals	ni, l; ye, f; cheng, ml; feng, y; deng, yq; zhao, h; wei, p; ge, jw; gou, mt; li, xl; sun, l; cao, ts; wang, pz; zhou, c; zhang, rr; liang, p; guo, h; wang, xq; qin, cf; chen, f; dong, c	immunity	2020	10.1016/j.immuni.2020.04.023	26
75	sars-cov-2-reactive t cells in healthy donors and patients with covid-19	braun, j; loyal, l; frentsch, m; wendisch, d; georg, p; kurth, f; hippenstiel, s; dingeldey, m; kruse, b; fauchere, f; baysal, e; mangold, m; henze, l; lauster, r; mall, ma; beyer, k; rohmel, j; voigt, s; schmitz, j; miltenyi, s; demuth, i; muller, ma; hocke, a; witzenrath, m; suttorp, n; kern, f; reimer, u; wenschuh, h; drosten, c; corman, vm; giesecke-thiel, c; sander, le; thiel, a	nature	2020	10.1038/s41586-020-2598-9	25
76	broad and strong memory cd4(+)and cd8(+)t cells induced by sars-cov-2 in uk convalescent individuals following covid-19	peng, yc; mentzer, aj; liu, gh; yao, x; yin, zx; dong, dn; dejnirattisai, w; rostron, t; supasa, p; liu, c; lopez-camacho, c; slon-campos, j; zhao, yg; stuart, di; paesen, gc; grimes, jm; antson, aa; bayfield, ow; hawkins, dedp; ker, ds; wang, bb; turtle, l; subramaniam, k; thomson, p; zhang, p; dold, c; ratcliff, j; simmonds, p; de silva, t; sopp, p; wellington, d; rajapaksa, u; chen, yl; salio, m; napolitani, g; paes, w; borrow, p; kessler, bm; fry, jw; schwabe, nf; semple, mg; baillie, jk; moore, sc; openshaw, pjm; ansari, ma; dunachie, s; barnes, e; frater, j; kerr, g; goulder, p; lockett, t; levin, r; zhang, yh; jing, rh; ho, lp; cornall, rj; conlon, cp; klenerman, p; screaton, gr; mongkolsapaya, j; mcmichael, a; knight, jc; ogg, g; dong, t	nature immunology	2020	10.1038/s41590-020-0782-6	31
77	phenotype and kinetics of sars-cov-2-specific t cells in covid-19 patients with acute respiratory distress syndrome	weiskopf, d; schmitz, ks; raadsen, mp; grifoni, a; okba, nma; endeman, h; van den akker, jpc; molenkamp, r; koopmans, mpg; van gorp, ecm; haagmans, bl; de swart, rl; sette, a; de vries, rd	science immunology	2020	10.1126/sciimmunol.abd2071	21
78	safety and immunogenicity of the chadox1 ncov-19 vaccine against sars-cov-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial	folegatti, pm; ewer, kj; aley, pk; angus, b; becker, s; belij-rammerstorfer, s; bellamy, d; bibi, s; bittaye, m; clutterbuck, ea; dold, c; faust, sn; finn, a; flaxman, al; hallis, b; heath, p; jenkin, d; lazarus, r; makinson, r; minassian, am; pollock, km; ramasamy, m; robinson, h; snape, m; tarrant, r; voysey, m; green, c; douglas, ad; hill, avs; lambe, t; gilbert, sc; pollard, aj	lancet	2020	10.1016/s0140-6736(20)31604-4	107
79	public preference for covid-19 vaccines in china: a discrete choice experiment	dong, d; xu, rh; wong, ely; hung, ct; feng, d; feng, zc; yeoh, ek; wong, sys	health expectations	2020	10.1111/hex.13140	6
80	immune cell profiling of covid-19 patients in the recovery stage by single-cell sequencing	wen, w; su, wr; tang, h; le, wq; zhang, xp; zheng, yf; liu, xx; xie, lh; li, jm; ye, jg; dong, lw; cui, xl; miao, ys; wang, dp; dong, jt; xiao, cl; chen, w; wang, hy	cell discovery	2020	10.1038/s41421-020-0168-9	5
81	deep immune profiling of covid-19 patients reveals distinct immunotypes with therapeutic implications	mathew, d; giles, jr; baxter, ae; oldridge, da; greenplate, ar; wu, je; alanio, c; kuri-cervantes, l; pampena, mb; d'andrea, k; manne, s; chen, zy; huang, yj; reilly, jp; weisman, ar; ittner, cag; kuthuru, o; dougherty, j; nzingha, k; han, n; kim, j; pattekar, a; goodwin, ec; anderson, em; weirick, me; gouma, s; arevalo, cp; bolton, mj; chen, f; lacey, sf; ramage, h; cherry, s; hensley, se; apostolidis, sa; huang, ac; vella, la; betts, mr; meyer, nj; wherry, ej	science	2020	10.1126/science.abc8511	21
82	selective and cross-reactive sars-cov-2 t cell epitopes in unexposed humans	mateus, j; grifoni, a; tarke, a; sidney, j; ramirez, si; dan, jm; burger, zc; rawlings, sa; smith, dm; phillips, e; mallal, s; lammers, m; rubiro, p; quiambao, l; sutherland, a; yu, edw; antunes, rd; greenbaum, j; frazier, a; markmann, aj; premkumar, l; de silva, a; peters, b; crotty, s; sette, a; weiskopf, d	science	2020	10.1126/science.abd3871	17
83	single-shot ad26 vaccine protects against sars-cov-2 in rhesus macaques	mercado, nb; zahn, r; wegmann, f; loos, c; chandrashekar, a; yu, jy; liu, jy; peter, l; mcmahan, k; tostanoski, lh; he, x; martinez, dr; rutten, l; bos, r; van manen, d; vellinga, j; custers, j; langedijk, jp; kwaks, t; bakkers, mjg; zuijdgeest, d; huber, skr; atyeo, c; fischinger, s; burke, js; feldman, j; hauser, bm; caradonna, tm; bondzie, ea; dagotto, g; gebre, ms; hoffman, e; jacob-dolan, c; kirilova, m; li, zf; lin, zj; mahrokhian, sh; maxfield, lf; nampanya, f; nityanandam, r; nkolola, jp; patel, s; ventura, jd; verrington, k; wan, hh; pessaint, l; van ry, a; blade, k; strasbaugh, a; cabus, m; brown, r; cook, a; zouantchangadou, s; teow, e; andersen, h; lewis, mg; cai, yf; chen, b; schmidt, ag; reeves, rk; baric, rs; lauffenburger, da; alter, g; stoffels, p; mammen, m; van hoof, j; schuitemaker, h; barouch, dh	nature	2020	10.1038/s41586-020-2607-z	60
84	a high-throughput neutralizing antibody assay for covid-19 diagnosis and vaccine evaluation	muruato, ae; fontes-garfias, cr; ren, p; garcia-blanco, ma; menachery, vd; xie, xp; shi, py	nature communications	2020	10.1038/s41467-020-17892-0	8
85	phase i/ii study of covid-19 rna vaccine bnt162b1 in adults	mulligan, mj; lyke, ke; kitchin, n; absalon, j; gurtman, a; lockhart, s; neuzil, k; raabe, v; bailey, r; swanson, ka; li, p; koury, k; kalina, w; cooper, d; fontes-garfias, c; shi, py; tureci, o; tompkins, kr; walsh, ee; frenck, r; falsey, ar; dormitzer, pr; gruber, wc; sahin, u; jansen, ku	nature	2020	10.1038/s41586-020-2639-4	66
86	pathogenesis of sars-cov-2 in transgenic mice expressing human angiotensin-converting enzyme 2	jiang, rd; liu, mq; chen, y; shan, c; zhou, yw; shen, xr; li, q; zhang, l; zhu, y; si, hr; wang, q; min, j; wang, x; zhang, w; li, b; zhang, hj; baric, rs; zhou, p; yang, xl; shi, zl	cell	2020	10.1016/j.cell.2020.05.027	11
87	infection and rapid transmission of sars-cov-2 in ferrets	kim, yi; kim, sg; kim, sm; kim, eh; park, sj; yu, km; chang, jh; kim, ej; lee, s; casel, mab; um, j; song, ms; jeong, hw; lai, vd; kim, y; chin, bs; park, js; chung, kh; foo, ss; poo, h; mo, ip; lee, oj; webby, rj; jung, ju; choi, yk	cell host & microbe	2020	10.1016/j.chom.2020.03.023	24
88	pathogenesis and transmission of sars-cov-2 in golden hamsters	sia, sf; yan, lm; chin, awh; fung, k; choy, kt; wong, ayl; kaewpreedee, p; perera, rapm; poon, llm; nicholls, jm; peiris, m; yen, hl	nature	2020	10.1038/s41586-020-2342-5	24
89	generation of a broadly useful model for covid-19 pathogenesis, vaccination, and treatment	sun, j; zhuang, z; zheng, j; li, k; wong, rly; liu, dl; huang, jc; he, jp; zhu, ar; zhao, jx; li, xb; xi, y; chen, rc; alshukairi, an; chen, z; zhang, zy; chen, ck; huang, xf; li, f; lai, xm; chen, db; wen, ly; zhuo, jf; zhang, yj; wang, yq; huang, sx; dai, j; shi, yx; zheng, k; leidinger, mr; chen, jk; li, ym; zhong, ns; meyerholz, dk; mccray, pb; perlman, s; zhao, jc	cell	2020	10.1016/j.cell.2020.06.010	13
90	a mouse model of sars-cov-2 infection and pathogenesis	sun, sh; chen, q; gu, hj; yang, g; wang, yx; huang, xy; liu, ss; zhang, nn; li, xf; xiong, r; guo, y; deng, yq; huang, wj; liu, q; liu, qm; shen, yl; zhou, y; yang, x; zhao, ty; fan, cf; zhou, ys; qin, cf; wang, yc	cell host & microbe	2020	10.1016/j.chom.2020.05.020	13
91	lessons for covid-19 immunity from other coronavirus infections	sariol, a; perlman, s	immunity	2020	10.1016/j.immuni.2020.07.005	7
92	chadox1 ncov-19 vaccine prevents sars-cov-2 pneumonia in rhesus macaques	van doremalen, n; lambe, t; spencer, a; belij-rammerstorfer, s; purushotham, jn; port, jr; avanzato, va; bushmaker, t; flaxman, a; ulaszewska, m; feldmann, f; allen, er; sharpe, h; schulz, j; holbrook, m; okumura, a; meade-white, k; perez-perez, l; edwards, nj; wright, d; bissett, c; gilbride, c; williamson, bn; rosenke, r; long, d; ishwarbhai, a; kailath, r; rose, l; morris, s; powers, c; lovaglio, j; hanley, pw; scott, d; saturday, g; de wit, e; gilbert, sc; munster, vj	nature	2020	10.1038/s41586-020-2608-y	29
93	development of an inactivated vaccine candidate, bbibp-corv, with potent protection against sars-cov-2	wang, h; zhang, yt; huang, by; deng, w; quan, yr; wang, wl; xu, wb; zhao, yx; li, n; zhang, j; liang, hy; bao, ll; xu, yf; ding, l; zhou, wm; gao, h; liu, jn; niu, ph; zhao, l; zhen, w; fu, h; yu, sz; zhang, zl; xu, gx; li, cg; lou, zy; xu, m; qin, c; wu, gz; gao, gf; tan, wj; yang, xm	cell	2020	10.1016/j.cell.2020.06.008	42
94	acute sars-cov-2 infection impairs dendritic cell and t cell responses	zhou, rh; to, kkw; wong, yc; liu, l; zhou, b; li, x; huang, hd; mo, yf; luk, ty; lau, ttk; yeung, p; chan, wm; wu, akl; lung, kc; tsang, oty; leung, ws; hung, ifn; yuen, ky; chen, zw	immunity	2020	10.1016/j.immuni.2020.07.026	9
95	immunological considerations for covid-19 vaccine strategies	jeyanathan, m; afkhami, s; smaill, f; miller, ms; lichty, bd; xing, z	nature reviews immunology	2020	10.1038/s41577-020-00434-6	21
96	impact of immune enhancement on covid-19 polyclonal hyperimmune globulin therapy and vaccine development	de alwis, r; chen, sw; gan, es; ooi, ee	ebiomedicine	2020	10.1016/j.ebiom.2020.102768	4
97	covid-19 outbreak: migration, effects on society, global environment and prevention	chakraborty, i; maity, p	science of the total environment	2020	10.1016/j.scitotenv.2020.138882	3
98	mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against covid-19 in italy	palamenghi, l; barello, s; boccia, s; graffigna, g	european journal of epidemiology	2020	10.1007/s10654-020-00675-8	21
99	the covid-19 vaccine race: challenges and opportunities in vaccine formulation	wang, jl; peng, y; xu, hy; cui, zr; williams, ro	aaps pharmscitech	2020	10.1208/s12249-020-01744-7	7
100	sars-cov-2 receptor ace2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues	ziegler, cgk; allon, sj; nyquist, sk; mbano, im; miao, vn; tzouanas, cn; cao, ym; yousif, as; bals, j; hauser, bm; feldman, j; muus, c; wadsworth, mh; kazer, sw; hughes, tk; doran, b; gatter, gj; vukovic, m; taliaferro, f; mead, be; guo, zr; wang, jp; gras, d; plaisant, m; ansari, m; angelidis, i; adler, h; sucre, jms; taylor, cj; lin, b; waghray, a; mitsialis, v; dwyer, df; buchheit, km; boyce, ja; barrett, na; laidlaw, tm; carroll, sl; colonna, l; tkachev, v; peterson, cw; yu, a; zheng, hb; gideon, hp; winchell, cg; lin, pl; bingle, cd; snapper, sb; kropski, ja; theis, fj; schiller, hb; zaragosi, le; barbry, p; leslie, a; kiem, hp; flynn, jl; fortune, sm; berger, b; finberg, rw; kean, ls; garber, m; schmidt, ag; lingwood, d; shalek, ak; ordovas-montanes, j	cell	2020	10.1016/j.cell.2020.04.035	14
101	systems biological assessment of immunity to mild versus severe covid-19 infection in humans	arunachalam, ps; wimmers, f; mok, ckp; perera, rapm; scott, m; hagan, t; sigal, n; feng, yp; bristow, l; tsang, oty; wagh, d; coller, j; pellegrini, kl; kazmin, d; alaaeddine, g; leung, ws; chan, jmc; chik, tsh; choi, cyc; huerta, c; mccullough, mp; lv, hb; anderson, e; edupuganti, s; upadhyay, aa; bosinger, se; maecker, ht; khatri, p; rouphael, n; peiris, m; pulendran, b	science	2020	10.1126/science.abc6261	8
102	a perspective on potential antibody-dependent enhancement of sars-cov-2	arvin, am; fink, k; schmid, ma; cathcart, a; spreafico, r; havenar-daughton, c; lanzavecchia, a; corti, d; virgin, hw	nature	2020	10.1038/s41586-020-2538-8	16
103	virology, epidemiology, pathogenesis, and control of covid-19	jin, yf; yang, hy; ji, wq; wu, wd; chen, sy; zhang, wg; duan, gc	viruses-basel	2020	10.3390/v12040372	9
104	pulmonary pathology and covid-19: lessons from autopsy. the experience of european pulmonary pathologists	calabrese, f; pezzuto, f; fortarezza, f; hofman, p; kern, i; panizo, a; von der thusen, j; timofeev, s; gorkiewicz, g; lunardi, f	virchows archiv	2020	10.1007/s00428-020-02886-6	2
105	evaluation of the mrna-1273 vaccine against sars-cov-2 in nonhuman primates	corbett, ks; flynn, b; foulds, ke; francica, jr; boyoglu-barnum, s; werner, ap; flach, b; o'connell, s; bock, kw; minai, m; nagata, bm; andersen, h; martinez, dr; noe, at; douek, n; donaldson, mm; nji, nn; alvarado, gs; edwards, dk; flebbe, dr; lamb, e; doria-rose, na; lin, bc; louder, mk; o'dell, s; schmidt, sd; phung, e; chang, la; yap, c; todd, jpm; pessaint, l; van ry, a; browne, s; greenhouse, j; putman-taylor, t; strasbaugh, a; campbell, ta; cook, a; dodson, a; steingrebe, k; shi, w; zhang, y; abiona, om; wang, ls; pegu, a; yang, es; leung, k; zhou, t; teng, it; widge, a; gordon, i; novik, l; gillespie, ra; loomis, rj; moliva, ji; stewart-jones, g; himansu, s; kong, wp; nason, mc; morabito, km; ruckwardt, tj; ledgerwood, je; gaudinski, mr; kwong, pd; mascola, jr; carfi, a; lewis, mg; baric, rs; mcdermott, a; moore, in; sullivan, nj; roederer, m; seder, ra; graham, bs	new england journal of medicine	2020	10.1056/nejmoa2024671	51
106	prospects for a safe covid-19 vaccine	haynes, bf; corey, l; fernandes, p; gilbert, pb; hotez, pj; rao, s; santos, mr; schuitemaker, h; watson, m; arvin, a	science translational medicine	2020	10.1126/scitranslmed.abe0948	8
107	the use of the health belief model to assess predictors of intent to receive the covid-19 vaccine and willingness to pay	wong, lp; alias, h; wong, pf; lee, hy; abubakar, s	human vaccines & immunotherapeutics	2020	10.1080/21645515.2020.1790279	23
108	understanding covid-19 vaccine demand and hesitancy: a nationwide online survey in china	lin, yl; hu, zj; zhao, qj; alias, h; danaee, m; wong, lp	plos neglected tropical diseases	2020	10.1371/journal.pntd.0008961	7
109	towards intervention development to increase the uptake of covid-19 vaccination among those at high risk: outlining evidence-based and theoretically informed future intervention content	williams, l; gallant, aj; rasmussen, s; nicholls, lab; cogan, n; deakin, k; young, d; flowers, p	british journal of health psychology	2020	10.1111/bjhp.12468	9
110	influences on attitudes regarding potential covid-19 vaccination in the united states	pogue, k; jensen, jl; stancil, ck; ferguson, dg; hughes, sj; mello, ej; burgess, r; berges, bk; quaye, a; poole, bd	vaccines	2020	10.3390/vaccines8040582	16
111	a universal design of betacoronavirus vaccines against covid-19, mers, and sars	dai, lp; zheng, ty; xu, k; han, yx; xu, ll; huang, eq; an, yl; cheng, yj; li, sh; liu, m; yang, m; li, y; cheng, hj; yuan, y; zhang, w; ke, cw; wong, g; qi, jx; qin, c; yan, jh; gao, gf	cell	2020	10.1016/j.cell.2020.06.035	16
112	phase 1-2 trial of a sars-cov-2 recombinant spike protein nanoparticle vaccine	keech, c; albert, g; cho, i; robertson, a; reed, p; neal, s; plested, js; zhu, mz; cloney-clark, s; zhou, hx; smith, g; patel, n; frieman, mb; haupt, re; logue, j; mcgrath, m; weston, s; piedra, pa; desai, c; callahan, k; lewis, m; price-abbott, p; formica, n; shinde, v; fries, l; lickliter, jd; griffin, p; wilkinson, b; glenn, gm	new england journal of medicine	2020	10.1056/nejmoa2026920	66
113	safety and immunogenicity of an rad26 and rad5 vector-based heterologous prime-boost covid-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from russia	logunov, dy; dolzhikova, iv; zubkova, ov; tukhvatullin, ai; shcheblyakov, dv; dzharullaeva, as; grousova, dm; erokhova, as; kovyrshina, av; botikov, ag; izhaeva, fm; popova, o; ozharovskaya, ta; esmagambetov, ib; favorskaya, ia; zrelkin, di; voronina, dv; shcherbinin, dn; semikhin, as; simakova, yv; tokarskaya, ea; lubenets, nl; egorova, da; shmarov, mm; nikitenko, na; morozova, lf; smolyarchuk, ea; kryukov, ev; babira, vf; borisevich, sv; naroditsky, bs; gintsburg, al	lancet	2020	10.1016/s0140-6736(20)31866-3	45
114	covid-19 vaccine bnt162b1 elicits human antibody and t(h)1 t cell responses	sahin, u; muik, a; derhovanessian, e; vogler, i; kranz, lm; vormehr, m; baum, a; pascal, k; quandt, j; maurus, d; brachtendorf, s; lorks, v; sikorski, j; hilker, r; becker, d; eller, ak; grutzner, j; boesler, c; rosenbaum, c; kuhnle, mc; luxemburger, u; kemmer-bruck, a; langer, d; bexon, m; bolte, s; kariko, k; palanche, t; fischer, b; schultz, a; shi, py; fontes-garfias, c; perez, jl; swanson, ka; loschko, j; scully, il; cutler, m; kalina, w; kyratsous, ca; cooper, d; dormitzer, pr; jansen, ku; tureci, o	nature	2020	10.1038/s41586-020-2814-7	59
115	safety and immunogenicity of two rna-based covid-19 vaccine candidates	walsh, ee; frenck, rw; falsey, ar; kitchin, n; absalon, j; gurtman, a; lockhart, s; neuzil, k; mulligan, mj; bailey, r; swanson, ka; li, p; koury, k; kalina, w; cooper, d; fontes-garfias, c; shi, py; tureci, o; tompkins, kr; lyke, ke; raabe, v; dormitzer, pr; jansen, ku; sahin, u; gruber, wc	new england journal of medicine	2020	10.1056/nejmoa2027906	116
116	effect of an inactivated vaccine against sars-cov-2 on safety and immunogenicity outcomes interim analysis of 2 randomized clinical trials	xia, sl; duan, k; zhang, yt; zhao, dy; zhang, hj; xie, zq; li, xg; peng, c; zhang, yb; zhang, w; yang, yk; chen, w; gao, xx; you, wy; wang, xw; wang, zj; shi, zl; wang, yx; yang, xq; zhang, lh; huang, ll; wang, q; lu, j; yang, yl; guo, j; zhou, w; wan, x; wu, c; wang, wh; huang, sh; du, jh; meng, zy; pan, a; yuan, zm; shen, s; guo, ws; yang, xm	jama-journal of the american medical association	2020	10.1001/jama.2020.15543	41
117	coronavirus vaccine development: from sars and mers to covid-19	li, yd; chi, wy; su, jh; ferrall, l; hung, cf; wu, tc	journal of biomedical science	2020	10.1186/s12929-020-00695-2	2
118	a snapshot of the global race for vaccines targeting sars-cov-2 and the covid-19 pandemic	funk, cd; laferriere, c; ardakani, a	frontiers in pharmacology	2020	10.3389/fphar.2020.00937	5
119	humoral and circulating follicular helper t cell responses in recovered patients with covid-19	juno, ja; tan, hx; lee, ws; reynaldi, a; kelly, hg; wragg, k; esterbauer, r; kent, he; batten, cj; mordant, fl; gherardin, na; pymm, p; dietrich, mh; scott, ne; tham, wh; godfrey, di; subbarao, k; davenport, mp; kent, sj; wheatley, ak	nature medicine	2020	10.1038/s41591-020-0995-0	13
120	antibody-dependent enhancement and sars-cov-2 vaccines and therapies	lee, ws; wheatley, ak; kent, sj; dekosky, bj	nature microbiology	2020	10.1038/s41564-020-00789-5	13
121	rapid reconstruction of sars-cov-2 using a synthetic genomics platform	thao, ttn; labroussaa, f; ebert, n; v'kovski, p; stalder, h; portmann, j; kelly, j; steiner, s; holwerda, m; kratzel, a; gultom, m; schmied, k; laloli, l; husser, l; wider, m; pfaender, s; hirt, d; cippa, v; crespo-pomar, s; schroder, s; muth, d; niemeyer, d; corman, vm; muller, ma; drosten, c; dijkman, r; jores, j; thiel, v	nature	2020	10.1038/s41586-020-2294-9	9
122	covid-19 vaccine development and a potential nanomaterial path forward	shin, md; shukla, s; chung, yh; beiss, v; chan, sk; ortega-rivera, oa; wirth, dm; chen, a; sack, m; pokorski, jk; steinmetz, nf	nature nanotechnology	2020	10.1038/s41565-020-0737-y	14
123	covid-19 vaccine frontrunners and their nanotechnology design	chung, yh; beiss, v; fiering, sn; steinmetz, nf	acs nano	2020	10.1021/acsnano.0c07197	5
124	immune responses in covid-19 and potential vaccines: lessons learned from sars and mers epidemic	prompetchara, e; kettoy, c; palaga, t	asian pacific journal of allergy and immunology	2020	10.12932/ap-200220-0772	9
125	emergence of drift variants that may affect covid-19 vaccine development and antibody treatment	koyama, t; weeraratne, d; snowdon, jl; parida, l	pathogens	2020	10.3390/pathogens9050324	3
126	eosinophil responses during covid-19 infections and coronavirus vaccination	lindsley, aw; schwartz, jt; rothenberg, me	journal of allergy and clinical immunology	2020	10.1016/j.jaci.2020.04.021	3
127	coronavirus disease 2019-covid-19	dhama, k; khan, s; tiwari, r; sircar, s; bhat, s; malik, ys; singh, kp; chaicumpa, w; bonilla-aldana, dk; rodriguez-morales, aj	clinical microbiology reviews	2020	10.1128/cmr.00028-20	0
128	fact-checking as risk communication: the multi-layered risk of misinformation in times of covid-19	krause, nm; freiling, i; beets, b; brossard, d	journal of risk research	2020	10.1080/13669877.2020.1756385	4
129	do covid-19 conspiracy theory beliefs form a monological belief system?	miller, jm	canadian journal of political science-revue canadienne de science	2020	10.1017/s0008423920000517	4
130	susceptibility to misinformation about covid-19 around the world	roozenbeek, j; schneider, cr; dryhurst, s; kerr, j; freeman, alj; recchia, g; van der bles, am; van der linden, s	royal society open science	2020	10.1098/rsos.201199	11
131	social media and vaccine hesitancy: new updates for the era of covid-19 and globalized infectious diseases	puri, n; coomes, ea; haghbayan, h; gunaratne, k	human vaccines & immunotherapeutics	2020	10.1080/21645515.2020.1780846	14
132	sars-cov-2 and covid-19: the most important research questions	yuen, ks; ye, zw; fung, sy; chan, cp; jin, dy	cell and bioscience	2020	10.1186/s13578-020-00404-4	5
133	towards effective covid-19 vaccines: updates, perspectives and challenges (review)	calina, d; docea, ao; petrakis, d; egorov, am; ishmukhametov, aa; gabibov, ag; shtilman, mi; kostoff, r; carvalho, f; vinceti, m; spandidos, da; tsatsakis, a	international journal of molecular medicine	2020	10.3892/ijmm.2020.4596	6
134	a sars-cov-2 protein interaction map reveals targets for drug repurposing	gordon, de; jang, gm; bouhaddou, m; xu, jw; obernier, k; white, km; o'meara, mj; rezelj, vv; guo, jfz; swaney, dl; tummino, ta; huttenhain, r; kaake, rm; richards, al; tutuncuoglu, b; foussard, h; batra, j; haas, k; modak, m; kim, m; haas, p; polacco, bj; braberg, h; fabius, jm; eckhardt, m; soucheray, m; bennett, mj; cakir, m; mcgregor, mj; li, qy; meyer, b; roesch, f; vallet, t; mac kain, a; miorin, l; moreno, e; naing, zzc; zhou, y; peng, sm; shi, y; zhang, zy; shen, wq; kirby, it; melnyk, je; chorba, js; lou, kv; dai, sza; barrio-hernandez, i; memon, d; hernandez-armenta, c; lyu, j; mathy, cjp; perica, t; pilla, kb; ganesan, sj; saltzberg, dj; rakesh, r; liu, x; rosenthal, sb; calviello, l; venkataramanan, s; liboy-lugo, j; lin, yz; huang, xp; liu, yf; wankowicz, sa; bohn, m; safari, m; ugur, fs; koh, c; savar, ns; tran, qd; shengjuler, d; fletcher, sj; o'neal, mc; cai, ym; chang, jcj; broadhurst, dj; klippsten, s; sharp, pp; wenzell, na; kuzuoglu-ozturk, d; wang, hy; trenker, r; young, jm; cavero, da; hiatt, j; roth, tl; rathore, u; subramanian, a; noack, j; hubert, m; stroud, rm; frankel, ad; rosenberg, os; verba, ka; agard, da; ott, m; emerman, m; jura, n; von zastrow, m; verdin, e; ashworth, a; schwartz, o; d'enfert, c; mukherjee, s; jacobson, m; malik, hs; fujimori, dg; ideker, t; craik, cs; floor, sn; fraser, js; gross, jd; sali, a; roth, bl; ruggero, d; taunton, j; kortemme, t; beltrao, p; vignuzzi, m; garcia-sastre, a; shokat, km; shoichet, bk; krogan, nj	nature	2020	10.1038/s41586-020-2286-9	11
135	immune responses and pathogenesis of sars-cov-2 during an outbreak in iran: comparison with sars and mers	rokni, m; ghasemi, v; tavakoli, z	reviews in medical virology	2020	10.1002/rmv.2107	5
136	nanotechnology for covid-19: therapeutics and vaccine research	chauhan, g; madou, mj; kalra, s; chopra, v; ghosh, d; martinez-chapa, so	acs nano	2020	10.1021/acsnano.0c04006	4
137	coronavirus disease 2019 (covid-19): current status and future perspectives	li, h; liu, sm; yu, xh; tang, sl; tang, ck	international journal of antimicrobial agents	2020	10.1016/j.ijantimicag.2020.105951	5
138	covid-19: pathogenesis, cytokine storm and therapeutic potential of interferons	nile, sh; nile, a; qiu, jy; li, l; jia, x; kai, gy	cytokine & growth factor reviews	2020	10.1016/j.cytogfr.2020.05.002	5
139	safety and efficacy of the bnt162b2 mrna covid-19 vaccine	polack, fp; thomas, sj; kitchin, n; absalon, j; gurtman, a; lockhart, s; perez, jl; marc, gp; moreira, ed; zerbini, c; bailey, r; swanson, ka; roychoudhury, s; koury, k; li, p; kalina, wv; cooper, d; frenck, rw; hammitt, ll; tureci, o; nell, h; schaefer, a; unal, s; tresnan, db; mather, s; dormitzer, pr; sahin, u; jansen, ku; gruber, wc	new england journal of medicine	2020	10.1056/nejmoa2034577	283
140	current status of potential therapeutic candidates for the covid-19 crisis	zhang, jc; xie, b; hashimoto, k	brain behavior and immunity	2020	10.1016/j.bbi.2020.04.046	4
141	attitudes toward a potential sars-cov-2 vaccine a survey of us adults	fisher, ka; bloomstone, sj; walder, j; crawford, s; fouayzi, h; mazor, km	annals of internal medicine	2020	10.7326/m20-3569	36
142	considering emotion in covid-19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence	chou, wys; budenz, a	health communication	2020	10.1080/10410236.2020.1838096	13
143	covid-19 infection: origin, transmission, and characteristics of human coronaviruses	shereen, ma; khan, s; kazmi, a; bashir, n; siddique, r	journal of advanced research	2020	10.1016/j.jare.2020.03.005	24
144	rheumatologists' perspective on coronavirus disease 19 (covid-19) and potential therapeutic targets	misra, dp; agarwal, v; gasparyan, ay; zimba, o	clinical rheumatology	2020	10.1007/s10067-020-05073-9	2
145	nanoparticle-based strategies to combat covid-19	medhi, r; srinoi, p; ngo, n; tran, hv; lee, tr	acs applied nano materials	2020	10.1021/acsanm.0c01978	0
146	the french public's attitudes to a future covid-19 vaccine: the politicization of a public health issue	ward, jk; alleaume, c; peretti-watel, p	social science & medicine	2020	10.1016/j.socscimed.2020.113414	13
147	managing cancer care during the covid-19 pandemic: agility and collaboration toward a common goal	ueda, m; martins, r; hendrie, pc; mcdonnell, t; crews, jr; wong, tl; mccreery, b; jagels, b; crane, a; byrd, dr; pergam, sa; davidson, ne; liu, c; stewart, fm	journal of the national comprehensive cancer network	2020	10.6004/jnccn.2020.7560	1
148	the impact of the covid-19 pandemic on cancer patients	al-quteimat, om; amer, am	american journal of clinical oncology-cancer clinical trials	2020	10.1097/coc.0000000000000712	0
149	a thermostable mrna vaccine against covid-19	zhang, nn; li, xf; deng, yq; zhao, h; huang, yj; yang, g; huang, wj; gao, p; zhou, c; zhang, rr; guo, y; sun, sh; fan, h; zu, sl; chen, q; he, q; cao, ts; huang, xy; qiu, hy; nie, jh; jiang, yh; yan, hy; ye, q; zhong, x; xue, xl; zha, zy; zhou, ds; yang, x; wang, yc; ying, b; qin, cf	cell	2020	10.1016/j.cell.2020.07.024	20
150	an evidence based perspective on mrna-sars-cov-2 vaccine development	wang, fz; kream, rm; stefano, gb	medical science monitor	2020	10.12659/msm.924700	0
151	covid-19: transmission, prevention, and potential therapeutic opportunities	lotfi, m; hamblin, mr; rezaei, n	clinica chimica acta	2020	10.1016/j.cca.2020.05.044	4
152	a comprehensive review of covid-19 characteristics	esakandari, h; nabi-afjadi, m; fakkari-afjadi, j; farahmandian, n; miresmaeili, sm; bahreini, e	biological procedures online	2020	10.1186/s12575-020-00128-2	0
153	multivalue ethical framework for fair global allocation of a covid-19 vaccine	liu, yz; salwi, s; drolet, bc	journal of medical ethics	2020	10.1136/medethics-2020-106516	4
154	covid-19 conspiracy beliefs, health behaviors, and policy support	earnshaw, va; eaton, la; kalichman, sc; brousseau, nm; hill, ec; fox, ab	translational behavioral medicine	2020	10.1093/tbm/ibaa090	5
155	rapid detection of covid-19 causative virus (sars-cov-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor	seo, g; lee, g; kim, mj; baek, sh; choi, m; ku, kb; lee, cs; jun, s; park, d; kim, hg; kim, sj; lee, jo; kim, bt; park, ec; kim, si	acs nano	2020	10.1021/acsnano.0c02823	12
156	biosensors: frontiers in rapid detection of covid-19	samson, r; navale, gr; dharne, ms	3 biotech	2020	10.1007/s13205-020-02369-0	0
157	a review of current interventions for covid-19 prevention	pradhan, d; biswasroy, p; naik, pk; ghosh, g; rath, g	archives of medical research	2020	10.1016/j.arcmed.2020.04.020	3
158	from covid-19 research to vaccine application: why might it take 17 months not 17 years and what are the wider lessons?	hanney, sr; wooding, s; sussex, j; grant, j	health research policy and systems	2020	10.1186/s12961-020-00571-3	1
159	the possible of immunotherapy for covid-19: a systematic review	aminjafari, a; ghasemi, s	international immunopharmacology	2020	10.1016/j.intimp.2020.106455	1
160	treatment for emerging viruses: convalescent plasma and covid-19	brown, bl; mccullough, j	transfusion and apheresis science	2020	10.1016/j.transci.2020.102790	2
161	covid-19: the first documented coronavirus pandemic in history	liu, yc; kuo, rl; shih, sr	biomedical journal	2020	10.1016/j.bj.2020.04.007	0
162	pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for covid-19	luo, p; liu, d; li, j	international journal of antimicrobial agents	2020	10.1016/j.ijantimicag.2020.105995	0
163	conspiracy beliefs, rejection of vaccination, and support for hydroxychloroquine: a conceptual replication-extension in the covid-19 pandemic context	bertin, p; nera, k; delouvee, s	frontiers in psychology	2020	10.3389/fpsyg.2020.565128	3
164	covid-19 treatment by repurposing drugs until the vaccine is in sight	phadke, m; saunik, s	drug development research	2020	10.1002/ddr.21666	0
165	evidence based management guideline for the covid-19 pandemic-review article	nicola, m; o'neill, n; sohrabi, c; khan, m; agha, m; agha, r	international journal of surgery	2020	10.1016/j.ijsu.2020.04.001	0
166	public perceptions of covid-19 in australia: perceived risk, knowledge, health-protective behaviors, and vaccine intentions	faasse, k; newby, jm	frontiers in psychology	2020	10.3389/fpsyg.2020.551004	3
167	potential therapeutic agents against covid-19: what we know so far	lu, cc; chen, my; lee, ws; chang, yl	journal of the chinese medical association	2020	10.1097/jcma.0000000000000318	2
168	structure of m-pro from sars-cov-2 and discovery of its inhibitors	jin, zm; du, xy; xu, yc; deng, yq; liu, mq; zhao, y; zhang, b; li, xf; zhang, lk; peng, c; duan, yk; yu, j; wang, l; yang, kl; liu, fj; jiang, rd; yang, xl; you, t; liu, xc; yang, xn; bai, f; liu, h; liu, x; guddat, lw; xu, wq; xiao, gf; qin, cf; shi, zl; jiang, hl; rao, zh; yang, ht	nature	2020	10.1038/s41586-020-2223-y	30
169	candidate drugs against sars-cov-2 and covid-19	mckee, dl; sternberg, a; stange, u; laufer, s; naujokat, c	pharmacological research	2020	10.1016/j.phrs.2020.104859	3
170	convalescent plasma in covid-19: possible mechanisms of action	rojas, m; rodriguez, y; monsalve, dm; acosta-ampudia, y; camacho, b; gallo, je; rojas-villarraga, a; ramirez-santana, c; diaz-coronado, jc; manrique, r; mantilla, rd; shoenfeld, y; anaya, jm	autoimmunity reviews	2020	10.1016/j.autrev.2020.102554	5
171	covid-19: a review of the proposed pharmacological treatments	lam, s; lombardi, a; ouanounou, a	european journal of pharmacology	2020	10.1016/j.ejphar.2020.173451	1
172	stability analysis and numerical simulation of seir model for pandemic covid-19 spread in indonesia	annas, s; pratama, mi; rifandi, m; sanusi, w; side, s	chaos solitons & fractals	2020	10.1016/j.chaos.2020.110072	0
173	assessing differential impacts of covid-19 on black communities	millett, ga; jones, at; benkeser, d; baral, s; mercer, l; beyrer, c; honermann, b; lankiewicz, e; mena, l; crowley, js; sherwood, j; sullivan, ps	annals of epidemiology	2020	10.1016/j.annepidem.2020.05.003	4
174	the challenges of modeling and forecasting the spread of covid-19	bertozzi, al; franco, e; mohler, g; short, mb; sledge, d	proceedings of the national academy of sciences of the united states of	2020	10.1073/pnas.2006520117	0
175	metropolitan wastewater analysis for covid-19 epidemiological surveillance	randazzo, w; cuevas-ferrando, e; sanjuan, r; domingo-calap, p; sanchez, g	international journal of hygiene and environmental health	2020	10.1016/j.ijheh.2020.113621	1
176	treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with covid-19	arshad, s; kilgore, p; chaudhry, zs; jacobsen, g; wang, dd; huitsing, k; brar, i; alangaden, gj; ramesh, ms; mckinnon, je; o'neill, w; zervos, m	international journal of infectious diseases	2020	10.1016/j.ijid.2020.06.099	4
177	immune response to sars-cov-2 and mechanisms of immunopathological changes in covid-19	azkur, ak; akdis, m; azkur, d; sokolowska, m; van de veen, w; bruggen, mc; o'mahony, l; gao, yd; nadeau, k; akdis, ca	allergy	2020	10.1111/all.14364	5
178	serology characteristics of sars-cov-2 infection after exposure and post-symptom onset	lou, b; li, td; zheng, sf; su, yy; li, zy; liu, w; yu, f; ge, sx; zou, qd; yuan, q; lin, s; hong, cm; yao, xy; zhang, xj; wu, dh; zhou, gl; hou, wh; li, tt; zhang, yl; zhang, sy; fan, j; zhang, j; xia, ns; chen, y	european respiratory journal	2020	10.1183/13993003.00763-2020	4
179	covid-19 serological tests: how well do they actually perform?	ghaffari, a; meurant, r; ardakani, a	diagnostics	2020	10.3390/diagnostics10070453	0
180	type i and type iii interferons - induction, signaling, evasion, and application to combat covid-19	park, a; iwasaki, a	cell host & microbe	2020	10.1016/j.chom.2020.05.008	5
181	mouse model of sars-cov-2 reveals inflammatory role of type i interferon signaling	israelow, b; song, e; mao, ty; lu, pw; meir, a; liu, fm; alfajaro, mm; wei, j; dong, hp; homer, rj; ring, ar; wilen, cb; iwasaki, a	journal of experimental medicine	2020	10.1084/jem.20201241	5
182	a mouse-adapted model of sars-cov-2 to test covid-19 countermeasures	dinnon, kh; leist, sr; schafer, a; edwards, ce; martinez, dr; montgomery, sa; west, a; yount, bl; hou, yxj; adams, le; gully, kl; brown, aj; huang, e; bryant, md; choong, ic; glenn, js; gralinski, le; sheahan, tp; baric, rs	nature	2020	10.1038/s41586-020-2708-8	6
183	animal models for covid-19	munoz-fontela, c; dowling, we; funnell, sgp; gsell, ps; riveros-balta, ax; albrecht, ra; andersen, h; baric, rs; carroll, mw; cavaleri, m; qin, c; crozier, i; dallmeier, k; de waal, l; de wit, e; delang, l; dohm, e; duprex, wp; falzarano, d; finch, cl; frieman, mb; graham, bs; gralinski, le; guilfoyle, k; haagmans, bl; hamilton, ga; hartman, al; herfst, s; kaptein, sjf; klimstra, wb; knezevic, i; krause, pr; kuhn, jh; le grand, r; lewis, mg; liu, wc; maisonnasse, p; mcelroy, ak; munster, v; oreshkova, n; rasmussen, al; rocha-pereira, j; rockx, b; rodriguez, e; rogers, tf; salguero, fj; schotsaert, m; stittelaar, kj; thibaut, hj; tseng, ct; vergara-alert, j; beer, m; brasel, t; chan, jfw; garcia-sastre, a; neyts, j; perlman, s; reed, ds; richt, ja; roy, cj; segales, j; vasan, ss; henao-restrepo, am; barouch, dh	nature	2020	10.1038/s41586-020-2787-6	11
184	threat of covid-19 vaccine hesitancy in pakistan: the need for measures to neutralize misleading narratives	khan, yh; mallhi, th; alotaibi, nh; alzarea, ai; alanazi, as; tanveer, n; hashmi, fk	american journal of tropical medicine and hygiene	2020	10.4269/ajtmh.20-0654	5
185	vaccine efficacy needed for a covid-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention	bartsch, sm; o'shea, kj; ferguson, mc; bottazzi, me; wedlock, pt; strych, u; mckinnell, ja; siegmund, ss; cox, sn; hotez, pj; lee, by	american journal of preventive medicine	2020	10.1016/j.amepre.2020.06.011	13
186	social distancing responses to covid-19 emergency declarations strongly differentiated by income	weill, ja; stigler, m; deschenes, o; springborn, mr	proceedings of the national academy of sciences of the united states of	2020	10.1073/pnas.2009412117	2
187	modeling and forecasting the covid-19 pandemic in india	sarkar, k; khajanchi, s; nieto, jj	chaos solitons & fractals	2020	10.1016/j.chaos.2020.110049	1
188	drug development and medicinal chemistry efforts toward sars-coronavirus and covid-19 therapeutics	ghosh, ak; brindisi, m; shahabi, d; chapman, me; mesecar, ad	chemmedchem	2020	10.1002/cmdc.202000223	3
189	an overview of covid-19	shi, y; wang, g; cai, xp; deng, jw; zheng, l; zhu, hh; zheng, m; yang, b; chen, z	journal of zhejiang university-science b	2020	10.1631/jzus.b2000083	0
190	risk factors for sars-cov-2 among patients in the oxford royal college of general practitioners research and surveillance centre primary care network: a cross-sectional study	de lusignan, s; dorward, j; correa, a; jones, n; akinyemi, o; amirthalingam, g; andrews, n; byford, r; dabrera, g; elliot, a; ellis, j; ferreira, f; bernal, jl; okusi, c; ramsay, m; sherlock, j; smith, g; williams, j; howsam, g; zambon, m; joy, m; hobbs, fdr	lancet infectious diseases	2020	10.1016/s1473-3099(20)30371-6	3
191	individuals with obesity and covid-19: a global perspective on the epidemiology and biological relationships	popkin, bm; du, sf; green, wd; beck, ma; algaith, t; herbst, ch; alsukait, rf; alluhidan, m; alazemi, n; shekar, m	obesity reviews	2020	10.1111/obr.13128	5
192	the battle against covid-19 in jordan: an early overview of the jordanian experience	al-tammemi, ab	frontiers in public health	2020	10.3389/fpubh.2020.00188	0
193	prevention and management of covid-19 among patients with diabetes: an appraisal of the literature	katulanda, p; dissanayake, ha; ranathunga, i; ratnasamy, v; wijewickrama, psa; yogendranathan, n; gamage, kkk; de silva, nl; sumanatilleke, m; somasundaram, np; matthews, dr	diabetologia	2020	10.1007/s00125-020-05164-x	1
194	statistical analysis of forecasting covid-19 for upcoming month in pakistan	yousaf, m; zahir, s; riaz, m; hussain, sm; shah, k	chaos solitons & fractals	2020	10.1016/j.chaos.2020.109926	1
195	an update on sars-cov-2/covid-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies	dhama, k; patel, sk; pathak, m; yatoo, mi; tiwari, r; malik, ys; singh, r; sah, r; rabaan, aa; bonilla-aldana, dk; rodriguez-morales, aj	travel medicine and infectious disease	2020	10.1016/j.tmaid.2020.101755	3
196	knowledge, perceptions, and attitude of egyptians towards the novel coronavirus disease (covid-19)	abdelhafiz, as; mohammed, z; ibrahim, me; ziady, hh; alorabi, m; ayyad, m; sultan, ea	journal of community health	2020	10.1007/s10900-020-00827-7	4
197	traditional chinese medicine in the treatment of patients infected with 2019-new coronavirus (sars-cov-2): a review and perspective	yang, y; islam, ms; wang, j; li, y; chen, x	international journal of biological sciences	2020	10.7150/ijbs.45538	8
198	dietary therapy and herbal medicine for covid-19 prevention: a review and perspective	panyod, s; ho, ct; sheen, ly	journal of traditional and complementary medicine	2020	10.1016/j.jtcme.2020.05.004	0
199	design of a multiepitope-based peptide vaccine against the e protein of human covid-19: an immunoinformatics approach	abdelmageed, mi; abdelmoneim, ah; mustafa, mi; elfadol, nm; murshed, ns; shantier, sw; makhawi, am	biomed research international	2020	10.1155/2020/2683286	4
200	immune-mediated approaches against covid-19	florindo, hf; kleiner, r; vaskovich-koubi, d; acurcio, rc; carreira, b; yeini, e; tiram, g; liubomirski, y; satchi-fainaro, r	nature nanotechnology	2020	10.1038/s41565-020-0732-3	6
201	covid-19: the potential treatment of pulmonary fibrosis associated with sars-cov-2 infection	lechowicz, k; drozdzal, s; machaj, f; rosik, j; szostak, b; zegan-baranska, m; biernawska, j; dabrowski, w; rotter, i; kotfis, k	journal of clinical medicine	2020	10.3390/jcm9061917	0
202	optimizing use of theranostic nanoparticles as a life-saving strategy for treating covid-19 patients	itani, r; tobaiqy, m; al faraj, a	theranostics	2020	10.7150/thno.46691	1
203	role of angiotensin-converting enzyme 2 (ace2) in covid-19	ni, wt; yang, xw; yang, dq; bao, j; li, r; xiao, yj; hou, c; wang, hb; liu, j; yang, dh; xu, y; cao, zl; gao, zc	critical care	2020	10.1186/s13054-020-03120-0	2
204	conspiracy theories as barriers to controlling the spread of covid-19 in the us	romer, d; jamieson, kh	social science & medicine	2020	10.1016/j.socscimed.2020.113356	9
205	in silico studies on therapeutic agents for covid-19: drug repurposing approach	shah, b; modi, p; sagar, sr	life sciences	2020	10.1016/j.lfs.2020.117652	0
206	potential effects of coronaviruses on the cardiovascular system a review	madjid, m; safavi-naeini, p; solomon, sd; vardeny, o	jama cardiology	2020	10.1001/jamacardio.2020.1286	5
207	angiotensin-converting enzyme 2 (ace2),sars-cov-2 and the pathophysiology of coronavirus disease 2019 (covid-19)	bourgonje, ar; abdulle, ae; timens, w; hillebrands, jl; navis, gj; gordijn, sj; bolling, mc; dijkstra, g; voors, aa; osterhaus, adme; van der voort, phj; mulder, dj; van goor, h	journal of pathology	2020	10.1002/path.5471	3
208	long-term respiratory and neurological sequelae of covid-19	wang, fz; kream, rm; stefano, gb	medical science monitor	2020	10.12659/msm.928996	0
209	is copper beneficial for covid-19 patients?	raha, s; mallick, r; basak, s; duttaroy, ak	medical hypotheses	2020	10.1016/j.mehy.2020.109814	1
210	a review of therapeutic agents and chinese herbal medicines against sars-cov-2 (covid-19)	huang, ff; li, y; leung, elh; liu, xh; liu, kf; wang, q; lan, yq; li, xl; yu, hb; cui, l; luo, h; luo, lx	pharmacological research	2020	10.1016/j.phrs.2020.104929	0
211	a proactive approach for managing covid-19: the importance of understanding the motivational roots of vaccination hesitancy for sars-cov2	taylor, s; landry, ca; paluszek, mm; groenewoud, r; rachor, gs; asmundson, gjg	frontiers in psychology	2020	10.3389/fpsyg.2020.575950	14
212	medicinal plants as sources of active molecules against covid-19	benarba, b; pandiella, a	frontiers in pharmacology	2020	10.3389/fphar.2020.01189	0
213	impact of sex and gender on covid-19 outcomes in europe	gebhard, c; regitz-zagrosek, v; neuhauser, hk; morgan, r; klein, sl	biology of sex differences	2020	10.1186/s13293-020-00304-9	2
214	applications of machine learning and artificial intelligence for covid-19 (sars-cov-2) pandemic: a review	lalmuanawma, s; hussain, j; chhakchhuak, l	chaos solitons & fractals	2020	10.1016/j.chaos.2020.110059	2
215	different longitudinal patterns of nucleic acid and serology testing results based on disease severity of covid-19 patients	zhang, yc; han, s; wang, xn; shi, xd; yang, l; yan, jw; chen, yx; bing, g	emerging microbes & infections	2020	10.1080/22221751.2020.1756699	2
216	development of crispr as an antiviral strategy to combat sars-cov-2 and influenza	abbott, tr; dhamdhere, g; liu, yx; lin, xq; goudy, l; zeng, lp; chemparathy, a; chmura, s; heaton, ns; debs, r; pande, t; endy, d; la russa, mf; lewis, db; qi, ls	cell	2020	10.1016/j.cell.2020.04.020	3
217	how can nanotechnology help to combat covid-19? opportunities and urgent need	campos, evr; pereira, aes; de oliveira, jl; carvalho, lb; guilger-casagrande, m; de lima, r; fraceto, lf	journal of nanobiotechnology	2020	10.1186/s12951-020-00685-4	2
218	assessment of lockdown effect in some states and overall india: a predictive mathematical study on covid-19 outbreak	sardar, t; nadim, ss; rana, s; chattopadhyay, j	chaos solitons & fractals	2020	10.1016/j.chaos.2020.110078	0
219	synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against sars-cov-2: what molecular dynamics studies of virus-host interactions reveal	fantini, j; chahinian, h; yahi, n	international journal of antimicrobial agents	2020	10.1016/j.ijantimicag.2020.106020	2
220	natural history of covid-19 and current knowledge on treatment therapeutic options	dos santos, wg	biomedicine & pharmacotherapy	2020	10.1016/j.biopha.2020.110493	1
221	review on the potential action mechanisms of chinese medicines in treating coronavirus disease 2019 (covid-19)	huang, yf; bai, c; he, f; xie, y; zhou, h	pharmacological research	2020	10.1016/j.phrs.2020.104939	1
222	clinical efficacy of convalescent plasma for treatment of covid-19 infections: results of a multicenter clinical study	abolghasemi, h; eshghi, p; cheraghali, am; fooladi, aai; moghaddam, fb; imanizadeh, s; maleki, mm; ranjkesh, m; rezapour, m; bahramifar, a; einollahi, b; hosseini, mj; jafari, nj; nikpouraghdam, m; sadri, n; tazik, m; sali, s; okati, s; askari, e; tabarsi, p; aslani, j; sharifipour, e; jarahzadeh, mh; khodakarim, n; salesi, m; jafari, r; shahverdi, s	transfusion and apheresis science	2020	10.1016/j.transci.2020.102875	1
223	factors associated with us adults' likelihood of accepting covid-19 vaccination	kreps, s; prasad, s; brownstein, js; hswen, y; garibaldi, bt; zhang, bb; kriner, dl	jama network open	2020	10.1001/jamanetworkopen.2020.25594	24
224	hesitant or not? the association of age, gender, and education with potential acceptance of a covid-19 vaccine: a country-level analysis	lazarus, jv; wyka, k; rauh, l; rabin, k; ratzan, s; gostin, lo; larson, hj; el-mohandes, a	journal of health communication	2020	10.1080/10810730.2020.1868630	2
225	covid-19-related web search behaviors and infodemic attitudes in italy: infodemiological study	rovetta, a; bhagavathula, as	jmir public health and surveillance	2020	10.2196/19374	0
226	uncontrolled innate and impaired adaptive immune responses in patients with covid-19 acute respiratory distress syndrome	hue, s; beldi-ferchiou, a; bendib, i; surenaud, m; fourati, s; frapard, t; rivoal, s; razazi, k; carteaux, g; delfau-larue, mh; mekontso-dessap, a; audureau, e; de prost, n	american journal of respiratory and critical care medicine	2020	10.1164/rccm.202005-1885oc	0
227	mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel coronavirus	ngonghala, cn; iboi, e; eikenberry, s; scotch, m; macintyre, cr; bonds, mh; gumel, ab	mathematical biosciences	2020	10.1016/j.mbs.2020.108364	4
228	modeling the impact of mass influenza vaccination and public health interventions on covid-19 epidemics with limited detection capability	li, q; tang, b; bragazzi, nl; xiao, yn; wu, jh	mathematical biosciences	2020	10.1016/j.mbs.2020.108378	1
229	effects of media reporting on mitigating spread of covid-19 in the ear y phase of the outbreak	zhou, wk; wang, al; xia, f; xiao, yn; tang, sy	mathematical biosciences and engineering	2020	10.3934/mbe.2020147	0
230	inter nation social lockdown versus medical care against covid-19, a mild environmental insight with special reference to india	paital, b; das, k; parida, sk	science of the total environment	2020	10.1016/j.scitotenv.2020.138914	0
231	the scientific literature on coronaviruses, covid-19 and its associated safety-related research dimensions: a scientometric analysis and scoping review	haghani, m; bliemer, mcj; goerlandt, f; li, j	safety science	2020	10.1016/j.ssci.2020.104806	1
232	covid-19: emergence, spread, possible treatments, and global burden	keni, r; alexander, a; nayak, pg; mudgal, j; nandakumar, k	frontiers in public health	2020	10.3389/fpubh.2020.00216	2
233	a review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against sar-cov-2 (covid-19) pandemic	tripathy, s; dassarma, b; roy, s; chabalala, h; matsabisa, mg	international journal of antimicrobial agents	2020	10.1016/j.ijantimicag.2020.106028	1
234	computers and viral diseases. preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the sars-cov-2 (2019-ncov, covid-19) coronavirus	robson, b	computers in biology and medicine	2020	10.1016/j.compbiomed.2020.103670	5
235	covid-19 coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance	robson, b	computers in biology and medicine	2020	10.1016/j.compbiomed.2020.103749	2
236	coronavirus disease 2019 (covid-19) pandemic and pregnancy	dashraath, p; wong, jlj; lim, mxk; lim, lm; li, s; biswas, a; choolani, m; mattar, c; su, ll	american journal of obstetrics and gynecology	2020	10.1016/j.ajog.2020.03.021	9
237	current response and management decisions of the european union to the covid-19 outbreak: a review	goniewicz, k; khorram-manesh, a; hertelendy, aj; goniewicz, m; naylor, k; burkle, fm	sustainability	2020	10.3390/su12093838	0
238	coopetition and covid-19: collaborative business-to-business marketing strategies in a pandemic crisis	crick, jm; crick, d	industrial marketing management	2020	10.1016/j.indmarman.2020.05.016	0
239	current pharmacological treatments for covid-19: what's next?	scavone, c; brusco, s; bertini, m; sportiello, l; rafaniello, c; zoccoli, a; berrino, l; racagni, g; rossi, f; capuano, a	british journal of pharmacology	2020	10.1111/bph.15072	2
240	the first 75 days of novel coronavirus (sars-cov-2) outbreak: recent advances, prevention, and treatment	yan, yx; shin, wi; pang, yx; meng, y; lai, jc; you, c; zhao, ht; lester, e; wu, t; pang, ch	international journal of environmental research and public health	2020	10.3390/ijerph17072323	2
241	repurposing of kinase inhibitors for treatment of covid-19	weisberg, e; parent, a; yang, pl; sattler, m; liu, qs; liu, qw; wang, jh; meng, cc; buhrlage, sj; gray, n; griffin, jd	pharmaceutical research	2020	10.1007/s11095-020-02851-7	0
242	challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (ppe) arising from coronavirus disease (covid19) pandemic - case study from the republic of ireland	rowan, nj; laffey, jg	science of the total environment	2020	10.1016/j.scitotenv.2020.138532	2
243	an environmental and health perspective for covid-19 outbreak: meteorology and air quality influence, sewage epidemiology indicator, hospitals disinfection, drug therapies and recommendations	barcelo, d	journal of environmental chemical engineering	2020	10.1016/j.jece.2020.104006	3
244	detecting the coronavirus (covid-19)	pokhrel, p; hu, cp; mao, hb	acs sensors	2020	10.1021/acssensors.0c01153	1
245	covid-19 and frequent use of hand sanitizers; human health and environmental hazards by exposure pathways	mahmood, a; eqan, m; pervez, s; alghamdi, ha; tabinda, ab; yasar, a; brindhadevi, k; pugazhendhi, a	science of the total environment	2020	10.1016/j.scitotenv.2020.140561	0
246	covid-19 lockdowns, income distribution, and food security: an analysis for south africa	arndt, c; davies, r; gabriel, s; harris, l; makrelov, k; robinson, s; levy, s; simbanegavi, w; van seventer, d; anderson, l	global food security-agriculture policy economics and environment	2020	10.1016/j.gfs.2020.100410	0
247	examining effects of the covid-19 national lockdown on ambient air quality across urban india	navinya, c; patidar, g; phuleria, hc	aerosol and air quality research	2020	10.4209/aaqr.2020.05.0256	0
248	nurture to nature via covid-19, a self-regenerating environmental strategy of environment in global context	paital, b	science of the total environment	2020	10.1016/j.scitotenv.2020.139088	0
249	current state of evidence: influence of nutritional and nutrigenetic factors on immunity in the covid-19 pandemic framework	galmes, s; serra, f; palou, a	nutrients	2020	10.3390/nu12092738	0
250	considering how biological sex impacts immune responses and covid-19 outcomes	scully, ep; haverfield, j; ursin, rl; tannenbaum, c; klein, sl	nature reviews immunology	2020	10.1038/s41577-020-0348-8	2
251	in silica screening of natural compounds against covid-19 by targeting mpro and ace2 using molecular docking	joshi, t; joshi, t; sharma, p; mathpal, s; pundir, h; bhatt, v; chandra, s	european review for medical and pharmacological sciences	2020		2
252	early nutritional interventions with zinc, selenium and vitamin d for raising anti-viral resistance against progressive covid-19	alexander, j; tinkov, a; strand, ta; alehagen, u; skalny, a; aaseth, j	nutrients	2020	10.3390/nu12082358	0
253	projecting hospital utilization during the covid-19 outbreaks in the united states	moghadas, sm; shoukat, a; fitzpatrick, mc; wells, cr; sah, p; pandey, a; sachs, jd; wang, z; meyers, la; singer, bh; galvani, ap	proceedings of the national academy of sciences of the united states of	2020	10.1073/pnas.2004064117	4
254	the implications of silent transmission for the control of covid-19 outbreaks	moghadas, sm; fitzpatrick, mc; sah, p; pandey, a; shoukat, a; singer, bh; galvani, ap	proceedings of the national academy of sciences of the united states of	2020	10.1073/pnas.2008373117	7
255	cross-country comparisons of covid-19: policy, politics and the price of life	balmford, b; annan, jd; hargreaves, jc; altoe, m; bateman, ij	environmental & resource economics	2020	10.1007/s10640-020-00466-5	0
256	covid-19 and neuromuscular disorders	guidon, ac; amato, aa	neurology	2020	10.1212/wnl.0000000000009566	1
257	opportunities and challenges for biosensors and nanoscale analytical tools for pandemics: covid-19	bhalla, n; pan, yw; yang, zg; payam, af	acs nano	2020	10.1021/acsnano.0c04421	0
258	therapeutic strategies for critically ill patients with covid-19	li, l; li, rr; wu, zx; yang, xh; zhao, my; liu, j; chen, dc	annals of intensive care	2020	10.1186/s13613-020-00661-z	0
259	characteristics of and public health responses to the coronavirus disease 2019 outbreak in china	deng, sq; peng, hj	journal of clinical medicine	2020	10.3390/jcm9020575	4
260	the role of lipid metabolism in covid-19 virus infection and as a drug target	abu-farha, m; thanaraj, ta; qaddoumi, mg; hashem, a; abubaker, j; al-mulla, f	international journal of molecular sciences	2020	10.3390/ijms21103544	0
261	rapid generation of neutralizing antibody responses in covid-19 patients	suthar, ms; zimmerman, mg; kauffman, rc; mantus, g; linderman, sl; hudson, wh; vanderheiden, a; nyhoff, l; davis, cw; adekunle, o; affer, m; sherman, m; reynolds, s; verkerke, hp; alter, dn; guarner, j; bryksin, j; horwath, mc; arthur, cm; saakadze, n; smith, gh; edupuganti, s; scherer, em; hellmeister, k; cheng, a; morales, ja; neish, as; stowell, sr; frank, f; ortlund, e; anderson, ej; menachery, vd; rouphael, n; mehta, ak; stephens, ds; ahmed, r; roback, jd; wrammert, j	cell reports medicine	2020	10.1016/j.xcrm.2020.100040	0
262	a molecular docking study repurposes fda approved iron oxide nanoparticles to treat and control covid-19 infection	abo-zeid, y; ismail, nsm; mclean, gr; hamdy, nm	european journal of pharmaceutical sciences	2020	10.1016/j.ejps.2020.105465	1
263	covid-19 and multisystem inflammatory syndrome in children and adolescents	jiang, l; tang, k; levin, m; irfan, o; morris, sk; wilson, k; klein, jd; bhutta, za	lancet infectious diseases	2020	10.1016/s1473-3099(20)30651-4	3
264	two linear epitopes on the sars-cov-2 spike protein that elicit neutralising antibodies in covid-19 patients	poh, cm; carissimo, g; wang, b; amrun, sn; lee, cyp; chee, rsl; fong, sw; yeo, nkw; lee, wh; torres-ruesta, a; leo, ys; chen, mic; tan, sy; chai, lya; kalimuddin, s; kheng, ssg; thien, sy; young, be; lye, dc; hanson, bj; wang, ci; renia, l; ng, lfp	nature communications	2020	10.1038/s41467-020-16638-2	6
265	covid-19 outbreak: an overview	ciotti, m; angeletti, s; minieri, m; giovannetti, m; benvenuto, d; pascarella, s; sagnelli, c; bianchi, m; bernardini, s; ciccozzi, m	chemotherapy	2020	10.1159/000507423	1
266	viral epitope profiling of covid-19 patients reveals cross-reactivity and correlates of severity	shrock, e; fujimura, e; kula, t; timms, rt; lee, ih; leng, ym; robinson, ml; sie, bm; li, mz; chen, yz; logue, j; zuiani, a; mcculloch, d; lelis, fjn; henson, s; monaco, dr; travers, m; habibi, s; clarke, wa; caturegli, p; laeyendecker, o; piechocka-trocha, a; li, jz; khatri, a; chu, hy; villani, ac; kays, k; goldberg, mb; hacohen, n; filbin, mr; yu, xg; walker, bd; wesemann, dr; larman, hb; lederer, ja; elledge, sj	science	2020	10.1126/science.abd4250	8
267	covid-19: epidemiology, evolution, and cross-disciplinary perspectives	sun, jm; he, wt; wang, lf; lai, a; ji, x; zhai, xf; li, gr; suchard, ma; tian, j; zhou, jy; veit, m; su, s	trends in molecular medicine	2020	10.1016/j.molmed.2020.02.008	3
268	inborn errors of type i ifn immunity in patients with life-threatening covid-19	zhang, q; bastard, p; liu, zy; le pen, j; moncada-velez, m; chen, j; ogishi, m; sabli, ikd; hodeib, s; korol, c; rosain, j; bilguvar, k; ye, jq; bolze, a; bigio, b; yang, r; arias, aa; zhou, qh; zhang, y; onodi, f; korniotis, s; karpf, l; philippot, q; chbihi, m; bonnet-madin, l; dorgham, k; smith, n; schneider, wm; razooky, bs; hoffmann, hh; michailidis, e; moens, l; han, je; lorenzo, l; bizien, l; meade, p; neehus, al; ugurbil, ac; corneau, a; kerner, g; zhang, p; rapaport, f; seeleuthner, y; manry, j; masson, c; schmitt, y; schluter, a; le voyer, t; khan, t; li, j; fellay, j; roussel, l; shahrooei, m; alosaimi, mf; mansouri, d; al-saud, h; al-mulla, f; almourfi, f; al-muhsen, sz; alsohime, f; al turki, s; hasanato, r; van de beek, dv; biondi, a; bettini, lr; d'angio, m; bonfanti, p; imberti, l; sottini, a; paghera, s; quiros-roldan, e; rossi, c; oler, aj; tompkins, mf; alba, c; vandernoot, i; goffard, jc; smits, g; migeotte, i; haerynck, f; soler-palacin, p; martin-nalda, a; colobran, r; morange, pe; keles, s; colkesen, f; ozcelik, t; yasar, kk; senoglu, s; karabela, sn; rodriguez-gallego, c; novelli, g; hraiech, s; tandjaoui-lambiotte, y; duval, x; laouenan, c; snow, al; dalgard, cl; milner, jd; vinh, dc; mogensen, th; marr, n; spaan, an; boisson, b; boisson-dupuis, s; bustamante, j; puel, a; ciancanelli, mj; meyts, i; maniatis, t; soumelis, v; amara, a; nussenzweig, m; garcia-sastre, a; krammer, f; pujol, a; duffy, d; lifton, rp; zhang, sy; gorochov, g; beziat, v; jouanguy, e; sancho-shimizu, v; rice, cm; abel, l; notarangelo, ld; cobat, a; su, hc; casanova, jl	science	2020	10.1126/science.abd4570	11
269	spreading of covid-19: density matters	wong, dws; li, y	plos one	2020	10.1371/journal.pone.0242398	0
270	convalescent plasma treatment of severe covid-19: a propensity score-matched control study	liu, sth; lin, hm; baine, i; wajnberg, a; gumprecht, jp; rahman, f; rodriguez, d; tandon, p; bassily-marcus, a; bander, j; sanky, c; dupper, a; zheng, a; nguyen, ft; amanat, f; stadlbauer, d; altman, dr; chen, bk; krammer, f; mendu, dr; firpo-betancourt, a; levin, ma; bagiella, e; casadevall, a; cordon-cardo, c; jhang, js; arinsburg, sa; reich, dl; aberg, ja; bouvier, nm	nature medicine	2020	10.1038/s41591-020-1088-9	8
271	organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of covid-19	cheng, h; wang, y; wang, gq	journal of medical virology	2020	10.1002/jmv.25785	1
272	social media and vaccine hesitancy	wilson, sl; wiysonge, c	bmj global health	2020	10.1136/bmjgh-2020-004206	7
273	antigen-specific adaptive immunity to sars-cov-2 in acute covid-19 and associations with age and disease severity	moderbacher, cr; ramirez, si; dan, jm; grifoni, a; hastie, km; weiskopf, d; belanger, s; abbott, rk; kim, c; choi, j; kato, y; crotty, eg; kim, c; rawlings, sa; mateus, j; tse, lpv; frazier, a; baric, r; peters, b; greenbaum, j; saphire, eo; smith, dm; sette, a; crotty, s	cell	2020	10.1016/j.cell.2020.09.038	28
274	sars-cov-2 immunity: review and applications to phase 3 vaccine candidates	poland, ga; ovsyannikova, ig; kennedy, rb	lancet	2020	10.1016/s0140-6736(20)32137-1	18
275	pathophysiology of covid-19: why children fare better than adults?	dhochak, n; singhal, t; kabra, sk; lodha, r	indian journal of pediatrics	2020	10.1007/s12098-020-03322-y	4
276	routine childhood immunisation during the covid-19 pandemic in africa: a benefit-risk analysis of health benefits versus excess risk of sars-cov-2 infection	abbas, k; procter, sr; van zandvoort, k; clark, a; funk, s; mengistu, t; hogan, d; dansereau, e; jit, m; flasche, s	lancet global health	2020	10.1016/52214-109x(20)30308-9	3
277	applications of digital technology in covid-19 pandemic planning and response	whitelaw, s; mamas, ma; topol, e; van spall, hgc	lancet digital health	2020	10.1016/s2589-7500(20)30142-4	2
278	distinct inflammatory profiles distinguish covid-19 from influenza with limited contributions from cytokine storm	mudd, pa; crawford, jc; turner, js; souquette, a; reynolds, d; bender, d; bosanquet, jp; anand, nj; striker, da; martin, rs; boon, acm; house, sl; remy, ke; hotchkiss, rs; presti, rm; o'halloran, ja; powderly, wg; thomas, pg; ellebedy, ah	science advances	2020	10.1126/sciadv.abe3024	0
279	review article: prevention, diagnosis and management of covid-19 in the ibd patient	al-ani, ah; prentice, re; rentsch, ca; johnson, d; ardalan, z; heerasing, n; garg, m; campbell, s; sasadeusz, j; macrae, fa; ng, sc; rubin, dt; christensen, b	alimentary pharmacology & therapeutics	2020	10.1111/apt.15779	0
280	why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? atomistic insights into the inhibitory mechanisms	nutho, b; mahalapbutr, p; hengphasatporn, k; pattaranggoon, nc; simanon, n; shigeta, y; hannongbua, s; rungrotmongkol, t	biochemistry	2020	10.1021/acs.biochem.0c00160	3
281	covid-19: drug targets and potential treatments	gil, c; ginex, t; maestro, i; nozal, v; barrado-gil, l; cuesta-geijo, ma; urquiza, j; ramirez, d; alonso, c; campillo, ne; martinez, a	journal of medicinal chemistry	2020	10.1021/acs.jmedchem.0c00606	2
282	cytokine storm and leukocyte changes in mild versus severe sars-cov-2 infection: review of 3939 covid-19 patients in china and emerging pathogenesis and therapy concepts	wang, j; jiang, mm; chen, x; montaner, lj	journal of leukocyte biology	2020	10.1002/jlb.3covr0520-272r	6
283	estimating the generation interval for coronavirus disease (covid-19) based on symptom onset data, march 2020	ganyani, t; kremer, c; chen, dx; torneri, a; faes, c; wallinga, j; hens, n	eurosurveillance	2020	10.2807/1560-7917.es.2020.25.17.2000257	7
284	pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (covid-19) a review	wiersinga, wj; rhodes, a; cheng, ac; peacock, sj; prescott, hc	jama-journal of the american medical association	2020	10.1001/jama.2020.12839	15
285	extrafollicular b cell responses correlate with neutralizing antibodies and morbidity in covid-19	woodruff, mc; ramonell, rp; nguyen, dc; cashman, ks; saini, as; haddad, ns; ley, am; kyu, s; howell, jc; ozturk, t; lee, sy; suryadevara, n; case, jb; bugrovsky, r; chen, wr; estrada, j; morrison-porter, a; derrico, a; anam, fa; sharma, m; wu, hm; le, sn; jenks, sa; tipton, cm; staitieh, b; daiss, jl; ghosn, e; diamond, ms; carnahan, rh; crowe, je; hu, wt; lee, feh; sanz, i	nature immunology	2020	10.1038/s41590-020-00814-z	8
286	molecular diagnosis of covid-19: challenges and research needs	feng, w; newbigging, am; le, c; pang, b; peng, hy; cao, yr; wu, jj; abbas, g; song, j; wang, db; cui, mm; tao, j; tyrrell, dl; zhang, xe; zhang, hq; le, xc	analytical chemistry	2020	10.1021/acs.analchem.0c02060	0
287	the science underlying covid-19 implications for the cardiovascular system	liu, pp; blet, a; smyth, d; li, hl	circulation	2020	10.1161/circulationaha.120.047549	1
288	longitudinal isolation of potent near-germline sars-cov-2-neutralizing antibodies from covid-19 patients	kreer, c; zehner, m; weber, t; ercanoglu, ms; gieselmann, l; rohde, c; halwe, s; korenkov, m; schommers, p; vanshylla, k; di cristanziano, v; janicki, h; brinker, r; ashurov, a; krahling, v; kupke, a; cohen-dvashi, h; koch, m; eckert, jm; lederer, s; pfeifer, n; wolf, t; vehreschild, mjgt; wendtner, c; diskin, r; gruell, h; becker, s; klein, f	cell	2020	10.1016/j.cell.2020.06.044	11
289	phytochemicals containing biologically active polyphenols as an effective agent against covid-19-inducing coronavirus	chojnacka, k; witek-krowiak, a; skrzypczak, d; mikula, k; mlynarz, p	journal of functional foods	2020	10.1016/j.jff.2020.104146	1
290	covid-19 pandemic: prevention and protection measures to be adopted at the workplace	cirrincione, l; plescia, f; ledda, c; rapisarda, v; martorana, d; moldovan, re; theodoridou, k; cannizzaro, e	sustainability	2020	10.3390/su12093603	0
291	rapid identification of potential inhibitors of sars-cov-2 main protease by deep docking of 1.3 billion compounds	ton, at; gentile, f; hsing, m; ban, fq; cherkasov, a	molecular informatics	2020	10.1002/minf.202000028	6
292	structural elucidation of sars-cov-2 vital proteins: computational methods reveal potential drug candidates against main protease, nsp12 polymerase and nsp13 helicase	mirza, mu; froeyen, m	journal of pharmaceutical analysis	2020	10.1016/j.jpha.2020.04.008	1
293	covid-19 and sars-cov-2. modeling the present, looking at the future	estrada, e	physics reports-review section of physics letters	2020	10.1016/j.physrep.2020.07.005	0
294	toward nanotechnology-enabled approaches against the covid-19 pandemic	weiss, c; carriere, m; fusco, l; capua, i; regla-nava, ja; pasquali, m; scott, aa; vitale, f; unal, ma; mattevi, c; bedognetti, d; merkoci, a; tasciotti, e; yilmazer, a; gogotsi, y; stellacci, f; delogu, lg	acs nano	2020	10.1021/acsnano.0c03697	4
295	the carnage of substandard research during the covid-19 pandemic: a call for quality	bramstedt, ka	journal of medical ethics	2020	10.1136/medethics-2020-106494	0
296	forecasting the daily and cumulative number of cases for the covid-19 pandemic in india	khajanchi, s; sarkar, k	chaos	2020	10.1063/5.0016240	1
297	a materials-science perspective on tackling covid-19	tang, zm; kong, n; zhang, xc; liu, y; hu, p; mou, s; liljestrom, p; shi, jl; tan, wh; kim, js; cao, yh; langer, r; leong, kw; farokhzad, oc; tao, w	nature reviews materials	2020	10.1038/s41578-020-00247-y	3
298	current drugs with potential for treatment of covid-19: a literature review	rabby, mii	journal of pharmacy and pharmaceutical sciences	2020		2
299	dynamic changes in anti-sars-cov-2 antibodies during sars-cov-2 infection and recovery from covid-19	li, kn; huang, b; wu, m; zhong, af; li, l; cai, y; wang, zh; wu, lx; zhu, my; li, j; wang, zy; wu, w; li, wl; bosco, b; gan, zh; qiao, qh; wu, j; wang, qh; wang, sk; xia, xy	nature communications	2020	10.1038/s41467-020-19943-y	1
300	resilience and demographic characteristics predicting distress during the covid-19 crisis	kimhi, s; marciano, h; eshel, y; adini, b	social science & medicine	2020	10.1016/j.socscimed.2020.113389	0
301	insights into the impact of covid-19 on household travel and activities in australia - the early days under restrictions	beck, mj; hensher, da	transport policy	2020	10.1016/j.tranpol.2020.07.001	2
302	immune response in covid-19: addressing a pharmacological challenge by targeting pathways triggered by sars-cov-2	catanzaro, m; fagiani, f; racchi, m; corsini, e; govoni, s; lanni, c	signal transduction and targeted therapy	2020	10.1038/s41392-020-0191-1	4
303	the covid 19 novel coronavirus pandemic 2020: seaweeds to the rescue? why does substantial, supporting research about the antiviral properties of seaweed polysaccharides seem to go unrecognized by the pharmaceutical community in these desperate times?	pereira, l; critchley, at	journal of applied phycology	2020	10.1007/s10811-020-02143-y	0
304	a review of sars-cov-2 and the ongoing clinical trials	tu, yf; chien, cs; yarmishyn, aa; lin, yy; luo, yh; lin, yt; lai, wy; yang, dm; chou, sj; yang, yp; wang, ml; chiou, sh	international journal of molecular sciences	2020	10.3390/ijms21072657	8
305	rethinking the role of hydroxychloroquine in the treatment of covid-19	meyerowitz, ea; vannier, agl; friesen, mgn; schoenfeld, s; gelfand, ja; callahan, mv; kim, ay; reeves, pm; poznansky, mc	faseb journal	2020	10.1096/fj.202000919	0
306	safety and immunogenicity of sars-cov-2 mrna-1273 vaccine in older adults	anderson, ej; rouphael, ng; widge, at; jackson, la; roberts, pc; makhene, m; chappell, jd; denison, mr; stevens, lj; pruijssers, aj; mcdermott, ab; flach, b; lin, bc; doria-rose, na; o'dell, s; schmidt, sd; corbett, ks; swanson, pa; padilla, m; neuzil, km; bennett, h; leav, b; makowski, m; albert, j; cross, k; edara, vv; floyd, k; suthar, ms; martinez, dr; baric, r; buchanan, w; luke, cj; phadke, vk; rostad, ca; ledgerwood, je; graham, bs; beigel, jh	new england journal of medicine	2020	10.1056/nejmoa2028436	80
307	safety and immunogenicity of chadox1 ncov-19 vaccine administered in a prime-boost regimen in young and old adults (cov002): a single-blind, randomised, controlled, phase 2/3 trial	ramasamy, mn; minassian, am; ewer, kj; flaxman, al; folegatti, pm; owens, dr; voysey, m; aley, pk; angus, b; babbage, g; belij-rammerstorfer, s; berry, l; bibi, s; bittaye, m; cathie, k; chappell, h; charlton, s; cicconi, p; clutterbuck, ea; colin-jones, r; dold, c; emary, krw; fedosyuk, s; fuskova, m; gbesemete, d; green, c; hallis, b; hou, mm; jenkin, d; joe, ccd; kelly, ej; kerridge, s; lawrie, am; lelliott, a; lwin, mn; makinson, r; marchevsky, ng; mujadidi, y; munro, aps; pacurar, m; plested, e; rand, j; rawlinson, t; rhead, s; robinson, h; ritchie, aj; ross-russell, al; saich, s; singh, n; smith, cc; snape, md; song, r; tarrant, r; themistocleous, y; thomas, km; villafana, tl; warren, sc; watson, mee; douglas, ad; hill, avs; lambe, t; gilbert, sc; faust, sn; pollard, aj	lancet	2020	10.1016/s0140-6736(20)32466-1	56
308	a sars-cov-2 vaccine candidate would likely match all currently circulating variants	dearlove, b; lewitus, e; bai, hj; li, yf; reeves, db; joyce, mg; scott, pt; amare, mf; vasan, s; michael, nl; modjarrad, k; rolland, m	proceedings of the national academy of sciences of the united states of	2020	10.1073/pnas.2008281117	4
309	key residues of the receptor binding motif in the spike protein of sars-cov-2 that interact with ace2 and neutralizing antibodies	yi, cy; sun, xy; ye, j; ding, lf; liu, mq; yang, z; lu, x; zhang, yg; ma, ly; gu, wp; qu, ad; xu, jq; shi, zl; ling, zy; sun, b	cellular & molecular immunology	2020	10.1038/s41423-020-0458-z	7
310	adaptation of sars-cov-2 in balb/c mice for testing vaccine efficacy	gu, hj; chen, q; yang, g; he, l; fan, h; deng, yq; wang, yx; teng, y; zhao, zp; cui, yj; li, yc; li, xf; li, jf; zhang, nn; yang, xl; chen, sl; guo, y; zhao, gy; wang, xl; luo, dy; wang, h; yang, x; li, y; han, gc; he, yx; zhou, xj; geng, ss; sheng, xl; jiang, sb; sun, sh; qin, cf; zhou, ys	science	2020	10.1126/science.abc4730	21
311	structure-based design of prefusion-stabilized sars-cov-2 spikes	hsieh, cl; goldsmith, ja; schaub, jm; divenere, am; kuo, hc; javanmardi, k; le, kc; wrapp, d; lee, ag; liu, yt; chou, cw; byrne, po; hjorth, ck; johnson, nv; ludes-meyers, j; nguyen, aw; park, j; wang, ns; amengor, d; lavinder, jj; ippolito, gc; maynard, ja; finkelstein, ij; mclellan, js	science	2020	10.1126/science.abd0826	27
312	sars-cov-2 vaccines in development	krammer, f	nature	2020	10.1038/s41586-020-2798-3	61
313	reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis	so, ad; woo, j	bmj-british medical journal	2020	10.1136/bmj.m4750	4
314	updated approaches against sars-cov-2	li, ho; zhou, yj; zhang, m; wang, hz; zhao, q; liu, j	antimicrobial agents and chemotherapy	2020	10.1128/aac.00483-20	0
315	covid-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties	asif, m; saleem, m; saadullah, m; yaseen, hs; al zarzour, r	inflammopharmacology	2020	10.1007/s10787-020-00744-0	0
316	association between mobility patterns and covid-19 transmission in the usa: a mathematical modelling study	badr, hs; du, hr; marshall, m; dong, es; squire, mm; gardner, lm	lancet infectious diseases	2020	10.1016/s1473-3099(20)30553-3	1
317	seasonal coronavirus protective immunity is short-lasting	edridge, awd; kaczorowska, j; hoste, acr; bakker, m; klein, m; loens, k; jebbink, mf; matser, a; kinsella, cm; rueda, p; ieven, m; goossens, h; prins, m; sastre, p; deijs, m; van der hoek, l	nature medicine	2020	10.1038/s41591-020-1083-1	14
318	persistence and decay of human antibody responses to the receptor binding domain of sars-cov-2 spike protein in covid-19 patients	iyer, as; jones, fk; nodoushani, a; kelly, m; becker, m; slater, d; mills, r; teng, e; kamruzzaman, m; garcia-beltran, wf; astudillo, m; yang, dn; miller, te; oliver, e; fischinger, s; atyeo, c; iafrate, aj; calderwood, sb; lauer, sa; yu, jy; li, zf; feldman, j; hauser, bm; caradonna, tm; branda, ja; turbett, se; larocque, rc; mellon, g; barouch, dh; schmidt, ag; azman, as; alter, g; ryan, et; harris, jb; charles, rc	science immunology	2020	10.1126/sciimmunol.abe0367	13
319	neutralization of sars-cov-2 by destruction of the prefusion spike	huo, jd; zhao, yg; ren, js; zhou, dm; duyvesteyn, hme; ginn, hm; carrique, l; malinauskas, t; ruza, rr; shah, pnm; tan, tk; rijal, p; coombes, n; bewley, kr; tree, ja; radecke, j; paterson, ng; supasa, p; mongkolsapaya, j; screaton, gr; carroll, m; townsend, a; fry, ee; owens, rj; stuart, di	cell host & microbe	2020	10.1016/j.chom.2020.06.010	11
320	attenuated sars-cov-2 variants with deletions at the s1/s2 junction	lau, sy; wang, p; mok, bwy; zhang, anjx; chu, h; lee, acy; deng, sf; chen, p; chan, kh; song, wj; chen, zw; to, kkw; chan, jfw; yuen, ky; chen, hl	emerging microbes & infections	2020	10.1080/22221751.2020.1756700	9
321	a sars-cov-2 surrogate virus neutralization test based on antibody-mediated blockage of ace2-spike protein-protein interaction	tan, cw; chia, wn; qin, xj; liu, p; chen, mic; tiu, c; hu, zl; chen, vcw; young, be; sia, wr; tan, yj; foo, r; yi, yx; lye, dc; anderson, de; wang, lf	nature biotechnology	2020	10.1038/s41587-020-0631-z	13
322	mapping neutralizing and immunodominant sites on the sars-cov-2 spike receptor-binding domain by structure-guided high-resolution serology	piccoli, l; park, yj; tortorici, ma; czudnochowski, n; walls, ac; beltramello, m; silacci-fregni, c; pinto, d; rosen, le; bowen, je; acton, oj; jaconi, s; guarino, b; minola, a; zatta, f; sprugasci, n; bassi, j; peter, a; de marco, a; nix, jc; mele, f; jovic, s; rodriguez, bf; gupta, sv; jin, f; piumatti, g; lo presti, g; pellanda, af; biggiogero, m; tarkowski, m; pizzuto, ms; cameroni, e; havenar-daughton, c; smithey, m; hong, d; lepori, v; albanese, e; ceschi, a; bernasconi, e; elzi, l; ferrari, p; garzoni, c; riva, a; snell, g; sallusto, f; fink, k; virgin, hw; lanzavecchia, a; corti, d; veesler, d	cell	2020	10.1016/j.cell.2020.09.037	34
323	quick covid-19 healers sustain anti-sars-cov-2 antibody production	chen, yz; zuiani, a; fischinger, s; mullur, j; atyeo, c; travers, m; lelis, fjn; pullen, km; martin, h; tong, p; gautam, a; habibi, s; bensko, j; gakpo, d; feldman, j; hauser, bm; caradonna, tm; cai, yf; burke, js; lin, jr; lederer, ja; lam, ec; lavine, cl; seaman, ms; chen, b; schmidt, ag; balazs, ab; lauffenburger, da; alter, g; wesemann, dr	cell	2020	10.1016/j.cell.2020.10.051	3
324	sars-cov-2 proteome microarray for mapping covid-19 antibody interactions at amino acid resolution	wang, hy; wu, x; zhang, xm; hou, x; liang, t; wang, d; teng, f; dai, jy; duan, h; guo, sb; li, yz; yu, xb	acs central science	2020	10.1021/acscentsci.0c00742	4
325	lessons learnt from easing covid-19 restrictions: an analysis of countries and regions in asia pacific and europe	han, e; tan, mmj; turk, e; sridhar, d; leung, gm; shibuya, k; asgari, n; oh, j; garcia-basteiro, al; hanefeld, j; cook, ar; hsu, l; teo, yy; heymann, d; clark, h; mckee, m; legido-quigley, h	lancet	2020	10.1016/s0140-6736(20)32007-9	3
326	conspiracy beliefs are associated with lower knowledge and higher anxiety levels regarding covid-19 among students at the university of jordan	sallam, m; dababseh, d; yaseen, a; al-haidar, a; ababneh, na; bakri, fg; mahafzah, a	international journal of environmental research and public health	2020	10.3390/ijerph17144915	3
327	current knowledge of covid-19 and infection prevention and control strategies in healthcare settings: a global analysis	islam, ms; rahman, km; sun, yn; qureshi, mo; abdi, i; chughtai, aa; seale, h	infection control and hospital epidemiology	2020	10.1017/ice.2020.237	0
328	modeling and analysis of covid-19 epidemics with treatment in fractional derivatives using real data from pakistan	naik, pa; yavuz, m; qureshi, s; zu, j; townley, s	european physical journal plus	2020	10.1140/epjp/s13360-020-00819-5	0
329	longitudinal covid-19 profiling associates il-1ra and il-10 with disease severity and rantes with mild disease	zhao, y; qin, l; zhang, p; li, k; liang, lc; sun, jp; xu, b; dai, yc; li, xm; zhang, c; peng, yc; feng, ym; li, a; hu, zj; xiang, hp; ogg, g; ho, lp; mcmichael, a; jin, rh; knight, jc; dong, t; zhang, yh	jci insight	2020	10.1172/jci.insight.139834	2
330	comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among covid-19 patients: a systemic review and meta-analysis	wang, xh; fang, xx; cai, zx; wu, xt; gao, xt; min, jx; wang, fd	research	2020	10.34133/2020/2402961	1
331	a vaccine targeting the rbd of the s protein of sars-cov-2 induces protective immunity	yang, jy; wang, w; chen, zm; lu, sy; yang, fl; bi, zf; bao, ll; mo, f; li, x; huang, y; hong, wq; yang, y; zhao, y; ye, f; lin, s; deng, w; chen, h; lei, h; zhang, zq; luo, m; gao, h; zheng, y; gong, yq; jiang, xh; xu, yf; lv, q; li, d; wang, mn; li, fd; wang, sy; wang, gp; yu, p; qu, yj; yang, l; deng, hx; tong, ap; li, j; wang, zl; yang, jl; shen, gb; zhao, zw; li, yh; luo, jw; liu, hq; yu, wh; yang, ml; xu, jw; wang, jb; li, hy; wang, hx; kuang, dx; lin, pp; hu, zt; guo, w; cheng, w; he, yl; song, xr; chen, c; xue, zh; yao, sh; chen, l; ma, xl; chen, sy; gou, ml; huang, wj; wang, yc; fan, cf; tian, zx; shi, m; wang, fs; dai, lz; wu, m; li, g; wang, gy; peng, y; qian, zy; huang, ch; lau, jyn; yang, zl; wei, yq; cen, xb; peng, xz; qin, c; zhang, k; lu, gw; wei, xw	nature	2020	10.1038/s41586-020-2599-8	13
332	multi-omics resolves a sharp disease-state shift between mild and moderate covid-19	su, yp; chen, d; yuan, d; lausted, c; choi, j; dai, czl; voillet, v; duvvuri, vr; scherler, k; troisch, p; baloni, p; qin, gr; smith, b; kornilov, sa; rostomily, c; xu, a; li, j; dong, s; rothchild, a; zhou, j; murray, k; edmark, r; hong, sg; heath, je; earls, j; zhang, ry; xie, jy; li, s; roper, r; jones, l; zhou, y; rowen, l; liu, r; mackay, s; o'mahony, ds; dale, cr; wallick, ja; algren, ha; zager, ma; wei, w; price, nd; huang, s; subramanian, n; wang, k; magis, at; hadlock, jj; hood, l; aderem, a; bluestone, ja; lanier, ll; greenberg, pd; gottardo, r; davis, mm; goldman, jd; heath, jr	cell	2020	10.1016/j.cell.2020.10.037	0
333	face mask use in the general population and optimal resource allocation during the covid-19 pandemic	worby, cj; chang, hh	nature communications	2020	10.1038/s41467-020-17922-x	2
334	human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2	nguyen, a; david, jk; maden, sk; wood, ma; weeder, br; nellore, a; thompson, rf	journal of virology	2020	10.1128/jvi.00510-20	0
335	covid-19 and individual genetic susceptibility/receptivity: role of ace1/ace2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against sars-cov-2 compared to the single x-chromosome in males?	gemmati, d; bramanti, b; serino, ml; secchiero, p; zauli, g; tisato, v	international journal of molecular sciences	2020	10.3390/ijms21103474	0
336	challenges in laboratory diagnosis of the novel coronavirus sars-cov-2	younes, n; al-sadeq, dw; al-jighefee, h; younes, s; al-jamal, o; daas, hi; yassine, hm; nasrallah, gk	viruses-basel	2020	10.3390/v12060582	2
337	individualizing risk prediction for positive coronavirus disease 2019 testing results from 11,672 patients	jehi, l; ji, xg; milinovich, a; erzurum, s; rubin, bp; gordon, s; young, jb; kattan, mw	chest	2020	10.1016/j.chest.2020.05.580	0
338	a national survey assessing sars-cov-2 vaccination intentions: implications for future public health communication efforts	head, kj; kasting, ml; sturm, la; hartsock, ja; zimet, gd	science communication	2020	10.1177/1075547020960463	9
339	the advisory committee on immunization practices' ethica principles for allocating initial supplies of covid-19 vaccine - united states, 2020	mcclung, n; chamberland, m; kinlaw, k; matthew, db; wallace, m; bell, bp; lee, gm; talbot, hk; romero, jr; oliver, se; dooling, k	mmwr-morbidity and mortality weekly report	2020		4
340	the advisory committee on immunization practices' interim recommendation for allocating initial supplies of covid-19 vaccine - united states, 2020	dooling, k; mcclung, n; chamberland, m; marin, m; wallace, m; bell, bp; lee, gm; talbot, hk; romero, jr; oliver, se	mmwr-morbidity and mortality weekly report	2020	10.15585/mmwr.mm6949e1	14
341	a systematic review of sars-cov-2 vaccine candidates	dong, yt; dai, t; wei, yj; zhang, l; zheng, m; zhou, ff	signal transduction and targeted therapy	2020	10.1038/s41392-020-00352-y	10
342	changes in health services use among commercially insured us populations during the covid-19 pandemic	whaley, cm; pera, mf; cantor, j; chang, j; velasco, j; hagg, hk; sood, n; bravata, dm	jama network open	2020	10.1001/jamanetworkopen.2020.24984	0
343	sars-cov-2 jumping the species barrier: zoonotic lessons from sars, mers and recent advances to combat this pandemic virus	dhama, k; patel, sk; sharun, k; pathak, m; tiwari, r; yatoo, mi; malik, ys; sah, r; rabaan, aa; panwar, pk; singh, kp; michalak, i; chaicumpa, w; martinez-pulgarin, df; bonilla-aldana, dk; rodriguez-morales, aj	travel medicine and infectious disease	2020	10.1016/j.tmaid.2020.101830	2
344	evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside hubei province, china: a descriptive and modelling study	zhang, jj; litvinova, m; wang, w; wang, y; deng, xw; chen, xh; li, m; zheng, w; yi, l; chen, xh; wu, qh; liang, yx; wang, xl; yang, j; sun, ky; longini, im; halloran, me; wu, p; cowling, bj; merler, s; viboud, c; vespignani, a; ajelli, m; yu, hj	lancet infectious diseases	2020	10.1016/s1473-3099(20)30230-9	8
345	epidemiology and transmission dynamics of covid-19 in two indian states	laxminarayan, r; wahl, b; dudala, sr; gopal, k; mohan, bc; neelima, s; reddy, ksj; radhakrishnan, j; lewnard, ja	science	2020	10.1126/science.abd7672	2
346	a single dose of an adenovirus-vectored vaccine provides protection against sars-cov-2 challenge	wu, sp; zhong, gx; zhang, j; shuai, l; zhang, z; wen, zy; wang, bs; zhao, zh; song, xh; chen, y; liu, rq; fu, l; zhang, jl; guo, q; wang, c; yang, yl; fang, t; lv, p; wang, jl; xu, jj; li, jm; yu, cm; hou, lh; bu, zg; chen, w	nature communications	2020	10.1038/s41467-020-17972-1	11
347	the advisory committee on immunization practices' interim recommendation for use of pfizer-biontech covid-19 vaccine - united states, december 2020	oliver, se; gargano, jw; marin, m; wallace, m; curran, kg; chamberland, m; mcclung, n; campos-outcalt, d; morgan, rl; mbaeyi, s; romero, jr; talbot, hk; lee, gm; bell, bp; dooling, k	mmwr-morbidity and mortality weekly report	2020		18
348	carrying out rapid qualitative research during a pandemic: emerging lessons from covid-19	vindrola-padros, c; chisnall, g; cooper, s; dowrick, a; djellouli, n; symmons, sm; martin, s; singleton, g; vanderslott, s; vera, n; johnson, ga	qualitative health research	2020	10.1177/1049732320951526	1
349	sars-cov-2 mrna vaccine design enabled by prototype pathogen preparedness	corbett, ks; edwards, dk; leist, sr; abiona, om; boyoglu-barnum, s; gillespie, ra; himansu, s; schafer, a; ziwawo, ct; dipiazza, at; dinnon, kh; elbashir, sm; shaw, ca; woods, a; fritch, ej; martinez, dr; bock, kw; minai, m; nagata, bm; hutchinson, gb; wu, k; henry, c; bahl, k; garcia-dominguez, d; ma, lz; renzi, i; kong, wp; schmidt, sd; wang, ls; zhang, y; phung, e; chang, la; loomis, rj; altaras, ne; narayanan, e; metkar, m; presnyak, v; liu, c; louder, mk; shi, w; leung, k; yang, es; west, a; gully, kl; west, a; gully, kl; wang, ns; wrapp, d; doria-rose, na; stewart-jones, g; bennett, h; alvarado, gs; nason, mc; ruckwardt, tj; mclellan, js; denison, mr; chappell, jd; moore, in; morabito, km; mascola, jr; baric, rs; carfi, a; graham, bs	nature	2020	10.1038/s41586-020-2622-0	8
350	ad26 vaccine protects against sars-cov-2 severe clinical disease in hamsters	tostanoski, lh; wegmann, f; martinot, aj; loos, c; mcmahan, k; mercado, nb; yu, jy; chan, cn; bondoc, s; starke, ce; nekorchuk, m; busman-sahay, k; piedra-mora, c; wrijil, lm; ducat, s; custers, j; atyeo, c; fischinger, s; burke, js; feldman, j; hauser, bm; caradonna, tm; bondzie, ea; dagotto, g; gebre, ms; jacob-dolan, c; lin, zj; mahrokhian, sh; nampanya, f; nityanandam, r; pessaint, l; porto, m; ali, v; benetiene, d; tevi, k; andersen, h; lewis, mg; schmidt, ag; lauffenburger, da; alter, g; estes, jd; schuitemaker, h; zahn, r; barouch, dh	nature medicine	2020	10.1038/s41591-020-1070-6	17
351	distinct conformational states of sars-cov-2 spike protein	cai, yf; zhang, j; xiao, ts; peng, hq; sterling, sm; walsh, rm; rawson, s; rits-volloch, s; chen, b	science	2020	10.1126/science.abd4251	8
352	characterisation of the transcriptome and proteome of sars-cov-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein	davidson, ad; williamson, mk; lewis, s; shoemark, d; carroll, mw; heesom, kj; zambon, m; ellis, j; lewis, pa; hiscox, ja; matthews, da	genome medicine	2020	10.1186/s13073-020-00763-0	6
353	free fatty acid binding pocket in the locked structure of sars-cov-2 spike protein	toelzer, c; gupta, k; yadav, skn; borucu, u; davidson, ad; williamson, mk; shoemark, dk; garzoni, f; staufer, o; milligan, r; capin, j; mulholland, aj; spatz, j; fitzgerald, d; berger, i; schaffitzel, c	science	2020	10.1126/science.abd3255	3
354	structural analysis of full-length sars-cov-2 spike protein from an advanced vaccine candidate	bangaru, s; ozorowski, g; turner, hl; antanasijevic, a; huang, dl; wang, xn; torres, jl; diedrich, jk; tian, jh; portnoff, ad; patel, n; massare, mj; yates, iii; nemazee, d; paulson, jc; glenn, g; smith, g; ward, ab	science	2020	10.1126/science.abe1502	14
355	detection of sars-cov-2 among residents and staff members of an independent and assisted living community for older adults - seattle, washington, 2020	roxby, ac; greninger, a; hatfield, km; lynch, jb; dellit, th; james, a; taylor, j; page, lc; kimball, a; arons, m; schieve, la; munanga, a; stone, n; jernigan, ja; reddy, sc; lewis, j; cohen, sa; jerome, kr; duchin, js; neme, s	mmwr-morbidity and mortality weekly report	2020	10.15585/mmwr.mm6914e2	1
356	outbreak investigation of covid-19 among residents and staff of an independent and assisted living community for older adults in seattle, washington	roxby, ac; greninger, al; hatfield, km; lynch, jb; dellit, th; james, a; taylor, j; page, lc; kimball, a; arons, m; munanga, a; stone, n; jernigan, ja; reddy, sc; lewis, j; cohen, sa; jerome, kr; duchin, js; neme, s	jama internal medicine	2020	10.1001/jamainternmed.2020.2233	1
357	humoral response and pcr positivity in patients with covid-19 in the new york city region, usa: an observational study	wajnberg, a; mansour, m; leven, e; bouvier, nm; patel, g; firpo-betancourt, a; mendu, r; jhang, j; arinsburg, s; gitman, m; houldsworth, j; sordillo, e; paniz-mondolfi, a; baine, i; simon, v; aberg, j; krammer, f; reich, d; cordon-cardo, c	lancet microbe	2020	10.1016/s2666-5247(20)30120-8	2
358	effects of the covid-19 pandemic on routine pediatric vaccine ordering and administration - united states, 2020	santoli, jm; lindley, mc; desilva, mb; kharbanda, eo; daley, mf; galloway, l; gee, j; glover, m; herring, b; kang, y; lucas, p; noblit, c; tropper, j; vogt, t; weintraub, e	mmwr-morbidity and mortality weekly report	2020	10.15585/mmwr.mm6919e2	2
359	masks do more than protect others during covid-19: reducing the inoculum of sars-cov-2 to protect the wearer	gandhi, m; beyrer, c; goosby, e	journal of general internal medicine	2020	10.1007/s11606-020-06067-8	1
360	coronavirus disease 2019: a bibliometric analysis and review	lou, j; tian, sj; niu, sm; kang, xq; lian, hx; zhang, lx; zhang, jj	european review for medical and pharmacological sciences	2020		0
361	diet supplementation, probiotics, and nutraceuticals in sars-cov-2 infection: a scoping review	infusino, f; marazzato, m; mancone, m; fedele, f; mastroianni, cm; severino, p; ceccarelli, g; santinelli, l; cavarretta, e; marullo, agm; miraldi, f; carnevale, r; nocella, c; biondi-zoccai, g; pagnini, c; schiavon, s; pugliese, f; frati, g; d'ettorre, g	nutrients	2020	10.3390/nu12061718	1
362	an alphavirus-derived replicon rna vaccine induces sars-cov-2 neutralizing antibody and t cell responses in mice and nonhuman primates	erasmus, jh; khandhar, ap; o'connor, ma; walls, ac; hemann, ea; murapa, p; archer, j; leventhal, s; fuller, jt; lewis, tb; draves, ke; randall, s; guerriero, ka; duthie, ms; carter, d; reed, sg; hawman, dw; feldmann, h; gale, m; veesler, d; berglund, p; fuller, dh	science translational medicine	2020	10.1126/scitranslmed.abc9396	5
363	the genetic sequence, origin, and diagnosis of sars-cov-2	wang, hh; li, xm; li, t; zhang, sb; wang, lz; wu, x; liu, jq	european journal of clinical microbiology & infectious diseases	2020	10.1007/s10096-020-03899-4	2
364	diagnostic methods and potential portable biosensors for coronavirus disease 2019	cui, fy; zhou, hss	biosensors & bioelectronics	2020	10.1016/j.bios.2020.112349	3
365	intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: a cross-sectional survey	wang, kl; wong, ely; ho, kf; cheung, awl; chan, eyy; yeoh, ek; wong, sys	vaccine	2020	10.1016/j.vaccine.2020.09.021	17
366	prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - united states, 2020-21 influenza season	grohskopf, la; alyanak, e; broder, kr; blanton, lh; fry, am; jernigan, db; atmar, rl	mmwr recommendations and reports	2020	10.15585/mmwr.rr6908a1	1
367	type i and type iii interferons restrict sars-cov-2 infection of human airway epithelial cultures	vanderheiden, a; ralfs, p; chirkova, t; upadhyay, aa; zimmerman, mg; bedoya, s; aoued, h; tharp, gm; pellegrini, kl; manfredi, c; sorscher, e; mainou, b; lobby, jl; kohlmeier, je; lowen, ac; shi, py; menachery, vd; anderson, lj; grakoui, a; bosinger, se; suthar, ms	journal of virology	2020	10.1128/jvi.00985-20	0
368	sars-cov-2: structure, biology, and structure-based therapeutics development	wang, my; zhao, r; gao, lj; gao, xf; wang, dp; cao, jm	frontiers in cellular and infection microbiology	2020	10.3389/fcimb.2020.587269	1
369	sars-cov-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists	yuen, ck; lam, jy; wong, wm; mak, lf; wang, xh; chu, h; cai, jp; jin, dy; to, kkw; chan, jfw; yuen, ky; kok, kh	emerging microbes & infections	2020	10.1080/22221751.2020.1780953	4
370	insight into 2019 novel coronavirus - an updated interim review and lessons from sars-cov and mers-cov	xie, mx; chen, q	international journal of infectious diseases	2020	10.1016/j.ijid.2020.03.071	1
371	a nanoluciferase sars-cov-2 for rapid neutralization testing and screening of anti-infective drugs for covid-19	xie, xp; muruato, ae; zhang, xw; lokugamage, kg; fontes-garfias, cr; zou, j; liu, jy; ren, p; balakrishnan, m; cihlar, t; tseng, ctk; makino, s; menachery, vd; bilello, jp; shi, py	nature communications	2020	10.1038/s41467-020-19055-7	1
372	current knowledge about the antivirals remdesivir (gs-5734) and gs-441524 as therapeutic options for coronaviruses	amirian, es; levy, jk	one health	2020	10.1016/j.onehlt.2020.100128	1
373	analysis of a sars-cov-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation	seydoux, e; homad, lj; maccamy, aj; parks, kr; hurlburt, nk; jennewein, mf; akins, nr; stuart, ab; wan, yh; feng, jl; whaley, re; singh, s; boeckh, m; cohen, kw; mcelrath, mj; englund, ja; chu, hy; pancera, m; mcguire, at; stamatatos, l	immunity	2020	10.1016/j.immuni.2020.06.001	5
374	peptide and peptide-based inhibitors of sars-cov-2 entry	schutz, d; ruiz-blanco, yb; munch, j; kirchhoff, f; sanchez-garcia, e; muller, ja	advanced drug delivery reviews	2020		2
375	bioactive natural compounds against human coronaviruses: a review and perspective	xian, yf; zhang, j; bian, zx; zhou, h; zhang, zb; lin, zx; xu, hx	acta pharmaceutica sinica b	2020	10.1016/j.apsb.2020.06.002	0
376	structural genomics of sars-cov-2 indicates evolutionary conserved functional regions of viral proteins	srinivasan, s; cui, hz; gao, zy; liu, m; lu, sb; mkandawire, w; narykov, o; sun, m; korkin, d	viruses-basel	2020	10.3390/v12040360	4
377	the natural history, pathobiology, and clinical manifestations of sars-cov-2 infections	machhi, j; herskovitz, j; senan, am; dutta, d; nath, b; oleynikov, md; blomberg, wr; meigs, dd; hasan, m; patel, m; kline, p; chang, rcc; chang, ld; gendelman, he; kevadiya, bd	journal of neuroimmune pharmacology	2020	10.1007/s11481-020-09944-5	4
378	the dynamics of humoral immune responses following sars-cov-2 infection and the potential for reinfection	kellam, p; barclay, w	journal of general virology	2020	10.1099/jgv.0.001439	3
379	multicenter initial guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2	chiotos, k; hayes, m; kimberlin, dw; jones, sb; james, sh; pinninti, sg; yarbrough, a; abzug, mj; macbrayne, ce; soma, vl; dulek, de; vora, sb; waghmare, a; wolf, j; olivero, r; grapentine, s; wattier, rl; bio, l; cross, sj; dillman, no; downes, kj; timberlake, k; young, j; orscheln, rc; tamma, pd; schwenk, ht; zachariah, p; aldrich, m; goldman, dl; groves, he; lamb, gs; tribble, ac; hersh, al; thorell, ea; denison, mr; ratner, aj; newland, jg; nakamura, mm	journal of the pediatric infectious diseases society	2020	10.1093/jpids/piaa045	2
380	potential applications of plant biotechnology against sars-cov-2	capell, t; twyman, rm; armario-najera, v; ma, jkc; schillberg, s; christou, p	trends in plant science	2020	10.1016/j.tplants.2020.04.009	0
381	hydroxychloroquine use against sars-cov-2 infection in non-human primates	maisonnasse, p; guedj, j; contreras, v; behillil, s; solas, c; marlin, r; naninck, t; pizzorno, a; lemaitre, j; goncalves, a; kahlaoui, n; terrier, o; fang, rht; enouf, v; dereuddre-bosquet, n; brisebarre, a; touret, f; chapon, c; hoen, b; lina, b; calatrava, mr; van der werf, s; de lamballerie, x; le grand, r	nature	2020	10.1038/s41586-020-2558-4	1
382	genotyping coronavirus sars-cov-2: methods and implications	yin, cc	genomics	2020	10.1016/j.ygeno.2020.04.016	2
383	community and close contact exposures associated with covid-19 among symptomatic adults >= 18years in 11 outpatient health care facilities - united states, july 2020	fisher, ka; tenforde, mw; feldstein, lr; lindsell, cj; shapiro, ni; files, dc; gibbs, kw; erickson, hl; prekker, me; steingrub, js; exline, mc; henning, dj; wilson, jg; brown, sm; peltan, id; rice, tw; hager, dn; ginde, aa; talbot, k; casey, jd; grijalva, cg; flannery, b; patel, mm; self, wh	mmwr-morbidity and mortality weekly report	2020		1
384	vitamin d receptor stimulation to reduce acute respiratory distress syndrome (ards) in patients with coronavirus sars-cov-2 infections revised ms sbmb 2020_166	quesada-gomez, jm; entrenas-castillo, m; bouillon, r	journal of steroid biochemistry and molecular biology	2020	10.1016/j.jsbmb.2020.105719	0
385	fruitful neutralizing antibody pipeline brings hope to defeat sars-cov-2	renn, a; fu, y; hall, md; simeonov, a; hu, x	trends in pharmacological sciences	2020	10.1016/j.tips.2020.07.004	2
386	increasing temperature and relative humidity accelerates inactivation of sars-cov-2 on surfaces	biryukov, j; boydston, ja; dunning, ra; yeager, jj; wood, s; reese, al; ferris, a; miller, d; weaver, w; zeitouni, ne; phillips, a; freeburger, d; hooper, i; ratnesar-shumate, s; yolitz, j; krause, m; williams, g; dawson, dg; herzog, a; dabisch, p; wahl, v; hevey, mc; altamura, la	msphere	2020	10.1128/msphere.00441-20	0
387	animal models of mechanisms ofsars-cov-2infection andcovid-19pathology	cleary, sj; pitchford, sc; amison, rt; carrington, r; cabrera, clr; magnen, m; looney, mr; gray, e; page, cp	british journal of pharmacology	2020	10.1111/bph.15143	3
388	discovery and genomic characterization of a 382-nucleotide deletion in orf7b and orf8 during the early evolution of sars-cov-2	su, ycf; anderson, de; young, be; linster, m; zhu, f; jayakumar, j; zhuang, y; kalimuddin, s; low, jgh; tan, cw; chia, wn; mak, tm; octavia, s; chavatte, jm; lee, rtc; pada, s; tan, sy; sun, l; yan, gz; maurer-stroh, s; mendenhall, ih; leo, ys; lye, dc; wang, lf; smith, gjd	mbio	2020	10.1128/mbio.01610-20	0
389	performance characteristics of the abbott architect sars-cov-2 igg assay and seroprevalence in boise, idaho	bryan, a; pepper, g; wener, mh; fink, sl; morishima, c; chaudhary, a; jerome, kr; mathias, pc; greninger, al	journal of clinical microbiology	2020	10.1128/jcm.00941-20	0
390	a mouse-adapted sars-cov-2 induces acute lung injury and mortality in standard laboratory mice	leist, sr; dinnon, kh; schafer, a; tse, lv; okuda, k; hou, yxj; west, a; edwards, ce; sanders, w; fritch, ej; gully, kl; scobey, t; brown, aj; sheahan, tp; moorman, nj; boucher, rc; gralinski, le; montgomery, sa; baric, rs	cell	2020	10.1016/j.cell.2020.09.050	9
391	structural and functional conservation of the programmed-1 ribosomal frameshift signal of sars coronavirus 2 (sars-cov-2)	kelly, ja; olson, an; neupane, k; munshi, s; san emeterio, j; pollack, l; woodside, mt; dinman, jd	journal of biological chemistry	2020	10.1074/jbc.ac120.013449	1
392	the molecular virology of coronaviruses	hartenian, e; nandakumar, d; lari, a; ly, m; tucker, jm; glaunsinger, ba	journal of biological chemistry	2020	10.1074/jbc.rev120.013930	0
393	structural and evolutionary analysis indicate that the sars-cov-2 mpro is a challenging target for small-molecule inhibitor design	bzowka, m; mitusinska, k; raczynska, a; samol, a; tuszynski, ja; gora, a	international journal of molecular sciences	2020	10.3390/ijms21093099	2
394	decline in child vaccination coverage during the covid-19 pandemic - michigan care improvement registry, may 2016-may 2020	bramer, ca; kimmins, lm; swanson, r; kuo, j; vranesich, p; jacques-carroll, la; shen, ak	mmwr-morbidity and mortality weekly report	2020	10.15585/mmwr.mm6920e1	1
395	deducing the n- and o-glycosylation profile of the spike protein of novel coronavirus sars-cov-2	shajahan, a; supekar, nt; gleinich, as; azadi, p	glycobiology	2020	10.1093/glycob/cwaa042	11
396	rapid production of sars-cov-2 receptor binding domain (rbd) and spike specific monoclonal antibody cr3022 in nicotiana benthamiana	rattanapisit, k; shanmugaraj, b; manopwisedjaroen, s; purwono, pb; siriwattananon, k; khorattanakulchai, n; hanittinan, o; boonyayothin, w; thitithanyanont, a; smith, dr; phoolcharoen, w	scientific reports	2020	10.1038/s41598-020-74904-1	0
397	identification of sars-cov rbd-targeting monoclonal antibodies with cross-reactive or neutralizing activity against sars-cov-2	tai, wb; zhang, xj; he, yx; jiang, sb; du, ly	antiviral research	2020	10.1016/j.antiviral.2020.104820	3
398	crystallographic and electrophilic fragment screening of the sars-cov-2 main protease	douangamath, a; fearon, d; gehrtz, p; krojer, t; lukacik, p; owen, cd; resnick, e; strain-damerell, c; aimon, a; abranyi-balogh, p; brandao-neto, j; carbery, a; davison, g; dias, a; downes, td; dunnett, l; fairhead, m; firth, jd; jones, sp; keeley, a; keseru, gm; klein, hf; martin, mp; noble, mem; o'brien, p; powell, a; reddi, rn; skyner, r; snee, m; waring, mj; wild, c; london, n; von delft, f; walsh, ma	nature communications	2020	10.1038/s41467-020-18709-w	2
399	boceprevir, gc-376, and calpain inhibitors ii, xii inhibit sars-cov-2 viral replication by targeting the viral main protease	ma, cl; sacco, md; hurst, b; townsend, ja; hu, ym; szeto, t; zhang, xj; tarbet, b; marty, mt; chen, y; wang, j	cell research	2020	10.1038/s41422-020-0356-z	3
400	the sars-cov-2 main protease as drug target	ullrich, s; nitsche, c	bioorganic & medicinal chemistry letters	2020	10.1016/j.bmcl.2020.127377	2
401	assessment of knowledge, attitudes, and practices towards new coronavirus (sars-cov-2) of health care professionals in greece before the outbreak period	papagiannis, d; malli, f; raptis, dg; papathanasiou, iv; fradelos, ec; daniil, z; rachiotis, g; gourgoulianis, ki	international journal of environmental research and public health	2020	10.3390/ijerph17144925	4
402	potently neutralizing and protective human antibodies against sars-cov-2	zost, sj; gilchuk, p; case, jb; binshtein, e; chen, rte; nkolola, jp; schafer, a; reidy, jx; trivette, a; nargi, rs; sutton, re; suryadevara, n; martinez, dr; williamson, le; chen, eec; jones, t; day, s; myers, l; hassan, ao; kafai, nm; winkler, es; fox, jm; shrihari, s; mueller, bk; meiler, j; chandrashekar, a; mercado, nb; steinhardt, jj; ren, ks; loo, ym; kallewaard, nl; mccune, bt; keeler, sp; holtzman, mj; barouch, dh; gralinski, le; baric, rs; thackray, lb; diamond, ms; carnahan, rh; crowe, je	nature	2020	10.1038/s41586-020-2548-6	21
403	lethality of sars-cov-2 infection in k18 human angiotensin-converting enzyme 2 transgenic mice	oladunni, fs; park, jg; pino, pa; gonzalez, o; akhter, a; allue-guardia, a; olmo-fontanez, a; gautam, s; garcia-vilanova, a; ye, cj; chiem, k; headley, c; dwivedi, v; parodi, lm; alfson, kj; staples, hm; schami, a; garcia, ji; whigham, a; platt, rn; gazi, m; martinez, j; chuba, c; earley, s; rodriguez, oh; mdaki, sd; kavelish, kn; escalona, r; hallam, cra; christie, c; patterson, jl; anderson, tjc; carrion, r; dick, ej; hall-ursone, s; schlesinger, ls; alvarez, x; kaushal, d; giavedoni, ld; turner, j; martinez-sobrido, l; torrelles, jb	nature communications	2020	10.1038/s41467-020-19891-7	1
404	discovery of sars-cov-2 antiviral drugs through large-scale compound repurposing	riva, l; yuan, sf; yin, x; martin-sancho, l; matsunaga, n; pache, l; burgstaller-muehlbacher, s; de jesus, pd; teriete, p; hull, mv; chang, mw; chan, jfw; cao, jl; poon, vkm; herbert, km; cheng, ky; nguyen, tth; rubanov, a; pu, y; nguyen, c; choi, a; rathnasinghe, r; schotsaert, m; miorin, l; dejosez, m; zwaka, tp; sit, ky; martinez-sobrido, l; liu, wc; white, km; chapman, me; lendy, ek; glynne, rj; albrecht, r; ruppin, e; mesecar, ad; johnson, jr; benner, c; sun, r; schultz, pg; su, ai; garcia-sastre, a; chatterjee, ak; yuen, ky; chanda, sk	nature	2020	10.1038/s41586-020-2577-1	5
405	a comparison of four serological assays for detecting anti-sars-cov-2 antibodies in human serum samples from different populations	grzelak, l; temmam, s; planchais, c; demeret, c; tondeur, l; huon, c; guivel-benhassine, f; staropoli, i; chazal, m; dufloo, j; planas, d; buchrieser, j; rajah, mm; robinot, r; porrot, f; albert, m; chen, ky; crescenzo-chaigne, b; donati, f; anna, f; souque, p; gransagne, m; bellalou, j; nowakowski, m; backovic, m; bouadma, l; le fevre, l; le hingrat, q; descamps, d; pourbaix, a; laouenan, c; ghosn, j; yazdanpanah, y; besombes, c; jolly, n; pellerin-fernandes, s; cheny, o; ungeheuer, mn; mellon, g; morel, p; rolland, s; rey, fa; behillil, s; enouf, v; lemaitre, a; creach, ma; petres, s; escriou, n; charneau, p; fontanet, a; hoen, b; bruel, t; eloit, m; mouquet, h; schwartz, o; van der werf, s	science translational medicine	2020	10.1126/scitranslmed.abc3103	10
406	cross-sectional evaluation of humoral responses against sars-cov-2 spike	prevost, j; gasser, r; beaudoin-bussieres, g; richard, j; duerr, r; laumaea, a; anand, sp; goyette, g; benlarbi, m; ding, sl; medjahed, h; lewin, a; perreault, j; tremblay, t; gendron-lepage, g; gauthier, n; carrier, m; marcoux, d; piche, a; lavoie, m; benoit, a; loungnarath, v; brochu, g; haddad, e; stacey, hd; miller, ms; desforges, m; talbot, pj; maule, gtg; cote, m; therrien, c; serhir, b; bazin, r; roger, m; finzi, a	cell reports medicine	2020	10.1016/j.xcrm.2020.100126	8
407	antibody signature induced by sars-cov-2 spike protein immunogens in rabbits	ravichandran, s; coyle, em; klenow, l; tang, jj; grubbs, g; liu, sf; wang, t; golding, h; khurana, s	science translational medicine	2020	10.1126/scitranslmed.abc3539	5
408	crystal structure of nsp15 endoribonuclease nendou from sars-cov-2	kim, y; jedrzejczak, r; maltseva, ni; wilamowski, m; endres, m; godzik, a; michalska, k; joachimiak, a	protein science	2020	10.1002/pro.3873	4
409	use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in wuhan, china: cross sectional study	liu, m; cheng, sz; xu, kw; yang, y; zhu, qt; zhang, h; yang, dy; cheng, sy; xiao, h; wang, jw; yao, hr; cong, yt; zhou, yq; peng, s; kuang, m; hou, ff; cheng, kk; xiao, hp	bmj-british medical journal	2020	10.1136/bmj.m2195	2
410	application of nanomaterials in treatment, anti-infection and detection of coronaviruses	nikaeen, g; abbaszadeh, s; yousefinejad, s	nanomedicine	2020	10.2217/nnm-2020-0117	0
411	structural basis for neutralization of sars-cov-2 and sars-cov by a potent therapeutic antibody	lv, z; deng, yq; ye, q; cao, l; sun, cy; fan, cf; huang, wj; sun, sh; sun, y; zhu, l; chen, q; wang, n; nie, jh; cui, z; zhu, dd; shaw, n; li, xf; li, qq; xie, lz; wang, yc; rao, zh; qin, cf; wang, xx	science	2020	10.1126/science.abc5881	13
412	sars-cov-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study	shields, a; faustini, se; perez-toledo, m; jossi, s; aldera, e; allen, jd; al-taei, s; backhouse, c; bosworth, a; dunbar, la; ebanks, d; emmanuel, b; garvey, m; gray, j; kidd, im; mcginnell, g; mcloughlin, de; morley, g; o'neill, j; papakonstantinou, d; pickles, o; poxon, c; richter, m; walker, em; wanigasooriya, k; watanabe, y; whalley, c; zielinska, ae; crispin, m; wraith, dc; beggs, ad; cunningham, af; drayson, mt; richter, ag	thorax	2020	10.1136/thoraxjnl-2020-215414	0
413	structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation	mccallum, m; walls, ac; bowen, je; corti, d; veesler, d	nature structural & molecular biology	2020	10.1038/s41594-020-0483-8	1
414	effects of a major deletion in the sars-cov-2 genome on the severity of infection and the inflammatory response: an observational cohort study	young, be; fong, sw; chan, yh; mak, tm; ang, lw; anderson, de; lee, cyp; amrun, sn; lee, b; goh, ys; su, ycf; wei, we; kalimuddin, s; chai, lya; pada, s; tan, sy; sun, l; parthasarathy, p; chen, yyc; barkham, t; lin, rtp; maurer-stroh, s; leo, ys; wang, lf; renia, l; lee, vj; smith, gjd; lye, dc; ng, lfp	lancet	2020	10.1016/s0140-6736(20)31757-8	8
415	sars-cov-2-specific t cells exhibit phenotypic features of helper function, lack of terminal differentiation, and high proliferation potential	neidleman, j; luo, xy; frouard, j; xie, gr; gill, g; stein, es; mcgregor, m; ma, tc; george, af; kosters, a; greene, wc; vasquez, j; ghosn, e; lee, s; roan, nr	cell reports medicine	2020	10.1016/j.xcrm.2020.100081	4
416	in silico studies on the comparative characterization of the interactions of sars-cov-2 spike glycoprotein with ace-2 receptor homologs and human tlrs	choudhury, a; mukherjee, s	journal of medical virology	2020	10.1002/jmv.25987	1
417	assessment of maternal and neonatal sars-cov-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the covid-19 pandemic	edlow, ag; li, jz; collier, ay; atyeo, c; james, ke; boatin, aa; gray, kj; bordt, ea; shook, ll; yonker, lm; fasano, a; diouf, k; croul, n; devane, s; yockey, lj; lima, r; shui, js; matute, jd; lerou, ph; akinwunmi, bo; schmidt, a; feldman, j; hauser, bm; caradonna, tm; de la flor, d; d'avino, p; regan, j; corry, h; coxen, k; fajnzylber, j; pepin, d; seaman, ms; barouch, dh; walker, bd; yu, xg; kaimal, aj; roberts, dj; alter, g	jama network open	2020	10.1001/jamanetworkopen.2020.30455	6
418	modeling the impact of non-pharmaceutical interventions on the dynamics of novel coronavirus with optimal control analysis with a case study	ullah, s; khan, ma	chaos solitons & fractals	2020	10.1016/j.chaos.2020.110075	2
419	potent neutralizing antibodies against multiple epitopes on sars-cov-2 spike	liu, lh; wang, pf; nair, ms; yu, j; rapp, m; wang, q; luo, y; chan, jfw; sahi, v; figueroa, a; guo, xzv; cerutti, g; bimela, j; gorman, j; zhou, tq; chen, zw; yuen, ky; kwong, pd; sodroski, jg; yin, mt; sheng, zz; huang, yx; shapiro, l; ho, dd	nature	2020	10.1038/s41586-020-2571-7	28
420	neutralizing antibodies correlate with protection from sars-cov-2 in humans during a fishery vessel outbreak with a high attack rate	addetia, a; crawford, khd; dingens, a; zhu, hy; roychoudhury, p; huang, ml; jerome, kr; bloom, jd; greninger, al	journal of clinical microbiology	2020	10.1128/jcm.02107-20	0
421	longitudinal observation and decline of neutralizing antibody responses in the three months following sars-cov-2 infection in humans	seow, j; graham, c; merrick, b; acors, s; pickering, s; steel, kja; hemmings, o; o'byrne, a; kouphou, n; galao, rp; betancor, g; wilson, hd; signell, aw; winstone, h; kerridge, c; huettner, i; jimenez-guardeno, jm; lista, mj; temperton, n; snell, lb; bisnauthsing, k; moore, a; green, a; martinez, l; stokes, b; honey, j; izquierdo-barras, a; arbane, g; patel, a; tan, mki; o'connell, l; o'hara, g; macmahon, e; douthwaite, s; nebbia, g; batra, r; martinez-nunez, r; shankar-hari, m; edgeworth, jd; neil, sjd; malim, mh; doores, kj	nature microbiology	2020	10.1038/s41564-020-00813-8	23
422	comparison of commercially available and laboratory-developed assays for in vitro detection of sars-cov-2 in clinical laboratories	lieberman, ja; pepper, g; naccache, sn; huang, ml; jerome, kr; greninger, al	journal of clinical microbiology	2020	10.1128/jcm.00821-20	0
423	syncytia formation by sars-cov-2-infected cells	buchrieser, j; dufloo, j; hubert, m; monel, b; planas, d; rajah, mm; planchais, c; porrot, f; guivel-benhassine, f; van der werf, s; casartelli, n; mouquet, h; bruel, t; schwartz, o	embo journal	2020	10.15252/embj.2020106267	5
424	the global phosphorylation landscape of sars-cov-2 infection	bouhaddou, m; memon, d; meyer, b; white, km; rezelj, vv; marrero, mc; polacco, bj; melnyk, je; ulferts, s; kaake, rm; batra, j; richards, al; stevenson, e; gordon, de; rojc, a; obernier, k; fabius, jm; soucheray, m; miorin, l; moreno, e; koh, c; tran, qd; hardy, a; robinot, r; vallet, t; nilsson-payant, be; hernandez-armenta, c; dunham, a; weigang, s; knerr, j; modak, m; quintero, d; zhou, y; dugourd, a; valdeolivas, a; patil, t; li, qy; huttenhain, r; cakir, m; muralidharan, m; kim, m; jang, g; tutuncuoglu, b; hiatt, j; guo, jz; xu, jw; bouhaddou, s; mathy, cjp; gaulton, a; manners, ej; felix, e; shi, y; goff, m; lim, jk; mcbride, t; o'neal, mc; cai, ym; chang, jcj; broadhurst, dj; klippsten, s; de wit, e; leach, ar; kortemme, t; shoichet, b; ott, m; saez-rodriguez, j; tenoever, br; mullins, rd; fischer, er; kochs, g; grosse, r; garcia-sastre, a; vignuzzi, m; johnson, jr; shokat, km; swaney, dl; beltrao, p; krogan, nj	cell	2020	10.1016/j.cell.2020.06.034	2
425	evasion of type i interferon by sars-cov-2	xia, hj; cao, zg; xie, xp; zhang, xw; chen, jyc; wang, hl; menachery, vd; rajsbaum, r; shi, py	cell reports	2020	10.1016/j.celrep.2020.108234	6
426	mechanisms of sars-cov-2 transmission and pathogenesis	harrison, ag; lin, t; wang, ph	trends in immunology	2020	10.1016/j.it.2020.10.004	0
427	broad anti-coronavirus activity of food and drug administration-approved drugs against sars-cov-2 in vitro and sars-cov in vivo	weston, s; coleman, cm; haupt, r; logue, j; matthews, k; li, yz; reyes, hm; weiss, sr; frieman, mb	journal of virology	2020	10.1128/jvi.01218-20	0
428	analytical and clinical performances of five immunoassays for the detection of sars-cov-2 antibodies in comparison with neutralization activity	padoan, a; bonfante, f; pagliari, m; bortolami, a; negrini, d; zuin, s; bozzato, d; cosma, c; sciacovelli, l; plebani, m	ebiomedicine	2020	10.1016/j.ebiom.2020.103101	2
429	overview of lethal human coronaviruses	chen, b; tian, ek; he, b; tian, lj; han, ry; wang, sw; xiang, qr; zhang, s; el arnaout, t; cheng, w	signal transduction and targeted therapy	2020	10.1038/s41392-020-0190-2	1
430	roles of flavonoids against coronavirus infection	russo, m; moccia, s; spagnuolo, c; tedesco, i; russo, gl	chemico-biological interactions	2020	10.1016/j.cbi.2020.109211	1
431	structural and biochemical characterization of the nsp12-nsp7-nsp8 core polymerase complex from sars-cov-2	peng, q; peng, rc; yuan, b; zhao, jr; wang, m; wang, xx; wang, q; sun, y; fan, z; qi, jx; gao, gf; shi, y	cell reports	2020	10.1016/j.celrep.2020.107774	1
432	activate: randomized clinical trial of bcg vaccination against infection in the elderly	giamarellos-bourboulis, ej; tsilika, m; moorlag, s; antonakos, n; kotsaki, a; dominguez-andres, j; kyriazopoulou, e; gkavogianni, t; adami, me; damoraki, g; koufargyris, p; karageorgos, a; bolanou, a; koenen, h; van crevel, r; droggiti, di; renieris, g; papadopoulos, a; netea, mg	cell	2020	10.1016/j.cell.2020.08.051	4
433	severe acute respiratory syndrome coronavirus-2 (sars-cov-2): a global pandemic and treatment strategies	sharma, a; tiwari, s; deb, mk; marty, jl	international journal of antimicrobial agents	2020	10.1016/j.ijantimicag.2020.106054	0
434	aromatic herbs, medicinal plant-derived essential oils, and phytochemical extracts as potential therapies for coronaviruses: future perspectives	boukhatem, mn; setzer, wn	plants-basel	2020	10.3390/plants9060800	1
435	multi-system inflammatory syndrome in children (mis-c) following sars-cov-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management	nakra, na; blumberg, da; herrera-guerra, a; lakshminrusimha, s	children-basel	2020	10.3390/children7070069	0
436	sars-cov-2 positivity rates associated with circulating 25-hydroxyvitamin d levels	kaufman, hw; niles, jk; kroll, mh; bi, cx; holick, mf	plos one	2020	10.1371/journal.pone.0239252	0
437	sars-cov-2 infection in pregnancy: a systematic review and meta-analysis of clinical features and pregnancy outcomes	khalil, a; kalafat, e; benlioglu, c; o'brien, p; morris, e; draycott, t; thangaratinam, s; le doare, k; heath, p; ladhani, s; von dadelszen, p; magee, la	eclinicalmedicine	2020	10.1016/j.eclinm.2020.100446	1
438	robust neutralizing antibodies to sars-cov-2 infection persist for months	wajnberg, a; amanat, f; firpo, a; altman, dr; bailey, mj; mansour, m; mcmahon, m; meade, p; mendu, dr; muellers, k; stadlbauer, d; stone, k; strohmeier, s; simon, v; aberg, j; reich, dl; krammer, f; cordon-cardo, c	science	2020	10.1126/science.abd7728	27
439	perioperative management of patients infected with the novel coronavirus: recommendation from the joint task force of the chinese society of anesthesiology and the chinese association of anesthesiologists	chen, xd; liu, yh; gong, yh; guo, xy; zuo, mz; li, j; shi, wz; li, h; xu, xh; mi, wd; huang, yg	anesthesiology	2020	10.1097/aln.0000000000003301	0
440	a thermostable, closed sars-cov-2 spike protein trimer	xiong, xl; qu, k; ciazynska, ka; hosmillo, m; carter, ap; ebrahimi, s; ke, zl; scheres, shw; bergamaschi, l; grice, gl; zhang, y; nathan, ja; baker, s; james, lc; baxendale, he; goodfellow, i; doffinger, r; briggs, jag; bradley, j; lyons, pa; smith, kgc; toshner, m; elmer, a; ribeiro, c; kourampa, j; jose, s; kennet, j; rowlands, j; meadows, a; o'brien, c; rastall, r; crucusio, c; hewitt, s; price, j; calder, j; laura, c; bucke, a; tordesillas, h; harris, j; ruffolo, v; domingo, j; graves, b; butcher, h; caputo, d; le gresley, e; dunmore, bj; martin, j; legchenko, e; treacy, c; huang, c; wood, j; sutcliffe, r; hodgson, j; shih, j; graf, s; tong, z; mescia, f; tilly, t; o'donnell, c; hunter, k; pointon, l; pond, n; wylot, m; jones, e; fawke, s; bullman, b; bergamaschi, l; turner, l; jarvis, i; omarjee, o; de sa, a; marsden, j; betancourt, a; perera, m; epping, m; richoz, n; bower, g; sharma, r; nice, f; huhn, o; stark, h; walker, n; stirrups, k; ovington, n; dewhust, e; li, e; papadia, s	nature structural & molecular biology	2020	10.1038/s41594-020-0478-5	8
441	beyond shielding: the roles of glycans in the sars-cov-2 spike protein	casalino, l; gaieb, z; goldsmith, ja; hjorth, ck; dommer, ac; harbison, am; fogarty, ca; barros, ep; taylor, bc; mclellan, js; fadda, e; amaro, re	acs central science	2020	10.1021/acscentsci.0c01056	9
442	the sars-cov-2 spike protein has a broad tropism for mammalian ace2 proteins	conceicao, c; thakur, n; human, s; kelly, jt; logan, l; bialy, d; bhat, s; stevenson-leggett, p; zagrajek, ak; hollinghurst, p; varga, m; tsirigoti, c; tully, m; chiu, c; moffat, k; silesian, ap; hammond, ja; maier, hj; bickerton, e; shelton, h; dietrich, i; graham, sc; bailey, d	plos biology	2020	10.1371/journal.pbio.3001016	2
443	a global survey of potential acceptance of a covid-19 vaccine	lazarus, jv; ratzan, sc; palayew, a; gostin, lo; larson, hj; rabin, k; kimball, s; el-mohandes, a	nature medicine	2021	10.1038/s41591-020-1124-9	63
444	will they, or won't they? examining patients' vaccine intention for flu and covid-19 using the health belief model	mercadante, ar; law, av	research in social & administrative pharmacy	2021	10.1016/j.sapharm.2020.12.012	1
445	psychological characteristics associated with covid-19 vaccine hesitancy and resistance in ireland and the united kingdom	murphy, j; vallieres, f; bentall, rp; shevlin, m; mcbride, o; hartman, tk; mckay, r; bennett, k; mason, l; gibson-miller, j; levita, l; martinez, ap; stocks, tva; karatzias, t; hyland, p	nature communications	2021	10.1038/s41467-020-20226-9	14
446	confidence and receptivity for covid-19 vaccines: a rapid systematic review	lin, c; tu, p; beitsch, lm	vaccines	2021	10.3390/vaccines9010016	8
447	international estimates of intended uptake and refusal of covid-19 vaccines: a rapid systematic review and meta-analysis of large nationally representative samples	robinson, e; jones, a; lesser, i; daly, m	vaccine	2021	10.1016/j.vaccine.2021.02.005	1
448	what defines an efficacious covid-19 vaccine? a review of the challenges assessing the clinical efficacy of vaccines against sars-cov-2	hodgson, sh; mansatta, k; mallett, g; harris, v; emary, krw; pollard, aj	lancet infectious diseases	2021	10.1016/s1473-3099(20)30773-8	13
449	covid-19 vaccine: a recent update in pipeline vaccines, their design and development strategies	rawat, k; kumari, p; saha, l	european journal of pharmacology	2021	10.1016/j.ejphar.2020.173751	7
450	intention to get vaccinations against covid-19 in french healthcare workers during the first pandemic wave: a cross-sectional survey	gagneux-brunon, a; detoc, m; bruel, s; tardy, b; rozaire, o; frappe, p; botelho-nevers, e	journal of hospital infection	2021	10.1016/j.jhin.2020.11.0200195-6701	15
451	fearing the disease or the vaccine: the case of covid-19	karlsson, lc; soveri, a; lewandowsky, s; karlsson, l; karlsson, h; nolvi, s; karukivi, m; lindfelt, m; antfolk, j	personality and individual differences	2021	10.1016/j.paid.2020.110590	4
452	intention to vaccinate against the novel 2019 coronavirus disease: the role of health locus of control and religiosity	olagoke, aa; olagoke, oo; hughes, am	journal of religion & health	2021	10.1007/s10943-020-01090-9	3
453	knowledge, attitudes and practices towards covid-19: an epidemiological survey in north-central nigeria	reuben, rc; danladi, mma; saleh, da; ejembi, pe	journal of community health	2021	10.1007/s10900-020-00881-1	1
454	covid-19 vaccination intention in the uk: results from the covid-19 vaccination acceptability study (covaccs), a nationally representative cross-sectional survey	sherman, sm; smith, le; sim, j; amlot, r; cutts, m; dasch, h; rubin, gj; sevdalis, n	human vaccines & immunotherapeutics	2021	10.1080/21645515.2020.1846397	17
455	covid-19 vaccine to vaccination: why leaders must invest in delivery strategies now	weintraub, rl; subramanian, l; karlage, a; ahmad, i; rosenberg, j	health affairs	2021	10.1377/hlthaff.2020.01523	2
456	covid-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates	sallam, m	vaccines	2021	10.3390/vaccines9020160	11
457	safety and efficacy of the chadox1 ncov-19 vaccine (azd1222) against sars-cov-2: an interim analysis of four randomised controlled trials in brazil, south africa, and the uk	voysey, m; clemens, sac; madhi, sa; weckx, ly; folegatti, pm; aley, pk; angus, b; baillie, vl; barnabas, sl; bhorat, qe; bibi, s; briner, c; cicconi, p; collins, am; colin-jones, r; cutland, cl; darton, tc; dheda, k; duncan, cja; emary, krw; ewer, kj; fairlie, l; faust, sn; feng, s; ferreira, dm; finn, a; goodman, al; green, cm; green, ca; heath, pt; hill, c; hill, h; hirsch, i; hodgson, shc; izu, a; jackson, s; jenkin, d; joe, ccd; kerridge, s; koen, a; kwatra, g; lazarus, r; lawrie, am; lelliott, a; libri, v; lillie, pj; mallory, r; mendes, ava; milan, ep; minassian, am; mcgregor, a; morrison, h; mujadidi, yf; nana, a; o'reilly, pj; padayachee, sd; pittella, a; plested, e; pollock, km; ramasamy, mn; rhead, s; schwarzbold, av; singh, n; smith, a; song, r; snape, md; sprinz, e; sutherland, rk; tarrant, r; thomson, ec; torok, me; toshner, m; turner, dpj; vekemans, j; villafana, tl; watson, mee; williams, cj; douglas, ad; hill, avs; lambe, t; gilbert, sc; pollard, aj	lancet	2021	10.1016/s0140-6736(20)32661-1	134
458	high rates of covid-19 vaccine hesitancy and its association with conspiracy beliefs: a study in jordan and kuwait among other arab countries	sallam, m; dababseh, d; eid, h; al-mahzoum, k; al-haidar, a; taim, d; yaseen, a; ababneh, na; bakri, fg; mahafzah, a	vaccines	2021	10.3390/vaccines9010042	10
459	factors associated with covid-19 vaccine hesitancy	soares, p; rocha, jv; moniz, m; gama, a; laires, pa; pedro, ar; dias, s; leite, a; nunes, c	vaccines	2021	10.3390/vaccines9030300	2
460	covid-19 vaccine hesitancy among medical students	lucia, vc; kelekar, a; afonso, nm	journal of public health	2021	10.1093/pubmed/fdaa230	5
461	individual preferences for covid-19 vaccination in china	leng, al; maitland, e; wang, sy; nicholas, s; liu, rg; wang, j	vaccine	2021	10.1016/j.vaccine.2020.12.009	1
462	acceptance of a covid-19 vaccine in japan during the covid-19 pandemic	machida, m; nakamura, i; kojima, t; saito, r; nakaya, t; hanibuchi, t; takamiya, t; odagiri, y; fukushima, n; kikuchi, h; amagasa, s; watanabe, h; inoue, s	vaccines	2021	10.3390/vaccines9030210	3
463	evaluation of covid-19 vaccine refusal in parents	yigit, m; ozkaya-parlakay, a; senel, e	pediatric infectious disease journal	2021	10.1097/inf.0000000000003042	1
464	measuring the impact of covid-19 vaccine misinformation on vaccination intent in the uk and usa	loomba, s; de figueiredo, a; piatek, sj; de graaf, k; larson, hj	nature human behaviour	2021	10.1038/s41562-021-01056-1	5
465	understanding covid-19 misinformation and vaccine hesitancy in context: findings from a qualitative study involving citizens in bradford, uk	lockyer, b; islam, s; rahman, a; dickerson, j; pickett, k; sheldon, t; wright, j; mceachan, r; sheard, l	health expectations	2021	10.1111/hex.13240	0
466	preferences for a covid-19 vaccine in australia	borriello, a; master, d; pellegrini, a; rose, jm	vaccine	2021	10.1016/j.vaccine.2020.12.032	1
467	willingness to vaccinate children against influenza after the coronavirus disease 2019 pandemic	goldman, rd; mcgregor, s; marneni, sr; katsuta, t; griffiths, ma; hall, je; seiler, m; klein, ej; cotanda, cp; gelernter, r; hoeffe, j; davis, al; gualco, g; mater, a; manzano, s; thompson, gc; ahmed, s; ali, s; brown, jc	journal of pediatrics	2021	10.1016/j.jpeds.2020.08.005	3
468	vaccine hesitancy in the era of covid-19	troiano, g; nardi, a	public health	2021	10.1016/j.puhe.2021.02.025	0
469	safety and immunogenicity of an inactivated sars-cov-2 vaccine, bbibp-corv: a randomised, double-blind, placebo-controlled, phase 1/2 trial	xia, sl; zhang, yt; wang, yx; wang, h; yang, yk; gao, gf; tan, wj; wu, gz; xu, m; lou, zy; huang, wj; xu, wb; huang, by; wang, hj; wang, w; zhang, w; li, n; xie, zq; ding, l; you, wy; zhao, yx; yang, xq; liu, y; wang, q; huang, ll; yang, yl; xu, gx; luo, bj; wang, wl; liu, pp; guo, ws; yang, xm	lancet infectious diseases	2021	10.1016/s1473-3099(20)30831-8	35
470	safety, tolerability, and immunogenicity of an inactivated sars-cov-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial	zhang, yj; zeng, g; pan, hx; li, cg; hu, yl; chu, k; han, wx; chen, z; tang, r; yin, wd; chen, x; hu, ys; liu, xy; jiang, cb; li, jx; yang, mn; song, y; wang, xx; gao, q; zhu, fc	lancet infectious diseases	2021	10.1016/s1473-3099(20)30843-4	40
471	covid-19 vaccines: rapid development, implications, challenges and future prospects	kashte, s; gulbake, a; el-amin, sf; gupta, a	human cell	2021	10.1007/s13577-021-00512-4	1
472	covid-19 vaccine acceptance and hesitancy among dental and medical students	kelekar, ak; lucia, vc; afonso, nm; mascarenhas, ak	journal of the american dental association	2021	10.1016/j.adaj.2021.03.006	0
473	efficacy and safety of the mrna-1273 sars-cov-2 vaccine	baden, lr; el sahly, hm; essink, b; kotloff, k; frey, s; novak, r; diemert, d; spector, sa; rouphael, n; creech, cb; mcgettigan, j; khetan, s; segall, n; solis, j; brosz, a; fierro, c; schwartz, h; neuzil, k; corey, l; gilbert, p; janes, h; follmann, d; marovich, m; mascola, j; polakowski, l; ledgerwood, j; graham, bs; bennett, h; pajon, r; knightly, c; leav, b; deng, wp; zhou, hh; han, s; ivarsson, m; miller, j; zaks, t	new england journal of medicine	2021	10.1056/nejmoa2035389	189
474	self-reported real-world safety and reactogenicity of covid-19 vaccines: a vaccine recipient survey	mathioudakis, ag; ghrew, m; ustianowski, a; ahmad, s; borrow, r; papavasileiou, lp; petrakis, d; bakerly, nd	life-basel	2021	10.3390/life11030249	2
475	d614g spike mutation increases sars cov-2 susceptibility to neutralization	weissman, d; alameh, mg; de silva, t; collini, p; hornsby, h; brown, r; labranche, cc; edwards, rj; sutherland, l; santra, s; mansouri, k; gobeil, s; mcdanal, c; pardi, n; hengartner, n; lin, pjc; tam, y; shaw, pa; lewis, mg; boesler, c; sahin, u; acharya, p; haynes, bf; korber, b; montefiori, dc	cell host & microbe	2021	10.1016/j.chom.2020.11.012	17
476	safety and immunogenicity of an inactivated sars-cov-2 vaccine, bbv152: a double-blind, randomised, phase 1 trial	ella, r; vadrevu, km; jogdand, h; prasad, s; reddy, s; sarangi, v; ganneru, b; sapkal, g; yadav, p; abraham, p; panda, s; gupta, n; reddy, p; verma, s; rai, sk; singh, c; redkar, sv; gillurkar, cs; kushwaha, js; mohapatra, s; rao, v; guleria, r; ella, k; bhargava, b	lancet infectious diseases	2021	10.1016/s1473-3099(20)30942-7	14
477	covid-19 vaccination readiness among nurse faculty and student nurses	manning, ml; gerolamo, am; marino, ma; hanson-zalot, me; pogorzelska-maziarz, m	nursing outlook	2021	10.1016/j.outlook.2021.01.019	1
478	covid-19 vaccines: where we stand and challenges ahead	forni, g; mantovani, a	cell death and differentiation	2021	10.1038/s41418-020-00720-9	9
479	vaccine hesitancy: beliefs and barriers associated with covid-19 vaccination among egyptian medical students	saied, sm; saied, em; kabbash, ia; abdo, sa	journal of medical virology	2021	10.1002/jmv.26910	1
480	covid-19 vaccine acceptance among health care workers in the united states	shekhar, r; sheikh, a; upadhyay, s; singh, m; kottewar, s; mir, h; barrett, e; pal, s	vaccines	2021	10.3390/vaccines9020119	5
481	interest in covid-19 vaccine trials participation among young adults in china: willingness, reasons for hesitancy, and demographic and psychosocial determinants	sun, sf; lin, dh; operario, d	preventive medicine reports	2021	10.1016/j.pmedr.2021.101350	4
482	medical students and sars-cov-2 vaccination: attitude and behaviors	szmyd, b; bartoszek, a; karuga, ff; staniecka, k; blaszczyk, m; radek, m	vaccines	2021	10.3390/vaccines9020128	3
483	covid-19 vaccine hesitancy among medical students in india	jain, j; saurabh, s; kumar, p; verma, mk; goel, ad; gupta, mk; bhardwaj, p; raghav, pr	epidemiology and infection	2021	10.1017/s0950268821001205	0
484	myocarditis following covid-19 mrna vaccination	abu mouch, s; roguin, a; hellou, e; ishai, a; shoshan, u; mahamid, l; zoabi, m; aisman, m; goldschmid, n; yanay, nb	vaccine	2021	10.1016/j.vaccine.2021.05.087	2
485	covid-19: a review of therapeutic strategies and vaccine candidates	izda, v; jeffries, ma; sawalha, ah	clinical immunology	2021	10.1016/j.clim.2020.108634	2
486	thrombosis and thrombocytopenia after chadox1 ncov-19 vaccination	schultz, nh; sorvoll, ih; michelsen, ae; munthe, la; lund-johansen, f; ahlen, mt; wiedmann, m; aamodt, ah; skattor, th; tjonnfjord, ge; holme, pa	new england journal of medicine	2021	10.1056/nejmoa2104882	36
487	pathologic antibodies to platelet factor 4 after chadox1 ncov-19 vaccination	scully, m; singh, d; lown, r; poles, a; solomon, t; levi, m; goldblatt, d; kotoucek, p; thomas, w; lester, w	new england journal of medicine	2021	10.1056/nejmoa2105385	21
488	the advisory committee on immunization practices' interim recommendation for use of janssen covid-19 vaccine - united states, february 2021	oliver, se; gargano, jw; scobie, h; wallace, m; hadler, sc; leung, j; blain, ae; mcclung, n; campos-outcalt, d; morgan, rl; mbaeyi, s; macneil, j; romero, jr; talbot, hk; lee, gm; bell, bp; dooling, k	mmwr-morbidity and mortality weekly report	2021		4
489	updated recommendations from the advisory committee on immunization practices for use of the janssen (johnson & johnson) covid-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients - united states, april 2021	macneil, jr; su, jr; broder, kr; guh, ay; gargano, jw; wallace, m; hadler, sc; scobie, hm; blain, ae; moulia, d; daley, mf; mcnally, vv; romero, jr; talbot, hk; lee, gm; bell, bp; oliver, se	mmwr-morbidity and mortality weekly report	2021		9
490	safety monitoring of the janssen (johnson & johnson) covid-19 vaccine - united states, march-april 2021	shay, dk; gee, j; su, jr; myers, tr; marquez, p; liu, rl; zhang, bc; licata, c; clark, ta; shimabukuro, tt	mmwr-morbidity and mortality weekly report	2021		6
491	us case reports of cerebral venous sinus thrombosis with thrombocytopenia after ad26.cov2.s vaccination, march 2 to april 21, 2021	see, i; su, jr; lale, a; woo, ej; guh, ay; shimabukuro, tt; streiff, mb; rao, ak; wheeler, ap; beavers, sf; durbin, ap; edwards, k; miller, e; harrington, ta; mba-jonas, a; nair, n; nguyen, dt; talaat, kr; urrutia, vc; walker, sc; creech, cb; clark, ta; destefano, f; broder, kr	jama-journal of the american medical association	2021	10.1001/jama.2021.7517	9
492	cerebral venous thrombosis after bnt162b2 mrna sars-cov-2 vaccine	dias, l; soares-dos-reis, r; meira, j; ferrao, d; soares, pr; pastor, a; gama, g; fonseca, l; fagundes, v; carvalho, m	journal of stroke & cerebrovascular diseases	2021	10.1016/j.jstrokecerebrovasdis.2021.105906	1
493	delayed localized hypersensitivity reactions to the moderna covid-19 vaccine a case series	johnston, ms; galan, a; watsky, kl; little, aj	jama dermatology	2021	10.1001/jamadermatol.2021.1214	2
494	patients with acute myocarditis following mrna covid-19 vaccination	kim, hw; jenista, er; wendell, dc; azevedo, cf; campbell, mj; darty, sn; parker, ma; kim, rj	jama cardiology	2021	10.1001/jamacardio.2021.2828	1
495	symptomatic acute myocarditis in 7 adolescents after pfizer-biontech covid-19 vaccination	marshall, m; ferguson, id; lewis, p; jaggi, p; gagliardo, c; collins, js; shaughnessy, r; caron, r; fuss, c; corbin, kje; emuren, l; faherty, e; hall, ek; di pentima, c; oster, me; paintsil, e; siddiqui, s; timchak, dm; guzman-cottrill, ja	pediatrics	2021	10.1542/peds.2021-052478	5
496	myocarditis following immunization with mrna covid-19 vaccines in members of the us military	montgomery, j; ryan, m; engler, r; hoffman, d; mcclenathan, b; collins, l; loran, d; hrncir, d; herring, k; platzer, m; adams, n; sanou, a; cooper, lt	jama cardiology	2021	10.1001/jamacardio.2021.2833	4
497	myocarditis with covid-19 mrna vaccines	bozkurt, b; kamat, i; hotez, pj	circulation	2021	10.1161/circulationaha.121.056135	0
498	covid-19 vaccination hesitancy in the united states: a rapid national assessment	khubchandani, j; sharma, s; price, jh; wiblishauser, mj; sharma, m; webb, fj	journal of community health	2021	10.1007/s10900-020-00958-x	10
499	the public's role in covid-19 vaccination: human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the united states	schoch-spana, m; brunson, ek; long, r; ruth, a; ravi, sj; trotochaud, m; borio, l; brewer, j; buccina, j; connell, n; hall, ll; kass, n; kirkland, a; koonin, l; larson, h; lu, bf; omer, sb; orenstein, wa; poland, ga; privor-dumm, l; quinn, sc; salmon, d; white, a	vaccine	2021	10.1016/j.vaccine.2020.10.059	3
500	predictors of covid-19 vaccine hesitancy in the uk household longitudinal study	robertson, e; reeve, ks; niedzwiedz, cl; moore, j; blake, m; green, m; katikireddi, sv; benzeval, mj	brain behavior and immunity	2021	10.1016/j.bbi.2021.03.008	1
501	a survey on covid-19 vaccine acceptance and concern among malaysians	alwi, sars; rafidah, e; zurraini, a; juslina, o; brohi, ib; lukas, s	bmc public health	2021	10.1186/s12889-021-11071-6	1
502	covid-19 vaccine acceptance in pregnant women	ayhan, sg; oluklu, d; atalay, a; beser, dm; tanacan, a; tekin, om; sahin, d	international journal of gynecology & obstetrics	2021	10.1002/ijgo.13713	1
503	reverse vaccinology approach to design a novel multi-epitope vaccine candidate against covid-19: an in silico study	enayatkhani, m; hasaniazad, m; faezi, s; guklani, h; davoodian, p; ahmadi, n; einakian, ma; karmostaji, a; ahmadi, k	journal of biomolecular structure & dynamics	2021	10.1080/07391102.2020.1756411	2
504	dna vaccines against covid-19: perspectives and challenges	silveira, mm; moreira, gmsg; mendonca, m	life sciences	2021	10.1016/j.lfs.2020.118919	1
505	recognition of the sars-cov-2 receptor binding domain by neutralizing antibodies	yuan, m; liu, hj; wu, nic; wilson, ia	biochemical and biophysical research communications	2021	10.1016/j.bbrc.2020.10.012	3
506	viral targets for vaccines against covid-19	dai, lp; gao, gf	nature reviews immunology	2021	10.1038/s41577-020-00480-0	11
507	a covid-19 vaccine: big strides come with big challenges	mellet, j; pepper, ms	vaccines	2021	10.3390/vaccines9010039	3
508	looking beyond covid-19 vaccine phase 3 trials	kim, jh; marks, f; clemens, jd	nature medicine	2021	10.1038/s41591-021-01230-y	8
509	change of willingness to accept covid-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in hong kong, china: repeated cross-sectional surveys	wang, kl; wong, ely; ho, kf; cheung, awl; yau, ps; dong, d; wong, sys; yeoh, ek	vaccines	2021	10.3390/vaccines9010062	8
510	willingness to vaccinate against covid-19 among bangladeshi adults: understanding the strategies to optimize vaccination coverage	abedin, m; islam, ma; rahman, fn; reza, hm; hossain, mz; hossain, ma; arefin, a; hossain, a	plos one	2021	10.1371/journal.pone.0250495	2
511	willingness to get the covid-19 vaccine with and without emergency use authorization	guidry, jpd; laestadius, li; vraga, ek; miller, ca; perrin, pb; burton, cw; ryan, m; fuemmeler, bf; carlyle, ke	american journal of infection control	2021	10.1016/j.ajic.2020.11.018	9
512	as the pandemic progresses, how does willingness to vaccinate against covid-19 evolve?	alley, sj; stanton, r; browne, m; to, qg; khalesi, s; williams, sl; thwaite, tl; fenning, as; vandelanotte, c	international journal of environmental research and public health	2021	10.3390/ijerph18020797	5
513	acceptance of a covid-19 vaccine and its related determinants among the general adult population in kuwait	alqudeimat, y; alenezi, d; alhajri, b; alfouzan, h; almokhaizeem, z; altamimi, s; almansouri, w; alzalzalah, s; ziyab, ah	medical principles and practice	2021	10.1159/000514636	2
514	safety, tolerability, and immunogenicity of an inactivated sars-cov-2 vaccine (coronavac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial	wu, zw; hu, yl; xu, m; chen, z; yang, wq; jiang, zw; li, mj; jin, h; cui, gl; chen, pp; wang, l; zhao, gq; ding, yz; zhao, yl; yin, wd	lancet infectious diseases	2021	10.1016/s1473-3099(20)30987-7	11
515	willingness to get the covid-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in turkey: a web-based survey	yurttas, b; poyraz, bc; sut, n; ozdede, a; oztas, m; ugurlu, s; tabak, f; hamuryudan, v; seyahi, e	rheumatology international	2021	10.1007/s00296-021-04841-3	2
516	predictors of covid-19 vaccine acceptance, intention, and hesitancy: a scoping review	joshi, a; kaur, m; kaur, r; grover, a; nash, d; el-mohandes, a	frontiers in public health	2021	10.3389/fpubh.2021.698111	0
517	enhanced sars-cov-2 neutralization by dimeric iga	wang, zj; lorenzi, jcc; muecksch, f; finkin, s; viant, c; gaebler, c; cipolla, m; hoffman, hh; oliveira, ty; oren, da; ramos, v; nogueira, l; michailidis, e; robbiani, df; gazumyan, a; rice, cm; hatziioannou, t; bieniasz, pd; caskey, m; nussenzweig, mc	science translational medicine	2021	10.1126/scitranslmed.abf1555	7
518	iga dominates the early neutralizing antibody response to sars-cov-2	sterlin, d; mathian, a; miyara, m; mohr, a; anna, f; claer, l; quentric, p; fadlallah, j; devilliers, h; ghillani, p; gunn, c; hockett, r; mudumba, s; guihot, a; luyt, ce; mayaux, j; beurton, a; fourati, s; bruel, t; schwartz, o; lacorte, jm; yssel, h; parizot, c; dorgham, k; charneau, p; amoura, z; gorochov, g	science translational medicine	2021	10.1126/scitranslmed.abd2223	5
519	intranasal vaccination with a lentiviral vector protects against sars-cov-2 in preclinical animal models	ku, mw; bourgine, m; authie, p; lopez, j; nemirov, k; moncoq, f; noirat, a; vesin, b; nevo, f; blanc, c; souque, p; tabbal, h; simon, e; hardy, d; le dudal, m; guinet, f; fiette, l; mouquet, h; anna, f; martin, a; escriou, n; majlessi, l; charneau, p	cell host & microbe	2021	10.1016/j.chom.2020.12.010	1
520	interim results of a phase 1-2a trial of ad26.cov2.s covid-19 vaccine	sadoff, j; le gars, m; shukarev, g; heerwegh, d; truyers, c; de groot, am; stoop, j; tete, s; van damme, w; leroux-roels, i; berghmans, pj; kimmel, m; van damme, p; de hoon, j; smith, w; stephenson, ke; de rosa, sc; cohen, kw; mcelrath, mj; cormier, e; scheper, g; barouch, dh; hendriks, j; struyf, f; douoguih, m; van hoof, j; schuitemaker, h	new england journal of medicine	2021	10.1056/nejmoa2034201	30
521	viral vectors for covid-19 vaccine development	lundstrom, k	viruses-basel	2021	10.3390/v13020317	0
522	safety and efficacy of an rad26 and rad5 vector-based heterologous prime-boost covid-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in russia	logunov, dy; dolzhikova, iv; shcheblyakov, dv; tukhvatulin, ai; zubkova, ov; dzharullaeva, as; kovyrshina, av; lubenets, nl; grousova, dm; erokhova, as; botikov, ag; izhaeva, fm; popova, o; ozharovskaya, ta; esmagambetov, ib; favorskaya, ia; zrelkin, di; voronina, dv; shcherbinin, dn; semikhin, as; simakova, yv; tokarskaya, ea; egorova, da; shmarov, mm; nikitenko, na; gushchin, va; smolyarchuk, ea; zyryanov, sk; borisevich, sv; naroditsky, bs; gintsburg, al	lancet	2021	10.1016/s0140-6736(21)00234-8	42
523	bnt162b vaccines protect rhesus macaques from sars-cov-2	vogel, ab; kanevsky, i; che, y; swanson, ka; muik, a; vormehr, m; kranz, lm; walzer, kc; hein, s; guler, a; loschko, j; maddur, ms; ota-setlik, a; tompkins, k; cole, j; lui, bg; ziegenhals, t; plaschke, a; eisel, d; dany, sc; fesser, s; erbar, s; bates, f; schneider, d; jesionek, b; sanger, b; wallisch, ak; feuchter, y; junginger, h; krumm, sa; heinen, ap; adams-quack, p; schlereth, j; schille, s; kroner, c; garcia, rdg; hiller, t; fischer, l; sellers, rs; choudhary, s; gonzalez, o; vascotto, f; gutman, mr; fontenot, ja; hall-ursone, s; brasky, k; griffor, mc; han, s; su, aah; lees, ja; nedoma, nl; mashalidis, eh; sahasrabudhe, pv; tan, cy; pavliakova, d; singh, g; fontes-garfias, c; pride, m; scully, il; ciolino, t; obregon, j; gazi, m; carrion, r; alfson, kj; kalina, wv; kaushal, d; shi, py; klamp, t; rosenbaum, c; kuhn, an; tureci, o; dormitzer, pr; jansen, ku; sahin, u	nature	2021	10.1038/s41586-021-03275-y	11
524	neutralization of sars-cov-2 lineage b.1.1.7 pseudovirus by bnt162b2 vaccine-elicited human sera	muik, a; wallisch, ak; sanger, b; swanson, ka; muhl, j; chen, w; cai, h; maurus, d; sarkar, r; tureci, o; dormitzer, pr; sahin, u	science	2021	10.1126/science.abg6105	34
525	genomic evidence for reinfection with sars-cov-2: a case study	tillett, rl; sevinsky, jr; hartley, pd; kerwin, h; crawford, n; gorzalski, a; laverdure, c; verma, sc; rossetto, cc; jackson, d; farrell, mj; van hooser, s; pandori, m	lancet infectious diseases	2021	10.1016/s1473-3099(20)30764-7	10
526	immunological memory to sars-cov-2 assessed for up to 8 months after infection	dan, jm; mateus, j; kato, y; hastie, km; yu, ed; faliti, ce; grifoni, a; ramirez, si; haupt, s; frazier, a; nakao, c; rayaprolu, v; rawlings, sa; peters, b; krammer, f; simon, v; saphire, eo; smith, dm; weiskopf, d; sette, a; crotty, s	science	2021	10.1126/science.abf4063	44
527	the antigenic anatomy of sars-cov-2 receptor binding domain	dejnirattisai, w; zhou, dm; ginn, hm; duyvesteyn, hme; supasa, p; case, jb; zhao, yg; walter, ts; mentzer, aj; liu, c; wang, bb; paesen, gc; slon-campos, j; lopez-camacho, c; kafai, nm; bailey, al; chen, re; ying, bl; thompson, c; bolton, j; fyfe, a; gupta, s; tan, tk; gilbert-jaramillo, j; james, w; knight, m; carroll, mw; skelly, d; dold, c; peng, yc; levin, r; dong, t; pollard, aj; knight, jc; klenerman, p; temperton, n; hall, dr; williams, ma; paterson, ng; bertram, fkr; siebert, ca; clare, dk; howe, a; radecke, j; song, y; townsend, ar; huang, kya; fry, ee; mongkolsapaya, j; diamond, ms; ren, js; stuart, di; screaton, gr	cell	2021	10.1016/j.cell.2021.02.032	7
528	t cell and antibody responses induced by a single dose of chadox1 ncov-19 (azd1222) vaccine in a phase 1/2 clinical trial	ewer, kj; barrett, jr; belij-rammerstorfer, s; sharpe, h; makinson, r; morter, r; flaxman, a; wright, d; bellamy, d; bittaye, m; dold, c; provine, nm; aboagye, j; fowler, j; silk, se; alderson, j; aley, pk; angus, b; berrie, e; bibi, s; cicconi, p; clutterbuck, ea; chelysheva, i; folegatti, pm; fuskova, m; green, cm; jenkin, d; kerridge, s; lawrie, a; minassian, am; moore, m; mujadidi, y; plested, e; poulton, i; ramasamy, mn; robinson, h; song, r; snape, md; tarrant, r; voysey, m; watson, mee; douglas, ad; hill, avs; gilbert, sc; pollard, aj; lambe, t	nature medicine	2021	10.1038/s41591-020-01194-5	10
529	phase 1/2 trial of sars-cov-2 vaccine chadox1 ncov-19 with a booster dose induces multifunctional antibody responses	barrett, jr; belij-rammerstorfer, s; dold, c; ewer, kj; folegatti, pm; gilbride, c; halkerston, r; hill, j; jenkin, d; stockdale, l; verheul, mk; aley, pk; angus, b; bellamy, d; berrie, e; bibi, s; bittaye, m; carroll, mw; cavell, b; clutterbuck, ea; edwards, n; flaxman, a; fuskova, m; gorringe, a; hallis, b; kerridge, s; lawrie, am; linder, a; liu, xx; madhavan, m; makinson, r; mellors, j; minassian, a; moore, m; mujadidi, y; plested, e; poulton, i; ramasamy, mn; robinson, h; rollier, cs; song, r; snape, md; tarrant, r; taylor, s; thomas, km; voysey, m; watson, mee; wright, d; douglas, ad; green, cm; hill, avs; lambe, t; gilbert, s; pollard, aj	nature medicine	2021	10.1038/s41591-020-01179-4	13
530	a single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against sars-cov-2 infection in rhesus macaques	hassan, ao; feldmann, f; zhao, hy; curiel, dt; okumura, a; tang-huau, tl; case, jb; meade-white, k; callison, j; lovaglio, j; hanley, pw; scott, dp; fremont, dh; feldmann, h; diamond, ms	cell reports medicine	2021	10.1016/j.xcrm.2021.100230	2
531	spike mutation d614g alters sars-cov-2 fitness	plante, ja; liu, y; liu, jy; xia, hj; johnson, ba; lokugamage, kg; zhang, xw; muruato, ae; zou, j; fontes-garfias, cr; mirchandani, d; scharton, d; bilello, jp; ku, zq; an, zq; kalveram, b; freiberg, an; menachery, vd; xie, xp; plante, ks; weaver, sc; shi, py	nature	2021	10.1038/s41586-020-2895-3	30
532	loss of furin cleavage site attenuates sars-cov-2 pathogenesis	johnson, ba; xie, xp; bailey, al; kalveram, b; lokugamage, kg; muruato, a; zou, j; zhang, xw; juelich, t; smith, jk; zhang, lh; bopp, n; schindewolf, c; vu, m; vanderheiden, a; winkler, es; swetnam, d; plante, ja; aguilar, p; plante, ks; popov, v; lee, b; weaver, sc; suthar, ms; routh, al; ren, p; ku, zq; an, zq; debbink, k; diamond, ms; shi, py; freiberg, an; menachery, vd	nature	2021	10.1038/s41586-021-03237-4	9
533	identification of sars-cov-2 spike mutations that attenuate monoclonal and serum antibody neutralization	liu, zm; vanblargan, la; bloyet, lm; rothlauf, pw; chen, re; stumpf, s; zhao, hy; errico, jm; theel, es; liebeskind, mj; alford, b; buchser, wj; ellebedy, ah; fremont, dh; diamond, ms; whelan, spj	cell host & microbe	2021	10.1016/j.chom.2021.01.014	11
534	broad and potent activity against sars-like viruses by an engineered human monoclonal antibody	rappazzo, cg; tse, lv; kaku, ci; wrapp, d; sakharkar, m; huang, dl; deveau, lm; yockachonis, tj; herbert, as; battles, mb; o'brien, cm; brown, me; geoghegan, jc; belk, j; peng, lh; yang, ll; hou, yx; scobey, td; burton, dr; nemazee, d; dye, jm; voss, je; gunn, bm; mclellan, js; baric, rs; gralinski, le; walker, lm	science	2021	10.1126/science.abf4830	5
535	antibody potency, effector function, and combinations in protection and therapy for sars-cov-2 infection in vivo	schafer, a; muecksch, f; lorenzi, jcc; leist, sr; cipolla, m; bournazos, s; schmidt, f; maison, rm; gazumyan, a; martinez, dr; baric, rs; robbiani, df; hatziioannou, t; ravetch, jv; bieniasz, pd; bowen, ra; nussenzweig, mc; sheahan, tp	journal of experimental medicine	2021	10.1084/jem.20201993	15
536	a whole blood test to measure sars-cov-2-specific response in covid-19 patients	petrone, l; petruccioli, e; vanini, v; cuzzi, g; fard, sn; alonzi, t; castilletti, c; palmieri, f; gualano, g; vittozzi, p; nicastri, e; lepore, l; antinori, a; vergori, a; caccamo, n; cantini, f; girardi, e; ippolito, g; grifoni, a; goletti, d	clinical microbiology and infection	2021	10.1016/j.cmi.2020.09.051	3
537	adaptive immunity to sars-cov-2 and covid-19	sette, a; crotty, s	cell	2021	10.1016/j.cell.2021.01.007	16
538	human neutralizing antibodies against sars-cov-2 require intact fc effector functions for optimal therapeutic protection	winkler, es; gilchuk, p; yu, js; bailey, al; chen, re; chong, zl; zost, sj; jang, h; huang, y; allen, jd; case, jb; sutton, re; carnahan, rh; darling, tl; boon, acm; mack, m; head, rd; ross, tm; crowe, je; diamond, ms	cell	2021	10.1016/j.cell.2021.02.026	7
539	engineering sars-cov-2 using a reverse genetic system	xie, xp; lokugamage, kg; zhang, xw; vu, mn; muruato, ae; menachery, vd; shi, py	nature protocols	2021	10.1038/s41596-021-00491-8	4
540	resistance of sars-cov-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies	chen, rte; zhang, xw; case, jb; winkler, es; liu, y; vanblargan, la; liu, jy; errico, jm; xie, xp; suryadevara, n; gilchuk, p; zost, sj; tahan, s; droit, l; turner, js; kim, w; schmitz, aj; thapa, m; wang, dv; boon, acm; presti, rm; o'halloran, ja; kim, ahj; deepak, p; pinto, d; fremont, dh; crowe, je; corti, d; virgin, hw; ellebedy, ah; shi, py; diamond, ms	nature medicine	2021	10.1038/s41591-021-01294-w	19
541	neutralizing and protective human monoclonal antibodies recognizing the n-terminal domain of the sars-cov-2 spike protein	suryadevara, n; shrihari, s; gilchuk, p; vanblargan, la; binshtein, e; zost, sj; nargi, rs; sutton, re; winkler, es; chen, ec; fouch, me; davidson, e; doranz, bj; chen, re; shi, py; carnahan, rh; thackray, lb; diamond, ms; crowe, je	cell	2021	10.1016/j.cell.2021.03.029	8
542	circulating sars-cov-2 spike n439k variants maintain fitness while evading antibody-mediated immunity	thomson, ec; rosen, le; shepherd, jg; spreafico, r; filipe, ad; wojcechowskyj, ja; davis, c; piccoli, l; pascall, dj; dillen, j; lytras, s; czudnochowski, n; shah, r; meury, m; jesudason, n; de marco, a; li, k; bassi, j; o'toole, a; pinto, d; colquhoun, rm; culap, k; jackson, b; zatta, f; rambaut, a; jaconi, s; sreenu, vb; nix, j; zhang, i; jarrett, rf; glass, wg; beltramello, m; nomikou, k; pizzuto, m; tong, l; cameroni, e; croll, ti; johnson, n; di iulio, j; wickenhagen, a; ceschi, a; harbison, am; mair, d; ferrari, p; smollett, k; sallusto, f; carmichael, s; garzoni, c; nichols, j; galli, m; hughes, j; riva, a; ho, a; schiuma, m; semple, mg; openshaw, pjm; fadda, e; baillie, jk; chodera, jd; rihn, sj; lycett, sj; virgin, hw; telenti, a; corti, d; robertson, dl; snell, g	cell	2021	10.1016/j.cell.2021.01.037	14
543	sensitivity of sars-cov-2 b.1.1.7 to mrna vaccine-elicited antibodies	collier, da; de marco, a; ferreira, iatm; meng, b; datir, rp; walls, ac; kemp, sa; bassi, j; pinto, d; silacci-fregni, c; bianchi, s; tortorici, ma; bowen, j; culap, k; jaconi, s; cameroni, e; snell, g; pizzuto, ms; pellanda, af; garzoni, c; riva, a; elmer, a; kingston, n; graves, b; mccoy, le; smith, kgc; bradley, jr; temperton, n; ceron-gutierrez, l; barcenas-morales, g; harvey, w; virgin, hw; lanzavecchia, a; piccoli, l; doffinger, r; wills, m; veesler, d; corti, d; gupta, rk	nature	2021	10.1038/s41586-021-03412-7	23
544	n-terminal domain antigenic mapping reveals a site of vulnerability for sars-cov-2	mccallum, m; de marco, a; lempp, f; tortorici, ma; pinto, d; walls, ac; beltramello, m; chen, a; liu, zm; zatta, f; zepeda, s; di iulio, j; bowen, je; montiel-ruiz, m; zhou, jy; rosen, le; bianchi, s; guarino, b; fregni, cs; abdelnabi, r; foo, syc; rothlauf, pw; bloyet, lm; benigni, f; cameroni, e; neyts, j; riva, a; snell, g; telenti, a; whelan, spj; virgin, hw; corti, d; pizzuto, ms; veesler, d	cell	2021	10.1016/j.cell.2021.03.028	13
545	antibody resistance of sars-cov-2 variants b.1.351 and b.1.1.7	wang, pf; nair, ms; liu, lh; iketani, s; luo, y; guo, yc; wang, m; yu, j; zhang, bs; kwong, pd; graham, bs; mascola, jr; chang, jy; yin, mt; sobieszczyk, m; kyratsous, ca; shapiro, l; sheng, zz; huang, yx; ho, dd	nature	2021	10.1038/s41586-021-03398-2	57
546	efficacy of the chadox1 ncov-19 covid-19 vaccine against the b.1.351 variant	madhi, sa; baillie, v; cutland, cl; voysey, m; koen, al; fairlie, l; padayachee, sd; dheda, k; barnabas, sl; bhorat, qe; briner, c; kwatra, g; ahmed, k; aley, p; bhikha, s; bhiman, jn; bhorat, ae; du plessis, j; esmail, a; groenewald, m; horne, e; hwa, sh; jose, a; lambe, t; laubscher, m; malahleha, m; masenya, m; masilela, m; mckenzie, s; molapo, k; moultrie, a; oelofse, s; patel, f; pillay, s; rhead, s; rodel, h; rossouw, l; taoushanis, c; tegally, h; thombrayil, a; van eck, s; wibmer, ck; durham, nm; kelly, ej; villafana, tl; gilbert, s; pollard, aj; de oliveira, t; moore, pl; sigal, a; izu, a	new england journal of medicine	2021	10.1056/nejmoa2102214	28
547	the covid-19 innovation system	sampat, bn; shadlen, kc	health affairs	2021	10.1377/hlthaff.2020.02097	1
548	covid-19 vaccine hesitancy in a representative working-age population in france: a survey experiment based on vaccine characteristics	schwarzinger, m; watson, v; arwidson, p; alla, f; luchini, s	lancet public health	2021	10.1016/s2468-2667(21)00012-8	7
549	challenges in ensuring global access to covid-19 vaccines: production, affordability, allocation, and deployment	wouters, oj; shadlen, kc; salcher-konrad, m; pollard, aj; larson, hj; teerawattananon, y; jit, m	lancet	2021	10.1016/s0140-6736(21)00306-8	4
550	molecular determinants and mechanism for antibody cocktail preventing sars-cov-2 escape	ku, zq; xie, xp; davidson, e; ye, xh; su, h; menachery, vd; li, yz; yuan, zh; zhang, xw; muruato, ae; escuer, agi; tyrell, b; doolan, k; doranz, bj; wrapp, d; bates, pf; mclellan, js; weiss, sr; zhang, ny; shi, py; an, zq	nature communications	2021	10.1038/s41467-020-20789-7	5
551	evidence of escape of sars-cov-2 variant b.1.351 from natural and vaccine-induced sera	zhou, dm; dejnirattisai, w; supasa, p; liu, c; mentzer, aj; ginn, hm; zhao, yg; duyvesteyn, hme; tuekprakhon, a; nutalai, r; wang, bb; paesen, gc; lopez-camacho, c; slon-campos, j; hallis, b; coombes, n; bewley, k; charlton, s; walter, ts; skelly, d; lumley, sf; dold, c; levin, r; dong, t; pollard, aj; knight, jc; crook, d; lambe, t; clutterbuck, e; bibi, s; flaxman, a; bittaye, m; belij-rammerstorfer, s; gilbert, s; james, w; carroll, mw; klenerman, p; barnes, e; dunachie, sj; fry, ee; mongkolsapaya, j; ren, js; stuart, di; screaton, gr	cell	2021	10.1016/j.cell.2021.02.037	17
552	evidence for antibody as a protective correlate for covid-19 vaccines	earle, ka; ambrosino, dm; fiore-gartland, a; goldblatt, d; gilbert, pb; siber, gr; dull, p; plotkin, sa	vaccine	2021	10.1016/j.vaccine.2021.05.063	8
553	the advisory committee on immunization practices' updated interim recommendation for allocation of covid-19 vaccine - united states, december 2020	dooling, k; marin, m; wallace, m; mcclung, n; chamberland, m; lee, gm; talbot, hk; romero, jr; bell, bp; oliver, se	mmwr-morbidity and mortality weekly report	2021	10.15585/mmwr.mm695152e2	10
554	thrombocytopenia including immune thrombocytopenia after receipt of mrna covid-19 vaccines reported to the vaccine adverse event reporting system (vaers)	welsh, kj; baumblatt, j; chege, w; goud, r; nair, n	vaccine	2021	10.1016/j.vaccine.2021.04.054	0
555	priority covid-19 vaccination for patients with cancer while vaccine supply is limited	ribas, a; sengupta, r; locke, t; zaidi, sk; campbell, km; carethers, jm; jaffee, em; wherry, ej; soria, jc; d'souza, g	cancer discovery	2021	10.1158/2159-8290.cd-20-1817	4
556	covid-19 vaccines for patients with cancer: benefits likely outweigh risks	hwang, jk; zhang, t; wang, az; li, zh	journal of hematology & oncology	2021	10.1186/s13045-021-01046-w	1
557	flattening the curve of covid-19 vaccine rejection-an international overview	feleszko, w; lewulis, p; czarnecki, a; waszkiewicz, p	vaccines	2021	10.3390/vaccines9010044	3
558	unilateral axillary adenopathy in the setting of covid-19 vaccine	mehta, n; sales, rm; babagbemi, k; levy, ad; mcgrath, al; drotman, m; dodelzon, k	clinical imaging	2021	10.1016/j.clinimag.2021.01.016	4
559	integrating health behavior theories to predict american's intention to receive a covid-19 vaccine	chu, hr; liu, sx	patient education and counseling	2021	10.1016/j.pec.2021.02.031	0
560	individual and social determinants of covid-19 vaccine uptake	viswanath, k; bekalu, m; dhawan, d; pinnamaneni, r; lang, jn; mcloud, r	bmc public health	2021	10.1186/s12889-021-10862-1	1
561	mrna vaccines for covid-19: what, why and how	park, jw; lagniton, pnp; liu, y; xu, rh	international journal of biological sciences	2021	10.7150/ijbs.59233	0
562	the science is there: key considerations for stabilizing viral vector-based covid-19 vaccines	crommelin, dja; volkin, db; hoogendoorn, kh; lubiniecki, as; jiskoot, w	journal of pharmaceutical sciences	2021	10.1016/j.xphs.2020.11.015	1
563	advances in gene-based vaccine platforms to address the covid-19 pandemic	pushparajah, d; jimenez, s; wong, s; alattas, h; nafissi, n; slavcev, ra	advanced drug delivery reviews	2021	10.1016/j.addr.2021.01.003	0
564	unfolding the determinants of covid-19 vaccine acceptance in china	yin, fl; wu, zl; xia, xy; ji, mq; wang, yy; hu, zw	journal of medical internet research	2021	10.2196/26089	0
565	covid-19 and cancer: from basic mechanisms to vaccine development using nanotechnology	han, hj; nwagwu, c; anyim, o; ekweremadu, c; kim, s	international immunopharmacology	2021	10.1016/j.intimp.2020.107247	0
566	intention to receive a covid-19 vaccine: results from a population-based survey in canada	ogilvie, gs; gordon, s; smith, lw; albert, a; racey, cs; booth, a; gottschlich, a; goldfarb, d; murray, mcm; galea, lam; kaida, a; brotto, la; sadarangani, m	bmc public health	2021	10.1186/s12889-021-11098-9	0
567	covid-19 vaccine hesitancy and resistance: correlates in a nationally representative longitudinal survey of the australian population	edwards, b; biddle, n; gray, m; sollis, k	plos one	2021	10.1371/journal.pone.0248892	1
568	willingness to receive covid-19 vaccination in japan	yoda, t; katsuyama, h	vaccines	2021	10.3390/vaccines9010048	4
569	vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of covid-19 vaccination in china: a national cross-sectional study	wang, c; han, bf; zhao, ts; liu, hy; liu, b; chen, ly; xie, mz; liu, j; zheng, h; zhang, sh; wang, y; huang, nh; du, j; liu, yq; lu, qb; cui, fq	vaccine	2021	10.1016/j.vaccine.2021.04.020	0
570	mrna vaccines to prevent covid-19 disease and reported allergic reactions: current evidence and suggested approach	banerji, a; wickner, pg; saff, r; stone, ca; robinson, lb; long, aa; wolfson, ar; williams, p; khan, da; phillips, e; blumenthal, kg	journal of allergy and clinical immunology-in practice	2021	10.1016/j.jaip.2020.12.047	7
571	the advisory committee on immunization practices' interim recommendation for use of moderna covid-19 vaccine - united states, december 2020	oliver, se; gargano, jw; marin, m; wallace, m; curran, kg; chamberland, m; mcclung, n; campos-outcalt, d; morgan, rl; mbaeyi, s; romero, jr; talbot, hk; lee, gm; bell, bp; dooling, k	mmwr-morbidity and mortality weekly report	2021	10.15585/mmwr.mm695152e1	5
572	first month of covid-19 vaccine safety monitoring - united states, december 14, 2020-january 13, 2021	gee, j; marques, p; su, j; calvert, gm; liu, rl; myers, t; nair, n; martin, s; clark, t; markowitz, l; lindsey, n; zhang, bc; licata, c; jazwa, a; sotir, m; shimabukuro, t	mmwr-morbidity and mortality weekly report	2021	10.15585/mmwr.mm7008e3	14
573	allergic reactions including anaphylaxis after receipt of the first dose of pfizer-biontech covid-19 vaccine - united states, december 14-23, 2020	shimabukuro, t	mmwr-morbidity and mortality weekly report	2021	10.15585/mmwr.mm7002e1	10
574	first-dose mrna covid-19 vaccine allergic reactions: limited role for excipient skin testing	wolfson, ar; robinson, lb; li, l; mcmahon, ae; cogan, as; fu, xq; wickner, p; samarakoon, u; saff, rr; blumenthal, kg; banerji, a	journal of allergy and clinical immunology-in practice	2021	10.1016/j.jaip.2021.06.010	0
575	covid-19: current knowledge in clinical features, immunological responses, and vaccine development	singh, r; kang, a; luo, xq; jeyanathan, m; gillgrass, a; afkhami, s; xing, z	faseb journal	2021	10.1096/fj.202002662r	0
576	lessons learned from frontline skilled nursing facility staff regarding covid-19 vaccine hesitancy	berry, sd; johnson, ks; myles, l; herndon, l; montoya, a; fashaw, s; gifford, d	journal of the american geriatrics society	2021	10.1111/jgs.17136	0
577	vaccine optimization for covid-19: who to vaccinate first?	matrajt, l; eaton, j; leung, t; brown, er	science advances	2021	10.1126/sciadv.abf1374	1
578	dynamic prioritization of covid-19 vaccines when social distancing is limited for essential workers	buckner, jh; chowell, g; springborn, mr	proceedings of the national academy of sciences of the united states of	2021	10.1073/pnas.2025786118	0
579	covid-19 vaccine development: a pediatric perspective	kamidani, s; rostad, ca; anderson, ej	current opinion in pediatrics	2021	10.1097/mop.0000000000000978	1
580	coronavirus disease (covid-19): current status and prospects for drug and vaccine development	ita, k	archives of medical research	2021	10.1016/j.arcmed.2020.09.010	2
581	acceptability of a covid-19 vaccine among healthcare workers in the kingdom of saudi arabia	qattan, amn; alshareef, n; alsharqi, o; al rahahleh, n; chirwa, gc; al-hanawi, mk	frontiers in medicine	2021	10.3389/fmed.2021.644300	2
582	covid-19 vaccine hesitancy among health care workers in palestine: a call for action	maraqa, b; nazzal, z; rabi, r; sarhan, n; al-shakhra, k; al-kaila, m	preventive medicine	2021	10.1016/j.ypmed.2021.106618	0
583	bnt162b2 mrna covid-19 vaccine in a nationwide mass vaccination setting	dagan, n; barda, n; kepten, e; miron, o; perchik, s; katz, ma; hernan, ma; lipsitch, m; reis, b; balicer, rd	new england journal of medicine	2021	10.1056/nejmoa2101765	83
584	effectiveness of the pfizer-biontech and oxford-astrazeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in england: test negative case-control study	bernal, jl; andrews, n; gower, c; robertson, c; stowe, j; tessier, e; simmons, r; cottrell, s; roberts, r; o'doherty, m; brown, k; cameron, c; stockton, d; mcmenamin, j; ramsay, m	bmj-british medical journal	2021	10.1136/bmj.n1088	17
585	reduced neutralization of sars-cov-2 b.1.1.7 variant by convalescent and vaccine sera	supasa, p; zhou, dm; dejnirattisai, w; liu, c; mentzer, aj; ginn, hm; zhao, y; duyvesteyn, hme; nutalai, r; tuekprakhon, a; wang, bb; paesen, gc; slon-campos, j; lopez-camacho, c; hallis, b; coombes, n; bewley, kr; charlton, s; walter, ts; barnes, e; dunachie, sj; skelly, d; lumley, sf; baker, n; shaik, i; humphries, he; godwin, k; gent, n; sienkiewicz, a; dold, c; levin, r; dong, t; pollard, aj; knight, jc; klenerman, p; crook, d; lambe, t; clutterbuck, e; bibi, s; flaxman, a; bittaye, m; belij-rammerstorfer, s; gilbert, s; hall, dr; williams, ma; paterson, ng; james, w; carroll, mw; fry, ee; mongkolsapaya, j; ren, js; stuart, di; screaton, gr	cell	2021	10.1016/j.cell.2021.02.033	12
586	single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of chadox1 ncov-19 (azd1222) vaccine: a pooled analysis of four randomised trials	voysey, m; clemens, sac; madhi, sa; weckx, ly; folegatti, pm; aley, pk; angus, b; baillie, vl; barnabas, sl; bhorat, qe; bibi, s; briner, c; cicconi, p; clutterbuck, ea; collins, am; cutland, cl; darton, tc; dheda, k; dold, c; duncan, cja; emary, krw; ewer, kj; flaxman, a; fairlie, l; faust, sn; feng, s; ferreira, dm; finn, a; galiza, e; goodman, al; green, cm; green, ca; greenland, m; hill, c; hill, hc; hirsch, i; izu, a; jenkin, d; joe, ccd; kerridge, s; koen, a; kwatra, g; lazarus, r; libri, v; lillie, pj; marchevsky, ng; marshall, rp; mendes, ava; milan, ep; minassian, am; mcgregor, a; mujadidi, yf; nana, a; padayachee, sd; phillips, dj; pittella, a; plested, e; pollock, km; ramasamy, mn; ritchie, aj; robinson, h; schwarzbold, av; smith, a; song, r; snape, md; sprinz, e; sutherland, rk; thomson, ec; torok, me; toshner, m; turner, dpj; vekemans, j; villafana, tl; white, t; williams, cj; douglas, ad; hill, avs; lambe, t; gilbert, sc; pollard, aj	lancet	2021	10.1016/s0140-6736(21)00432-3	23
587	efficacy of chadox1 ncov-19 (azd1222) vaccine against sars-cov-2 variant of concern 202012/01 (b.1.1.7): an exploratory analysis of a randomised controlled trial	emary, krw; golubchik, t; aley, pk; ariani, cv; angus, b; bibi, s; blane, b; bonsall, d; cicconi, p; charlton, s; clutterbuck, ea; collins, am; cox, t; darton, tc; dold, c; douglas, ad; duncan, cja; ewer, kj; flaxman, al; faust, sn; ferreira, dm; feng, s; finn, a; folegatti, pm; fuskova, m; galiza, e; goodman, al; green, cm; green, ca; greenland, m; hallis, b; heath, pt; hay, j; hill, hc; jenkin, d; kerridge, s; lazarus, r; libri, v; lillie, pj; ludden, c; marchevsky, ng; minassian, am; mcgregor, ac; mujadidi, yf; phillips, dj; plested, e; pollock, km; robinson, h; smith, a; song, r; snape, md; sutherland, rk; thomson, ec; toshner, m; turner, dpj; vekemans, j; villafana, tl; williams, cj; hill, avs; lambe, t; gilbert, sc; voysey, m; ramasamy, mn; pollard, aj	lancet	2021	10.1016/s0140-6736(21)00628-0	18
588	covid-19 vaccine coverage in health-care workers in england and effectiveness of bnt162b2 mrna vaccine against infection (siren): a prospective, multicentre, cohort study	hall, vj; foulkes, s; saei, a; andrews, n; oguti, b; charlett, a; wellington, e; stowe, j; gillson, n; atti, a; islam, j; karagiannis, i; munro, k; khawam, j; chand, ma; brown, cs; ramsay, m; lopez-bernal, j; hopkins, s	lancet	2021	10.1016/s0140-6736(21)00790-x	19
589	sars-cov-2 spike glycoprotein vaccine candidate nvx-cov2373 immunogenicity in baboons and protection in mice	tian, jh; patel, n; haupt, r; zhou, hx; weston, s; hammond, h; logue, j; portnoff, ad; norton, j; guebre-xabier, m; zhou, b; jacobson, k; maciejewski, s; khatoon, r; wisniewska, m; moffitt, w; kluepfel-stahl, s; ekechukwu, b; papin, j; boddapati, s; wong, cj; piedra, pa; frieman, mb; massare, mj; fries, l; bengtsson, kl; stertman, l; ellingsworth, l; glenn, g; smith, g	nature communications	2021	10.1038/s41467-020-20653-8	8
590	efficacy of nvx-cov2373 covid-19 vaccine against the b.1.351 variant	shinde, v; bhikha, s; hoosain, z; archary, m; bhorat, q; fairlie, l; lalloo, u; masilela, msl; moodley, d; hanley, s; fouche, l; louw, c; tameris, m; singh, n; goga, a; dheda, k; grobbelaar, c; kruger, g; carrim-ganey, n; baillie, v; de oliveira, t; koen, al; lombaard, jj; mngqibisa, r; bhorat, ae; benade, g; lalloo, n; pitsi, a; vollgraaff, pl; luabeya, a; esmail, a; petrick, fg; oommen-jose, a; foulkes, s; ahmed, k; thombrayil, a; fries, l; cloney-clark, s; zhu, m; bennett, c; albert, g; faust, e; plested, js; robertson, a; neal, s; cho, i; glenn, gm; dubovsky, f; madhi, sa	new england journal of medicine	2021	10.1056/nejmoa2103055	10
591	interim estimates of vaccine effectiveness of bnt162b2 and mrna-1273 covid-19 vaccines in preventing sars-cov-2 infection among health care personnel, first responders, and other essential and frontline workers - eight us locations, december 2020-march 2021	thompson, mg; burgess, jl; naleway, al; tyner, hl; yoon, sk; meece, j; olsho, lew; caban-martinez, aj; fowlkes, a; lutrick, k; kuntz, jl; dunnigan, k; odean, mj; hegmann, kt; stefanski, e; edwards, lj; schaefer-solle, n; grant, l; ellingson, k; groom, hc; zunie, t; thiese, ms; ivacic, l; wesley, mg; lamberte, jm; sun, xx; smith, me; phillips, al; groover, kd; yoo, ym; gerald, j; brown, rt; herring, mk; joseph, g; beitel, s; morrill, tc; mak, j; rivers, p; harris, km; hunt, dr; arvay, ml; kutty, p; fry, am; gaglani, m	mmwr-morbidity and mortality weekly report	2021	10.15585/mmwr.mm7013e3	21
592	effectiveness of covid-19 vaccines against the b.1.617.2 (delta) variant	bernal, jl; andrews, n; gower, c; gallagher, e; simmons, r; thelwall, s; stowe, j; tessier, e; groves, n; dabrera, g; myers, r; campbell, cnj; amirthalingam, g; edmunds, m; zambon, m; brown, ke; hopkins, s; chand, m; ramsay, m	new england journal of medicine	2021	10.1056/nejmoa2108891	23
593	interim findings from first-dose mass covid-19 vaccination roll-out and covid-19 hospital admissions in scotland: a national prospective cohort study	vasileiou, e; simpson, cr; shi, t; kerr, s; agrawal, u; akbari, a; bedston, s; beggs, j; bradley, d; chuter, a; de lusignan, s; docherty, ab; ford, d; hobbs, fdr; joy, m; katikireddi, sv; marple, j; mccowan, c; mcgagh, d; mcmenamin, j; moore, e; murray, jlk; pan, jf; ritchie, l; shah, sa; stock, s; torabi, f; tsang, rsm; wood, r; woolhouse, m; robertson, c; sheikh, a	lancet	2021	10.1016/s0140-6736(21)00677-2	18
594	covid-19 vaccines for low- and middle-income countries	choi, em	transactions of the royal society of tropical medicine and hygiene	2021	10.1093/trstmh/trab045	0
595	covid-19 vaccine rollout risk communication strategies in europe: a rapid response	warren, gw; lofstedt, r	journal of risk research	2021	10.1080/13669877.2020.1870533	0
596	monitoring covid-19 vaccine acceptance in kuwait during the pandemic: results from a national serial study	awadhi, ea; zein, d; mallallah, f; haider, nb; hossain, a	risk management and healthcare policy	2021	10.2147/rmhp.s300602	0
597	covid-19 vaccines: the status and perspectives in delivery points of view	chung, jy; thone, mn; kwon, yj	advanced drug delivery reviews	2021	10.1016/j.addr.2020.12.011	0
598	sars-cov-2 mrna vaccines: immunological mechanism and beyond	bettini, e; locci, m	vaccines	2021	10.3390/vaccines9020147	3
599	minor to moderate side effects of pfizer-biontech covid-19 vaccine among saudi residents: a retrospective cross-sectional study	el-shitany, na; harakeh, s; badr-eldin, sm; bagher, am; eid, b; almukadi, h; alghamdi, bs; alahmadi, aa; hassan, na; sindi, n; alghamdi, sa; almohaimeed, hm; mohammedsaleh, zm; al-shaikh, tm; almuhayawi, ms; ali, ss; el-hamamsy, m	international journal of general medicine	2021	10.2147/ijgm.s310497	1
600	non-life-threatening adverse effects with covid-19 mrna-1273 vaccine: a randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms	kadali, rak; janagama, r; peruru, s; gajula, v; madathala, rr; chennaiahgari, n; malayala, sv	journal of medical virology	2021	10.1002/jmv.26996	2
601	cutaneous reactions reported after moderna and pfizer covid-19 vaccination: a registry-based study of 414 cases	mcmahon, de; amerson, e; rosenbach, m; lipoff, jb; moustafa, d; tyagi, a; desai, sr; french, le; lim, hw; thiers, bh; hruza, gj; blumenthal, kg; fox, lp; freeman, ee	journal of the american academy of dermatology	2021		2
602	vaccine side-effects and sars-cov-2 infection after vaccination in users of the covid symptom study app in the uk: a prospective observational study	menni, c; klaser, k; may, a; polidori, l; capdevila, j; louca, p; sudre, ch; nguyen, lh; drew, da; merino, j; hu, c; selvachandran, s; antonelli, m; murray, b; canas, ls; molteni, e; graham, ms; modat, m; joshi, ad; mangino, m; hammers, a; goodman, al; chan, at; wolf, j; steves, cj; valdes, am; ourselin, s; spector, td	lancet infectious diseases	2021	10.1016/s1473-3099(21)00224-3	7
603	acceptance of a covid-19 vaccine is associated with ability to detect fake news and health literacy	montagni, i; ouazzani-touhami, k; mebarki, a; texier, n; schuck, s; tzourio, c	journal of public health	2021	10.1093/pubmed/fdab028	1
604	attitude and behaviors towards sars-cov-2 vaccination among healthcare workers: a cross-sectional study from poland	szmyd, b; karuga, ff; bartoszek, a; staniecka, k; siwecka, n; bartoszek, a; blaszczyk, m; radek, m	vaccines	2021	10.3390/vaccines9030218	2
605	prevalence of covid-19 vaccine side effects among healthcare workers in the czech republic	riad, a; pokorna, a; attia, s; klugarova, j; koscik, m; klugar, m	journal of clinical medicine	2021	10.3390/jcm10071428	2
606	prevalence and risk factors of coronavac side effects: an independent cross-sectional study among healthcare workers in turkey	riad, a; sagiroglu, d; ustun, b; pokorna, a; klugarova, j; attia, s; klugar, m	journal of clinical medicine	2021	10.3390/jcm10122629	1
607	side effects of mrna-based and viral vector-based covid-19 vaccines among german healthcare workers	klugar, m; riad, a; mekhemar, m; conrad, j; buchbender, m; howaldt, hp; attia, s	biology-basel	2021	10.3390/biology10080752	0
608	no populations left behind: vaccine hesitancy and equitable diffusion of effective covid-19 vaccines	hooper, mw; napoles, am; perez-stable, ej	journal of general internal medicine	2021	10.1007/s11606-021-06698-5	2
609	sars-cov-2 vaccines in advanced clinical trials: where do we stand?	chakraborty, s; mallajosyula, v; tato, cm; tan, gs; wang, tt	advanced drug delivery reviews	2021	10.1016/j.addr.2021.01.014	2
610	the 2020 race towards sars-cov-2 specific vaccines	karpinski, tm; ozarowski, m; seremak-mrozikiewicz, a; wolski, h; wlodkowic, d	theranostics	2021	10.7150/thno.53691	1
611	immunogenicity of the ad26.cov2.s vaccine for covid-19	stephenson, ke; le gars, m; sadoff, j; de groot, am; heerwegh, d; truyers, c; atyeo, c; loos, c; chandrashekar, a; mcmahan, k; tostanoski, lh; yu, jy; gebre, ms; jacob-dolan, c; li, zf; patel, s; peter, l; liu, jy; borducchi, en; nkolola, jp; souza, m; tan, cs; zash, r; julg, b; nathavitharana, rr; shapiro, rl; azim, aa; alonso, cd; jaegle, k; ansel, jl; kanjilal, dg; guiney, cj; bradshaw, c; tyler, a; makoni, t; yanosick, ke; seaman, ms; lauffenburger, da; alter, g; struyf, f; douoguih, m; van hoof, j; schuitemaker, h; barouch, dh	jama-journal of the american medical association	2021	10.1001/jama.2021.3645	3
612	immunogenicity and protective efficacy of bbv152, whole virion inactivated sars-cov-2 vaccine candidates in the syrian hamster model	mohandas, s; yadav, pd; shete-aich, a; abraham, p; vadrevu, km; sapkal, g; mote, c; nyayanit, d; gupta, n; srinivas, vk; kadam, m; kumar, a; majumdar, t; jain, r; deshpande, g; patil, s; sarkale, p; patil, d; ella, r; prasad, sd; sharma, s; ella, km; panda, s; bhargava, b	iscience	2021	10.1016/j.isci.2021.102054	2
613	immunogenicity and protective efficacy of inactivated sars-cov-2 vaccine candidate, bbv152 in rhesus macaques	yadav, pd; ella, r; kumar, s; patil, dr; mohandas, s; shete, am; vadrevu, km; bhati, g; sapkal, g; kaushal, h; patil, s; jain, r; deshpande, g; gupta, n; agarwal, k; gokhale, m; mathapati, b; metkari, s; mote, c; nyayanit, d; patil, dy; prasad, bss; suryawanshi, a; kadam, m; kumar, a; daigude, s; gopale, s; majumdar, t; mali, d; sarkale, p; baradkar, s; gawande, p; joshi, y; fulari, s; dighe, h; sharma, s; gunjikar, r; kumar, a; kalele, k; srinivas, vk; gangakhedkar, rr; ella, km; abraham, p; panda, s; bhargava, b	nature communications	2021	10.1038/s41467-021-21639-w	2
614	covid-19 vaccines: a review of the safety and efficacy of current clinical trials	yan, zp; yang, m; lai, cl	pharmaceuticals	2021	10.3390/ph14050406	3
615	associations of covid-19 risk perception with vaccine hesitancy over time for italian residents	caserotti, m; girardi, p; rubaltelli, e; tasso, a; lotto, l; gavaruzzi, t	social science & medicine	2021	10.1016/j.socscimed.2021.113688	4
616	lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to covid-19 vaccines	thi, tth; suys, eja; lee, js; nguyen, dh; park, kd; truong, np	vaccines	2021	10.3390/vaccines9040359	0
617	covid-19 vaccination and antirheumatic therapy	arnold, j; winthrop, k; emery, p	rheumatology	2021	10.1093/rheumatology/keab223	1
618	covid-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries	skjefte, m; ngirbabul, m; akeju, o; escudero, d; hernandez-diaz, s; wyszynski, df; wu, jw	european journal of epidemiology	2021	10.1007/s10654-021-00728-6	2
619	psychological and behavioral predictors of vaccine efficacy: considerations for covid-19	madison, aa; shrout, mr; renna, me; kiecolt-glaser, jk	perspectives on psychological science	2021	10.1177/1745691621989243	1
620	vaccinology in the post-covid-19 era	rappuoli, r; de gregorio, e; del giudice, g; phogat, s; pecetta, s; pizza, m; hanon, e	proceedings of the national academy of sciences of the united states of	2021	10.1073/pnas.2020368118	0
621	covid-19 vaccination acceptance and its associated factors among a middle eastern population	al-qerem, wa; jarab, as	frontiers in public health	2021	10.3389/fpubh.2021.632914	2
622	correlates and disparities of intention to vaccinate against covid-19	callaghan, t; moghtaderi, a; lueck, ja; hotez, p; strych, u; dor, a; fowler, ef; motta, m	social science & medicine	2021	10.1016/j.socscimed.2020.113638	3
623	can a covid-19 vaccine live up to americans ' expectations? a conjoint analysis of how vaccine characteristics influence vaccination intentions	motta, m	social science & medicine	2021	10.1016/j.socscimed.2020.113642	1
624	predictors of intention to vaccinate against covid-19: results of a nationwide survey	ruiz, jb; bell, ra	vaccine	2021	10.1016/j.vaccine.2021.01.010	3
625	willing or hesitant? a socioeconomic study on the potential acceptance of covid-19 vaccine in japan	kadoya, y; watanapongvanich, s; yuktadatta, p; putthinun, p; lartey, st; khan, msr	international journal of environmental research and public health	2021	10.3390/ijerph18094864	0
626	sars-cov-2 vaccines and autoimmune diseases amidst the covid-19 crisis	velikova, t; georgiev, t	rheumatology international	2021	10.1007/s00296-021-04792-9	1
627	"thrombocytopenia and intracranial venous sinus thrombosis after ""covid-19 vaccine astrazeneca"" exposure"	wolf, me; luz, b; niehaus, l; bhogal, p; bazner, h; henkes, h	journal of clinical medicine	2021	10.3390/jcm10081599	2
628	a tale of two crises: addressing covid-19 vaccine hesitancy as promoting racial justice	bunch, l	hec forum	2021	10.1007/s10730-021-09440-0	1
629	american college of rheumatology guidance for covid-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 1	curtis, jr; johnson, sr; anthony, dd; arasaratnam, rj; baden, lr; bass, ar; calabrese, c; gravallese, em; harpaz, r; sadun, re; turner, as; williams, ea; mikuls, tr	arthritis & rheumatology	2021	10.1002/art.41734	3
630	a longitudinal study of sars-cov-2-infected patients reveals a high correlation between neutralizing antibodies and covid-19 severity	legros, v; denolly, s; vogrig, m; boson, b; siret, e; rigaill, j; pillet, s; grattard, f; gonzalo, s; verhoeven, p; allatif, o; berthelot, p; pelissier, c; thiery, g; botelho-nevers, e; millet, g; morel, jm; paul, s; walzer, t; cosset, fl; bourlet, t; pozzetto, b	cellular & molecular immunology	2021	10.1038/s41423-020-00588-2	2
631	reduced humoral response to mrna sars-cov-2 bnt162b2 vaccine in kidney transplant recipients without prior exposure to the virus	grupper, a; rabinowich, l; schwartz, d; schwartz, if; ben-yehoyada, m; shashar, m; katchman, e; halperin, t; turner, d; goykhman, y; shibolet, o; levy, s; houri, i; baruch, r; katchman, h	american journal of transplantation	2021	10.1111/ajt.16615	8
632	immunogenicity and safety of the bnt162b2 mrna covid-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study	furer, v; eviatar, t; zisman, d; peleg, h; paran, d; levartovsky, d; zisapel, m; elalouf, o; kaufman, i; meidan, r; broyde, a; polachek, a; wollman, j; litinsky, i; meridor, k; nochomovitz, h; silberman, a; rosenberg, d; feld, j; haddad, a; gazzit, t; elias, m; higazi, n; kharouf, f; shefer, g; sharon, o; pel, s; nevo, s; elkayam, o	annals of the rheumatic diseases	2021	10.1136/annrheumdis-2021-220647	6
633	point of view on the vaccination against covid-19 in patients with autoimmune inflammatory rheumatic diseases	furer, v; rondaan, c; agmon-levin, n; van assen, s; bijl, m; kapetanovic, mc; de thurah, a; mueller-ladner, u; paran, d; schreiber, k; warnatz, k; wulffraat, nm; elkayam, o	rmd open	2021	10.1136/rmdopen-2021-001594	3
634	vaccination of patients with inflammatory rheumatic diseases against sars-cov-2: considerations before widespread availability of the vaccines	schulze-koops, h; specker, c; skapenko, a	rmd open	2021	10.1136/rmdopen-2020-001553	1
635	factors associated with racial/ethnic group-based medical mistrust and perspectives on covid-19 vaccine trial participation and vaccine uptake in the us	thompson, hs; manning, m; mitchell, j; kim, s; harper, fwk; cresswell, s; johns, k; pal, s; dowe, b; tariq, m; sayed, n; saigh, lm; rutledge, l; lipscomb, c; lilly, jy; gustine, h; sanders, a; landry, m; marks, b	jama network open	2021	10.1001/jamanetworkopen.2021.11629	1
636	early experience of covid-19 vaccination in adults with systemic rheumatic diseases: results from the covid-19 global rheumatology alliance vaccine survey	sattui, se; liew, jw; kennedy, k; sirotich, e; putman, m; moni, tt; akpabio, a; alpizar-rodriguez, d; berenbaum, f; bulina, i; conway, r; singh, ad; duff, e; durrant, kl; gheita, ta; hill, cl; howard, ra; hoyer, bf; hsieh, e; el kibbi, l; kilian, a; kim, ah; liew, dfl; lo, c; miller, b; mingolla, s; nudel, m; palmerlee, ca; singh, ja; singh, n; ugarte-gil, mf; wallace, j; young, kj; bhana, s; costello, w; grainger, r; machado, pm; robinson, pc; sufka, p; wallace, zs; yazdany, j; harrison, c; larche, m; levine, m; foster, g; thabane, l; rider, lg; hausmann, js; simard, jf; sparks, ja	rmd open	2021	10.1136/rmdopen-2021-001814	0
637	acceptance of the covid-19 vaccine based on the health belief model: a population-based survey in hong kong	wong, mcs; wong, ely; huang, jj; cheung, awl; law, k; chong, mkc; ng, rwy; lai, ckc; boon, ss; lau, jtf; chen, zg; chan, pks	vaccine	2021	10.1016/j.vaccine.2020.12.083	3
638	diagnosis and management of vaccine-related thrombosis following astrazeneca covid-19 vaccination: guidance statement from the gth	oldenburg, j; klamroth, r; langer, f; albisetti, m; von auer, c; ay, c; korte, w; scharf, re; potzsch, b; greinacher, a	hamostaseologie	2021	10.1055/a-1469-7481	6
639	successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (vipit)	thaler, j; ay, c; gleixner, kv; hauswirth, aw; cacioppo, f; grafeneder, j; quehenberger, p; pabinger, i; knobl, p	journal of thrombosis and haemostasis	2021	10.1111/jth.15346	2
640	thrombosis with thrombocytopenia syndrome associated with covid-19 vaccines	long, b; bridwell, r; gottlieb, m	american journal of emergency medicine	2021	10.1016/j.ajem.2021.05.054	0
641	acute transverse myelitis (atm):clinical review of 43 patients with covid-19-associated atm and 3 post-vaccination atm serious adverse events with the chadox1 ncov-19 vaccine (azd1222)	roman, gc; gracia, f; torres, a; palacios, a; gracia, k; harris, d	frontiers in immunology	2021	10.3389/fimmu.2021.653786	0
642	influence of a covid-19 vaccine's effectiveness and safety profile on vaccination acceptance	kaplan, rm; milstein, a	proceedings of the national academy of sciences of the united states of	2021	10.1073/pnas.2021726118	0
643	attitudes of lebanese adults regarding covid-19 vaccination	al halabi, ck; obeid, s; sacre, h; akel, m; hallit, r; salameh, p; hallit, s	bmc public health	2021	10.1186/s12889-021-10902-w	1
644	reported orofacial adverse effects of covid-19 vaccines: the knowns and the unknowns	cirillo, n	journal of oral pathology & medicine	2021	10.1111/jop.13165	1
645	covid-19 vaccines and treatments nationalism: challenges for low-income countries and the attainment of the sdgs	nhamo, g; chikodzi, d; kunene, hp; mashula, n	global public health	2021	10.1080/17441692.2020.1860249	0
646	multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: radiology scientific expert panel	becker, as; perez-johnston, r; chikarmane, sa; chen, mm; el homsi, m; feigin, kn; gallagher, km; hanna, ey; hicks, m; ilica, at; mayer, el; shinagare, ab; yeh, r; mayerhoefer, me; hricak, h; vargas, ha	radiology	2021	10.1148/radiol.2021210436	1
647	management of unilateral axillary lymphadenopathy detected on breast mri in the era of covid-19 vaccination	edmonds, ce; zuckerman, sp; conant, ef	american journal of roentgenology	2021	10.2214/ajr.21.25604	3
648	lymphadenopathy in covid-19 vaccine recipients: diagnostic dilemma in oncologic patients	ozutemiz, c; krystosek, la; church, al; chauhan, a; ellermann, jm; domingo-musibay, e; steinberger, d	radiology	2021	10.1148/radiol.2021210275	2
649	hypermetabolic lymphadenopathy following administration of bnt162b2 mrna covid-19 vaccine: incidence assessed by [f-18]fdg pet-ct and relevance to study interpretation	cohen, d; krauthammer, sh; wolf, i; even-sapir, e	european journal of nuclear medicine and molecular imaging	2021	10.1007/s00259-021-05314-2	2
650	sars-cov-2 vaccines for cancer patients: a call to action	corti, c; crimini, e; tarantino, p; pravettoni, g; eggermont, amm; delaloge, s; curigliano, g	european journal of cancer	2021	10.1016/j.ejca.2021.01.046	2
651	vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar	kelkar, ah; blake, ja; cherabuddi, k; cornett, h; mckee, bl; cogle, cr	healthcare	2021	10.3390/healthcare9030351	2
652	estimated transmissibility and impact of sars-cov-2 lineage b.1.1.7 in england	davies, ng; abbott, s; barnard, rc; jarvis, ci; kucharski, aj; munday, jd; pearson, cab; russell, tw; tully, dc; washburne, ad; wenseleers, t; gimma, a; waites, w; wong, klm; van zandvoort, k; silverman, jd; diaz-ordaz, k; keogh, r; eggo, rm; funk, s; jit, m; atkins, ke; edmunds, wj	science	2021	10.1126/science.abg3055	41
653	safety and immunogenicity of one versus two doses of the covid-19 vaccine bnt162b2 for patients with cancer: interim analysis of a prospective observational study	monin, l; laing, ag; munoz-ruiz, m; mckenzie, dr; del barrio, id; alaguthurai, t; domingo-vila, c; hayday, ts; graham, c; seow, j; abdul-jawad, s; kamdar, s; harvey-jones, e; graham, r; cooper, j; khan, m; vidler, j; kakkassery, h; sinha, s; davis, r; dupont, l; quijorna, if; o'brien-gore, c; lee, pl; eum, j; poole, mc; joseph, m; davies, d; wu, y; swampillai, a; north, bv; montes, a; harries, m; rigg, a; spicer, j; malim, mh; fields, p; patten, p; di rosa, f; papa, s; tree, t; doores, kj; hayday, ac; irshad, s	lancet oncology	2021	10.1016/s1470-2045(21)00213-8	13
654	the bnt162b2 mrna covid-19 vaccine in adolescents and young adults with cancer: a monocentric experience	revon-riviere, g; ninove, l; min, vc; rome, a; coze, c; verschuur, a; de lamballerie, x; andre, n	european journal of cancer	2021	10.1016/j.ejca.2021.06.002	2
655	willingness to pay for a covid-19 vaccine	cerda, aa; garcia, ly	applied health economics and health policy	2021	10.1007/s40258-021-00644-6	2
656	an online survey of the attitude and willingness of chinese adults to receive covid-19 vaccination	chen, ms; li, yj; chen, js; wen, zy; feng, fl; zou, hc; fu, cx; chen, l; shu, yl; sun, cj	human vaccines & immunotherapeutics	2021	10.1080/21645515.2020.1853449	2
657	willingness to obtain covid-19 vaccination in adults with multiple sclerosis in the united states	ehde, dm; roberts, mk; herring, te; alschuler, kn	multiple sclerosis and related disorders	2021	10.1016/j.msard.2021.102788	2
658	covid-19 vaccination intention among healthcare workers in vietnam	huynh, g; tran, tt; nguyen, htn; pham, l	asian pacific journal of tropical medicine	2021	10.4103/1995-7645.312513	1
659	willingness of long-term care staff to receive a covid-19 vaccine: a single state survey	unroe, kt; evans, r; weaver, l; rusyniak, d; blackburn, j	journal of the american geriatrics society	2021	10.1111/jgs.17022	2
660	mask usage, social distancing, racial, and gender correlates of covid-19 vaccine intentions among adults in the us	latkin, ca; dayton, l; yi, g; colon, b; kong, xr	plos one	2021	10.1371/journal.pone.0246970	3
661	cross-sectional analysis of covid-19 vaccine intention, perceptions and hesitancy across latin america and the caribbean	urrunaga-pastor, d; bendezu-quispe, g; herrera-anazco, p; uyen-cateriano, a; toro-huamanchumo, cj; rodriguez-morales, aj; hernandez, av; benites-zapata, va	travel medicine and infectious disease	2021	10.1016/j.tmaid.2021.102059	1
662	"the willingness to receive covid-19 vaccine and its associated factors: ""vaccination refusal could prolong the war of this pandemic"" a systematic review"	wake, ad	risk management and healthcare policy	2021	10.2147/rmhp.s311074	0
663	factors affecting covid-19 vaccine acceptance: an international survey among low-and middle-income countries	bono, sa; villela, efd; siau, cs; chen, ws; pengpid, s; hasan, mt; sessou, p; ditekemena, jd; amodan, bo; hosseinipour, mc; dolo, h; fodjo, jns; low, wy; colebunders, r	vaccines	2021	10.3390/vaccines9050515	0
664	covid-19 vaccine hesitancy in canada: content analysis of tweets using the theoretical domains framework	griffith, j; marani, h; monkman, h	journal of medical internet research	2021	10.2196/26874	0
665	knowledge, attitude, and acceptance of healthcare workers and the public regarding the covid-19 vaccine: a cross-sectional study	elhadi, m; alsoufi, a; alhadi, a; hmeida, a; alshareea, e; dokali, m; abodabos, s; alsadiq, o; abdelkabir, m; ashini, a; shaban, a; mohammed, s; alghudban, n; bureziza, e; najah, q; abdulrahman, k; mshareb, n; derwish, k; shnfier, n; burkan, r; al-azomi, m; hamdan, a; algathafi, k; abdulwahed, e; alheerish, k; lindi, n; anaiba, m; elbarouni, a; alsharif, m; alhaddad, k; alwhishi, e; aboughuffah, m; aljadidi, w; jaafari, a; khaled, a; zaid, a; msherghi, a	bmc public health	2021	10.1186/s12889-021-10987-3	1
666	panuveitis following vaccination for covid-19	mudie, li; zick, jd; dacey, ms; palestine, ag	ocular immunology and inflammation	2021	10.1080/09273948.2021.1949478	1
667	covid-19: characteristics and therapeutics	chilamakuri, r; agarwal, s	cells	2021	10.3390/cells10020206	1
668	will healthcare workers accept a covid-19 vaccine when it becomes available? a cross-sectional study in china	sun, yf; chen, xh; cao, m; xiang, t; zhang, jm; wang, p; dai, h	frontiers in public health	2021	10.3389/fpubh.2021.664905	0
669	vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection	batty, cj; heise, mt; bachelder, em; ainslie, km	advanced drug delivery reviews	2021	10.1016/j.addr.2020.12.006	2
670	self-assembled mrna vaccines	kim, j; eygeris, y; gupta, m; sahay, g	advanced drug delivery reviews	2021	10.1016/j.addr.2020.12.014	4
671	safety and immunogenicity of an mrna-lipid nanoparticle vaccine candidate against sars-cov-2 a phase 1 randomized clinical trial	kremsner, pg; mann, p; kroidl, a; leroux-roels, i; schindler, c; gabor, jj; schunk, m; leroux-roels, g; bosch, jj; fendel, r; kreidenweiss, a; velavan, tp; fotin-mleczek, m; mueller, so; quintini, g; schonborn-kellenberger, o; vahrenhorst, d; verstraeten, t; de mesquita, ma; walz, l; wolz, oo; oostvogels, l	wiener klinische wochenschrift	2021	10.1007/s00508-021-01922-y	2
672	the dawn of mrna vaccines: the covid-19 case	verbeke, r; lentacker, i; de smedt, sc; dewitte, h	journal of controlled release	2021	10.1016/j.jconrel.2021.03.043	1
673	mrna-lipid nanoparticle covid-19 vaccines: structure and stability	schoenmaker, l; witzigmann, d; kulkarni, ja; verbeke, r; kersten, g; jiskoot, w; crommelin, dja	international journal of pharmaceutics	2021	10.1016/j.ijpharm.2021.120586	1
674	beliefs and barriers associated with covid-19 vaccination among the general population in saudi arabia	magadmi, rm; kamel, fo	bmc public health	2021	10.1186/s12889-021-11501-5	0
675	immunogenicity of bnt162b2 mrna covid-19 vaccine and sars-cov-2 infection in lung transplant recipients	havlin, j; svorcova, m; dvorackova, e; lastovicka, j; lischke, r; kalina, t; hubacek, p	journal of heart and lung transplantation	2021	10.1016/j.healun.2021.05.004	4
676	recent insights for the emerging covid-19: drug discovery, therapeutic options and vaccine development	zhu, yf; li, j; pang, zq	asian journal of pharmaceutical sciences	2021	10.1016/j.ajps.2020.06.001	0
677	a rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the covid-19 vaccine administration	d'agostino, v; caranci, f; negro, a; piscitelli, v; tuccillo, b; fasano, f; sirabella, g; marano, i; granata, v; grassi, r; pupo, d; grassi, r	journal of personalized medicine	2021	10.3390/jpm11040285	2
678	non-viral covid-19 vaccine delivery systems	park, ks; sun, xq; aikins, me; moon, jj	advanced drug delivery reviews	2021	10.1016/j.addr.2020.12.008	2
679	allergic reactions including anaphylaxis after receipt of the first dose of moderna covid-19 vaccine - united states, december 21, 2020-january 10, 2021	shimabukuro, t	mmwr-morbidity and mortality weekly report	2021		3
680	eaaci statement on the diagnosis, management and prevention of severe allergic reactions to covid-19 vaccines	sokolowska, m; eiwegger, t; ollert, m; torres, mj; barber, d; del giacco, s; jutel, m; nadeau, kc; palomares, o; rabin, rl; riggioni, c; vieths, s; agache, i; shamji, mh	allergy	2021	10.1111/all.14739	2
681	allergic reactions to current available covid-19 vaccinations: pathophysiology, causality, and therapeutic considerations	kounis, ng; koniari, i; de gregorio, c; velissaris, d; petalas, k; brinia, a; assimakopoulos, sf; gogos, c; kouni, sn; kounis, gn; calogiuri, g; hung, my	vaccines	2021	10.3390/vaccines9030221	3
682	thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based covid-19 vaccine	blauenfeldt, ra; kristensen, sr; ernstsen, sl; kristensen, cch; simonsen, cz; hvas, am	journal of thrombosis and haemostasis	2021	10.1111/jth.15347	3
683	cerebral venous sinus thrombosis and thrombocytopenia after covid-19 vaccination-a report of two uk cases	mehta, pr; mangion, sa; benger, m; stanton, br; czuprynska, j; arya, r; sztriha, lk	brain behavior and immunity	2021	10.1016/j.bbi.2021.04.006	4
684	vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post covid-19 vaccination; a systematic review	sharifian-dorche, m; bahmanyar, m; sharifian-dorche, a; mohammadi, p; nomovi, m; mowla, a	journal of the neurological sciences	2021	10.1016/j.jns.2021.117607	1
685	systemic effects of missense mutations on sars-cov-2 spike glycoprotein stability and receptor-binding affinity	teng, sl; sobitan, a; rhoades, r; liu, dx; tang, qy	briefings in bioinformatics	2021	10.1093/bib/bbaa233	2
686	transmission, infectivity, and neutralization of a spike l452r sars-cov-2 variant	deng, xd; garcia-knight, ma; khalid, mm; servellita, v; wang, cdc; morris, mk; sotomayor-gonzalez, a; glasner, dr; reyes, kr; gliwa, as; reddy, np; san martin, cs; federman, s; cheng, j; balcerek, j; taylor, j; streithorst, ja; miller, s; sreekumar, b; chen, py; schulze-gahmen, u; taha, ty; hayashi, jm; simoneau, cr; kumar, gr; mcmahon, s; lidsky, pv; xiao, yh; hemarajata, p; green, nm; espinosa, a; kath, c; haw, m; bell, j; hacker, jk; hanson, c; wadford, da; anaya, c; ferguson, d; frankino, pa; shivram, h; lareau, lf; wyman, sk; ott, m; andino, r; chiu, cy	cell	2021	10.1016/j.cell.2021.04.025	7
687	sars-cov-2 variant of concern 202012/01 has about twofold replicative advantage and acquires concerning mutations	grabowski, f; preibisch, g; gizinski, s; kochanczyk, m; lipniacki, t	viruses-basel	2021	10.3390/v13030392	4
688	a trimeric human angiotensin-converting enzyme 2 as an anti-sars-cov-2 agent	xiao, ts; lu, jm; zhang, j; johnson, ri; mckay, lga; storm, n; lavine, cl; peng, hq; cai, yf; rits-volloch, s; lu, s; quinlan, bd; farzan, m; seaman, ms; griffiths, a; chen, b	nature structural & molecular biology	2021	10.1038/s41594-020-00549-3	3
689	d614g mutation alters sars-cov-2 spike conformation and enhances protease cleavage at the s1/s2 junction	gobeil, smc; janowska, k; mcdowell, s; mansouri, k; parks, r; manne, k; stalls, v; kopp, mf; henderson, r; edwards, rj; haynes, bf; acharya, p	cell reports	2021	10.1016/j.celrep.2020.108630	4
690	structural impact on sars-cov-2 spike protein by d614g substitution	zhang, j; cai, yf; xiao, ts; lu, jm; peng, hq; sterling, sm; walsh, rm; rits-volloch, s; zhu, hs; woosley, an; yang, w; sliz, p; chen, b	science	2021	10.1126/science.abf2303	2
691	structural basis for enhanced infectivity and immune evasion of sars-cov-2 variants	cai, yf; zhang, j; xiao, ts; lavine, cl; rawson, s; peng, hq; zhu, hs; anand, k; tong, p; gautam, a; lu, s; sterling, sm; walsh, rm; rits-volloch, s; lu, jm; wesemann, dr; yang, w; seaman, ms; chen, b	science	2021	10.1126/science.abi9745	1
692	sars-cov-2 variant b.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines	shen, xy; tang, hl; mcdanal, c; wagh, k; fischer, w; theiler, j; yoon, h; li, dp; haynes, bf; sanders, ko; gnanakaran, s; hengartner, n; pajon, r; smith, g; glenn, gm; korber, b; montefiori, dc	cell host & microbe	2021	10.1016/j.chom.2021.03.002	14
693	the effect of spike mutations on sars-cov-2 neutralization	rees-spear, c; muir, l; griffith, sa; heaney, j; aldon, y; snitselaar, jl; thomas, p; graham, c; seow, j; lee, n; rosa, a; roustan, c; houlihan, cf; sanders, rw; gupta, rk; cherepanov, p; stauss, hj; nastouli, e; doores, kj; van gils, mj; mccoy, le	cell reports	2021	10.1016/j.celrep.2021.108890	5
694	sensitivity of infectious sars-cov-2 b.1.1.7 and b.1.351 variants to neutralizing antibodies	planas, d; bruel, t; grzelak, l; guivel-benhassine, f; staropoli, i; porrot, f; planchais, c; buchrieser, j; rajah, mm; bishop, e; albert, m; donati, f; prot, m; behillil, s; enouf, v; maquart, m; smati-lafarge, m; varon, e; schortgen, f; yahyaoui, l; gonzalez, m; de seze, jm; pere, h; veyer, d; seve, a; simon-loriere, e; fafi-kremer, s; stefic, k; mouquet, h; hocqueloux, l; van der werf, s; prazuck, t; schwartz, o	nature medicine	2021	10.1038/s41591-021-01318-5	16
695	sars-cov-2-derived peptides define heterologous and covid-19-induced t cell recognition	nelde, a; bilich, t; heitmann, js; maringer, y; salih, hr; roerden, m; lubke, m; bauer, j; rieth, j; wacker, m; peter, a; horber, s; traenkle, b; kaiser, pd; rothbauer, u; becker, m; junker, d; krause, g; strengert, m; schneiderhan-marra, n; templin, mf; joos, to; kowalewski, dj; stos-zweifel, v; fehr, m; rabsteyn, a; mirakaj, v; karbach, j; jager, e; graf, m; gruber, lc; rachfalski, d; preuss, b; hagelstein, i; marklin, m; bakchoul, t; gouttefangeas, c; kohlbacher, o; klein, r; stevanovic, s; rammensee, hg; walz, js	nature immunology	2021	10.1038/s41590-020-00808-x	11
696	comprehensive analysis of t cell immunodominance and immunoprevalence of sars-cov-2 epitopes in covid-19 cases	tarke, a; sidney, j; kidd, ck; dan, jm; ramirez, si; yu, ed; mateus, j; antunes, rd; moore, e; rubiro, p; methot, n; phillips, e; mallal, s; frazier, a; rawlings, sa; greenbaum, ja; peters, b; smith, dm; crotty, s; weiskopf, d; grifoni, a; sette, a	cell reports medicine	2021	10.1016/j.xcrm.2021.100204	3
697	escape of sars-cov-2 501y.v2 from neutralization by convalescent plasma	cele, s; gazy, i; jackson, l; hwa, sh; tegally, h; lustig, g; giandhari, j; pillay, s; wilkinson, e; naidoo, y; karim, f; ganga, y; khan, k; bernstein, m; balazs, ab; gosnell, bi; hanekom, w; moosa, mys; lessells, rj; de oliveira, t; sigal, a	nature	2021	10.1038/s41586-021-03471-w	12
698	antibody evasion by the p.1 strain of sars-cov-2	dejnirattisai, w; zhou, dm; supasa, p; liu, c; mentzer, aj; ginn, hm; zhao, yg; duyvesteyn, hme; tuekprakhon, a; nutalai, r; wang, bb; lopez-camacho, c; slon-campos, j; walter, ts; skelly, d; clemens, sac; naveca, fg; nascimento, v; nascimento, f; da costa, cf; resende, pc; pauvolid-correa, a; siqueira, mm; dold, c; levin, r; dong, t; pollard, aj; knight, jc; crook, d; lambe, t; clutterbuck, e; bibi, s; flaxman, a; bittaye, m; belij-rammerstorfer, s; gilbert, sc; carroll, mw; klenerman, p; barnes, e; dunachie, sj; paterson, ng; williams, ma; hall, dr; hulswit, rjg; bowden, ta; fry, ee; mongkolsapaya, j; ren, js; stuart, di; screaton, gr	cell	2021	10.1016/j.cell.2021.03.055	7
699	structural analysis of neutralizing epitopes of the sars-cov-2 spike to guide therapy and vaccine design strategies	finkelstein, mt; mermelstein, ag; miller, ep; seth, pc; stancofski, esd; fera, d	viruses-basel	2021	10.3390/v13010134	3
700	cov3d: a database of high resolution coronavirus protein structures	gowthaman, r; guest, jd; yin, r; adolf-bryfogle, j; schief, wr; pierce, bg	nucleic acids research	2021	10.1093/nar/gkaa731	2
701	sars-cov-2 variants b.1.351 and p.1 escape from neutralizing antibodies	hoffmann, m; arora, p; gross, r; seidel, a; hornich, bf; hahn, as; kruger, n; graichen, l; hofmann-winkler, h; kempf, a; winkler, ms; schulz, s; jack, hm; jahrsdorfer, b; schrezenmeier, h; muller, m; kleger, a; munch, j; pohlmann, s	cell	2021	10.1016/j.cell.2021.03.036	17
702	sars-cov-2 escape from a highly neutralizing covid-19 convalescent plasma	andreano, e; piccini, g; licastro, d; casalino, l; johnson, nv; paciello, i; dal monego, s; pantano, e; manganaro, n; manenti, a; manna, r; casa, e; hyseni, i; benincasa, l; montomoli, e; amaro, re; mclellan, js; rappuoli, r	proceedings of the national academy of sciences of the united states of	2021	10.1073/pnas.2103154118	3
703	t cell and antibody kinetics delineate sars-cov-2 peptides mediating long-term immune responses in covid-19 convalescent individuals	bilich, t; nelde, a; heitmann, js; maringer, y; roerden, m; bauer, j; rieth, j; wacker, m; peter, a; horber, s; rachfalski, d; marklin, m; stevanovic, s; rammensee, hg; salih, hr; walz, js	science translational medicine	2021	10.1126/scitranslmed.abf7517	3
704	immunological characteristics govern the transition of covid-19 to endemicity	lavine, js; bjornstad, on; antia, r	science	2021	10.1126/science.abe6522	4
705	evolution of immune responses to sars-cov-2 in mild-moderate covid-19	wheatley, ak; juno, ja; wang, jj; selva, kj; reynaldi, a; tan, hx; lee, ws; wragg, km; kelly, hg; esterbauer, r; davis, sk; kent, he; mordant, fl; schlub, te; gordon, dl; khoury, ds; subbarao, k; cromer, d; gordon, tp; chung, aw; davenport, mp; kent, sj	nature communications	2021	10.1038/s41467-021-21444-5	5
706	prospects for durable immune control of sars-cov-2 and prevention of reinfection	cromer, d; juno, ja; khoury, d; reynaldi, a; wheatley, ak; kent, sj; davenport, mp	nature reviews immunology	2021	10.1038/s41577-021-00550-x	2
707	neutralizing antibody levels are highly predictive of immune protection from symptomatic sars-cov-2 infection	khoury, ds; cromer, d; reynaldi, a; schlub, te; wheatley, ak; juno, ja; subbarao, k; kent, sj; triccas, ja; davenport, mp	nature medicine	2021	10.1038/s41591-021-01377-8	33
708	analysis of sars-cov-2 variant mutations reveals neutralization escape mechanisms and the ability to use ace2 receptors from additional species	wang, rk; zhang, q; ge, jw; ren, wl; zhang, r; lan, j; ju, b; su, b; yu, ft; chen, p; liao, hy; feng, ym; li, xm; shi, xl; zhang, z; zhang, fj; ding, q; zhang, t; wang, xq; zhang, lq	immunity	2021	10.1016/j.immuni.2021.06.003	2
709	structural and functional ramifications of antigenic drift in recent sars-cov-2 variants	yuan, m; huang, dl; lee, ccd; wu, nc; jackson, am; zhu, xy; liu, hj; peng, lh; van gils, mj; sanders, rw; burton, dr; reincke, sm; pruss, h; kreye, j; nemazee, d; ward, ab; wilson, ia	science	2021	10.1126/science.abh1139	2
710	neutralizing activity of sputnik v vaccine sera against sars-cov-2 variants	ikegame, s; siddiquey, m; hung, ct; haas, g; brambilla, l; oguntuyo, k; kowdle, s; chiu, hp; stevens, cs; vilardo, ae; edelstein, a; perandones, c; kamil, j; lee, b	nature communications	2021	10.1038/s41467-021-24909-9	2
711	a single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against sars-cov-2 in mice	powell, ae; zhang, km; sanyal, m; tang, sg; weidenbacher, pa; li, ss; pham, td; pak, je; chiu, w; kim, ps	acs central science	2021	10.1021/acscentsci.0c01405	2
712	safety and immunogenicity of s-trimer (scb-2019), a protein subunit vaccine candidate for covid-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial	richmond, p; hatchuel, l; dong, m; ma, b; hu, b; smolenov, i; li, p; liang, p; han, hh; liang, js; clemens, r	lancet	2021	10.1016/s0140-6736(21)00241-5	7
713	safety and immunogenicity of ino-4800 dna vaccine against sars-cov-2: a preliminary report of an open-label, phase 1 clinical trial	tebas, p; yang, sp; boyer, jd; reuschel, el; patel, a; christensen-quick, a; andrade, vm; morrow, mp; kraynyak, k; agnes, j; purwar, m; sylvester, a; pawlicki, j; gillespie, e; maricic, i; zaidi, fi; kim, ky; dia, yy; frase, d; pezzoli, p; schultheis, k; smith, trf; ramos, sj; mcmullan, t; buttigieg, k; carroll, mw; ervin, j; diehl, mc; blackwood, e; mammen, mp; lee, j; dallas, mj; brown, as; shea, je; kim, jj; weiner, db; broderick, ke; humeau, lm	eclinicalmedicine	2021	10.1016/j.eclinm.2020.100689	5
714	a comprehensive review of the global efforts on covid-19 vaccine development	li, yz; tenchov, r; smoot, j; liu, c; watkins, s; zhou, qq	acs central science	2021	10.1021/acscentsci.1c00120	2
715	nanocarrier vaccines for sars-cov-2	machhi, j; shahjin, f; das, s; patel, m; abdelmoaty, mm; cohen, jd; singh, pa; baldi, a; bajwa, n; kumar, r; vora, lk; patel, ta; oleynikov, md; soni, d; yeapuri, p; mukadam, i; chakraborty, r; saksena, cg; herskovitz, j; hasan, m; oupicky, d; das, s; donnelly, rf; hettie, ks; chang, ld; gendelman, he; kevadiya, bd	advanced drug delivery reviews	2021	10.1016/j.addr.2021.01.002	1
716	clinical endpoints for evaluating efficacy in covid-19 vaccine trials	mehrotra, dv; janes, he; fleming, tr; annunziato, pw; neuzil, km; carpp, ln; benkeser, d; brown, er; carone, m; cho, i; donnell, d; fay, mp; fong, yy; han, s; hirsch, i; huang, y; huang, yd; hyrien, o; juraska, m; luedtke, a; nason, m; vandebosch, a; zhou, hh; cohen, ms; corey, l; hartzel, j; follmann, d; gilbert, pb	annals of internal medicine	2021	10.7326/m20-6169	3
717	safety and efficacy of single-dose ad26.cov2.s vaccine against covid-19	sadoff, j; gray, g; vandebosch, a; cardenas, v; shukarev, g; grinsztejn, b; goepfert, pa; truyers, c; fennema, h; spiessens, b; offergeld, k; scheper, g; taylor, kl; robb, ml; treanor, j; barouch, dh; stoddard, j; ryser, mf; marovich, ma; neuzil, km; corey, l; cauwenberghs, n; tanner, t; hardt, k; ruiz-guinazu, j; le gars, m; schuitemaker, h; van hoof, j; struyf, f; douoguih, m	new england journal of medicine	2021	10.1056/nejmoa2101544	20
718	covid-19: unmasking emerging sars-cov-2 variants, vaccines and therapeutic strategies	raman, r; patel, kj; ranjan, k	biomolecules	2021	10.3390/biom11070993	0
719	covid-19, fake news, and vaccines: should regulation be implemented?	marco-franco, je; pita-barros, p; vivas-orts, d; gonzalez-de-julian, s; vivas-consuelo, d	international journal of environmental research and public health	2021	10.3390/ijerph18020744	2
720	attitudes and acceptance of covid-19 vaccination among nurses and midwives in cyprus: a cross-sectional survey	fakonti, g; kyprianidou, m; toumbis, g; giannakou, k	frontiers in public health	2021	10.3389/fpubh.2021.656138	0
721	what is the extent of covid-19 vaccine hesitancy in bangladesh? a cross-sectional rapid national survey	ali, m; hossain, a	bmj open	2021	10.1136/bmjopen-2021-050303	0
722	covid-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of pfizer/biontech and moderna vaccines	meo, sa; bukhari, ia; akram, j; meo, as; klonoff, dc	european review for medical and pharmacological sciences	2021	10.26355/eurrev_202102_24877	3
723	insights from nanotechnology in covid-19 treatment	tang, zm; zhang, xc; shu, yq; guo, m; zhang, h; tao, w	nano today	2021	10.1016/j.nantod.2020.101019	1
724	role of nanotechnology behind the success of mrna vaccines for covid-19	khurana, a; allawadhi, p; khurana, i; allwadhi, s; weiskirchen, r; banothu, ak; chhabra, d; joshi, k; bharani, kk	nano today	2021	10.1016/j.nantod.2021.101142	1
725	a preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mrna-1273 sars-cov-2 vaccine	chu, lrc; mcphee, r; huang, wm; bennett, h; pajon, r; nestorova, b; leav, b	vaccine	2021	10.1016/j.vaccine.2021.02.007	7
726	sars-cov-2 vaccines strategies: a comprehensive review of phase 3 candidates	kyriakidis, nc; lopez-cortes, a; gonzalez, ev; grimaldos, ab; prado, eo	npj vaccines	2021	10.1038/s41541-021-00292-w	5
727	safety and immunogenicity of a recombinant tandem-repeat dimeric rbd-based protein subunit vaccine (zf2001) against covid-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials	yang, sl; li, y; dai, lp; wang, jf; he, p; li, cg; fang, x; wang, cf; zhao, x; huang, eq; wu, cw; zhong, zx; wang, fz; duan, xm; tian, sy; wu, ll; liu, y; luo, y; chen, zh; li, fj; li, jh; yu, x; ren, h; liu, lh; meng, sf; yan, jh; hu, zy; gao, ld; gao, gf	lancet infectious diseases	2021	10.1016/s1473-3099(21)00127-4	3
728	efficacy and safety of covid-19 vaccines: a systematic review and meta-analysis of randomized clinical trials	pormohammad, a; zarei, m; ghorbani, s; mohammadi, m; razizadeh, mh; turner, dl; turner, rj	vaccines	2021	10.3390/vaccines9050467	1
729	public acceptance of covid-19 vaccines: cross-national evidence on levels and individual-level predictors using observational data	lindholt, mf; jorgensen, f; bor, a; petersen, mb	bmj open	2021	10.1136/bmjopen-2020-048172	0
730	pervasive transmission of e484k and emergence of vui-np13l with evidence of sars-cov-2 co-infection events by two different lineages in rio grande do sul, brazil	francisco, rd; benites, lf; lamarca, ap; de almeida, lgp; hansen, aw; gularte, js; demoliner, m; gerber, al; guimara, apd; antunes, ake; heldt, fh; mallmann, l; hermann, b; ziulkoski, al; goes, v; schallenberger, k; fillipi, m; pereira, f; weber, mn; de almeida, pr; fleck, jd; vasconcelos, atr; spilki, fr	virus research	2021	10.1016/j.virusres.2021.198345	2
731	an overview of current covid-19 vaccine platforms	nagy, a; alhatlani, b	computational and structural biotechnology journal	2021	10.1016/j.csbj.2021.04.061	0
732	mini-review discussing the reliability and efficiency of covid-19 vaccines	doroftei, b; ciobica, a; ilie, od; maftei, r; ilea, c	diagnostics	2021	10.3390/diagnostics11040579	2
733	covid-19 vaccination in our transplant recipients: the time is now	aslam, s; goldstein, dr; vos, r; gelman, ae; kittleson, mm; wolfe, c; danziger-isakov, l	journal of heart and lung transplantation	2021	10.1016/j.healun.2020.12.009	2
734	covid-19 related medical mistrust, health impacts, and potential vaccine hesitancy among black americans living with hiv	bogart, lm; ojikutu, bo; tyagi, k; klein, dj; mutchler, mg; dong, l; lawrence, sj; thomas, dr; kellman, s	jaids-journal of acquired immune deficiency syndromes	2021	10.1097/qai.0000000000002570	4
735	resistance to covid-19 vaccination has increased in ireland and the united kingdom during the pandemic	hyland, p; vallieres, f; shevlin, m; bentall, rp; mckay, r; hartman, tk; mcbride, o; murphy, j	public health	2021	10.1016/j.puhe.2021.04.009	0
736	covid-19 vaccine hesitancy and related fears and anxiety	bendau, a; plag, j; petzold, mb; strohle, a	international immunopharmacology	2021	10.1016/j.intimp.2021.107724	0
737	antibody-mediated procoagulant platelets in thrombotic thrombocytopenia	althaus, k; moller, p; uzun, g; singh, a; beck, a; bettag, m; bosmuller, h; guthoff, m; dorn, f; petzold, gc; henkes, h; heyne, n; jumaa, h; kreiser, k; limpach, c; luz, b; maschke, m; muller, ja; munch, j; nagel, s; potzsch, b; muller, j; schlegel, c; viardot, a; bazner, h; wolf, m; pelzl, l; warm, v; willinek, wa; steiner, j; schneiderhan-marra, n; vollherbst, d; sachs, uj; fend, f; bakchoul, t	haematologica	2021	10.3324/haematol.2021.279000	1
738	vaccine-induced immune thrombotic thrombocytopenia (vitt): targeting pathomechanisms with bruton tyrosine kinase inhibitors	von hundelshausen, p; lorenz, r; siess, w; weber, c	thrombosis and haemostasis	2021	10.1055/a-1481-3039	3
739	hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after sars-cov-2 vaccination	douxfils, j; favresse, j; dogne, jm; lecompte, t; susen, s; cordonnier, c; lebreton, a; gosselin, r; sie, p; pernod, g; gruel, y; nguyen, p; vayne, c; mullier, f	thrombosis research	2021	10.1016/j.thromres.2021.05.010	1
740	an observational study to identify the prevalence of thrombocytopenia and anti-pf4/polyanion antibodies in norwegian health care workers after covid-19 vaccination	sorvoll, ih; horvei, kd; ernstsen, sl; laegreid, ij; lund, s; gronli, rh; olsen, mk; jacobsen, hk; eriksson, a; halstensen, am; tjonnfjord, e; ghanima, w; ahlen, mt	journal of thrombosis and haemostasis	2021	10.1111/jth.15352	2
741	laboratory testing for suspected covid-19 vaccine-induced (immune) thrombotic thrombocytopenia	favaloro, ej	international journal of laboratory hematology	2021	10.1111/ijlh.13629	1
742	short-term outcome of pregnant women vaccinated with bnt162b2 mrna covid-19 vaccine	peretz, sb; regev, n; novick, l; nachshol, m; goffer, e; ben-david, a; asraf, k; doolman, r; levin, eg; yochay, gr; yinon, y	ultrasound in obstetrics & gynecology	2021	10.1002/uog.23729	2
743	adverse reactions following the first dose of chadox1 ncov-19 vaccine and bnt162b2 vaccine for healthcare workers in south korea	bae, s; lee, yw; lim, sy; lee, jh; lim, js; lee, s; park, s; kim, sk; lim, yj; kim, eo; jung, j; kwon, hs; kim, tb; kim, sh	journal of korean medical science	2021	10.3346/jkms.2021.36.e115	1
744	adverse events in healthcare workers after the first dose of chadox1 ncov-19 or bnt162b2 mrna covid-19 vaccination: a single center experience	kim, sh; wi, ym; yun, sy; ryu, js; shin, jm; lee, eh; seo, kh; lee, sh; peck, kr	journal of korean medical science	2021	10.3346/jkms.2021.36.e107	1
745	first-dose chadox1 and bnt162b2 covid-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in scotland	simpson, cr; shi, t; vasileiou, e; katikireddi, sv; kerr, s; moore, e; mccowan, c; agrawal, u; shah, sa; ritchie, ld; murray, j; pan, j; bradley, dt; stock, sj; wood, r; chuter, a; beggs, j; stagg, hr; joy, m; tsang, rsm; de lusignan, s; hobbs, r; lyons, ra; torabi, f; bedston, s; o'leary, m; akbari, a; mcmenamin, j; robertson, c; sheikh, a	nature medicine	2021	10.1038/s41591-021-01408-4	3
746	evaluation of the safety profile of covid-19 vaccines: a rapid review	wu, qh; dudley, mz; chen, xh; bai, xf; dong, kg; zhuang, ty; salmon, d; yu, hj	bmc medicine	2021	10.1186/s12916-021-02059-5	1
747	attitudes towards anti-sars-cov2 vaccination among healthcare workers: results from a national survey in italy	di gennaro, f; murri, r; segala, fv; cerruti, l; abdulle, a; saracino, a; bavaro, df; fantoni, m	viruses-basel	2021	10.3390/v13030371	2
748	attitudes of healthcare personnel towards vaccinations before and during the covid-19 pandemic	ledda, c; costantino, c; cuccia, m; maltezou, hc; rapisarda, v	international journal of environmental research and public health	2021	10.3390/ijerph18052703	1
749	the nature and extent of covid-19 vaccination hesitancy in healthcare workers	biswas, n; mustapha, t; khubchandani, j; price, jh	journal of community health	2021	10.1007/s10900-021-00984-3	0
750	rapid decline of neutralizing antibodies against sars-cov-2 among infected healthcare workers	marot, s; malet, i; leducq, v; zafilaza, k; sterlin, d; planas, d; gothland, a; jary, a; dorgham, k; bruel, t; burrel, s; boutolleau, d; schwartz, o; gorochov, g; calvez, v; marcelin, ag	nature communications	2021	10.1038/s41467-021-21111-9	3
751	antibody response to the bnt162b2 mrna covid-19 vaccine in subjects with prior sars-cov-2 infection	gobbi, f; buonfrate, d; moro, l; rodari, p; piubelli, c; caldrer, s; riccetti, s; sinigaglia, a; barzon, l	viruses-basel	2021	10.3390/v13030422	2
752	vaccination against covid-19: a systematic review and meta-analysis of acceptability and its predictors	wang, q; yang, lq; jin, h; lin, l	preventive medicine	2021	10.1016/j.ypmed.2021.106694	0
753	low covid-19 vaccine acceptance is correlated with conspiracy beliefs among university students in jordan	sallam, m; dababseh, d; eid, h; hasan, h; taim, d; al-mahzoum, k; al-haidar, a; yaseen, a; ababneh, na; assaf, a; bakri, fg; matar, s; mahafzah, a	international journal of environmental research and public health	2021	10.3390/ijerph18052407	0
754	sars-cov-2: vaccines in the pandemic era	li, dd; li, qh	military medical research	2021	10.1186/s40779-020-00296-y	0
755	the impact of vaccination on coronavirus disease 2019 (covid-19) outbreaks in the united states	moghadas, sm; vilches, tn; zhang, k; wells, cr; shoukat, a; singer, bh; meyers, la; neuzil, km; langley, jm; fitzpatrick, mc; galvani, ap	clinical infectious diseases	2021	10.1093/cid/ciab079	1
756	willingness to be vaccinated against covid-19: an exploratory online survey in a portuguese cohort of multiple sclerosis patients	serrazina, f; pinho, as; cabral, g; salavisa, m; correia, as	multiple sclerosis and related disorders	2021	10.1016/j.msard.2021.102880	1
757	covid-19 vaccine rumors and conspiracy theories: the need for cognitive inoculation against misinformation to improve vaccine adherence	islam, ms; kamal, ahm; kabir, a; southern, dl; khan, sh; hasan, smm; sarkar, t; sharmin, s; das, s; roy, t; harun, mgd; chughtai, aa; homaira, n; seale, h	plos one	2021	10.1371/journal.pone.0251605	1
758	knowledge, attitudes and perceptions towards covid-19 vaccinations: a cross-sectional community survey in bangladesh	islam, ms; siddique, a; akter, r; tasnim, r; sujan, msh; ward, pr; sikder, mt	bmc public health	2021	10.1186/s12889-021-11880-9	0
759	development and deployment of covid-19 vaccines for those most vulnerable	koff, wc; schenkelberg, t; williams, t; baric, rs; mcdermott, a; cameron, cm; cameron, mj; friemann, mb; neumann, g; kawaoka, y; kelvin, aa; ross, tm; schultz-cherry, s; mastro, td; priddy, fh; moore, ka; ostrowsky, jt; osterholm, mt; goudsmit, j	science translational medicine	2021	10.1126/scitranslmed.abd1525	0
760	covid-19 vaccine hesitancy: race/ethnicity, trust, and fear	willis, de; andersen, ja; bryant-moore, k; selig, jp; long, cr; felix, hc; curran, gm; mcelfish, pa	cts-clinical and translational science	2021	10.1111/cts.13077	0
761	severe acute respiratory syndrome coronavirus 2 (sars-cov-2) transmission dynamics should inform policy	cevik, m; marcus, jl; buckee, c; smith, tc	clinical infectious diseases	2021	10.1093/cid/ciaa1442	1
762	initial report of decreased sars-cov-2 viral load after inoculation with the bnt162b2 vaccine	levine-tiefenbrun, m; yelin, i; katz, r; herzel, e; golan, z; schreiber, l; wolf, t; nadler, v; ben-tov, a; kuint, j; gazit, s; patalon, t; chodick, g; kishony, r	nature medicine	2021	10.1038/s41591-021-01316-7	9
763	immunogenicity of pfizer-biontech covid-19 vaccine in patients with inborn errors of immunity	hagin, d; freund, t; navon, m; halperin, t; adir, d; marom, r; levi, i; benor, s; alcalay, y; freund, nt	journal of allergy and clinical immunology	2021	10.1016/j.jaci.2021.05.029	2
764	a domain-based vaccine construct against sars-cov-2, the causative agent of covid-19 pandemic: development of self-amplifying mrna and peptide vaccines	pourseif, mm; parvizpour, s; jafari, b; dehghani, j; naghili, b; omidi, y	bioimpacts	2021	10.34172/bi.2021.11	0
765	immunogenicity of the bnt162b2 vaccine in frail or disabled nursing home residents: covid-a study	rios, ss; romero, mm; zamora, ebc; sahuquillo, mtt; rizos, lr; sanchez-jurado, pm; sanchez-nievas, g; senalada, jjb; nogueras, ig; cazalla, jde; andres-pretel, f; romero, am; lauschke, vm; stebbing, j; abizanda, p	journal of the american geriatrics society	2021	10.1111/jgs.17153	1
766	novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment	boopathi, s; poma, ab; kolandaivel, p	journal of biomolecular structure & dynamics	2021	10.1080/07391102.2020.1758788	4
767	potential therapeutic agents to covid-19: an update review on antiviral therapy, immunotherapy, and cell therapy	mirtaleb, ms; mirtaleb, ah; nosrati, h; heshmatnia, j; falak, r; emameh, rz	biomedicine & pharmacotherapy	2021	10.1016/j.biopha.2021.111518	0
768	covid-19 vaccination-related uptake on fdg pet/ct: an emerging dilemma and suggestions for management	mcintosh, lj; bankier, aa; vijayaraghavan, gr; licho, r; rosen, mp	american journal of roentgenology	2021	10.2214/ajr.21.25728	0
769	application of nanotechnology in the covid-19 pandemic	yang, d	international journal of nanomedicine	2021	10.2147/ijn.s296383	0
770	online social endorsement and covid-19 vaccine hesitancy in the united kingdom	chadwick, a; kaiser, j; vaccari, c; freeman, d; lambe, s; loe, bs; vanderslott, s; lewandowsky, s; conroy, m; ross, arn; innocenti, s; pollard, aj; waite, f; larkin, m; rosebrock, l; jenner, l; mcshane, h; giubilini, a; petit, a; yu, lm	social media + society	2021	10.1177/20563051211008817	2
771	covid-19 transmission, current treatment, and future therapeutic strategies	salian, vs; wright, ja; vedell, pt; nair, s; li, cx; kandimalla, m; tang, xj; porquera, emc; kalari, kr; kandimalla, kk	molecular pharmaceutics	2021	10.1021/acs.molpharmaceut.0c00608	0
772	clinical outcomes of a covid-19 vaccine: implementation over efficacy	paltiel, ad; schwartz, jl; zheng, a; walensky, rp	health affairs	2021	10.1377/hlthaff.2020.02054	1
773	a study of ethnic, gender and educational differences in attitudes toward covid-19 vaccines in israel - implications for vaccination implementation policies	green, ms; abdullah, r; vered, s; nitzan, d	israel journal of health policy research	2021	10.1186/s13584-021-00458-w	0
774	comprehensive analysis of covid-19 during pregnancy	moore, km; suthar, ms	biochemical and biophysical research communications	2021	10.1016/j.bbrc.2020.12.064	0
775	covid-19 vaccination in patients with multiple sclerosis: what we have learnt by february 2021	achiron, a; dolev, m; menascu, s; zohar, dn; dreyer-alster, s; miron, s; shirbint, e; magalashvili, d; flechter, s; givon, u; guber, d; stern, y; polliack, m; falb, r; gurevich, m	multiple sclerosis journal	2021	10.1177/13524585211003476	2
776	humoral immune response to covid-19 mrna vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies	achiron, a; mandel, m; dreyer-alster, s; harari, g; magalashvili, d; sonis, p; dolev, m; menascu, s; flechter, s; falb, r; gurevich, m	therapeutic advances in neurological disorders	2021	10.1177/17562864211012835	7
777	aria-eaaci statement on severe allergic reactions to covid-19 vaccines - an eaaci-aria position paper	klimek, l; jutel, m; akdis, ca; bousquet, j; akdis, m; torres, mj; agache, i; canonica, gw; del giacco, s; o'mahony, l; shamji, mh; schwarze, j; untersmayr, e; ring, jn; bedbrook, a; worm, m; zuberbier, t; knol, e; hoffmann-sommergruber, k; chivato, t	allergy	2021	10.1111/all.14726	1
778	covid-19 vaccine acceptance, hesitancy, and refusal among canadian healthcare workers: a multicenter survey	dzieciolowska, s; hamel, d; gadio, s; dionne, m; gagnon, d; robitaille, l; cook, e; caron, i; talib, a; parkes, l; dube, e; longtin, y	american journal of infection control	2021	10.1016/j.ajic.2021.04.079	1
779	predicting intention to receive covid-19 vaccine among the general population using the health belief model and the theory of planned behavior model	shmueli, l	bmc public health	2021	10.1186/s12889-021-10816-7	1
780	knowledge and acceptance of covid-19 vaccination among undergraduate students from central and southern italy	galle, f; sabella, ea; roma, p; de giglio, o; caggiano, g; tafuri, s; da molin, g; ferracuti, s; montagna, mt; liguori, g; orsi, gb; napoli, c	vaccines	2021	10.3390/vaccines9060638	0
781	coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study	gray, kj; bordt, ea; atyeo, c; deriso, e; akinwunmi, b; young, n; baez, am; shook, ll; cvrk, d; james, k; de guzman, r; brigida, s; diouf, k; goldfarb, i; bebell, lm; yonker, lm; fasano, a; rabi, sa; elovitz, ma; alter, g; edlow, ag	american journal of obstetrics and gynecology	2021	10.1016/j.ajog.2021.03.023	5
782	preliminary findings of mrna covid-19 vaccine safety in pregnant persons	shimabukuro, tt; kim, sy; myers, tr; moro, pl; oduyebo, t; panagiotakopoulos, l; marquez, pl; olson, ck; liu, rl; chang, kt; ellington, sr; burkel, vk; smoots, an; green, cj; licata, c; zhang, bcc; alimchandani, m; mba-jonas, a; martin, sw; gee, jm; meaney-delman, dm	new england journal of medicine	2021	10.1056/nejmoa2104983	3
783	covid-19 and vaccine hesitancy: a longitudinal study	fridman, a; gershon, r; gneezy, a	plos one	2021	10.1371/journal.pone.0250123	3
784	interim estimates of vaccine effectiveness of pfizer-biontech and moderna covid-19 vaccines among health care personnel-33 us sites, january-march 2021	pilishvili, t; fleming-dutra, ke; farrar, jl; gierke, r; mohr, nm; talan, da; krishnadasan, a; harland, kk; smithline, ha; hou, pc; lee, lc; lim, sc; moran, gj; krebs, e; steele, m; beiser, dg; faine, b; haran, jp; nandi, u; schrading, wa; chinnock, b; henning, dj; lovecchio, f; nadle, j; barter, d; brackney, m; britton, a; marceaux-galli, k; lim, s; phipps, ec; dumyati, g; pierce, r; markus, tm; anderson, dj; debes, ak; lin, m; mayer, j; babcock, hm; safdar, n; fischer, m; singleton, r; chea, n; magill, ss; verani, j; schrag, s	mmwr-morbidity and mortality weekly report	2021	10.15585/mmwr.mm7020e2	4
785	the first 12 months of covid-19: a timeline of immunological insights	carvalho, t; krammer, f; iwasaki, a	nature reviews immunology	2021	10.1038/s41577-021-00522-1	3
786	prolonged evolution of the human b cell response to sars-cov-2 infection	sakharkar, m; rappazzo, cg; wieland-alter, wf; hsieh, cl; wrapp, d; esterman, es; kaku, ci; wec, az; geoghegan, jc; mclellan, js; connor, ri; wright, pf; walker, lm	science immunology	2021	10.1126/sciimmunol.abg6916	2
787	distinct antibody and memory b cell responses in sars-cov-2 naive and recovered individuals after mrna vaccination	goel, rr; apostolidis, sa; painter, mm; mathew, d; pattekar, a; kuthuru, o; gouma, s; hicks, p; meng, wz; rosenfeld, am; dysinger, s; lundgreen, ka; kuri-cervantes, l; adamski, s; hicks, a; korte, s; oldridge, da; baxter, ae; giles, jr; weirick, me; mcallister, cm; dougherty, j; long, s; d'andrea, k; hamilton, jt; betts, mr; prak, etl; bates, p; hensley, se; greenplate, ar; wherry, ej	science immunology	2021	10.1126/sciimmunol.abi6950	12
788	humoral response to the pfizer bnt162b2 vaccine in patients undergoing maintenance hemodialysis	grupper, a; sharon, n; finn, t; cohen, r; israel, m; agbaria, a; rechavi, y; schwartz, if; schwartz, d; lellouch, y; shashar, m	clinical journal of the american society of nephrology	2021	10.2215/cjn.03500321	14
789	impaired humoral immunity to sars-cov-2 bnt162b2 vaccine in kidney transplant recipients and dialysis patients	rincon-arevalo, h; choi, m; stefanski, al; halleck, f; weber, u; szelinski, f; jahrsdorfer, b; schrezenmeier, h; ludwig, c; sattler, a; kotsch, k; potekhin, a; chen, yd; burmester, gr; eckardt, ku; guerra, gm; durek, p; heinrich, f; ferreira-gomes, m; radbruch, a; budde, k; lino, ac; mashreghi, mf; schrezenmeier, e; dorner, t	science immunology	2021	10.1126/sciimmunol.abj1031	6
790	effectiveness of pfizer-biontech and moderna vaccines against covid-19 among hospitalized adults aged >= 65 years - united states, january-march 2021	tenforde, mw; olson, sm; self, wh; talbot, hk; lindsell, cj; steingrub, js; shapiro, ni; ginde, aa; douin, dj; prekker, me; brown, sm; peltan, id; gong, mn; mohamed, a; khan, a; aline, mc; files, dc; gibbs, kw; stubblefield, wb; casey, jd; rice, tw; grijalva, cg; hager, dn; shehu, a; qadir, n; chang, sy; wilson, jg; gaglani, m; murthy, k; calhoun, n; monto, as; martin, et; malani, a; zimmerman, rk; silveira, fp; middleton, db; zhu, yw; wyatt, d; stephenson, m; baughman, a; womack, kn; hart, kw; kobayashi, m; verani, jr; patel, mm	mmwr-morbidity and mortality weekly report	2021		11
791	effectiveness of mrna covid-19 vaccine among us health care personnel	pilishvili, t; gierke, r; fleming-dutra, ke; farrar, jl; mohr, nm; talan, da; krishnadasan, a; harland, kk; smithline, ha; hou, pc; lee, lc; lim, sc; moran, gj; krebs, e; steele, mt; beiser, dg; faine, b; haran, jp; nandi, u; schrading, wa; chinnock, b; henning, dj; lovecchio, f; lee, j; barter, d; brackney, m; fridkin, sk; marceaux-galli, k; lim, s; phipps, ec; dumyati, g; pierce, r; markus, tm; anderson, dj; debes, ak; lin, my; mayer, j; kwon, jh; safdar, n; fischer, m; singleton, r; chea, n; magill, ss; verani, jr; schrag, sj	new england journal of medicine	2021	10.1056/nejmoa2106599	0
792	safety and efficacy of nvx-cov2373 covid-19 vaccine	heath, pt; galiza, ep; baxter, dn; boffito, m; browne, d; burns, f; chadwick, dr; clark, r; cosgrove, c; galloway, j; goodman, al; heer, a; higham, a; iyengar, s; jamal, a; jeanes, c; kalra, pa; kyriakidou, c; mcauley, df; meyrick, a; minassian, am; minton, j; moore, p; munsoor, i; nicholls, h; osanlou, o; packham, j; pretswell, ch; ramos, as; saralaya, d; sheridan, rp; smith, r; soiza, rl; swift, pa; thomson, ec; turner, j; viljoen, me; albert, g; cho, i; dubovsky, f; glenn, g; rivers, j; robertson, a; smith, k; toback, s	new england journal of medicine	2021	10.1056/nejmoa2107659	4
793	recommendations for the clinical and laboratory diagnosis of vitt against covid-19: communication from the isth ssc subcommittee on platelet immunology	nazy, i; sachs, uj; arnold, dm; mckenzie, se; choi, p; althaus, k; ahlen, mt; sharma, r; grace, rf; bakchoul, t	journal of thrombosis and haemostasis	2021	10.1111/jth.15341	2
794	cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 covid-19 cases	taquet, m; husain, m; geddes, jr; luciano, s; harrison, pj	eclinicalmedicine	2021	10.1016/j.eclinm.2021.101061	3
795	cerebral venous thrombosis after vaccination against covid-19 in the uk: a multicentre cohort study	perry, rj; tamborska, a; singh, b; craven, b; marigold, r; arthur-farraj, p; yeo, jm; zhang, lq; hassan-smith, g; jones, m; hutchcroft, c; hobson, e; warcel, d; white, d; ferdinand, p; webb, a; solomon, t; scully, m; werring, dj; roffe, c	lancet	2021	10.1016/s0140-6736(21)01608-1	1
796	characteristics of endothelial corneal transplant rejection following immunisation with sars-cov-2 messenger rna vaccine	phylactou, m; li, jpo; larkin, dfp	british journal of ophthalmology	2021	10.1136/bjophthalmol-2021-319338	1
797	acute abducens nerve palsy following covid-19 vaccination	reyes-capo, dp; stevens, sm; cavuoto, km	journal of aapos	2021	10.1016/j.jaapos.2021.05.003	1
798	covid-19 vaccine-associated cerebral venous thrombosis in germany	schulz, jb; berlit, p; diener, hc; gerloff, c; greinacher, a; klein, c; petzold, gc; piccininni, m; poli, s; rohrig, r; steinmetz, h; thiele, t; kurth, t	annals of neurology	2021	10.1002/ana.26172	1
799	association of covid-19 vaccination and facial nerve palsy a case-control study	shemer, a; pras, e; einan-lifshitz, a; dubinsky-pertzov, b; hecht, i	jama otolaryngology-head & neck surgery	2021	10.1001/jamaoto.2021.1259	1
800	the sars-cov-2 as an instrumental trigger of autoimmunity	dotan, a; muller, s; kanduc, d; david, p; halpert, g; shoenfeld, y	autoimmunity reviews	2021	10.1016/j.autrev.2021.102792	3
801	two cases of graves' disease following sars-cov-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants	vera-lastra, o; navarro, ao; domiguez, mpc; medina, g; valadez, tis; jara, lj	thyroid	2021	10.1089/thy.2021.0142	2
802	immune-mediated disease flares or new-onset disease in 27 subjects following mrna/dna sars-cov-2 vaccination	watad, a; de marco, g; mahajna, h; druyan, a; eltity, m; hijazi, n; haddad, a; elias, m; zisman, d; naffaa, me; brodavka, m; cohen, y; abu-much, a; abu elhija, m; bridgewood, c; langevitz, p; mclorinan, j; bragazzi, nl; marzo-ortega, h; lidar, m; calabrese, c; calabrese, l; vital, e; shoenfeld, y; amital, h; mcgonagle, d	vaccines	2021	10.3390/vaccines9050435	2
803	ocular adverse events after covid-19 vaccination	le ng, x; betzler, bk; testi, i; ho, sl; tien, m; ngo, wk; zierhut, m; chee, sp; gupta, v; pavesio, ce; de smet, md; agrawal, r	ocular immunology and inflammation	2021	10.1080/09273948.2021.1976221	0
804	easl position paper on the use of covid-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients	cornberg, m; buti, m; eberhardt, cs; grossi, pa; shouval, d	journal of hepatology	2021	10.1016/j.jhep.2021.01.032	1
805	to what extent are conspiracy theorists concerned for self versus others? a covid-19 test case	hornsey, mj; chapman, cm; alvarez, b; bentley, s; casara, bgs; crimston, cr; ionescu, o; krug, h; selvanathan, hp; steffens, nk; jetten, j	european journal of social psychology	2021	10.1002/ejsp.2737	1
806	anca-associated vasculitis following pfizer-biontech covid-19 vaccine	shakoor, mt; birkenbach, mp; lynch, m	american journal of kidney diseases	2021	10.1053/j.ajkd.2021.06.016	0
807	mrna-1273 covid-19 vaccine effectiveness against the b.1.1.7 and b.1.351 variants and severe covid-19 disease in qatar	chemaitelly, h; yassine, hm; benslimane, fm; al khatib, ha; tang, p; hasan, mr; malek, ja; coyle, p; ayoub, hh; al kanaani, z; al kuwari, e; jeremijenko, a; kaleeckal, ah; latif, an; shaik, rm; rahim, haf; nasrallah, gk; al kuwari, mg; al romaihi, he; al-thani, mh; al khal, a; butt, aa; bertollini, r; abu-raddad, lj	nature medicine	2021	10.1038/s41591-021-01446-y	6
808	effectiveness of the pfizer-biontech covid-19 vaccine among residents of two skilled nursing facilities experiencing covid-19 outbreaks - connecticut, december 2020-february 2021	britton, a; slifka, kmj; edens, c; nanduri, sa; bart, sm; shang, n; harizaj, a; armstrong, j; xu, kr; ehrlich, hy; soda, e; derado, g; verani, jr; schrag, sj; jernigan, ja; leung, vh; parikh, s	mmwr-morbidity and mortality weekly report	2021	10.15585/mmwr.mm7011e3	6
809	impact and effectiveness of mrna bnt162b2 vaccine against sars-cov-2 infections and covid-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in israel: an observational study using national surveillance data	haas, ej; angulo, fj; mclaughlin, jm; anis, e; singer, sr; khan, f; brooks, n; smaja, m; mircus, g; pan, kj; southern, j; swerdlow, dl; jodar, l; levy, y; alroy-preis, s	lancet	2021	10.1016/s0140-6736(21)00947-8	17
810	prevention and attenuation of covid-19 with the bnt162b2 and mrna-1273 vaccines	thompson, mg; burgess, jl; naleway, al; tyner, h; yoon, sk; meece, j; olsho, lew; caban-martinez, aj; fowlkes, al; lutrick, k; groom, hc; dunnigan, k; odean, mj; hegmann, k; stefanski, e; edwards, lj; schaefer-solle, n; grant, l; ellingson, k; kuntz, jl; zunie, t; thiese, ms; ivacic, l; wesley, mg; lamberte, jm; sun, xx; smith, me; phillips, al; groover, kd; yoo, ym; gerald, j; brown, rt; herring, mk; joseph, g; beitel, s; morrill, tc; mak, j; rivers, p; poe, bp; lynch, b; zhou, yt; zhang, j; kelleher, a; li, y; dickerson, m; hanson, e; guenther, k; tong, sx; bateman, a; reisdorf, e; barnes, j; azziz-baumgartner, e; hunt, dr; arvay, ml; kutty, p; fry, am; gaglani, m	new england journal of medicine	2021	10.1056/nejmoa2107058	4
811	effectiveness of bnt162b2 and mrna-1273 covid-19 vaccines against symptomatic sars-cov-2 infection and severe covid-19 outcomes in ontario, canada: test negative design study	chung, h; he, sy; nasreen, s; sundaram, me; buchan, sa; wilson, se; chen, b; calzavara, a; fell, db; austin, pc; wilson, k; schwartz, kl; brown, ka; gubbay, jb; basta, ne; mahmud, sm; righolt, ch; svenson, lw; macdonald, se; janjua, nz; tadrous, m; kwong, jc	bmj-british medical journal	2021	10.1136/bmj.n1943	2
812	national study of youth opinions on vaccination for covid-19 in the us	brandt, ej; rosenberg, j; waselewski, me; amaro, x; wasag, j; chang, t	journal of adolescent health	2021	10.1016/j.jadohealth.2021.02.013	1
813	multi-organ involvement in covid-19: beyond pulmonary manifestations	thakur, v; ratho, rk; kumar, p; bhatia, sk; bora, i; mohi, gk; saxena, sk; devi, m; yadav, d; mehariya, s	journal of clinical medicine	2021	10.3390/jcm10030446	0
814	synthetic messenger rna-based vaccines: from scorn to hype	pascolo, s	viruses-basel	2021	10.3390/v13020270	1
815	cutaneous adverse effects of the available covid-19 vaccines	bogdanov, g; bogdanov, i; kazandjieva, j; tsankov, n	clinics in dermatology	2021	10.1016/j.clindermatol.2021.04.001	0
816	single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as sars-cov-2 vaccine candidates	he, ll; lin, xh; wang, y; abraham, c; sou, c; ngo, t; zhang, y; wilson, ia; zhu, j	science advances	2021	10.1126/sciadv.abf1591	3
817	two-component spike nanoparticle vaccine protects macaques from sars-cov-2 infection	brouwer, pjm; brinkkemper, m; maisonnasse, p; dereuddre-bosquet, n; grobben, m; claireaux, m; de gast, m; marlin, r; chesnais, v; diry, s; allen, jd; watanabe, y; giezen, jm; kerster, g; turner, hl; van der straten, k; van der linden, ca; aldon, y; naninck, t; bontjer, i; burger, ja; poniman, m; mykytyn, az; okba, nma; schermer, ee; van breemen, mj; ravichandran, r; caniels, tg; van schooten, j; kahlaoui, n; contreras, v; lemaitre, j; chapon, c; fang, rht; villaudy, j; sliepen, k; van der velden, yu; haagmans, bl; de bree, gj; ginoux, e; ward, ab; crispin, m; king, np; van der werf, s; van gils, mj; le grand, r; sanders, rw	cell	2021	10.1016/j.cell.2021.01.035	1
818	emerging concepts in the science of vaccine adjuvants	pulendran, b; arunachalam, ps; o'hagan, dt	nature reviews drug discovery	2021	10.1038/s41573-021-00163-y	1
819	adjuvanting a subunit covid-19 vaccine to induce protective immunity	arunachalam, ps; walls, ac; golden, n; atyeo, c; fischinger, s; li, cf; aye, p; navarro, mj; lai, ll; edara, vv; roltgen, k; rogers, k; shirreff, l; ferrell, de; wrenn, s; pettie, d; kraft, jc; miranda, mc; kepl, e; sydeman, c; brunette, n; murphy, m; fiala, b; carter, l; white, ag; trisal, m; hsieh, cl; russell-lodrigue, k; monjure, c; dufour, j; spencer, s; doyle-meyers, l; bohm, rp; maness, nj; roy, c; plante, ja; plante, ks; zhu, a; gorman, mj; shin, s; shen, xy; fontenot, j; gupta, s; o'hagan, dt; van der most, r; rappuoli, r; coffman, rl; novack, d; mclellan, js; subramaniam, s; montefiori, d; boyd, sd; flynn, jl; alter, g; villinger, f; kleanthous, h; rappaport, j; suthar, ms; king, np; veesler, d; pulendran, b	nature	2021	10.1038/s41586-021-03530-2	2
820	immunogenicity of clinically relevant sars-cov-2 vaccines in nonhuman primates and humans	klasse, pj; nixon, df; moore, jp	science advances	2021	10.1126/sciadv.abe8065	3
821	recombinant protein vaccines, a proven approach against coronavirus pandemics	pollet, j; chen, wh; strych, u	advanced drug delivery reviews	2021	10.1016/j.addr.2021.01.001	1
822	a covid-19 vaccine candidate using spycatcher multimerization of the sars-cov-2 spike protein receptor-binding domain induces potent neutralising antibody responses	tan, tk; rijal, p; rahikainen, r; keeble, ah; schimanski, l; hussain, s; harvey, r; hayes, jwp; edwards, jc; mclean, rk; martini, v; pedrera, m; thakur, n; conceicao, c; dietrich, i; shelton, h; ludi, a; wilsden, g; browning, c; zagrajek, ak; bialy, d; bhat, s; stevenson-leggett, p; hollinghurst, p; tully, m; moffat, k; chiu, c; waters, r; gray, a; azhar, m; mioulet, v; newman, j; asfor, as; burman, a; crossley, s; hammond, ja; tchilian, e; charleston, b; bailey, d; tuthill, tj; graham, sp; duyvesteyn, hme; malinauskas, t; huo, jd; tree, ja; buttigieg, kr; owens, rj; carroll, mw; daniels, rs; mccauley, jw; stuart, di; huang, kya; howarth, m; townsend, ar	nature communications	2021	10.1038/s41467-020-20654-7	1
823	a summary of the sars-cov-2 vaccines and technologies available or under development	abdulla, za; al-bashir, sm; al-salih, ns; aldamen, aa; abdulazeez, mz	pathogens	2021	10.3390/pathogens10070788	0
824	effect of 2 inactivated sars-cov-2 vaccines on symptomatic covid-19 infection in adults a randomized clinical trial	al kaabi, n; zhang, yt; xia, sl; yang, yk; al qahtani, mm; abdulrazzaq, n; al nusair, m; hassany, m; jawad, js; abdalla, j; hussein, se; al mazrouei, sk; al karam, m; li, xg; yang, xq; wang, w; lai, ba; chen, w; huang, sh; wang, q; yang, t; liu, y; ma, r; hussain, zm; khan, t; fasihuddin, ms; you, wy; xie, zq; zhao, yx; jiang, zw; zhao, gq; zhang, yb; mahmoud, s; eltantawy, i; xiao, p; koshy, a; zaher, wa; wang, h; duan, k; pan, a; yang, xm	jama-journal of the american medical association	2021	10.1001/jama.2021.8565	3
825	impact of vaccination on new sars-cov-2 infections in the united kingdom	pritchard, e; matthews, pc; stoesser, n; eyre, dw; gethings, o; vihta, kd; jones, j; house, t; vansteenhouse, h; bell, i; bell, ji; newton, jn; farrar, j; diamond, i; rourke, e; studley, r; crook, d; peto, tea; walker, as; pouwels, kb	nature medicine	2021	10.1038/s41591-021-01410-w	5
826	correlates of protection against symptomatic and asymptomatic sars-cov-2 infection	feng, s; phillips, dj; white, t; sayal, h; aley, pk; bibi, s; dold, c; fuskova, m; gilbert, sc; hirsch, i; humphries, he; jepson, b; kelly, ej; plested, e; shoemaker, k; thomas, km; vekemans, j; villafana, tl; lambe, t; pollard, aj; voysey, m	nature medicine	2021	10.1038/s41591-021-01540-1	5
827	changes in symptomatology, reinfection, and transmissibility associated with the sars-cov-2 variant b.1.1.7: an ecological study	graham, ms; sudre, ch; may, a; antonelli, m; murray, b; varsaysky, t; klaser, k; canas, ls; molteni, e; modat, m; drew, da; nguyen, lh; polidori, l; selvachandran, s; hu, c; capdevila, j; hammers, a; chan, at; wolf, j; spector, td; steves, cj; ourselin, s	lancet public health	2021	10.1016/s2468-2667(21)00055-4	5
828	effectiveness of an inactivated sars-cov-2 vaccine in chile	jara, a; undurraga, ea; gonzalez, c; paredes, f; fontecilla, t; jara, g; pizarro, a; acevedo, j; leo, k; leon, f; sans, c; leighton, p; suarez, p; garcia-escorza, h; araos, r	new england journal of medicine	2021	10.1056/nejmoa2107715	6
829	model-informed covid-19 vaccine prioritization strategies by age and serostatus	bubar, km; reinholt, k; kissler, sm; lipsitch, m; cobey, s; grad, yh; larremore, db	science	2021	10.1126/science.abe6959	3
830	t cell immunity to sars-cov-2 following natural infection and vaccination	dipiazza, at; graham, bs; ruckwardt, tj	biochemical and biophysical research communications	2021	10.1016/j.bbrc.2020.10.060	3
831	immunological surrogate endpoints of covid-2019 vaccines: the evidence we have versus the evidence we need	jin, pf; li, jx; pan, hx; wu, yf; zhu, fc	signal transduction and targeted therapy	2021	10.1038/s41392-021-00481-y	4
832	bnt162b2 vaccine induces neutralizing antibodies and poly-specific t cells in humans	sahin, u; muik, a; vogler, i; derhovanessian, e; kranz, lm; vormehr, m; quandt, j; bidmon, n; ulges, a; baum, a; pascal, ke; maurus, d; brachtendorf, s; lorks, v; sikorski, j; koch, p; hilker, r; becker, d; eller, ak; grutzner, j; tonigold, m; boesler, c; rosenbaum, c; heesen, l; kuhnle, mc; poran, a; dong, jz; luxemburger, u; kemmer-bruck, a; langer, d; bexon, m; bolte, s; palanche, t; schultz, a; baumann, s; mahiny, aj; boros, g; reinholz, j; szabo, gt; kariko, k; shi, py; fontes-garfias, c; perez, jl; cutler, m; cooper, d; kyratsous, ca; dormitzer, pr; jansen, ku; tureci, o	nature	2021	10.1038/s41586-021-03653-6	7
833	bnt162b2-elicited neutralization of b.1.617 and other sars-cov-2 variants	liu, jy; liu, y; xia, hj; zou, j; weaver, sc; swanson, ka; cai, h; cutler, m; cooper, d; muik, a; jansen, ku; sahin, u; xie, xp; dormitzer, pr; shi, py	nature	2021	10.1038/s41586-021-03693-y	8
834	israel's rapid rollout of vaccinations for covid-19	rosen, b; waitzberg, r; israeli, a	israel journal of health policy research	2021	10.1186/s13584-021-00440-6	2
835	a global database of covid-19 vaccinations	mathieu, e; ritchie, h; ortiz-ospina, e; roser, m; hasell, j; appel, c; giattino, c; rodes-guirao, l	nature human behaviour	2021	10.1038/s41562-021-01122-8	2
836	comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against sars-cov-2	mcdonald, i; murray, sm; reynolds, cj; altmann, dm; boyton, rj	npj vaccines	2021	10.1038/s41541-021-00336-1	1
837	sars-cov-2 infection rates of antibody-positive compared with antibody-negative health-care workers in england: a large, multicentre, prospective cohort study (siren)	hall, vj; foulkes, s; charlett, a; atti, a; monk, ejm; simmons, r; wellington, e; cole, mj; saei, a; oguti, b; munro, k; wallace, s; kirwan, pd; shrotri, m; vusirikala, a; rokadiya, s; kall, m; zambon, m; ramsay, m; brooks, t; brown, cs; chand, ma; hopkins, s	lancet	2021	10.1016/s0140-6736(21)00675-9	8
838	longitudinal dynamics of the neutralizing antibody response to severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection	wang, k; long, qx; deng, hj; hu, j; gao, qz; zhang, gj; he, cl; huang, ly; hu, jl; chen, j; tang, n; huang, al	clinical infectious diseases	2021	10.1093/cid/ciaa1143	1
839	sars-cov-2 infection induces long-lived bone marrow plasma cells in humans	turner, js; kim, w; kalaidina, e; goss, cw; rauseo, am; schmitz, aj; hansen, l; haile, a; klebert, mk; pusic, i; o'halloran, ja; presti, rm; ellebedy, ah	nature	2021	10.1038/s41586-021-03647-4	3
840	naturally enhanced neutralizing breadth against sars-cov-2 one year after infection	wang, zj; muecksch, f; schaefer-babajew, d; finkin, s; viant, c; gaebler, c; hoffmann, hh; barnes, co; cipolla, m; ramos, v; oliveira, ty; cho, al; schmidt, f; da silva, j; bednarski, e; aguado, l; yee, j; daga, m; turroja, m; millard, kg; jankovic, m; gazumyan, a; zhao, z; rice, cm; bieniasz, pd; caskey, m; hatziioannou, t; nussenzweig, mc	nature	2021	10.1038/s41586-021-03696-9	7
841	sars-cov-2 mrna vaccination induces functionally diverse antibodies to ntd, rbd, and s2	amanat, f; thapa, m; lei, tt; ahmed, sms; adelsberg, dc; carreno, jm; strohmeier, s; schmitz, aj; zafar, s; zhou, jlq; rijnink, w; alshammary, h; borcherding, n; reiche, ag; srivastava, k; sordillo, em; van bakel, h; turner, js; bajic, g; simon, v; ellebedy, ah; krammer, f	cell	2021	10.1016/j.cell.2021.06.005	2
842	sars-cov-2 mrna vaccines induce persistent human germinal centre responses	turner, js; o'halloran, ja; kalaidina, e; kim, w; schmitz, aj; zhou, jq; lei, tt; thapa, m; chen, re; case, jb; amanat, f; rauseo, am; haile, a; xie, xp; klebert, mk; suessen, t; middleton, wd; shi, py; krammer, f; teefey, sa; diamond, ms; presti, rm; ellebedy, ah	nature	2021	10.1038/s41586-021-03738-2	5
843	safety and immunogenicity of sars-cov-2 variant mrna vaccine boosters in healthy adults: an interim analysis	choi, a; koch, m; wu, k; chu, l; ma, lz; hill, a; nunna, n; huang, wm; oestreicher, j; colpitts, t; bennett, h; legault, h; paila, y; nestorova, b; ding, by; montefiori, d; pajon, r; miller, jm; leav, b; carfi, a; mcphee, r; edwards, dk	nature medicine	2021	10.1038/s41591-021-01527-y	2
844	sars-cov-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera	kuzmina, a; khalaila, y; voloshin, o; keren-naus, a; boehm-cohen, l; raviv, y; shemer-avni, y; rosenberg, e; taube, r	cell host & microbe	2021	10.1016/j.chom.2021.03.008	4
845	evidence for increased breakthrough rates of sars-cov-2 variants of concern in bnt162b2-mrna-vaccinated individuals	kustin, t; harel, n; finkel, u; perchik, s; harari, s; tahor, m; caspi, i; levy, r; leshchinsky, m; dror, sk; bergerzon, g; gadban, h; gadban, f; eliassian, e; shimron, o; saleh, l; ben-zvi, h; taraday, ek; amichay, d; ben-dor, a; sagas, d; strauss, m; avni, ys; huppert, a; kepten, e; balicer, rd; netzer, d; ben-shachar, s; stern, a	nature medicine	2021	10.1038/s41591-021-01413-7	7
846	safety, immunogenicity, and efficacy of the bnt162b2 covid-19 vaccine in adolescents	frenck, rw; klein, np; kitchin, n; gurtman, a; absalon, j; lockhart, s; perez, jl; walter, eb; senders, s; bailey, r; swanson, ka; ma, h; xu, x; koury, k; kalina, wv; cooper, d; jennings, t; brandon, dm; thomas, sj; tureci, o; tresnan, db; mather, s; dormitzer, pr; sahin, u; jansen, ku; gruber, wc	new england journal of medicine	2021	10.1056/nejmoa2107456	7
847	safety and efficacy of the bnt162b2 mrna covid-19 vaccine through 6 months	thomas, sj; moreira, ed; kitchin, n; absalon, j; gurtman, a; lockhart, s; perez, jl; marc, gp; polack, fp; zerbini, c; bailey, r; swanson, ka; xu, x; roychoudhury, s; koury, k; bouguermouh, s; kalina, wv; cooper, d; frenck, rw; hammitt, ll; tureci, o; nell, h; schaefer, a; unal, s; yang, q; liberator, p; tresnan, db; mather, s; dormitzer, pr; sahin, u; gruber, wc; jansen, ku	new england journal of medicine	2021	10.1056/nejmoa2110345	4
848	variant sars-cov-2 mrna vaccines confer broad neutralization as primary or booster series in mice	wu, k; choi, a; koch, m; elbashir, s; ma, lz; lee, d; woods, a; henry, c; palandjian, c; hill, a; jani, h; quinones, j; nunna, n; o'connell, s; mcdermott, ab; falcone, s; narayanan, e; colpitts, t; bennett, h; corbett, ks; seder, r; graham, bs; stewart-jones, gbe; carfi, a; edwards, dk	vaccine	2021	10.1016/j.vaccine.2021.11.001	3
849	progress of the covid-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape	tregoning, js; flight, ke; higham, sl; wang, zy; pierce, be	nature reviews immunology	2021	10.1038/s41577-021-00592-1	0
850	bnt162b2 mrna covid-19 vaccine: first approval	lamb, yn	drugs	2021	10.1007/s40265-021-01480-7	0
851	immunological mechanisms of vaccine-induced protection against covid-19 in humans	sadarangani, m; marchant, a; kollmann, tr	nature reviews immunology	2021	10.1038/s41577-021-00578-z	2
852	a case of longitudinally extensive transverse myelitis following vaccination against covid-19	pagenkopf, c; sudmeyer, m	journal of neuroimmunology	2021	10.1016/j.jneuroim.2021.577606	0
853	the cytokine storm and covid-19	hu, by; huang, sy; yin, lh	journal of medical virology	2021	10.1002/jmv.26232	1
854	immunogenicity of covid-19 mrna vaccines in pregnant and lactating women	collier, ary; mcmahan, k; yu, jy; tostanoski, lh; aguayo, r; ansel, j; chandrashekar, a; patel, s; bondzie, ea; sellers, d; barrett, j; sanborn, o; wan, hh; chang, aq; anioke, t; nkolola, j; bradshaw, c; jacob-dolan, c; feldman, j; gebre, m; borducchi, en; liu, jy; schmidt, ag; suscovich, t; linde, c; alter, g; hacker, mr; barouch, dh	jama-journal of the american medical association	2021	10.1001/jama.2021.7563	4
855	artificial intelligence-enabled analysis of public attitudes on facebook and twitter toward covid-19 vaccines in the united kingdom and the united states: observational study	hussain, a; tahir, a; hussain, z; sheikh, z; gogate, m; dashtipour, k; ali, a; sheikh, a	journal of medical internet research	2021	10.2196/26627	0
856	emerging sars-cov-2 variants and impact in global vaccination programs against sars-cov-2/covid-19	gomez, ce; perdiguero, b; esteban, m	vaccines	2021	10.3390/vaccines9030243	4
857	efficacy of the bnt162b2 mrna covid-19 vaccine in patients with chronic lymphocytic leukemia	herishanu, y; avivi, i; aharon, a; shefer, g; levi, s; bronstein, y; morales, m; ziv, t; arbel, ys; scarfo, l; joffe, e; perry, c; ghia, p	blood	2021	10.1182/blood.2021011568	12
858	low immunogenicity to sars-cov-2 vaccination among liver transplant recipients	rabinowich, l; grupper, a; baruch, r; ben-yehoyada, m; halperin, t; turner, d; katchman, e; levi, s; houri, i; lubezky, n; shibolet, o; katchman, h	journal of hepatology	2021	10.1016/j.jhep.2021.04.020	8
859	covid-19 dynamics after a national immunization program in israel	rossman, h; shilo, s; meir, t; gorfine, m; shalit, u; segal, e	nature medicine	2021	10.1038/s41591-021-01337-2	3
860	bnt162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized covid-19 patients in israel	brosh-nissimov, t; orenbuch-harroch, e; chowers, m; elbaz, m; nesher, l; stein, m; maor, y; cohen, r; hussein, k; weinberger, m; zimhony, o; chazan, b; najjar, r; zayyad, h; rahav, g; wiener-well, y	clinical microbiology and infection	2021	10.1016/j.cmi.2021.06.036	1
861	the persistence of vaccine hesitancy: covid-19 vaccination intention in new zealand	thaker, j	journal of health communication	2021	10.1080/10810730.2021.1899346	0
862	wastewater surveillance for sars-cov-2: lessons learnt from recent studies to define future applications	hamouda, m; mustafa, f; maraqa, m; rizvi, t; hassan, aa	science of the total environment	2021	10.1016/j.scitotenv.2020.143493	1
863	household transmission of sars-cov-2 and risk factors for susceptibility and infectivity in wuhan: a retrospective observational study	li, f; li, yy; liu, mj; fang, lq; dean, ne; wong, gwk; yang, xb; longini, i; halloran, me; wang, hj; liu, pl; pang, yh; yan, yq; liu, s; xia, w; lu, xx; liu, q; yang, y; xu, sq	lancet infectious diseases	2021	10.1016/s1473-3099(20)30981-6hubei430030	3
864	lessons learned 1 year after sars-cov-2 emergence leading to covid-19 pandemic	to, kkw; sridhar, s; chiu, khy; hung, dll; li, x; hung, ifn; tam, ar; chung, twh; chan, jfw; zhang, ajx; cheng, vcc; yuen, ky	emerging microbes & infections	2021	10.1080/22221751.2021.1898291	0
865	an asia-pacific study on healthcare workers' perceptions of, and willingness to receive, the covid-19 vaccination	chew, nws; cheong, c; kong, g; phua, k; ngiam, jn; tan, byq; wang, bk; hao, fy; tan, wq; han, xf; tran, bx; hoang, mt; pham, hq; vu, gt; chen, y; danuaji, r; rn, k; pv, m; talati, k; ho, cs; sharma, ak; ho, rc; sharma, vk	international journal of infectious diseases	2021	10.1016/j.ijid.2021.03.069	1
866	human igg and iga responses to covid-19 mrna vaccines	wisnewski, av; luna, jc; redlich, ca	plos one	2021	10.1371/journal.pone.0249499	0
867	parents' willingness and attitudes concerning the covid-19 vaccine: a cross-sectional study	yilmaz, m; sahin, mk	international journal of clinical practice	2021	10.1111/ijcp.14364	1
868	effectiveness of covid-19 vaccines in ambulatory and inpatient care settings	thompson, mg; stenehjem, e; grannis, s; ball, sw; naleway, al; ong, tc; desilva, mb; natarajan, k; bozio, ch; lewis, n; dascomb, k; dixon, be; birch, rj; irving, sa; rao, s; kharbanda, e; han, j; reynolds, s; goddard, k; grisel, n; fadel, wf; levy, me; ferdinands, j; fireman, b; arndorfer, j; valvi, nr; rowley, ea; patel, p; zerbo, o; griggs, ep; porter, rm; demarco, m; blanton, l; steffens, a; zhuang, y; olson, n; barron, m; shifflett, p; schrag, sj; verani, jr; fry, a; gaglani, m; azziz-baumgartner, e; klein, np	new england journal of medicine	2021	10.1056/nejmoa2110362	1
869	a megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment	milkman, kl; patel, ms; gandhi, l; graci, hn; gromet, dm; ho, h; kay, js; lee, tw; akinola, m; beshears, j; bogard, je; buttenheim, a; chabris, cf; chapman, gb; choi, jj; dai, hc; fox, cr; goren, a; hilchey, md; hmurovic, j; john, lk; karlan, d; kim, m; laibson, d; lamberton, c; madrian, bc; meyer, mn; modanu, m; nam, j; rogers, t; rondina, r; saccardo, s; shermohammed, m; soman, d; sparks, j; warren, c; weber, m; berman, r; evans, cn; snider, ck; tsukayama, e; van den bulte, c; volpp, kg; duckworth, al	proceedings of the national academy of sciences of the united states of	2021	10.1073/pnas.2101165118	2
870	covid-19 vaccine acceptance and hesitancy in low- and middle-income countries	arce, jss; warren, ss; meriggi, nf; scacco, a; mcmurry, n; voors, m; syunyaev, g; malik, aa; aboutajdine, s; adeojo, o; anigo, d; armand, a; asad, s; atyera, m; augsburg, b; awasthi, m; ayesiga, ge; bancalari, a; nyqvist, mb; borisova, e; bosancianu, cm; garcia, mrc; cheema, a; collins, e; cuccaro, f; farooqi, az; fatima, t; fracchia, m; soria, mlg; guariso, a; hasanain, a; jaramillo, s; kallon, s; kamwesigye, a; kharel, a; kreps, s; levine, m; littman, r; malik, m; manirabaruta, g; mfura, jlh; momoh, f; mucauque, a; mussa, i; nsabimana, ja; obara, i; otalora, mj; ouedraogo, bw; pare, tb; platas, mr; polanco, l; qureshi, ja; raheem, m; ramakrishna, v; rendra, i; shah, t; shaked, se; shapiro, jn; svensson, j; tariq, a; tchibozo, am; tiwana, ha; trivedi, b; vernot, c; vicente, pc; weissinger, lb; zafar, b; zhang, bb; karlan, d; callen, m; teachout, m; humphreys, m; mobarak, am; omer, sb	nature medicine	2021	10.1038/s41591-021-01454-y	0
871	phase 3 safety and efficacy of azd1222 (chadox1 ncov-19) covid-19 vaccine	falsey, ar; sobieszczyk, me; hirsch, i; sproule, s; robb, ml; corey, l; neuzil, km; hahn, w; hunt, j; mulligan, mj; mcevoy, c; dejesus, e; hassman, m; little, sj; pahud, ba; durbin, a; pickrell, p; daar, es; bush, l; solis, j; carr, qo; oyedele, t; buchbinder, s; cowden, j; vargas, sl; benavides, ag; call, r; keefer, mc; kirkpatrick, bd; pullman, j; tong, tn; isaacs, mb; benkeser, d; janes, he; nason, mc; green, ja; kelly, ej; maaske, j; mueller, n; shoemaker, k; takas, t; marshall, rp; pangalos, mn; villafana, t; gonzalez-lopez, a	new england journal of medicine	2021	10.1056/nejmoa2105290	0
872	evidence-based strategies for clinical organizations to address covid-19 vaccine hesitancy	rutten, ljf; zhu, x; leppin, al; ridgeway, jl; swift, md; griffin, jm; st sauver, jl; virk, a; jacobson, rm	mayo clinic proceedings	2021	10.1016/j.mayocp.2020.12.024	0
873	covid-19 vaccine guidance for patients with cancer participating in oncology clinical trials	desai, a; gainor, jf; hegde, a; schram, am; curigiliano, g; pal, s; liu, sv; halmos, b; groisberg, r; grande, e; dragovich, t; matrana, m; agarwal, n; chawla, s; kato, s; morgan, g; kasi, pm; solomon, b; loong, hh; park, h; choueiri, tk; subbiah, im; pemmaraju, n; subbiah, v	nature reviews clinical oncology	2021	10.1038/s41571-021-00487-z	2
874	vaccine ethics: an ethical framework for global distribution of covid-19 vaccines	jecker, ns; wightman, ag; diekema, ds	journal of medical ethics	2021	10.1136/medethics-2020-107036	0
875	acceptance and attitudes toward covid-19 vaccines: a cross-sectional study from jordan	el-elimat, t; abualsamen, mm; almomani, ba; al-sawalha, na; alali, fq	plos one	2021	10.1371/journal.pone.0250555	1
876	impact of disease-modifying treatments on humoral response after covid-19 vaccination: a mirror of the response after sars-cov-2 infection	bigaut, k; kremer, l; fleury, m; lanotte, l; collongues, n; de seze, j	revue neurologique	2021	10.1016/j.neurol.2021.05.001	1
877	safety and efficacy of covid-19 vaccines in multiple sclerosis patients	kelly, h; sokola, b; abboud, h	journal of neuroimmunology	2021	10.1016/j.jneuroim.2021.577599	0
878	accelerated vaccine rollout is imperative to mitigate highly transmissible covid-19 variants	sah, p; vilches, tn; moghadas, sm; fitzpatrick, mc; singer, bh; hotez, pj; galvani, ap	eclinicalmedicine	2021	10.1016/j.eclinm.2021.100865	0
879	coronavirus disease 2019 (covid-19) vaccines and pregnancy what obstetricians need to know	rasmussen, sa; kelley, cf; horton, jp; jamieson, dj	obstetrics and gynecology	2021	10.1097/aog.0000000000004290	1
880	science skepticism in times of covid-19	rutjens, bt; van der linden, s; van der lee, r	group processes & intergroup relations	2021	10.1177/1368430220981415	0
881	attitudes, current behaviours and barriers to public health measures that reduce covid-19 transmission: a qualitative study to inform public health messaging	benham, jl; lang, r; burns, kk; mackean, g; leveille, t; mccormack, b; sheikh, h; fullerton, mm; tang, t; boucher, jc; constantinescu, c; mourali, m; oxoby, rj; manns, bj; hu, j; marshall, da	plos one	2021	10.1371/journal.pone.0246941	1
882	estimating the reproductive number r-0 of sars-cov-2 in the united states and eight european countries and implications for vaccination	ke, ra; romero-severson, e; sanche, s; hengartner, n	journal of theoretical biology	2021	10.1016/j.jtbi.2021.110621	1
883	examining the effect of information channel on covid-19 vaccine acceptance	piltch-loeb, r; savoia, e; goldberg, b; hughes, b; verhey, t; kayyem, j; miller-idriss, c; testa, m	plos one	2021	10.1371/journal.pone.0251095	1
884	attitudes, acceptance and hesitancy among the general population worldwide to receive the covid-19 vaccines and their contributing factors: a systematic review	cascini, f; pantovic, a; al-ajlouni, y; failla, g; ricciardi, w	eclinicalmedicine	2021	10.1016/j.eclinm.2021.101113	1
885	methotrexate hampers immunogenicity to bnt162b2 mrna covid-19 vaccine in immune-mediated inflammatory disease	haberman, rh; herati, rs; simon, d; samanovic, m; blank, rb; tuen, m; koralov, sb; atreya, r; tascilar, k; allen, jr; castillo, r; cornelius, ar; rackoff, p; solomon, g; adhikari, s; azar, n; rosenthal, p; izmirly, p; samuels, j; golden, b; reddy, s; neurath, m; abramson, sb; schett, g; mulligan, mj; scher, ju	annals of the rheumatic diseases	2021	10.1136/annrheumdis-2021-220597	5
886	efficacy of synthetic glucocorticoids in covid-19 endothelites	ferrara, f; vitiello, a	naunyn-schmiedebergs archives of pharmacology	2021	10.1007/s00210-021-02049-7	0
887	comprehensive assessment of humoral response after pfizer bnt162b2 mrna covid-19 vaccination: a three-case series	danese, e; montagnana, m; salvagno, gl; peserico, d; pighi, l; de nitto, s; henry, bm; porru, s; lippi, g	clinical chemistry and laboratory medicine	2021	10.1515/cclm-2021-0339	2
888	side effects of bnt162b2 mrna covid-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers	kadali, rak; janagama, r; peruru, s; malayala, sv	international journal of infectious diseases	2021	10.1016/j.ijid.2021.04.047	0
889	magnitude and kinetics of anti-severe acute respiratory syndrome coronavirus 2 antibody responses and their relationship to disease severity	lynch, kl; whitman, jd; lacanienta, np; beckerdite, ew; kastner, sa; shy, br; goldgof, gm; levine, ag; bapat, sp; stramer, sl; esensten, jh; hightower, aw; bern, c; wu, ahb	clinical infectious diseases	2021	10.1093/cid/ciaa979	2
890	bnt162b2 covid-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers	lustig, y; sapir, e; regev-yochay, g; cohen, c; fluss, r; olmer, l; indenbaum, v; mandelboim, m; doolman, r; amit, s; mendelson, e; ziv, a; huppert, a; rubin, c; freedman, l; kreiss, y	lancet respiratory medicine	2021	10.1016/s2213-2600(21)00220-4	3
891	protection of bnt162b2 vaccine booster against covid-19 in israel	bar-on, ym; goldberg, y; mandel, m; bodenheimer, o; freedman, l; kalkstein, n; mizrahi, b; alroy-preis, s; ash, n; milo, r; huppert, a	new england journal of medicine	2021	10.1056/nejmoa2114255	6
892	review on 3d printing: fight against covid-19	oladapo, bi; ismail, so; afolalu, td; olawade, db; zahedi, m	materials chemistry and physics	2021	10.1016/j.matchemphys.2020.123943	0
893	one year update on the covid-19 pandemic: where are we now?	mishra, sk; tripathi, t	acta tropica	2021	10.1016/j.actatropica.2020.105778	0
894	modifications in an emergency: the role of n1-methylpseudouridine in covid-19 vaccines	nance, kd; meier, jl	acs central science	2021	10.1021/acscentsci.1c00197	0
895	covid-19 vaccine-associated immune thrombosis and thrombocytopenia (vitt): diagnostic and therapeutic recommendations for a new syndrome	franchini, m; liumbruno, gm; pezzo, m	european journal of haematology	2021	10.1111/ejh.13665	0
896	covid-19 and quality of life: twelve reflections	shek, dtl	applied research in quality of life	2021	10.1007/s11482-020-09898-z	0
897	aging in covid-19: vulnerability, immunity and intervention	chen, yy; klein, sl; garibaldi, bt; li, hf; wu, cj; osevala, nm; li, ts; margolick, jb; pawelec, g; leng, sx	ageing research reviews	2021	10.1016/j.arr.2020.101205	0
898	covid-19: a global challenge with old history, epidemiology and progress so far	khan, m; adil, sf; alkhathlan, hz; tahir, mn; saif, s; khan, m; khan, st	molecules	2021	10.3390/molecules26010039	0
899	covid-19: rethinking the lockdown groupthink	joffe, ar	frontiers in public health	2021	10.3389/fpubh.2021.625778	0
900	minimal change disease following the pfizer-biontech covid-19 vaccine	lebedev, l; sapojnikov, m; wechsler, a; varadi-levi, r; zamir, d; tobar, a; levin-iaina, n; fytlovich, s; yagil, y	american journal of kidney diseases	2021	10.1053/j.ajkd.2021.03.010	1
901	antibody persistence in the first 6 months following sars-cov-2 infection among hospital workers: a prospective longitudinal study	l'huillier, ag; meyer, b; andrey, do; arm-vernez, i; baggio, s; didierlaurent, a; eberhardt, cs; eckerle, i; grasset-salomon, c; huttner, a; posfay-barbe, km; royo, is; pralong, ja; vuilleumier, n; yerly, s; siegrist, ca; kaiser, l	clinical microbiology and infection	2021	10.1016/j.cmi.2021.01.005	3
902	antibodies against severe acute respiratory syndrome coronavirus type 2 (sars-cov-2) in individuals with and without covid-19 vaccination: a method comparison of two different commercially available serological assays from the same manufacturer	mueller, t	clinica chimica acta	2021	10.1016/j.cca.2021.03.007	2
903	anti-sars-cov-2 receptor-binding domain total antibodies response in seropositive and seronegative healthcare workers undergoing covid-19 mrna bnt162b2 vaccination	salvagno, gl; henry, bm; di piazza, g; pighi, l; de nitto, s; bragantini, d; gianfilippi, gl; lippi, g	diagnostics	2021	10.3390/diagnostics11050832	2
904	prediction and mitigation of mutation threats to covid-19 vaccines and antibody therapies	chen, jh; gao, kf; wang, r; wei, gw	chemical science	2021	10.1039/d1sc01203g	1
905	exhaled aerosol increases with covid-19 infection, age, and obesity	edwards, da; ausiello, d; salzman, j; devlin, t; langer, r; beddingfield, bj; fears, ac; doyle-meyers, la; redmann, rk; killeen, sz; maness, nj; roy, cj	proceedings of the national academy of sciences of the united states of	2021	10.1073/pnas.2021830118	0
906	leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against covid-19	fantini, j; chahinian, h; yahi, n	biochemical and biophysical research communications	2021	10.1016/j.bbrc.2020.10.015	1
907	research progress of traditional chinese medicine against covid-19	ren, w; liang, p; ma, y; sun, q; pu, qr; dong, l; luo, g; mazhar, m; liu, jl; wang, rq; yang, sj	biomedicine & pharmacotherapy	2021	10.1016/j.biopha.2021.111310	0
908	a comprehensive review on potential therapeutics interventions for covid-19	chugh, h; awasthi, a; agarwal, y; gaur, rk; dhawan, g; chandra, r	european journal of pharmacology	2021	10.1016/j.ejphar.2020.173741	1
909	immunogenicity of sars-cov-2 vaccine in dialysis	lacson, e; argyropoulos, cp; manley, hj; aweh, g; chin, ai; salman, lh; hsu, cm; johnson, ds; weiner, de	journal of the american society of nephrology	2021	10.1681/asn.2021040432	1
910	efficacy of the bnt162b2 mrna covid-19 vaccine in patients with b-cell non-hodgkin lymphoma	perry, c; luttwak, e; balaban, r; shefer, g; morales, mm; aharon, a; tabib, y; cohen, yc; benyamini, n; beyar-katz, o; neaman, m; vitkon, r; keren-khadmy, n; levin, m; herishanu, y; avivi, i	blood advances	2021	10.1182/bloodadvances.2021005094	2
911	current advances in the development of sars-cov-2 vaccines	awadasseid, a; wu, yl; tanaka, y; zhang, w	international journal of biological sciences	2021	10.7150/ijbs.52569	1
912	misinformation about covid-19: evidence for differential latent profiles and a strong association with trust in science	agley, j; xiao, yy	bmc public health	2021	10.1186/s12889-020-10103-x	1
913	unwillingness to engage in behaviors that protect against covid-19: the role of conspiracy beliefs, trust, and endorsement of complementary and alternative medicine	soveri, a; karlsson, lc; antfolk, j; lindfelt, m; lewandowsky, s	bmc public health	2021	10.1186/s12889-021-10643-w	1
914	prospects of nanomaterials-enabled biosensors for covid-19 detection	srivastava, m; srivastava, n; mishra, pk; malhotra, bd	science of the total environment	2021	10.1016/j.scitotenv.2020.142363	0
915	antibody response to inactivated covid-19 vaccine (coronavac) in immune-mediated diseases: a controlled study among hospital workers and elderly	seyahi, e; bakhdiyarli, g; oztas, m; kuskucu, ma; tok, y; sut, n; ozcifci, g; ozcaglayan, a; balkan, ii; saltoglu, n; tabak, f; hamuryudan, v	rheumatology international	2021	10.1007/s00296-021-04910-7	2
916	a high rate of covid-19 vaccine hesitancy in a large-scale survey on arabs	qunaibi, ea; helmy, m; basheti, i; sultan, i	elife	2021	10.7554/elife.68038	0
917	the variant gambit: covid-19's next move	plante, ja; mitchell, bm; plante, ks; debbink, k; weaver, sc; menachery, vd	cell host & microbe	2021	10.1016/j.chom.2021.02.020	5
918	infection- and vaccine-induced antibody binding and neutralization of the b.1.351 sars-cov-2 variant	edara, vv; norwood, c; floyd, k; lai, ll; davis-gardner, me; hudson, wh; mantus, g; nyhoff, le; adelman, mw; fineman, r; patel, s; byram, r; gomes, dn; michael, g; abdullahi, h; beydoun, n; panganiban, b; mcnair, n; hellmeister, k; pitts, j; winters, j; kleinhenz, j; usher, j; o'keefe, jb; piantadosi, a; waggoner, jj; babiker, a; stephens, ds; anderson, ej; edupuganti, s; rouphael, n; ahmed, r; wrammert, j; suthar, ms	cell host & microbe	2021	10.1016/j.chom.2021.03.009	6
919	mrna vaccination boosts cross-variant neutralizing antibodies elicited by sars-cov-2 infection	stamatatos, l; czartoski, j; wan, yh; homad, lj; rubin, v; glantz, h; neradilek, m; seydoux, e; jennewein, mf; maccamy, aj; feng, jl; mize, g; de rosa, sc; finzi, a; lemos, mp; cohen, kw; moodie, z; mcelrath, mj; mcguire, at	science	2021	10.1126/science.abg9175	3
920	longitudinal analysis shows durable and broad immune memory after sars-cov-2 infection with persisting antibody responses and memory b and t cells	cohen, kw; linderman, sl; moodie, z; czartoski, j; lai, ll; mantus, g; norwood, c; nyhoff, le; edara, vv; floyd, k; de rosa, sc; ahmed, h; whaley, r; patel, sn; prigmore, b; lemos, mp; davis, cw; furth, s; o'keefe, jb; gharpure, mp; gunisetty, s; stephens, k; antia, r; zarnitsyna, vi; stephens, ds; edupuganti, s; rouphael, n; anderson, ej; mehta, ak; wrammert, j; sulthar, ms; ahmed, r; mcelrath, mj	cell reports medicine	2021	10.1016/j.xcrm.2021.100354	2
921	sars-cov-2 human t cell epitopes: adaptive immune response against covid-19	grifoni, a; sidney, j; vita, r; peters, b; crotty, s; weiskopf, d; sette, a	cell host & microbe	2021	10.1016/j.chom.2021.05.010	2
922	durability of mrna-1273 vaccine-induced antibodies against sars-cov-2 variants	pegu, a; o'connell, s; schmidt, sd; o'dell, s; talana, ca; lai, ll; albert, j; anderson, e; bennett, h; corbett, ks; flach, b; jackson, l; leav, b; ledgerwood, je; luke, cj; makowski, m; roberts, pc; roederer, m; rebolledo, pa; rostad, ca; rouphael, ng; shi, w; wang, ls; widge, at; yang, es; beigel, jh; graham, bs; mascola, jr; suthar, ms; mcdermott, a; doria-rose, na	science	2021	10.1126/science.abj4176	3
923	early induction of functional sars-cov-2-specific t cells associates with rapid viral clearance and mild disease in covid-19 patients	tan, at; linster, m; tan, cw; le bert, n; chia, wn; kunasegaran, k; zhuang, y; tham, cyl; chia, a; smith, gjd; young, b; kalimuddin, s; low, jgh; lye, d; wang, lf; bertoletti, a	cell reports	2021	10.1016/j.celrep.2021.108728	7
924	a single dose of the sars-cov-2 vaccine bnt162b2 elicits fc-mediated antibody effector functions and t cell responses	tauzin, a; nayrac, m; benlarbi, m; gong, sy; gasser, r; beaudoin-bussieres, g; brassard, n; laumaea, a; vezina, d; prevost, j; anand, sp; bourassa, c; gendron-lepage, g; medjahed, h; goyette, g; niessl, j; tastet, o; gokool, l; morrisseau, c; arlotto, p; stamatatos, l; mcguire, at; larochelle, c; uchil, p; lu, ml; mothes, w; de serres, g; moreira, s; roger, m; richard, j; martel-laferriere, v; duerr, r; tremblay, c; kaufmann, de; finzi, a	cell host & microbe	2021	10.1016/j.chom.2021.06.001	2
925	low-dose mrna-1273 covid-19 vaccine generates durable memory enhanced by cross-reactive t cells	mateus, j; dan, jm; zhang, zl; moderbacher, cr; lammers, m; goodwin, b; sette, a; crotty, s; weiskopf, d	science	2021	10.1126/science.abj9853	0
926	herpes zoster following bnt162b2 mrna covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series	furer, v; zisman, d; kibari, a; rimar, d; paran, y; elkayam, o	rheumatology	2021	10.1093/rheumatology/keab345	0
927	addressing justified vaccine hesitancy in the black community	laurencin, ct	journal of racial and ethnic health disparities	2021	10.1007/s40615-021-01025-4	0
928	myocarditis after covid-19 vaccination in a large health care organization	witberg, g; barda, n; hoss, s; richter, i; wiessman, m; aviv, y; grinberg, t; auster, o; dagan, n; balicer, rd; kornowski, r	new england journal of medicine	2021	10.1056/nejmoa2110737	1
929	myocarditis after bnt162b2 mrna vaccine against covid-19 in israel	mevorach, d; anis, e; cedar, n; bromberg, m; haas, ej; nadir, e; olsha-castell, s; arad, d; hasin, t; levi, n; asleh, r; amir, o; meir, k; cohen, d; dichtiar, r; novick, d; hershkovitz, y; dagan, r; leitersdorf, i; ben-ami, r; miskin, i; saliba, w; muhsen, k; levi, y; green, ms; keinan-boker, l; alroy-preis, s	new england journal of medicine	2021	10.1056/nejmoa2109730	0
930	covid-19 vaccine challenges: what have we learned so far and what remains to be done?	forman, r; shah, s; jeurissen, p; jit, m; mossialos, e	health policy	2021	10.1016/j.healthpol.2021.03.013	1
931	mucormycosis and covid-19: an epidemic within a pandemic in india	selarka, l; sharma, s; saini, d; sharma, s; batra, a; waghmare, vt; dileep, p; patel, s; shah, m; parikh, t; darji, p; patel, a; goswami, g; shah, a; shah, s; lathiya, h; shah, m; sharma, p; chopra, s; gupta, a; jain, n; khan, e; sharma, vk; sharma, ak; chan, acy; ong, jjy	mycoses	2021	10.1111/myc.13353	0
932	the impact of the covid-19 pandemic on immunization campaigns and programs: a systematic review	lassi, zs; naseem, r; salam, ra; siddiqui, f; das, jk	international journal of environmental research and public health	2021	10.3390/ijerph18030988	1
933	immunogenicity of the bnt162b2 mrna vaccine in heart transplant recipients - a prospective cohort study	ben zadok, oi; shaul, aa; ben-avraham, b; yaari, v; ben zvi, h; shostak, y; pertzov, b; eliakim-raz, n; abed, g; abuhazira, m; barac, yd; mats, i; kramer, mr; aravot, d; kornowski, r; ben-gal, t	european journal of heart failure	2021	10.1002/ejhf.2199	2
934	evaluation of the automated liaison (r) sars-cov-2 trimerics igg assay for the detection of circulating antibodies	bonelli, f; blocki, fa; bunnell, t; chu, e; de la, oa; grenache, dg; marzucchi, g; montomoli, e; okoye, l; pallavicini, l; streva, va; torelli, a; wagner, a; zanin, d; zierold, c; wassenberg, jj	clinical chemistry and laboratory medicine	2021	10.1515/cclm-2021-0023	1
935	antibody response to first and second dose of bnt162b2 in a cohort of characterized healthcare workers	padoan, a; dall'olmo, l; della rocca, f; barbaro, f; cosma, c; basso, d; cattelan, a; cianci, v; plebani, m	clinica chimica acta	2021	10.1016/j.cca.2021.04.006	3
936	anti-sars-cov-2 antibodies testing in recipients of covid-19 vaccination: why, when, and how?	lippi, g; henry, bm; plebani, m	diagnostics	2021	10.3390/diagnostics11060941	0
937	assessment of effectiveness of 1 dose of bnt162b2 vaccine for sars-cov-2 infection 13 to 24 days after immunization	chodick, g; tene, l; patalon, t; gazit, s; ben tov, a; cohen, d; muhsen, k	jama network open	2021	10.1001/jamanetworkopen.2021.15985	1
938	covid-19 mrna vaccine induced antibody responses against three sars-cov-2 variants	jalkanen, p; kolehmainen, p; hakkinen, hk; huttunen, m; tahtinen, pa; lundberg, r; maljanen, s; reinholm, a; tauriainen, s; pakkanen, sh; levonen, i; nousiainen, a; miller, t; valimaa, h; ivaska, l; pasternack, a; naves, r; ritvos, o; osterlund, p; kuivanen, s; smura, t; hepojoki, j; vapalahti, o; lempainen, j; kakkola, l; kantele, a; julkunen, i	nature communications	2021	10.1038/s41467-021-24285-4	1
939	covid-19 and italian healthcare workers from the initial sacrifice to the mrna vaccine: pandemic chrono-history, epidemiological data, ethical dilemmas, and future challenges	nioi, m; napoli, pe; lobina, j; fossarello, m; d'aloja, e	frontiers in public health	2021	10.3389/fpubh.2020.591900	0
940	recent developments on therapeutic and diagnostic approaches for covid-19	majumder, j; minko, t	aaps journal	2021	10.1208/s12248-020-00532-2	0
941	role of toll-like receptors in the pathogenesis of covid-19	khanmohammadi, s; rezaei, n	journal of medical virology	2021	10.1002/jmv.26826	0
942	how new models of vaccine development for covid-19 have helped address an epic public health crisis	bloom, de; cadarette, d; ferranna, m; hyer, rn; tortorice, dl	health affairs	2021	10.1377/hlthaff.2020.02012	0
943	theoretical framework for retrospective studies of the effectiveness of sars-cov-2 vaccines	lewnard, ja; patel, mm; jewell, np; verani, jr; kobayashi, m; tenforde, mw; dean, ne; cowling, bj; lopman, ba	epidemiology	2021	10.1097/ede.0000000000001366	5
944	an overview of vaccine development, approval, and regulation, with implications for covid-19	kesselheim, as; darrow, jj; kulldorff, m; brown, bl; mitra-majumdar, m; lee, cc; moneer, o; avorn, j	health affairs	2021	10.1377/hlthaff.2020.01620	0
945	first-dose mrna vaccination is sufficient to reactivate immunological memory to sars-cov-2 in subjects who have recovered from covid-19	mazzoni, a; di lauria, n; maggi, l; salvati, l; vanni, a; capone, m; lamacchia, g; mantengoli, e; spinicci, m; zammarchi, l; kiros, st; rocca, a; lagi, f; colao, mg; parronchi, p; scaletti, c; turco, l; liotta, f; rossolini, gm; cosmi, l; bartoloni, a; annunziato, f	journal of clinical investigation	2021	10.1172/jci149150	0
946	reduced neutralization of sars-cov-2 b.1.617 by vaccine and convalescent serum	liu, c; ginn, hm; dejnirattisai, w; supasa, p; wang, bb; tuekprakhon, a; nutalai, r; zhou, dm; mentzer, aj; zhao, yg; duyvesteyn, hme; lopez-camacho, c; slon-campos, j; walter, ts; skelly, d; johnson, sa; ritter, tg; mason, c; clemens, sac; naveca, fg; nascimento, v; nascimento, f; da costa, cf; resende, pc; pauvolid-correa, a; siqueira, mm; dold, c; temperton, n; dong, t; pollard, aj; knight, jc; crook, d; lambe, t; clutterbuck, e; bibi, s; flaxman, a; bittaye, m; belij-rammerstorfer, s; gilbert, sc; malik, t; carroll, mw; klenerman, p; barnes, e; dunachie, sj; baillie, v; serafin, n; ditse, z; da silva, k; paterson, ng; williams, ma; hall, dr; madhi, s; nunes, mc; goulder, p; fry, ee; mongkolsapaya, j; ren, js; stuart, di; screaton, gr	cell	2021	10.1016/j.cell.2021.06.020	3
947	reduced sensitivity of sars-cov-2 variant delta to antibody neutralization	planas, d; veyer, d; baidaliuk, a; staropoli, i; guivel-benhassine, f; rajah, mm; planchais, c; porrot, f; robillard, n; puech, j; prot, m; gallais, f; gantner, p; velay, a; le guen, j; kassis-chikhani, n; edriss, d; belec, l; seve, a; courtellemont, l; pere, h; hocqueloux, l; fafi-kremer, s; prazuck, t; mouquet, h; bruel, t; simon-loriere, e; rey, fa; schwartz, o	nature	2021	10.1038/s41586-021-03777-9	6
948	effectiveness of inactivated sars-cov-2 vaccines against the delta variant infection in guangzhou: a test-negative case-control real-world study	li, xn; huang, y; wang, w; jing, ql; zhang, ch; qin, pz; guan, wj; gan, l; li, yl; liu, wh; dong, h; miao, yt; fan, sj; zhang, zb; zhang, dm; zhong, ns	emerging microbes & infections	2021	10.1080/22221751.2021.1969291	0
949	health outcomes and economic burden of hospitalized covid-19 patients in the united states	di fusco, m; shea, km; lin, j; nguyen, jl; angulo, fj; benigno, m; malhotra, d; emir, b; sung, ah; hammond, jl; stoychev, s; charos, a	journal of medical economics	2021	10.1080/13696998.2021.1886109	0
950	polysaccharides obtained from natural edible sources and their role in modulating the immune system: biologically active potential that can be exploited against covid-19	barbosa, jr; de carvalho, rn	trends in food science & technology	2021	10.1016/j.tifs.2020.12.026	0
951	s-trimer, a covid-19 subunit vaccine candidate, induces protective immunity in nonhuman primates	liang, jg; su, dm; song, tz; zeng, yl; huang, wj; wu, jh; xu, r; luo, pw; yang, xf; zhang, xd; luo, sr; liang, y; li, xl; huang, jj; wang, q; huang, xq; xu, qs; luo, m; huang, al; luo, dx; zhao, cy; yang, f; han, jb; zheng, yt; liang, p	nature communications	2021	10.1038/s41467-021-21634-1	0
952	sars-cov-2 and the pandemic of covid-19	adil, mt; rahman, r; whitelaw, d; jain, v; al-taan, o; rashid, f; munasinghe, a; jambulingam, p	postgraduate medical journal	2021	10.1136/postgradmedj-2020-138386	0
953	vaccine-escape and fast-growing mutations in the united kingdom, the united states, singapore, spain, india, and other covid-19-devastated countries	wang, r; chen, jh; gao, kf; wei, gw	genomics	2021	10.1016/j.ygeno.2021.05.006	0
954	sars-cov-2 seroprevalence worldwide: a systematic review and meta-analysis	rostami, a; sepidarkish, m; leeflang, mmg; riahi, sm; shiadeh, mn; esfandyari, s; mokdad, ah; hotez, pj; gasser, rb	clinical microbiology and infection	2021	10.1016/j.cmi.2020.10.020	2
955	point of care diagnostics in the age of covid-19	rezaei, m; bazaz, sr; zhand, s; sayyadi, n; jin, d; stewart, mp; warkiani, me	diagnostics	2021	10.3390/diagnostics11010009	0
956	promising extracellular vesicle-based vaccines against viruses, including sars-cov-2	sabanovic, b; piva, f; cecati, m; giulietti, m	biology-basel	2021	10.3390/biology10020094	0
957	heterologous vaccination regimens with self-amplifying rna and adenoviral covid vaccines induce robust immune responses in mice	spencer, aj; mckay, pf; belij-rammerstorfer, s; ulaszewska, m; bissett, cd; hu, k; samnuan, k; blakney, ak; wright, d; sharpe, hr; gilbride, c; truby, a; allen, er; gilbert, sc; shattock, rj; lambe, t	nature communications	2021	10.1038/s41467-021-23173-1	4
958	immunogenicity and reactogenicity of bnt162b2 booster in chadox1-s-primed participants (combivacs): a multicentre, open-label, randomised, controlled, phase 2 trial	borobia, am; carcas, aj; perez-olmeda, m; castano, l; bertran, mj; garcia-perez, j; campins, m; portoles, a; gonzalez-perez, m; morales, mtg; arana-arri, e; aldea, m; diez-fuertes, f; fuentes, i; ascaso, a; lora, d; imaz-ayo, n; baron-mira, le; agusti, a; perez-ingidua, c; de la camara, ag; arribas, jr; ochando, j; alcami, j; belda-iniesta, c; frias, j	lancet	2021	10.1016/s0140-6736(21)01420-3	3
959	bnt162b2 covid-19 vaccine is significantly less effective in patients with hematologic malignancies	tzarfati, kh; gutwein, o; apel, a; rahimi-levene, n; sadovnik, m; harel, l; benveniste-levkovitz, p; bar chaim, a; koren-michowitz, m	american journal of hematology	2021	10.1002/ajh.26284	3
960	a review on possible mechanistic insights of nitazoxanide for repurposing in covid-19	lokhande, as; devarajan, pv	european journal of pharmacology	2021	10.1016/j.ejphar.2020.173748	0
961	the health belief model predicts vaccination intentions against covid-19: a survey experiment approach	zampetakis, la; melas, c	applied psychology-health and well being	2021	10.1111/aphw.12262	0
962	pandemics, tourism and global change: a rapid assessment of covid-19	gossling, s; scott, d; hall, cm	journal of sustainable tourism	2021	10.1080/09669582.2020.1758708	1
963	safety and immunogenicity of a dna sars-cov-2 vaccine (zycov-d): results of an open-label, non-randomized phase i part of phase i/ii clinical study by intradermal route in healthy subjects in india	momin, t; kansagra, k; patel, h; sharma, s; sharma, b; patel, j; mittal, r; sanmukhani, j; maithal, k; dey, a; chandra, h; rajanathan, ctm; pericherla, hpr; kumar, p; narkhede, a; parmar, d	eclinicalmedicine	2021	10.1016/j.eclinm.2021.101020	0
964	ivermectin as a potential drug for treatment of covid-19: an in-sync review with clinical and computational attributes	kaur, h; shekhar, n; sharma, s; sarma, p; prakash, a; medhi, b	pharmacological reports	2021	10.1007/s43440-020-00195-y	0
965	a review of potential suggested drugs for coronavirus disease (covid-19) treatment	tarighi, p; eftekhari, s; chizari, m; sabernavaei, m; jafari, d; mirzabeigi, p	european journal of pharmacology	2021	10.1016/j.ejphar.2021.173890	0
966	impact of virus genetic variability and host immunity for the success of covid-19 vaccines	dos santos, wg	biomedicine & pharmacotherapy	2021	10.1016/j.biopha.2021.111272	0
967	projections and fractional dynamics of covid-19 with optimal control strategies	nabi, kn; kumar, p; erturk, vs	chaos solitons & fractals	2021	10.1016/j.chaos.2021.110689	0
968	lead sars-cov-2 candidate vaccines: expectations from phase iii trials and recommendations post-vaccine approval	tumban, e	viruses-basel	2021	10.3390/v13010054	1
969	international collaboration to ensure equitable access to vaccines for covid-19: the act-accelerator and the covax facility	eccleston-turner, m; upton, h	milbank quarterly	2021	10.1111/1468-0009.12503	0
970	a review on deep learning techniques for the diagnosis of novel coronavirus (covid-19)	islam, mm; karray, f; alhajj, r; zeng, j	ieee access	2021	10.1109/access.2021.3058537	0
971	the covid-19 pandemic face mask waste: a blooming threat to the marine environment	dharmaraj, s; ashokkumar, v; hariharan, s; manibharathi, a; show, pl; chong, ct; ngamcharussrivichai, c	chemosphere	2021	10.1016/j.chemosphere.2021.129601	0
972	the potential neurological effect of the covid-19 vaccines: a review	lu, l; xiong, wx; mu, j; zhang, q; zhang, hs; zou, l; li, wm; he, l; sander, jw; zhou, d	acta neurologica scandinavica	2021	10.1111/ane.13417	0
973	use of mrna covid-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices - united states, june 2021	gargano, jw; wallace, m; hadler, sc; langley, g; su, jr; oster, me; broder, kr; gee, j; weintraub, e; shimabukuro, t; scobie, hm; moulia, d; markowitz, le; wharton, m; mcnally, vv; romero, jr; talbot, hk; lee, gm; daley, mf; oliver, se	mmwr-morbidity and mortality weekly report	2021		3
974	association of myocarditis with bnt162b2 messenger rna covid-19 vaccine in a case series of children	dionne, a; sperotto, f; chamberlain, s; baker, al; powell, aj; prakash, a; castellanos, da; saleeb, sf; de ferranti, sd; newburger, jw; friedman, kg	jama cardiology	2021	10.1001/jamacardio.2021.3471	0
975	forecasting of covid-19 cases using deep learning models: is it reliable and practically significant?	devaraj, j; elavarasan, rm; pugazhendhi, r; shafiullah, gm; ganesan, s; jeysree, ak; khan, ia; hossain, e	results in physics	2021	10.1016/j.rinp.2021.103817	0
976	calming the storm: natural immunosuppressants as adjuvants to target the cytokine storm in covid-19	peter, ae; sandeep, bv; rao, bg; kalpana, vl	frontiers in pharmacology	2021	10.3389/fphar.2020.583777	0
977	age groups that sustain resurging covid-19 epidemics in the united states	monod, m; blenkinsop, a; xi, xy; hebert, d; bershan, s; tietze, s; baguelin, m; bradley, vc; chen, y; coupland, h; filippi, s; ish-horowicz, j; mcmanus, m; mellan, t; gandy, a; hutchinson, m; unwin, hjt; van elsland, sl; vollmer, mac; weber, s; zhu, h; bezancon, a; ferguson, nm; mishra, s; flaxman, s; bhatt, s; ratmann, o	science	2021	10.1126/science.abe8372	1
978	aging, immunity, and covid-19: how age influences the host immune response to coronavirus infections?	bajaj, v; gadi, n; spihlman, ap; wu, sc; choi, ch; moulton, vr	frontiers in physiology	2021	10.3389/fphys.2020.571416	2
979	knowledge, attitudes, and practices (kap) toward covid-19: a cross-sectional study in south korea	lee, m; kang, ba; you, m	bmc public health	2021	10.1186/s12889-021-10285-y	0
980	safety and immunogenicity of the sars-cov-2 bnt162b1 mrna vaccine in younger and older chinese adults: a randomized, placebo-controlled, double-blind phase 1 study	li, jx; hui, am; zhang, x; yang, ym; tang, r; ye, hy; ji, rr; lin, m; zhu, zk; tureci, o; lagkadinou, e; jia, sy; pan, hx; peng, fz; ma, zl; wu, zg; guo, xl; shi, yf; muik, a; sahin, u; zhu, l; zhu, fc	nature medicine	2021	10.1038/s41591-021-01330-9	1
981	age-related immune response heterogeneity to sars-cov-2 vaccine bnt162b2	collier, da; ferreira, iatm; kotagiri, p; datir, rp; lim, ey; touizer, e; meng, b; abdullahi, a; elmer, a; kingston, n; graves, b; le gresley, e; caputo, d; bergamaschi, l; smith, kgc; bradley, jr; ceron-gutierrez, l; cortes-acevedo, p; barcenas-morales, g; linterman, ma; mccoy, le; davis, c; thomson, e; lyons, pa; mckinney, e; doffinger, r; wills, m; gupta, rk	nature	2021	10.1038/s41586-021-03739-1	2
982	delayed production of neutralizing antibodies correlates with fatal covid-19	lucas, c; klein, j; sundaram, me; liu, fm; wong, p; silva, j; mao, ty; oh, je; mohanty, s; huang, jf; tokuyama, m; lu, pw; venkataraman, a; park, a; israelow, b; vogels, cbf; muenker, mc; chang, ch; casanovas-massana, a; moore, aj; zell, j; fournier, jb; obaid, a; robertson, aj; lu-culligan, a; zhao, a; nelson, a; brito, a; nunez, a; martin, a; watkins, ae; geng, b; chun, cj; kalinich, cc; harden, ca; todeasa, c; jensen, c; dorgay, ce; kim, d; mcdonald, d; shepard, d; courchaine, e; white, eb; song, e; silva, e; kudo, e; deiuliis, g; rahming, h; park, hj; matos, i; ott, i; nouws, j; valdez, j; fauver, j; lim, j; rose, ka; anastasio, k; brower, k; glick, l; sharma, l; sewanan, l; knaggs, l; minasyan, m; batsu, m; petrone, m; kuang, m; nakahata, m; linehan, m; askenase, mh; simonov, m; smolgovsky, m; balkcom, nc; sonnert, n; naushad, n; vijayakumar, p; martinello, r; datta, r; handoko, r; bermejo, s; prophet, s; bickerton, s; velazquez, s; alpert, t; rice, t; khoury-hanold, w; peng, xh; yang, yx; cao, yy; strong, y; lin, zt; wyllie, al; campbell, m; lee, a; chun, hj; grubaugh, nd; schulz, wl; farhadian, s; dela cruz, c; ring, am; shaw, ac; wisnewski, av; yildirim, i; ko, ali; omer, s; iwasaki, a	nature medicine	2021	10.1038/s41591-021-01355-0	1
983	neutralisation of sars-cov-2 lineage p.1 by antibodies elicited through natural sars-cov-2 infection or vaccination with an inactivated sars-cov-2 vaccine: an immunological study	souza, wm; amorim, mr; sesti-costa, r; coimbra, ld; brunetti, ns; toledo-teixeira, da; souza, gfd; muraro, sp; parise, pl; barbosa, pp; bispo-dos-santos, k; mofatto, ls; simeoni, cl; claro, im; duarte, ass; coletti, tm; zangirolami, ab; costa-lima, c; gomes, absp; buscaratti, li; sales, fc; costa, va; franco, lam; candido, ds; pybus, og; de jesus, jg; silva, cam; ramundo, ms; ferreira, gm; pinho, mc; souza, lm; rocha, ec; andrade, ps; crispim, mae; maktura, gc; manuli, er; santos, mnn; camilo, cc; angerami, rn; moretti, ml; spilki, fr; arns, cw; addas-carvalho, m; benites, bd; vinolo, mar; mori, mas; gaburo, n; dye, c; marques-souza, h; marques, re; farias, as; diamond, ms; faria, nr; sabino, ec; granja, f; proenca-modena, jl	lancet microbe	2021	10.1016/s2666-5247(21)00129-4	2
984	efficacy and safety of an inactivated whole-virion sars-cov-2 vaccine (coronavac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in turkey	tanriover, md; doganay, hl; akova, m; guner, hr; azap, a; akhan, s; kose, s; erdinc, fs; akalin, eh; tabak, of; pullukcu, h; batum, o; yavuz, ss; turhan, o; yildirmak, mt; koksal, i; tasova, y; korten, v; yilmaz, g; celen, mk; altin, s; celik, i; bayindir, y; karaoglan, i; yilmaz, a; ozkul, a; gur, h; unal, s	lancet	2021	10.1016/s0140-6736(21)01429-x	4
985	effectiveness of the coronavac vaccine in older adults during a gamma variant associated epidemic of covid-19 in brazil: test negative case-control study	ranzani, o; hitchings, mdt; dorion, m; d'agostini, tl; de paula, rc; de paula, ofp; villela, efd; torres, mss; de oliveira, sb; schulz, w; almiron, m; said, r; de oliveira, rd; da silva, pv; de araijo, wn; gorinchteyn, jc; andrews, jr; cummings, dat; ko, ai; croda, j	bmj-british medical journal	2021	10.1136/bmj.n2015	1
986	a covid-19 prophylaxis? lower incidence associated with prophylactic administration of ivermectin	hellwig, md; maia, a	international journal of antimicrobial agents	2021	10.1016/j.ijantimicag.2020.106248	0
987	safety of the bnt162b2 mrna covid-19 vaccine in a nationwide setting	barda, n; dagan, n; ben-shlomo, y; kepten, e; waxman, j; ohana, r; hernan, ma; lipsitch, m; kohane, i; netzer, d; reis, b; balicer, rd	new england journal of medicine	2021	10.1056/nejmoa2110475	1
988	humoral and cellular immune response and safety of two-dose sars-cov-2 mrna-1273 vaccine in solid organ transplant recipients	hall, vg; ferreira, vh; ierullo, m; ku, t; marinelli, t; majchrzak-kita, b; yousuf, a; kulasingam, v; humar, a; kumar, d	american journal of transplantation	2021	10.1111/ajt.16766	1
989	systematic review of safety and efficacy of covid-19 vaccines in patients with kidney disease	glenn, da; hegde, a; kotzen, e; walter, eb; kshirsagar, av; falk, r; mottl, a	kidney international reports	2021	10.1016/j.ekir.2021.02.011	4
990	high immunogenicity of a messenger rna-based vaccine against sars-cov-2 in chronic dialysis patients	longlune, n; nogier, mb; miedouge, m; gabilan, c; cartou, c; seigneuric, b; del bello, a; marion, o; faguer, s; izopet, j; kamar, n	nephrology dialysis transplantation	2021	10.1093/ndt/gfab193	4
991	mesenchymal stem cell (msc)-derived exosomes as a cell-free therapy for patients infected with covid-19: real opportunities and range of promises	rezakhani, l; kelishadrokhi, af; soleimanizadeh, a; rahmati, s	chemistry and physics of lipids	2021	10.1016/j.chemphyslip.2020.105009	0
992	quantification of sars-cov-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays	bewley, kr; coombes, ns; gagnon, l; mcinroy, l; baker, n; shaik, i; st-jean, jr; st-amant, n; buttigieg, kr; humphries, he; godwin, kj; brunt, e; allen, l; leung, s; brown, pj; penn, ej; thomas, k; kulnis, g; hallis, b; carroll, m; funnell, s; charlton, s	nature protocols	2021	10.1038/s41596-021-00536-y	1
993	safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with chadox1 ncov-19 and bnt162b2: a prospective cohort study	hillus, d; schwarz, t; tober-lau, p; vanshylla, k; hastor, h; thibeault, c; jentzsch, s; helbig, et; lippert, lj; tscheak, p; schmidt, ml; riege, j; solarek, a; von kalle, c; dang-heine, c; gruell, h; kopankiewicz, p; suttorp, n; drosten, c; bias, h; seybold, j; klein, f; kurth, f; corman, vm; sander, le	lancet respiratory medicine	2021	10.1016/s2213-2600(21)00357-x	1
994	safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mrna covid-19 vaccine (com-cov): a single-blind, randomised, non-inferiority trial	liu, xx; shaw, rh; stuart, asv; greenland, m; aley, pk; andrews, nj; cameron, jc; charlton, s; clutterbuck, ea; collins, am; dinesh, t; england, a; faust, sn; ferreira, dm; finn, a; green, ca; hallis, b; heath, pt; hill, h; lambe, t; lazarus, r; libri, v; long, f; mujadidi, yf; plested, el; provstgaard-morys, s; ramasamy, mn; ramsay, m; read, rc; robinson, h; singh, n; turner, dpj; turner, pj; walker, ll; white, r; nguyen-van-tam, js; snape, md	lancet	2021	10.1016/s0140-6736(21)01694-9	3
995	effects of different types of written vaccination information on covid-19 vaccine hesitancy in the uk (oceans-iii) : a randomised controlled trial	freeman, d; loe, bs; yu, lm; freeman, j; chadwick, a; vaccari, c; shanyinde, m; harris, v; waite, f; rosebrock, l; petit, a; vanderslott, s; lewandowsky, s; larkin, m; innocenti, s; pollard, aj; mcshane, h; lambe, s	lancet public health	2021	10.1016/s2468-2667(21)00096-7	0
996	impaired humoral response in renal transplant recipients to sars-cov-2 vaccination with bnt162b2 (pfizer-biontech)	korth, j; jahn, m; dorsch, o; anastasiou, oe; sorge-hadicke, b; eisenberger, u; gackler, a; dittmer, u; witzke, o; wilde, b; dolff, s; kribben, a	viruses-basel	2021	10.3390/v13050756	5
997	cellular immunity predominates over humoral immunity after homologous and heterologous mrna and vector-based covid-19 vaccine regimens in solid organ transplant recipients	schmidt, t; klemis, v; schub, d; schneitler, s; reichert, mc; wilkens, h; sester, u; sester, m; mihm, j	american journal of transplantation	2021	10.1111/ajt.16818	2
998	deep learning based detection and analysis of covid-19 on chest x-ray images	jain, r; gupta, m; taneja, s; hemanth, dj	applied intelligence	2021	10.1007/s10489-020-01902-1	0
999	convalescent plasma may be a possible treatment for covid-19: a systematic review	wang, y; huo, pf; dai, rl; lv, x; yuan, sf; zhang, y; guo, ym; li, r; yu, q; zhu, k	international immunopharmacology	2021	10.1016/j.intimp.2020.107262	0
1000	overview of covid-19 inflammatory pathogenesis from the therapeutic perspective	lee, c; choi, wj	archives of pharmacal research	2021	10.1007/s12272-020-01301-7	0
1001	the legal extension of the role of pharmacists in light of the covid-19 global pandemic	merks, p; jakubowska, m; drelich, e; swieczkowski, d; bogusz, j; bilmin, k; sola, kf; may, a; majchrowska, a; koziol, m; pawlikowski, j; jaguszewski, m; vaillancourt, r	research in social & administrative pharmacy	2021	10.1016/j.sapharm.2020.05.033	0
1002	efficient maternal to neonatal transfer of antibodies against sars-cov-2 and bnt162b2 mrna covid-19 vaccine	beharier, o; mayo, rp; raz, t; sacks, kn; schreiber, l; suissa-cohen, y; chen, r; gomez-tolub, r; hadar, e; gabbay-benziv, r; moshkovich, yj; biron-shental, t; shechter-maor, g; farladansky-gershnabel, s; sela, hy; benyamini-raischer, h; sela, nd; goldman-wohl, d; shulman, z; many, a; barr, h; yagel, s; neeman, m; kovo, m	journal of clinical investigation	2021	10.1172/jci150319	0
1003	vaccine breakthrough infections with sars-cov-2 variants	hacisuleyman, e; hale, c; saito, y; blachere, ne; bergh, m; conlon, eg; schaefer-babajew, dj; dasilva, j; muecksch, f; gaebler, c; lifton, r; nussenzweig, mc; hatziioannou, t; bieniasz, pd; darnell, rb	new england journal of medicine	2021	10.1056/nejmoa2105000	2
1004	covid-19 breakthrough infections in vaccinated health care workers	bergwerk, m; gonen, t; lustig, y; amit, s; lipsitch, m; cohen, c; mandelboim, m; levin, eg; rubin, c; indenbaum, v; tal, i; zavitan, m; zuckerman, n; bar-chaim, a; kreiss, y; regev-yochay, g	new england journal of medicine	2021	10.1056/nejmoa2109072	6
1005	serologic status and toxic effects of the sars-cov-2 bnt162b2 vaccine in patients undergoing treatment for cancer	goshen-lago, t; waldhorn, i; holland, r; szwarcwort-cohen, m; reiner-benaim, a; shachor-meyouhas, y; hussein, k; fahoum, l; baruch, m; peer, a; reiter, y; almog, r; halberthal, m; ben-aharon, i	jama oncology	2021	10.1001/jamaoncol.2021.2675	3
1006	waning immune humoral response to bnt162b2 covid-19 vaccine over 6 months	levin, eg; lustig, y; cohen, c; fluss, r; indenbaum, v; amit, s; doolman, r; asraf, k; mendelson, e; ziv, a; rubin, c; freedman, l; kreiss, y; regev-yochay, g	new england journal of medicine	2021	10.1056/nejmoa2114583	0
1007	the tragedy of the commons: how individualism and collectivism affected the spread of the covid-19 pandemic	maaravi, y; levy, a; gur, t; confino, d; segal, s	frontiers in public health	2021	10.3389/fpubh.2021.627559	0
1008	reactogenicity and immunogenicity after a late second dose or a third dose of chadox1 ncov-19 in the uk: a substudy of two randomised controlled trials (cov001 and cov002)	flaxman, a; marchevsky, ng; jenkin, d; aboagye, j; aley, pk; angus, b; belij-rammerstorfer, s; bibi, s; bittaye, m; cappuccini, f; cicconi, p; clutterbuck, ea; davies, s; dejnirattisai, w; dold, c; ewer, kj; folegatti, pm; fowler, j; hill, avs; kerridge, s; minassian, am; mongkolsapaya, j; mujadidi, yf; plested, e; ramasamy, mn; robinson, h; sanders, h; sheehan, e; smith, h; snape, md; song, r; woods, d; screaton, g; gilbert, sc; voysey, m; pollard, aj; lambe, t	lancet	2021	10.1016/s0140-6736(21)01699-8	2
1009	waning of bnt162b2 vaccine protection against sars-cov-2 infection in qatar	chemaitelly, h; tang, p; hasan, mr; almukdad, s; yassine, hm; benslimane, fm; al khatib, ha; coyle, p; ayoub, hh; al kanaani, z; al kuwari, e; jeremijenko, a; kaleeckal, ah; latif, an; shaik, rm; rahim, hfa; nasrallah, gk; al kuwari, mg; al romaihi, he; butt, aa; al-thani, mh; al khal, a; bertollini, r; abu-raddad, lj	new england journal of medicine	2021	10.1056/nejmoa2114114	5
1010	effectiveness of mrna bnt162b2 covid-19 vaccine up to 6 months in a large integrated health system in the usa: a retrospective cohort study	tartof, sy; slezak, jm; fischer, h; hong, v; ackerson, bk; ranasinghe, on; frankland, tb; ogun, oa; zamparo, jm; gray, s; valluri, sr; pan, k; angulo, fj; jodar, l; mclaughlin, jm	lancet	2021	10.1016/s0140-6736(21)02183-8	5
1011	bnt162b2 and mrna-1273 covid-19 vaccine effectiveness against the sars-cov-2 delta variant in qatar	tang, p; hasan, mr; chemaitelly, h; yassine, hm; benslimane, fm; al khatib, ha; almukdad, s; coyle, p; ayoub, hh; al kanaani, z; al kuwari, e; jeremijenko, a; kaleeckal, ah; latif, an; shaik, rm; rahim, hfa; nasrallah, gk; al kuwari, mg; al romaihi, he; butt, aa; al-thani, mh; al khal, a; bertollini, r; abu-raddad, lj	nature medicine	2021	10.1038/s41591-021-01583-4	0
1012	effectiveness of a third dose of the bnt162b2 mrna covid-19 vaccine for preventing severe outcomes in israel: an observational study	barda, n; dagan, n; cohen, c; hernan, ma; lipsitch, m; kohane, is; reis, b; balicer, rd	lancet	2021	10.1016/s0140-6736(21)02249-2	1
1013	dual lateral flow optical/chemiluminescence immunosensors for the rapid detection of salivary and serum iga in patients with covid-19 disease	roda, a; cavalera, s; di nardo, f; calabria, d; rosati, s; simoni, p; colitti, b; baggiani, c; roda, m; anfossi, l	biosensors & bioelectronics	2021	10.1016/j.bios.2020.112765	1
1014	diagnosis of covid-19 for controlling the pandemic: a review of the state-of-the-art	taleghani, n; taghipour, f	biosensors & bioelectronics	2021	10.1016/j.bios.2020.112830	0
1015	analytical sensitivity of the abbott binaxnow covid-19 ag card	perchetti, ga; huang, ml; mills, mg; jerome, kr; greninger, al	journal of clinical microbiology	2021	10.1128/jcm.02880-20	0
1016	factors associated with willingness to be vaccinated against covid-19 in a large convenience sample	dorman, c; perera, a; condon, c; chau, c; qian, j; kalk, k; diazdeleon, d	journal of community health	2021	10.1007/s10900-021-00987-0	0
1017	managing the covid-19 pandemic in poor urban neighborhoods: the case of accra and johannesburg	durizzo, k; asiedu, e; van der merwe, a; van niekerk, a; gunther, i	world development	2021	10.1016/j.worlddev.2020.105175	0
1018	crystal structure of sars-cov-2 papain-like protease	gao, xp; qin, b; chen, p; zhu, kx; hou, pj; wojdyla, ja; wang, mt; cui, s	acta pharmaceutica sinica b	2021	10.1016/j.apsb.2020.08.014	1
1019	a critical overview of computational approaches employed for covid-19 drug discovery	muratov, en; amaro, r; andrade, ch; brown, n; ekins, s; fourches, d; isayev, o; kozakov, d; medina-franco, jl; merz, km; oprea, ti; poroikov, v; schneider, g; todd, mh; varnek, a; winkler, da; zakharov, av; cherkasov, a; tropsha, a	chemical society reviews	2021	10.1039/d0cs01065k	0
1020	clinical approval of nanotechnology-based sars-cov-2 mrna vaccines: impact on translational nanomedicine	milane, l; amiji, m	drug delivery and translational research	2021	10.1007/s13346-021-00911-y	0
1021	reaction of human monoclonal antibodies to sars-cov-2 proteins with tissue antigens: implications for autoimmune diseases	vojdani, a; vojdani, e; kharrazian, d	frontiers in immunology	2021	10.3389/fimmu.2020.617089	1
1022	three cases of subacute thyroiditis following sars-cov-2 vaccine: postvaccination asia syndrome	iremli, bg; sendur, sn; unluturk, u	journal of clinical endocrinology & metabolism	2021	10.1210/clinem/dgab373	0
1023	can n-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for covid-19-associated cardiovascular complications?	darwesh, am; bassiouni, w; sosnowski, dk; seubert, jm	pharmacology & therapeutics	2021	10.1016/j.pharmthera.2020.107703	0
1024	estimating global and regional disruptions to routine childhood vaccine coverage during the covid-19 pandemic in 2020: a modelling study	causey, k; fullman, n; sorensen, rjd; galles, nc; zheng, p; aravkin, a; danovaro-holliday, mc; martinez-piedra, r; sodha, sv; velandia-gonzalez, mp; gacic-dobo, m; castro, e; he, jw; schipp, m; deen, a; hay, si; lim, ss; mosser, jf	lancet	2021	10.1016/s0140-6736(21)01337-4	0
1025	mrna vaccine: a potential therapeutic strategy	wang, y; zhang, zq; luo, jw; han, xj; wei, yq; wei, xw	molecular cancer	2021	10.1186/s12943-021-01311-z	0
1026	chronic kidney disease is a key risk factor for severe covid-19: a call to action by the era-edta	ortiz, a; cozzolino, m; duivenvoorden, r; fliser, d; fouque, d; franssen, cfm; goumenos, d; hemmelder, mh; hilbrands, lb; jager, kj; massy, za; noordzij, m; rosenkranz, ar; rychlik, i; soler, mj; stevens, k; torra, r; tuglular, s; vart, p; wanner, c; gansevoort, rt	nephrology dialysis transplantation	2021	10.1093/ndt/gfaa314	1
1027	improved covid-19 icu admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis	vahedian-azimi, a; mohammadi, sm; beni, fh; banach, m; guest, pc; jamialahmadi, t; sahebkar, a	archives of medical science	2021	10.5114/aoms/132950	0
1028	covid-19 serology at population scale: sars-cov-2-specific antibody responses in saliva	randad, pr; pisanic, n; kruczynski, k; manabe, yc; thomas, d; pekosz, a; klein, sl; betenbaugh, mj; clarke, wa; laeyendecker, o; caturegli, pp; larman, hb; detrick, b; fairley, jk; sherman, ac; rouphael, n; edupuganti, s; granger, da; granger, sw; collins, m; heaney, cd	journal of clinical microbiology	2021	10.1128/jcm.02204-20	0
1029	methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized covid-19 patients: a triple-blinded randomized controlled trial	ranjbar, k; moghadami, m; mirahmadizadeh, a; fallahi, mj; khaloo, v; shahriarirad, r; erfani, a; khodamoradi, z; saadi, mhg	bmc infectious diseases	2021	10.1186/s12879-021-06045-3	0
1030	risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study	hippisley-cox, j; coupland, cac; mehta, n; keogh, rh; diaz-ordaz, k; khunti, k; lyons, ra; kee, f; sheikh, a; rahman, s; valabhji, j; harrison, em; sellen, p; haq, n; semple, mg; johnson, pwm; hayward, a; nguyen-van-tam, js	bmj-british medical journal	2021	10.1136/bmj.n2244	0
1031	in silicodrug repurposing for covid-19: targeting sars-cov-2 proteins through docking and consensus ranking	cavasotto, cn; di filippo, ji	molecular informatics	2021	10.1002/minf.202000115	0
1032	behavioural nudges increase covid-19 vaccinations	dai, hc; saccardo, s; han, ma; roh, l; raja, n; vangala, s; modi, h; pandya, s; sloyan, m; croymans, dm	nature	2021	10.1038/s41586-021-03843-2	0
1033	immune-boosting role of vitamins d, c, e, zinc, selenium and omega-3 fatty acids: could they help against covid-19?	shakoor, h; feehan, j; al dhaheri, as; ali, hi; platat, c; ismail, lc; apostolopoulos, v; stojanovska, l	maturitas	2021	10.1016/j.maturitas.2020.08.003	0
1034	a fractional order mathematical model for covid-19 dynamics with quarantine, isolation, and environmental viral load	oud, maa; ali, a; alrabaiah, h; ullah, s; khan, ma; islam, s	advances in difference equations	2021	10.1186/s13662-021-03265-4	0
1035	the advisory committee on immunization practices' interim recommendation for use of pfizer-biontech covid-19 vaccine in adolescents aged 12-15 years - united states, may 2021	wallace, m; woodworth, kr; gargano, jw; scobie, hm; blain, ae; moulia, d; chamberland, m; reisman, n; hadler, sc; macneil, jr; campos-outcalt, d; morgan, rl; daley, mf; romero, jr; talbot, hk; lee, gm; bell, bp; oliver, se	mmwr-morbidity and mortality weekly report	2021	10.15585/mmwr.mm7020e1	1
1036	covid-19 vaccine breakthrough infections reported to cdc - united states, january 1-april 30, 2021	birhane, m; bressler, s; chang, g; clark, t; dorough, l; fischer, m; watkins, lf; goldstein, jm; kugeler, k; langley, g; lecy, k; martin, s; medalla, f; mitruka, k; nolen, l; sadigh, k; spratling, r; thompson, g; trujillo, a	mmwr-morbidity and mortality weekly report	2021	10.15585/mmwr.mm7021e3	3
1037	comparative effectiveness of moderna, pfizer-biontech, and janssen (johnson & johnson) vaccines in preventing covid-19 hospitalizations among adults without immunocompromising conditions - united states, march-august 2021	self, wh; tenforde, mw; rhoads, jp; gaglani, m; ginde, aa; douin, dj; olson, sm; talbot, k; casey, jd; mohr, nm; zepeski, a; mcneal, t; ghamande, s; gibbs, kw; files, dc; hager, dn; shchu, a; prekker, me; erickson, hl; gong, mn; mohamed, a; henning, dj; steingrub, js; peltan, id; ten lohuis, cc; duggal, a; wilson, jg; gordon, aj; qadir, n; chang, sy; mallow, c; rivas, c; babcock, hm; kwon, jh; exline, mc; halasa, n; chappell, jd; lauring, as; grijalva, cg; rice, tw; jones, id; stubblefield, wb; baughman, a; womack, kn; lindsell, cj; hart, kw; zhu, yw; mills, l; lester, sn; stumpf, mm; naioti, ea; kobayashi, m; verani, jr; thornburg, nj; patel, mm; brown, sm; martin, et; monto, as; khan, a; hough, cl; busse, lw	mmwr-morbidity and mortality weekly report	2021		2
1038	association between mrna vaccination and covid-19 hospitalization and disease severity	tenforde, mw; self, wh; adams, k; gaglani, m; ginde, aa; mcneal, t; ghamande, s; douin, dj; talbot, hk; casey, jd; mohr, nm; zepeski, a; shapiro, ni; gibbs, kw; files, dc; hager, dn; shehu, a; prekker, me; erickson, hl; exline, mc; gong, mn; mohamed, a; henning, dj; steingrub, js; peltan, id; brown, sm; martin, et; monto, as; khan, a; hough, cl; busse, lw; ten lohuis, cc; duggal, a; wilson, jg; gordon, aj; qadir, n; chang, sy; mallow, c; rivas, c; babcock, hm; kwon, jh; halasa, n; chappell, jd; lauring, as; grijalva, cg; rice, tw; jones, id; stubblefield, wb; baughman, a; womack, kn; rhoads, jp; lindsell, cj; hart, kw; zhu, yw; olson, sm; kobayashi, m; verani, jr; patel, mm	jama-journal of the american medical association	2021	10.1001/jama.2021.19499	0
1039	coronavirus disease-2019 (covid-19) and cardiovascular complications	ma, ll; song, kc; huang, yg	journal of cardiothoracic and vascular anesthesia	2021	10.1053/j.jvca.2020.04.041	0
1040	immune correlates of protection by mrna-1273 vaccine against sars-cov-2 in nonhuman primates	corbett, ks; nason, mc; flach, b; gagne, m; o' connell, s; johnston, ts; shah, sn; edara, vv; floyd, k; lai, ll; mcdanal, c; francica, jr; flynn, b; wu, k; choi, a; koch, m; abiona, om; werner, ap; moliva, ji; andrew, sf; donaldson, mm; fintzi, j; flebbe, dr; lamb, e; noe, at; nurmukhambetova, st; provost, sj; cook, a; dodson, a; faudree, a; greenhouse, j; kar, s; pessaint, l; porto, m; steingrebe, k; valentin, d; zouantcha, s; bock, kw; minai, m; nagata, bm; van de wetering, r; boyoglu-barnum, s; leung, k; shi, w; yang, es; zhang, y; todd, jpm; wang, ls; alvarado, gs; andersen, h; foulds, ke; edwards, dk; mascola, jr; moore, in; lewis, mg; carfi, a; monterfiori, d; suthar, ms; mcdermott, a; roederer, m; sullivan, nj; douek, dc; graham, bs; seder, ra	science	2021	10.1126/science.abj0299	5
1041	antibody responses to sars-cov-2 vaccines in 45,965 adults from the general population of the united kingdom	wei, j; stoesser, n; matthews, pc; ayoubkhani, d; studley, r; bell, i; bell, ji; newton, jn; farrar, j; diamond, i; rourke, e; howarth, a; marsden, bd; hoosdally, s; jones, ey; stuart, di; crook, dw; peto, tea; pouwels, kb; eyre, dw; walker, as	nature microbiology	2021	10.1038/s41564-021-00947-3	2
1042	effect of delta variant on viral burden and vaccine effectiveness against new sars-cov-2 infections in the uk	pouwels, kb; pritchard, e; matthews, pc; stoesser, n; eyre, dw; vihta, kd; house, t; hay, j; bell, ji; newton, jn; farrar, j; crook, d; cook, d; rourke, e; studley, r; peto, tea; diamond, i; walker, as	nature medicine	2021	10.1038/s41591-021-01548-7	6
1043	impact of sars-cov-2 variants on the total cd4(+) and cd8(+) t cell reactivity in infected or vaccinated individuals	tarke, a; sidney, j; methot, n; yu, ed; zhang, y; dan, jm; goodwin, b; rubiro, p; sutherland, a; wang, e; frazier, a; ramirez, si; rawlings, sa; smith, dm; antunes, rd; peters, b; scheuermann, rh; weiskopf, d; crotty, s; grifoni, a; sette, a	cell reports medicine	2021	10.1016/j.xcrm.2021.100355	3
1044	safety and immunogenicity of seven covid-19 vaccines as a third dose (booster) following two doses of chadox1 ncov-19 or bnt162b2 in the uk (cov-boost): a blinded, multicentre, randomised, controlled, phase 2 trial	munro, aps; janani, l; cornelius, v; aley, pk; babbage, g; baxter, d; bula, m; cathie, k; chatterjee, k; dodd, k; enever, y; gokani, k; goodman, al; green, ca; harndahl, l; haughney, j; hicks, a; van der klaauw, aa; kwok, j; lambe, t; libri, v; llewelyn, mj; mcgregor, ac; minassian, am; moore, p; mughal, m; mujadidi, yf; murira, j; osanlou, o; osanlou, r; owens, dr; pacurar, m; palfreeman, a; pan, d; rampling, t; regan, k; saich, s; salkeld, j; saralaya, d; sharma, s; sheridan, r; sturdy, a; thomson, ec; todd, s; twelves, c; read, rc; charlton, s; hallis, b; ramsay, m; andrews, n; nguyen-van-tam, js; snape, md; liu, xx; faust, sn	lancet	2021		1
1045	expanded access programs, compassionate drug use, and emergency use authorizations during the covid-19 pandemic.	rizk, jg; forthal, dn; kalantar-zadeh, k; mehra, mr; lavie, cj; rizk, y; pfeiffer, jp; lewin, jc	drug discovery today	2021	10.1016/j.drudis.2020.11.025	1
1046	seroconversion rates following covid-19 vaccination among patients with cancer	thakkar, a; gonzalez-lugo, jd; goradia, n; gali, r; shapiro, lc; pradhan, k; rahman, s; kim, sy; ko, b; sica, ra; kornblum, n; bachier-rodriguez, l; mccort, m; goel, s; perez-soler, r; packer, s; sparano, j; gartrell, b; makower, d; goldstein, yd; wolgast, l; verma, a; halmos, b	cancer cell	2021	10.1016/j.ccell.2021.06.002	4
1047	surveillance for adverse events after covid-19 mrna vaccination	klein, np; lewis, n; goddard, k; fireman, b; zerbo, o; hanson, ke; donahue, jg; kharbanda, eo; naleway, a; nelson, jc; xu, s; yih, wk; glanz, jm; williams, jtb; hambidge, sj; lewin, bj; shimabukuro, tt; destefano, f; weintraub, es	jama-journal of the american medical association	2021	10.1001/jama.2021.15072	0
1048	the challenges of containing sars-cov-2 via test-trace-and-isolate	contreras, s; dehning, j; loidolt, m; zierenberg, j; spitzner, fp; urrea-quintero, jh; mohr, sb; wilczek, m; wibral, m; priesemann, v	nature communications	2021	10.1038/s41467-020-20699-8	1
1049	vaccination and non-pharmaceutical interventions for covid-19: a mathematical modelling study	moore, s; hill, em; tildesley, mj; dyson, l; keeling, mj	lancet infectious diseases	2021	10.1016/s1473-3099(21)00143-2	0
1050	novel coronavirus disease 2019 (covid-19) pandemic: from transmission to control with an interdisciplinary vision	anand, u; cabreros, c; mal, j; ballesteros, f; sillanpaa, m; tripathi, v; bontempi, e	environmental research	2021	10.1016/j.envres.2021.111126	0
1051	inactivated trivalent influenza vaccination is associated with lower mortality among patients with covid-19 in brazil	fink, g; orlova-fink, n; schindler, t; grisi, s; ferrer, aps; daubenberger, c; brentani, a	bmj evidence-based medicine	2021	10.1136/bmjebm-2020-111549	0
1052	impact of the covid-19 pandemic on travel behavior in istanbul: a panel data analysis	shakibaei, s; de jong, gc; alpkokin, p; rashidi, th	sustainable cities and society	2021	10.1016/j.scs.2020.102619	0
1053	characterization of sars-cov-2 rna, antibodies, and neutralizing capacity in milk produced by women with covid-19	pace, rm; williams, je; jarvinen, km; belfort, mb; pace, cdw; lackey, ka; gogel, ac; nguyen-contant, p; kanagaiah, p; fitzgerald, t; ferri, r; young, b; rosen-carole, c; diaz, n; meehan, cl; caffe, b; sangster, my; topham, d; mcguire, ma; seppo, a; mcguire, mk	mbio	2021	10.1128/mbio.03192-20	0
1054	subcutaneous regen-cov antibody combination to prevent covid-19	o'brien, mp; forleo-neto, e; musser, bj; isa, f; chan, kc; sarkar, n; bar, kj; barnabas, rv; barouch, dh; cohen, ms; hurt, cb; burwen, dr; marovich, ma; hou, p; heirman, i; davis, jd; turner, kc; ramesh, d; mahmood, a; hooper, at; hamilton, jd; kim, y; purcell, la; baum, a; kyratsous, ca; krainson, j; perez-perez, r; mohseni, r; kowal, b; dicioccio, at; stahl, n; lipsich, l; braunstein, n; herman, g; yancopoulos, gd; weinreich, dm	new england journal of medicine	2021	10.1056/nejmoa2109682	0
1055	herbal immune-boosters: substantial warriors of pandemic covid-19 battle	khanna, k; kohli, sk; kaur, r; bhardwaj, a; bhardwaj, v; ohri, p; sharma, a; ahmad, a; bhardwaj, r; ahmad, p	phytomedicine	2021	10.1016/j.phymed.2020.153361	1
1056	hypothesis: alpha-1-antitrypsin is a promising treatment option for covid-19	bai, xy; hippensteel, j; leavitt, a; maloney, jp; beckham, d; garcia, c; li, q; freed, bm; ordway, d; sandhaus, ra; chan, ed	medical hypotheses	2021	10.1016/j.mehy.2020.110394	1
1057	patients with covid-19: in the dark-nets of neutrophils	ackermann, m; anders, hj; bilyy, r; bowlin, gl; daniel, c; de lorenzo, r; egeblad, m; henneck, t; hidalgo, a; hoffmann, m; hohberger, b; kanthi, y; kaplan, mj; knight, js; knopf, j; kolaczkowska, e; kubes, p; leppkes, m; mahajan, a; manfredi, aa; maueroder, c; maugeri, n; mitroulis, i; munoz, le; narasaraju, t; naschberger, e; neeli, i; ng, lg; radic, mz; ritis, k; rovere-querini, p; schapher, m; schauer, c; simon, hu; singh, j; skendros, p; stark, k; sturzl, m; van der vlag, j; vandenabeele, p; vitkov, l; von kockritz-blickwede, m; yanginlar, c; yousefi, s; zarbock, a; schett, g; herrmann, m	cell death and differentiation	2021	10.1038/s41418-021-00805-z	0
1058	one dose of sars-cov-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic covid-19	levi, r; azzolini, e; pozzi, c; ubaldi, l; lagioia, m; mantovani, a; rescigno, m	journal of clinical investigation	2021	10.1172/jci149154	0
1059	the effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the covid-19 vaccine bnt162b2: a cohort study	mahil, sk; bechman, k; raharja, a; domingo-vila, c; baudry, d; brown, ma; cope, ap; dasandi, t; graham, c; lechmere, t; malim, mh; meynell, f; pollock, e; seow, j; sychowska, k; barker, jn; norton, s; galloway, jb; doores, kj; tree, tim; smith, ch	lancet rheumatology	2021	10.1016/s2665-9913(21)00212-5	1
1060	key considerations on the potential impacts of the covid-19 pandemic on antimicrobial resistance research and surveillance	rodriguez-bano, j; rossolini, gm; schultsz, c; tacconelli, e; murthy, s; ohmagari, n; holmes, a; bachmann, t; goossens, h; canton, r; roberts, ap; henriques-normark, b; clancy, cj; huttner, b; fagerstedt, p; lahiri, s; kaushic, c; hoffman, sj; warren, m; zoubiane, g; essack, s; laxminarayan, r; plant, l	transactions of the royal society of tropical medicine and hygiene	2021	10.1093/trstmh/trab048	0
1061	global minimum estimates of children affected by covid-19-associated orphanhood and deaths of caregivers: a modelling study	hillis, sd; unwin, hjt; chen, y; cluver, l; sherr, l; goldman, ps; ratmann, o; donnelly, ca; bhatt, s; villaveces, a; butchart, a; bachman, g; rawlings, l; green, p; nelson, ca; flaxman, s	lancet	2021	10.1016/s0140-6736(21)01253-8	0
1062	global pandemics interconnected - obesity, impaired metabolic health and covid-19	stefan, n; birkenfeld, al; schulze, mb	nature reviews endocrinology	2021	10.1038/s41574-020-00462-1	0
1063	sars-cov-2 transmission from people without covid-19 symptoms	johansson, ma; quandelacy, tm; kada, s; prasad, pv; steele, m; brooks, jt; slayton, rb; biggerstaff, m; butler, jc	jama network open	2021	10.1001/jamanetworkopen.2020.35057	0
1064	the deregulated immune reaction and cytokines release storm (crs) in covid-19 disease	pasrija, r; naime, m	international immunopharmacology	2021	10.1016/j.intimp.2020.107225	0
1065	did the covid-19 pandemic spark a public interest in pet adoption?	ho, jf; hussain, s; sparagano, o	frontiers in veterinary science	2021	10.3389/fvets.2021.647308	0
1066	tlr9 and covid-19: a multidisciplinary theory of a multifaceted therapeutic target	bezemer, gfg; garssen, j	frontiers in pharmacology	2021	10.3389/fphar.2020.601685	0
1067	use of baricitinib in patients with moderate to severe coronavirus disease 2019	titanji, bk; farley, mm; mehta, a; connor-schuler, r; moanna, a; cribbs, sk; o'shea, j; desilva, k; chan, bn; edwards, a; gavegnano, c; schinazi, rf; marconi, vc	clinical infectious diseases	2021	10.1093/cid/ciaa879	3
1068	covid-19: discovery, diagnostics and drug development	asselah, t; durantel, d; pasmant, e; lau, g; schinazi, rf	journal of hepatology	2021	10.1016/j.jhep.2020.09.031	1
1069	wearable sensing and telehealth technology with potential applications in the coronavirus pandemic	ding, xr; clifton, d; ji, n; lovell, nh; bonato, p; chen, w; yu, xg; xue, z; xiang, t; long, x; xu, k; jiang, xy; wang, q; yin, b; feng, gd; zhang, yt	ieee reviews in biomedical engineering	2021	10.1109/rbme.2020.2992838	0
1070	a deep learning-based social distance monitoring framework for covid-19	ahmed, i; ahmad, m; rodrigues, jjpc; jeon, g; din, s	sustainable cities and society	2021	10.1016/j.scs.2020.102571	0
1071	humoral response to sars-cov-2-vaccination with bnt162b2 (pfizer-biontech) in patients on hemodialysis	jahn, m; korth, j; dorsch, o; anastasiou, oe; sorge-hadicke, b; tyczynski, b; gackler, a; witzke, o; dittmer, u; dolff, s; wilde, b; kribben, a	vaccines	2021	10.3390/vaccines9040360	3
1072	association of sars-cov-2 seropositive antibody test with risk of future infection	harvey, ra; rassen, ja; kabelac, ca; turenne, w; leonard, s; klesh, r; meyer, wa; kaufman, hw; anderson, s; cohen, o; petkov, vi; cronin, ka; van dyke, al; lowy, dr; sharpless, ne; penberthy, lt	jama internal medicine	2021	10.1001/jamainternmed.2021.0366	4
1073	antibody response to sars-cov-2 mrna vaccine among kidney transplant recipients: a prospective cohort study	rozen-zvi, b; yahav, d; agur, t; zingerman, b; ben-zvi, h; atamna, a; tau, n; mashraki, t; nesher, e; rahamimov, r	clinical microbiology and infection	2021	10.1016/j.cmi.2021.04.028	2
1074	haemodialysis patients show a highly diminished antibody response after covid-19 mrna vaccination compared with healthy controls	simon, b; rubey, h; treipl, a; gromann, m; hemedi, b; zehetmayer, s; kirsch, b	nephrology dialysis transplantation	2021	10.1093/ndt/gfab179	3
1075	early humoral responses of hemodialysis patients after covid-19 vaccination with bnt162b2	speer, c; goth, d; benning, l; buylaert, m; schaier, m; grenz, j; nusshag, c; kalble, f; kreysing, m; reichel, p; tollner, m; hidmark, a; ponath, g; schnitzler, p; zeier, m; susal, c; morath, c; klein, k	clinical journal of the american society of nephrology	2021	10.2215/cjn.03700321	4
1076	review of early immune response to sars-cov-2 vaccination among patients with ckd	carr, ej; kronbichler, a; graham-brown, m; abra, g; argyropoulos, c; harper, l; lerma, ev; suri, rs; topf, j; willicombe, m; hiremath, s	kidney international reports	2021	10.1016/j.ekir.2021.06.027	0
1077	frontline healthcare workers' experiences with personal protective equipment during the covid-19 pandemic in the uk: a rapid qualitative appraisal	hoernke, k; djellouli, n; andrews, l; lewis-jackson, s; manby, l; martin, s; vanderslott, s; vindrola-padros, c	bmj open	2021	10.1136/bmjopen-2020-046199	0
1078	phase 1 randomized trial of a plant-derived virus-like particle vaccine for covid-19	ward, bj; gobeil, p; seguin, a; atkins, j; boulay, i; charbonneau, py; couture, m; d'aoust, ma; dhaliwall, j; finkle, c; hager, k; mahmood, a; makarkov, a; cheng, mp; pillet, s; schimke, p; st-martin, s; trepanier, s; landry, n	nature medicine	2021	10.1038/s41591-021-01370-1	0
1079	covid-19: virology, biology and novel laboratory diagnosis	mohamadian, m; chiti, h; shoghli, a; biglari, s; parsamanesh, n; esmaeilzadeh, a	journal of gene medicine	2021	10.1002/jgm.3303	0
1080	guillain-barre syndrome following chadox1-s/ncov-19 vaccine	maramattom, bv; krishnan, p; paul, r; padmanabhan, s; nampoothiri, scv; syed, aa; mangat, hs	annals of neurology	2021	10.1002/ana.26143	0
1081	identification of dominant risk factor involved in spread of covid-19 using hesitant fuzzy mcdm methodology	ghorui, n; ghosh, a; mondal, sp; bajuri, my; ahmadian, a; salahshour, s; ferrara, m	results in physics	2021	10.1016/j.rinp.2020.103811	0
1082	role of favipiravir in the treatment of covid-19	joshi, s; parkar, j; ansari, a; vora, a; talwar, d; tiwaskar, m; patil, s; barkate, h	international journal of infectious diseases	2021	10.1016/j.ijid.2020.10.069	0
1083	computational drug discovery and repurposing for the treatment of covid-19: a systematic review	mohamed, k; yazdanpanah, n; saghazadeh, a; rezaei, n	bioorganic chemistry	2021	10.1016/j.bioorg.2020.104490	0
1084	the panic buying behavior of consumers during the covid-19 pandemic: examining the influences of uncertainty, perceptions of severity, perceptions of scarcity, and anxiety	omar, na; nazri, ma; ali, mh; alam, ss	journal of retailing and consumer services	2021	10.1016/j.jretconser.2021.102600	0
1085	mathematical modeling of the covid-19 pandemic with intervention strategies	khajanchi, s; sarkar, k; mondal, j; nisar, ks; abdelwahab, sf	results in physics	2021	10.1016/j.rinp.2021.104285	0
1086	targets and strategies for vaccine development against sars-cov-2	malik, ja; mulla, ah; farooqi, t; pottoo, fh; anwar, s; rengasamy, krr	biomedicine & pharmacotherapy	2021	10.1016/j.biopha.2021.111254	0
1087	tracking covid-19 discourse on twitter in north america: infodemiology study using topic modeling and aspect-based sentiment analysis	jang, hj; rempel, e; roth, d; carenini, g; janjua, nz	journal of medical internet research	2021	10.2196/25431	0
1088	unlocking the surge in demand for personal and protective equipment (ppe) and improvised face coverings arising from coronavirus disease (covid-19) pandemic - implications for efficacy, re-use and sustainable waste management	rowan, nj; laffey, jg	science of the total environment	2021	10.1016/j.scitotenv.2020.142259	0
1089	virtual screening and molecular dynamics simulation study of plant-derived compounds to identify potential inhibitors of main protease from sars-cov-2	mahmud, s; uddin, ma; paul, gk; shimu, mss; islam, s; rahman, e; islam, a; islam, ms; promi, mm; bin emran, t; abu saleh, m	briefings in bioinformatics	2021	10.1093/bib/bbaa428	1
1090	a review on plant bioactive compounds and their modes of action against coronavirus infection	remali, j; aizat, wm	frontiers in pharmacology	2021	10.3389/fphar.2020.589044	1
1091	sars-cov-2 infection in farmed minks, associated zoonotic concerns, and importance of the one health approach during the ongoing covid-19 pandemic	sharun, k; tiwari, r; natesan, s; dhama, k	veterinary quarterly	2021	10.1080/01652176.2020.1867776	1
1092	diverse immunological factors influencing pathogenesis in patients with covid-19: a review on viral dissemination, immunotherapeutic options to counter cytokine storm and inflammatory responses	rabaan, aa; al-ahmed, sh; garout, ma; al-qaaneh, am; sule, aa; tirupathi, r; mutair, aa; alhumaid, s; hasan, a; dhawan, m; tiwari, r; sharun, k; mohapatra, rk; mitra, s; emran, tb; bilal, m; singh, r; alyami, sa; moni, ma; dhama, k	pathogens	2021	10.3390/pathogens10050565	0
1093	applications of artificial intelligence in battling against covid-19: a literature review	tayarani, nmh	chaos solitons & fractals	2021	10.1016/j.chaos.2020.110338	0
1094	single-dose bnt162b2 vaccine protects against asymptomatic sars-cov-2 infection	jones, nk; rivett, l; seaman, s; samworth, rj; warne, b; workman, c; ferris, m; wright, j; quinnell, n; shaw, a; goodfellow, ig; lehner, pj; howes, r; wright, g; matheson, nj; weekes, mp	elife	2021	10.7554/elife.68808	0
1095	who should be prioritized for covid-19 vaccination in china? a descriptive study	yang, j; zheng, w; shi, hl; yan, xm; dong, kg; you, q; zhong, gj; gong, h; chen, zy; jit, m; viboud, c; ajelli, m; yu, hj	bmc medicine	2021	10.1186/s12916-021-01923-8	1
1096	quantitative analysis of sars-cov-2 rna from wastewater solids in communities with low covid-19 incidence and prevalence	d'aoust, pm; mercier, e; montpetit, d; jia, jj; alexandrov, i; neault, n; baig, at; mayne, j; zhang, x; alain, t; langlois, ma; servos, mr; mackenzie, m; figeys, d; mackenzie, ae; graber, te; delatolla, r	water research	2021	10.1016/j.watres.2020.116560	1
1097	american college of rheumatology guidance for covid-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 2	curtis, jr; johnson, sr; anthony, dd; arasaratnam, rj; baden, lr; bass, ar; calabrese, c; gravallese, em; harpaz, r; kroger, a; sadun, re; turner, as; williams, ea; mikuls, tr	arthritis & rheumatology	2021	10.1002/art.41877	1
1098	compact development and adherence to stay-at-home order during the covid-19 pandemic: a longitudinal investigation in the united states	hamidi, s; zandiatashbar, a	landscape and urban planning	2021	10.1016/j.landurbplan.2020.103952	0
1099	american college of rheumatology guidance for covid-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 3	curtis, jr; johnson, sr; anthony, dd; arasaratnam, rj; baden, lr; bass, ar; calabrese, c; gravallese, em; harpaz, r; kroger, a; sadun, re; turner, as; williams, ea; mikuls, tr	arthritis & rheumatology	2021	10.1002/art.41928	1
1100	mrna vaccine for cancer immunotherapy	miao, l; zhang, y; huang, l	molecular cancer	2021	10.1186/s12943-021-01335-5	0
1101	evaluation of mrna-1273 sars-cov-2 vaccine in adolescents	ali, k; berman, g; zhou, hh; deng, wp; faughnan, v; coronado-voges, m; ding, by; dooley, j; girard, b; hillebrand, w; pajon, r; miller, jm; leav, b; mcphee, r	new england journal of medicine	2021	10.1056/nejmoa2109522	1
1102	efficacy of the mrna-1273 sars-cov-2 vaccine at completion of blinded phase	el sahly, hm; baden, lr; essink, b; doblecki-lewis, s; martin, jm; anderson, ej; campbell, tb; clark, j; jackson, la; fichtenbaum, cj; zervos, m; rankin, b; eder, f; feldman, g; kennelly, c; han-conrad, l; levin, m; neuzil, km; corey, l; gilbert, p; janes, h; follmann, d; marovich, m; polakowski, l; mascola, jr; ledgerwood, je; graham, bs; august, a; clouting, h; deng, w; han, s; leav, b; manzo, d; pajon, r; schodel, f; tomassini, je; zhou, h; miller, j	new england journal of medicine	2021	10.1056/nejmoa2113017	1
1103	comparison of the characteristics, morbidity, and mortality of covid-19 and seasonal influenza: a nationwide, population-based retrospective cohort study	piroth, l; cottenet, j; mariet, as; bonniaud, p; blot, m; tubert-bitter, p; quantin, c	lancet respiratory medicine	2021	10.1016/s2213-2600(20)30527-0	1
1104	bamlanivimab plus etesevimab in mild or moderate covid-19	dougan, m; nirula, a; azizad, m; mocherla, b; gottlieb, rl; chen, p; hebert, c; perry, r; boscia, j; heller, b; morris, j; crystal, c; igbinadolor, a; huhn, g; cardona, j; shawa, i; kumar, p; adams, ac; van naarden, j; custer, kl; durante, m; oakley, g; schade, ae; holzer, tr; ebert, pj; higgs, re; kallewaard, nl; sabo, j; patel, dr; dabora, mc; klekotka, p; shen, l; skovronsky, dm	new england journal of medicine	2021	10.1056/nejmoa2102685	0
1105	covid-deepnet: hybrid multimodal deep learning system for improving covid-19 pneumonia detection in chest x-ray images	al-waisy, as; mohammed, ma; al-fandawi, s; maashi, ms; garcia-zapirain, b; abdulkareem, kh; mostafa, sa; kumar, nm; le, dn	cmc-computers materials & continua	2021	10.32604/cmc.2021.012955	0
1106	sars-cov-2 variants, spike mutations and immune escape	harvey, wt; carabelli, am; jackson, b; gupta, rk; thomson, ec; harrison, em; ludden, c; reeve, r; rambaut, a; peacock, sj; robertson, dl	nature reviews microbiology	2021	10.1038/s41579-021-00573-0	6
1107	the sars-coronavirus infection cycle: a survey of viral membrane proteins, their functional interactions and pathogenesis	wong, na; saier, mh	international journal of molecular sciences	2021	10.3390/ijms22031308	1
1108	sars-cov-2 infection: new molecular, phylogenetic, and pathogenetic insights. efficacy of current vaccines and the potential risk of variants	rotondo, jc; martini, f; maritati, m; mazziotta, c; di mauro, g; lanzillotti, c; barp, n; gallerani, a; tognon, m; contini, c	viruses-basel	2021	10.3390/v13091687	0
1109	willingness to vaccinate against covid-19 in the us: representative longitudinal evidence from april to october 2020	daly, m; robinson, e	american journal of preventive medicine	2021	10.1016/j.amepre.2021.01.008	0
1110	covid-19 in early 2021: current status and looking forward	wang, cd; wang, zf; wang, gy; lau, jyn; zhang, k; li, wm	signal transduction and targeted therapy	2021	10.1038/s41392-021-00527-1	0
1111	disease-modifying therapies and sars-cov-2 vaccination in multiple sclerosis: an expert consensus	centonze, d; rocca, ma; gasperini, c; kappos, l; hartung, hp; magyari, m; oreja-guevara, c; trojano, m; wiendl, h; filippi, m	journal of neurology	2021	10.1007/s00415-021-10545-2	0
1112	association of ocular adverse events with inactivated covid-19 vaccination in patients in abu dhabi	pichi, f; aljneibi, s; neri, p; hay, s; dackiw, c; ghazi, ng	jama ophthalmology	2021	10.1001/jamaophthalmol.2021.3477	0
1113	ccr5 inhibition in critical covid-19 patients decreases in fl ammatory cytokines, increases cd8 t-cells, and decreases sars-cov2 rna in plasma by day 14	patterson, bk; seethamraju, h; dhody, k; corley, mj; kazempour, k; lalezari, j; pang, aps; sugai, c; mahyari, e; francisco, eb; pise, a; rodrigues, h; wu, hl; webb, gm; park, bs; kelly, s; pourhassan, n; lelic, a; kdouh, l; herrera, m; hall, e; bimber, bn; plassmeyer, m; gupta, r; alpan, o; o'halloran, ja; mudd, pa; akalin, e; ndhlovu, lc; sacha, jb	international journal of infectious diseases	2021	10.1016/j.ijid.2020.10.101	0
1114	identifying the natural polyphenol catechin as a multi-targeted agent against sars-cov-2 for the plausible therapy of covid-19: an integrated computational approach	mishra, cb; pandey, p; sharma, rd; malik, mz; mongre, rk; lynn, am; prasad, r; jeon, r; prakash, a	briefings in bioinformatics	2021	10.1093/bib/bbaa378	0
1115	covid-19 vaccine efficacy in patients with chronic lymphocytic leukemia	roeker, le; knorr, da; thompson, mc; nivar, m; lebowitz, s; peters, n; deonarine, i; momotaj, s; sharan, s; chanlatte, v; hampton, b; butala, l; amato, l; richford, a; lunkenheimer, j; battiato, k; laudati, c; mato, ar	leukemia	2021	10.1038/s41375-021-01270-w	1
1116	antibody responses after first and second covid-19 vaccination in patients with chronic lymphocytic leukaemia	parry, h; mcilroy, g; bruton, r; ali, m; stephens, c; damery, s; otter, a; mcskeane, t; rolfe, h; faustini, s; wall, n; hillmen, p; pratt, g; paneesha, s; zuo, j; richter, a; moss, p	blood cancer journal	2021	10.1038/s41408-021-00528-x	3
1117	trust predicts covid-19 prescribed and discretionary behavioral intentions in 23 countries	pagliaro, s; sacchi, s; pacilli, mg; brambilla, m; lionetti, f; bettache, k; bianchi, m; biella, m; bonnot, v; boza, m; butera, f; ceylan-batur, s; chong, k; chopova, t; crimston, cr; alvarez, b; cuadrado, i; ellemers, n; formanowicz, m; graupmann, v; gkinopoulos, t; jeong, ehk; jasinskaja-lahti, i; jetten, j; bin, km; mao, yh; mccoy, c; mehnaz, f; minescu, a; sirlopu, d; simic, a; travaglino, g; uskul, ak; zanetti, c; zinn, a; zubieta, e	plos one	2021	10.1371/journal.pone.0248334	0
1118	dose-dependent response to infection with sars-cov-2 in the ferret model and evidence of protective immunity	ryan, ka; bewley, kr; fotheringham, sa; slack, gs; brown, p; hall, y; wand, ni; marriott, ac; cavell, be; tree, ja; allen, l; aram, mj; bean, tj; brunt, e; buttigieg, kr; carter, dp; cobb, r; coombes, ns; findlay-wilson, sj; godwin, kj; gooch, ke; gouriet, j; halkerston, r; harris, dj; hender, th; humphries, he; hunter, l; ho, cmk; kennard, cl; leung, s; longet, s; ngabo, d; osman, kl; paterson, j; penn, ej; pullan, st; rayner, e; skinner, o; steeds, k; taylor, i; tipton, t; thomas, s; turner, c; watson, rj; wiblin, nr; charlton, s; hallis, b; hiscox, ja; funnell, s; dennis, mj; whittaker, cj; catton, mg; druce, j; salguero, fj; carroll, mw	nature communications	2021	10.1038/s41467-020-20439-y	3
1119	comparison of rhesus and cynomolgus macaques as an infection model for covid-19	salguero, fj; white, ad; slack, gs; fotheringham, sa; bewley, kr; gooch, ke; longet, s; humphries, he; watson, rj; hunter, l; ryan, ka; hall, y; sibley, l; sarfas, c; allen, l; aram, m; brunt, e; brown, p; buttigieg, kr; cavell, be; cobb, r; coombes, ns; darby, a; daykin-pont, o; elmore, mj; garcia-dorival, i; gkolfinos, k; godwin, kj; gouriet, j; halkerston, r; harris, dj; hender, t; ho, cmk; kennard, cl; knott, d; leung, s; lucas, v; mabbutt, a; morrison, al; nelson, c; ngabo, d; paterson, j; penn, ej; pullan, s; taylor, i; tipton, t; thomas, s; tree, ja; turner, c; vamos, e; wand, n; wiblin, nr; charlton, s; dong, xf; hallis, b; pearson, g; rayner, el; nicholson, ag; funnell, sg; hiscox, ja; dennis, mj; gleeson, fv; sharpe, s; carroll, mw	nature communications	2021	10.1038/s41467-021-21389-9	0
1120	impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the bnt162b2 mrna covid-19 vaccine: real-world evidence from healthcare workers, israel, december 2020 to january 2021	abu jabal, k; ben-amram, h; beiruti, k; batheesh, y; sussan, c; zarka, s; edelstein, m	eurosurveillance	2021	10.2807/1560-7917.es.2021.26.6.2100096	0
1121	covid-19: current understanding of its pathophysiology, clinical presentation and treatment	parasher, a	postgraduate medical journal	2021	10.1136/postgradmedj-2020-138577	0
1122	hospital pharmacists' pharmaceutical care for hospitalized patients with covid-19: recommendations and guidance from clinical experience	song, zw; hu, y; zheng, sq; yang, l; zhao, rs	research in social & administrative pharmacy	2021	10.1016/j.sapharm.2020.03.027	0
1123	modeling vaccination rollouts, sars-cov-2 variants and the requirement for non-pharmaceutical interventions in italy	giordano, g; colaneri, m; di filippo, a; blanchini, f; bolzern, p; de nicolao, g; sacchi, p; colaneri, p; bruno, r	nature medicine	2021	10.1038/s41591-021-01334-5	1
1124	integrated vaccination and physical distancing interventions to prevent future covid-19 waves in chinese cities	huang, b; wang, jh; cai, jx; yao, sq; chan, pks; tam, thw; hong, yy; ruktanonchai, cw; carioli, a; floyd, jr; ruktanonchai, nw; yang, wz; li, zj; tatem, aj; lai, sj	nature human behaviour	2021	10.1038/s41562-021-01063-2	1
1125	despite vaccination, china needs non-pharmaceutical interventions to prevent widespread outbreaks of covid-19 in 2021	yang, j; marziano, v; deng, xw; guzzetta, g; zhang, jj; trentini, f; cai, j; poletti, p; zheng, w; wang, w; wu, qh; zhao, zy; dong, kg; zhong, gj; viboud, c; merler, s; ajelli, m; yu, hj	nature human behaviour	2021	10.1038/s41562-021-01155-z	0
1126	a meta-analysis: the mortality and severity of covid-19 among patients with mental disorders	toubasi, aa; abuanzeh, rb; abu tawileh, hb; aldebei, rh; alryalat, sas	psychiatry research	2021	10.1016/j.psychres.2021.113856	0
1127	a novel covid-19 model with fractional differential operators with singular and non-singular kernels: analysis and numerical scheme based on newton polynomial	atangana, a; araz, si	alexandria engineering journal	2021	10.1016/j.aej.2021.02.016	0
1128	attitudes of healthcare workers towards covid-19 vaccination: a survey in france and french-speaking parts of belgium and canada, 2020	verger, p; scronias, d; dauby, n; adedzi, ka; gobert, c; bergeat, m; gagneur, a; dube, e	eurosurveillance	2021	10.2807/1560-7917.es.2021.26.3.2002047	0
1129	evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill covid-19 patients: an exploratory clinical trial	xu, xw; jiang, wl; chen, lj; xu, zy; zhang, q; zhu, mf; ye, p; li, h; yu, l; zhou, xy; zhou, cl; chen, xb; zheng, xq; xu, kj; cai, hl; zheng, sf; jiang, wb; wu, xj; li, d; chen, l; luo, qq; wang, yy; qu, jj; li, yf; zheng, wd; jiang, yg; tang, ll; xiang, c; li, lj	clinical and translational medicine	2021	10.1002/ctm2.297	0
1130	unilateral lymphadenopathy after covid-19 vaccination: a practical management plan for radiologists across specialties	lehman, cd; d'alessandro, ha; mendoza, dp; succi, md; kambadakone, a; lamb, lr	journal of the american college of radiology	2021	10.1016/j.jacr.2021.03.001	0
1131	sars-cov-2 infection, covid-19 and timing of elective surgery a multidisciplinary consensus statement on behalf of the association of anaesthetists, the centre for peri-operative care, the federation of surgical specialty associations, the royal college of anaesthetists and the royal college of surgeons of england	el-boghdadly, k; cook, tm; goodacre, t; kua, j; blake, l; denmark, s; mcnally, s; mercer, n; moonesinghe, sr; summerton, dj	anaesthesia	2021	10.1111/anae.15464	0
1132	one year of sars-cov-2: how much has the virus changed?	vilar, s; isom, dg	biology-basel	2021	10.3390/biology10020091	1
1133	neutralising antibody escape of sars-cov-2 spike protein: risk assessment for antibody-based covid-19 therapeutics and vaccines	focosi, d; maggi, f	reviews in medical virology	2021	10.1002/rmv.2231	0
1134	the origins and potential future of sars-cov-2 variants of concern in the evolving covid-19 pandemic	otto, sp; day, t; arino, j; colijn, c; dushoff, j; li, mc; mechai, s; van domselaar, g; wu, jh; earn, djd; ogden, nh	current biology	2021	10.1016/j.cub.2021.06.049	0
1135	sars-cov-2 genomics: an indian perspective on sequencing viral variants	srivastava, s; banu, s; singh, p; sowpati, dt; mishra, rk	journal of biosciences	2021	10.1007/s12038-021-00145-7	0
1136	antibody development after covid-19 vaccination in patients with autoimmune diseases in the netherlands: a substudy of data from two prospective cohort studies	boekel, l; steenhuis, m; hooijberg, f; besten, yr; van kempen, zle; kummer, ly; van dam, kpj; stalman, ew; vogelzang, eh; cristianawati, o; keijzer, s; vidarsson, g; voskuyl, ae; wieske, l; eftimov, f; van vollenhoven, r; kuijpers, tw; van ham, sm; tas, sw; killestein, j; boers, m; nurmohamed, mt; rispens, t; wolbink, g	lancet rheumatology	2021	10.1016/s2665-9913(21)00222-8	2
1137	covid-19 cg enables sars-cov-2 mutation and lineage tracking by locations and dates of interest	chen, at; altschuler, k; zhan, sh; chan, ya; deverman, be	elife	2021	10.7554/elife.63409	0
1138	optimal covid-19 quarantine and testing strategies	wells, cr; townsend, jp; pandey, a; moghadas, sm; krieger, g; singer, b; mcdonald, rh; fitzpatrick, mc; galvani, ap	nature communications	2021	10.1038/s41467-020-20742-8	0
1139	the risk of allergic reaction to sars-cov-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, grade assessment, and international consensus approach	greenhawt, m; abrams, em; shaker, m; chu, dk; khan, d; akin, c; alqurashi, w; arkwright, p; baldwin, jl; ben-shoshan, m; bernstein, j; bingemann, t; blumchen, k; byrne, a; bognanni, a; campbell, d; campbell, r; chagla, z; chan, eds; chan, jf; comberiati, p; dribin, te; ellis, ak; fleischer, dm; fox, a; frischmeyer-guerrerio, pa; gagnon, r; grayson, mh; horner, cc; hourihane, j; katelaris, ch; kim, h; kelso, jm; lang, dv; ledford, d; levin, m; lieberman, j; loh, r; mack, d; mazer, b; mosnaim, g; munblit, d; mustafa, ss; nanda, a; oppenheimer, j; perrett, kp; ramsey, a; rank, m; robertson, k; sheikh, j; spergel, jm; stukus, d; tang, mlk; tracy, jm; turner, pj; whalen-browne, a; wallace, d; wang, jl; waserman, s; witry, jk; worm, m; vander leek, tk; golden, dbk	journal of allergy and clinical immunology-in practice	2021	10.1016/j.jaip.2021.06.006	0
1140	poor humoral and t-cell response to two-dose sars-cov-2 messenger rna vaccine bnt162b2 in cardiothoracic transplant recipients	schramm, r; costard-jackle, a; rivinius, r; fischer, b; muller, b; boeken, u; haneya, a; provaznik, z; knabbe, c; gummert, j	clinical research in cardiology	2021	10.1007/s00392-021-01880-5	2
1141	an oral sars-cov-2 m-pro inhibitor clinical candidate for the treatment of covid-19	owen, dr; allerton, cmn; anderson, as; aschenbrenner, l; avery, m; berritt, s; boras, b; cardin, rd; carlo, a; coffman, kj; dantonio, a; di, l; eng, h; ferre, r; gajiwala, ks; gibson, sa; greasley, se; hurst, bl; kadar, ep; kalgutkar, as; lee, jc; lee, j; liu, w; mason, sw; noell, s; novak, jj; obach, rs; ogilvie, k; patel, nc; pettersson, m; rai, dk; reese, mr; sammons, mf; sathish, jg; singh, rsp; steppan, cm; stewart, a; tuttle, jb; updyke, l; verhoest, pr; wei, lq; yang, qy; zhu, ya	science	2021	10.1126/science.abl4784	0
1142	epidemiology and outcomes of covid-19 in hiv-infected individuals: a systematic review and meta-analysis	ssentongo, p; heilbrunn, es; ssentongo, ae; advani, s; chinchilli, vm; nunez, jj; du, p	scientific reports	2021	10.1038/s41598-021-85359-3	1
1143	extracorporeal blood purification and organ support in the critically ill patient during covid-19 pandemic: expert review and recommendation	ronco, c; bagshaw, sm; bellomo, r; clark, wr; husain-syed, f; kellum, ja; ricci, z; rimmel, t; reis, t; ostermann, m	blood purification	2021	10.1159/000508125	0
1144	immunogenicity of the bnt162b2 covid-19 mrna vaccine and early clinical outcomes in patients with haematological malignancies in lithuania: a national prospective cohort study	maneikis, k; sablauskas, k; ringeleviciute, u; vaitekenaite, v; cekauskiene, r; kryzauskaite, l; naumovas, d; banys, v; peceliunas, v; beinortas, t; griskevicius, l	lancet haematology	2021	10.1016/s2352-3026(21)00169-1	3
1145	initial observations on age, gender, bmi and hypertension in antibody responses to sars-cov-2 bnt162b2 vaccine	pellini, r; venuti, a; pimpinelli, f; abril, e; blandino, g; campo, f; conti, l; de virgilio, a; de marco, f; di domenico, eg; di bella, o; di martino, s; ensoli, f; giannarelli, d; mandoj, c; manciocco, v; marchesi, p; mazzola, f; moretto, s; petruzzi, g; petrone, f; pichi, b; pontone, m; zocchi, j; vidiri, a; vujovic, b; piaggio, g; morrone, a; ciliberto, g	eclinicalmedicine	2021	10.1016/j.eclinm.2021.100928	0
1146	mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (vitt) compared to natural sars-cov-2 infection	mcgonagle, d; de marco, g; bridgewood, c	journal of autoimmunity	2021	10.1016/j.jaut.2021.102662	0
1147	epitope-resolved profiling of the sars-cov-2 antibody response identifies cross-reactivity with endemic human coronaviruses	ladner, jt; henson, sn; boyle, as; engelbrektson, al; fink, zw; rahee, f; d'ambrozio, j; schaecher, ke; stone, m; dong, wj; dadwal, s; yu, jh; caligiuri, ma; cieplak, p; bjoras, m; fenstad, mh; nordbo, sa; kainov, de; muranaka, n; chee, ms; shiryaev, sa; altin, ja	cell reports medicine	2021	10.1016/j.xcrm.2020.100189	1
1148	humoral signatures of protective and pathological sars-cov-2 infection in children	bartsch, yc; wang, cq; zohar, t; fischinger, s; atyeo, c; burke, js; kang, j; edlow, ag; fasano, a; baden, lr; nilles, ej; woolley, ae; karlson, ew; hopke, ar; irimia, d; fischer, es; ryan, et; charles, rc; julg, bd; lauffenburger, da; yonker, lm; alter, g	nature medicine	2021	10.1038/s41591-021-01263-3	1
1149	after the pandemic: perspectives on the future trajectory of covid-19	telenti, a; arvin, a; corey, l; corti, d; diamond, ms; garcia-sastre, a; garry, rf; holmes, ec; pang, ps; virgin, hw	nature	2021	10.1038/s41586-021-03792-w	0
1150	sleeping under the waves: a longitudinal study across the contagion peaks of the covid-19 pandemic in italy	salfi, f; d'atri, a; tempesta, d; ferrara, m	journal of sleep research	2021	10.1111/jsr.13313	0
1151	the impact of contact tracing and household bubbles on deconfinement strategies for covid-19	willem, l; abrams, s; libin, pjk; coletti, p; kuylen, e; petrof, o; mogelmose, s; wambua, j; herzog, sa; faes, c; beutels, p; hens, n	nature communications	2021	10.1038/s41467-021-21747-7	0
1152	sars-cov-2 501y.v2 escapes neutralization by south african covid-19 donor plasma	wibmer, ck; ayres, f; hermanus, t; madzivhandila, m; kgagudi, p; oosthuysen, b; lambson, be; de oliveira, t; vermeulen, m; van der berg, k; rossouw, t; boswell, m; ueckermann, v; meiring, s; von gottberg, a; cohen, c; morris, l; bhiman, jn; moore, pl	nature medicine	2021	10.1038/s41591-021-01285-x	0
1153	prospect of biobased antiviral face mask to limit the coronavirus outbreak	chowdhury, ma; shuvho, mba; shahid, ma; haque, akmm; kashem, ma; lam, ss; ong, hc; uddin, ma; mofijur, m	environmental research	2021	10.1016/j.envres.2020.110294	1
1154	impact of covid-19 on the social, economic, environmental and energy domains: lessons learnt from a global pandemic	mofijur, m; fattah, imr; alam, ma; islam, abms; ong, hc; rahman, sma; najafi, g; ahmed, sf; uddin, ma; mahlia, tmi	sustainable production and consumption	2021	10.1016/j.spc.2020.10.016	1
1155	saverunner: a network-based algorithm for drug repurposing and its application to covid-19	fiscon, g; conte, f; farina, l; paci, p	plos computational biology	2021	10.1371/journal.pcbi.1008686	0
1156	social media exposure, risk perception, preventive behaviors and attitudes during the covid-19 epidemic in la paz, bolivia: a cross sectional study	rivas, drz; jaldin, mll; canaviri, bn; escalante, lfp; fernandez, amca; ticona, jpa	plos one	2021	10.1371/journal.pone.0245859	0
1157	urgent lessons from covid-19: why the world needs a standing, coordinated system and sustainable financing for global research and development	lurie, n; keusch, gt; dzau, vj	lancet	2021	10.1016/s0140-6736(21)00503-1	0
1158	mass spectrometry analysis of newly emerging coronavirus hcov-19 spike protein and human ace2 reveals camouflaging glycans and unique post-translational modifications	sun, zy; ren, ky; zhang, x; chen, jh; jiang, zy; jiang, j; ji, fy; ouyang, xx; li, lj	engineering	2021	10.1016/j.eng.2020.07.014	1
1159	genetic comparison among various coronavirus strains for the identification of potential vaccine targets of sars-cov2	kaur, n; singh, r; dar, z; bijarnia, rk; dhingra, n; kaur, t	infection genetics and evolution	2021	10.1016/j.meegid.2020.104490	0
1160	repurposing existing drugs for the treatment of covid-19/sars-cov-2 infection: a review describing drug mechanisms of action	yousefi, h; mashouri, l; okpechi, sc; alahari, n; alahari, sk	biochemical pharmacology	2021	10.1016/j.bcp.2020.114296	0
1161	antibody titres decline 3-month post-vaccination with bnt162b2	favresse, j; bayart, jl; mullier, f; elsen, m; eucher, c; van eeckhoudt, s; roy, t; wieers, g; laurent, c; dogne, jm; closset, m; douxfils, j	emerging microbes & infections	2021	10.1080/22221751.2021.1953403	0
1162	medical disinformation and the unviable nature of covid-19 conspiracy theories	grimes, dr	plos one	2021	10.1371/journal.pone.0245900	0
1163	a comparative analysis of sars-cov-2 antivirals characterizes 3cl(pro) inhibitor pf-00835231 as a potential new treatment for covid-19	de vries, m; mohamed, as; prescott, ra; valero-jimenez, am; desvignes, l; o'connor, r; steppan, c; devlin, jc; ivanova, e; herrera, a; schinlever, a; loose, p; ruggles, k; koralov, sb; anderson, as; binder, j; dittmann, m	journal of virology	2021	10.1128/jvi.01819-20	0
1164	analysis of sars-cov-2 antibodies in covid-19 convalescent blood using a coronavirus antigen microarray	de assis, rr; jain, a; nakajima, r; jasinskas, a; felgner, j; obiero, jm; norris, pj; stone, m; simmons, g; bagri, a; irsch, j; schreiber, m; buser, a; holbro, a; battegay, m; hosimer, p; noesen, c; adenaiye, o; tai, s; hong, f; milton, dk; davies, dh; contestable, p; corash, lm; busch, mp; felgner, pl; khan, s	nature communications	2021	10.1038/s41467-020-20095-2	0
1165	role of structural and non-structural proteins and therapeutic targets of sars-cov-2 for covid-19	yadav, r; chaudhary, jk; jain, n; chaudhary, pk; khanra, s; dhamija, p; sharma, a; kumar, a; handu, s	cells	2021	10.3390/cells10040821	0
1166	a plasmid dna-launched sars-cov-2 reverse genetics system and coronavirus toolkit for covid-19 research	rihn, sj; merits, a; bakshi, s; turnbull, ml; wickenhagen, a; alexander, ajt; baillie, c; brennan, b; brown, f; brunker, k; bryden, sr; burness, ka; carmichael, s; cole, sj; cowton, vm; davies, p; davis, c; de lorenzo, g; donald, cl; dorward, m; dunlop, ji; elliott, m; fares, m; filipe, ad; freitas, jr; furnon, w; gestuveo, rj; geyer, a; giesel, d; goldfarb, dm; goodman, n; gunson, r; hastie, cj; herder, v; hughes, j; johnson, c; johnson, n; kohl, a; kerr, k; leech, h; lello, ls; li, k; lieber, g; liu, x; lingala, r; loney, c; mair, d; mcelwee, mj; mcfarlane, s; nichols, j; nomikou, k; orr, a; orton, rj; palmarini, m; parr, ya; pinto, rm; raggett, s; reid, e; robertson, dl; royle, j; cameron-ruiz, n; shepherd, jg; smollett, k; stewart, dg; stewart, m; sugrue, e; szemiel, am; taggart, a; thomson, ec; tong, l; torrie, ls; toth, r; varjak, m; wang, sn; wilkinson, sg; wyatt, pg; zusinaite, e; alessi, dr; patel, ah; zaid, a; wilson, sj; mahalingam, s	plos biology	2021	10.1371/journal.pbio.3001091	0
1167	neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses	saunders, ko; lee, e; parks, r; martinez, dr; li, dp; chen, hy; edwards, rj; gobeil, s; barr, m; mansouri, k; alam, sm; sutherland, ll; cai, fp; sanzone, am; berry, m; manne, k; bock, kw; minai, m; nagata, bm; kapingidza, ab; azoitei, m; tse, lv; scobey, td; spreng, rl; rountree, rw; demarco, ct; denny, tn; woods, cw; petzold, ew; tang, jj; oguin, th; sempowski, gd; gagne, m; douek, dc; tomai, ma; fox, cb; seder, r; wiehe, k; weissman, d; pardi, n; golding, h; khurana, s; acharya, p; andersen, h; lewis, mg; moore, in; montefiori, dc; baric, rs; haynes, bf	nature	2021	10.1038/s41586-021-03594-0	1
1168	mrna vaccines for infectious diseases: principles, delivery and clinical translation	chaudhary, n; weissman, d; whitehead, ka	nature reviews drug discovery	2021	10.1038/s41573-021-00283-5	0
1169	hesitation and refusal factors in individuals' decision-making processes regarding a coronavirus disease 2019 vaccination	cerda, aa; garcia, ly	frontiers in public health	2021	10.3389/fpubh.2021.626852	0
1170	nanomedicine for the sars-cov-2: state-of-the-art and future prospects	varahachalam, sp; lahooti, b; chamaneh, m; bagchi, s; chhibber, t; morris, k; bolanos, jf; kim, ny; kaushik, a	international journal of nanomedicine	2021	10.2147/ijn.s283686	0
1171	risk of thrombocytopenia and thromboembolism after covid-19 vaccination and sars-cov-2 positive testing: self-controlled case series study	hippisley-cox, j; patone, m; mei, xw; saatci, d; dixon, s; khunti, k; zaccardi, f; watkinson, p; shankar-hari, m; doidge, j; harrison, da; griffin, sj; sheikh, a; coupland, cac	bmj-british medical journal	2021	10.1136/bmj.n1931	0
1172	waning immunity after the bnt162b2 vaccine in israel	goldberg, y; mandel, m; bar-on, ym; bodenheimer, o; freedman, l; haas, ej; milo, r; alroy-preis, s; ash, n; huppert, a	new england journal of medicine	2021	10.1056/nejmoa2114228	1
1173	rapid development of sars-cov-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates	kang, yf; sun, c; zhuang, z; yuan, ry; zheng, qb; li, jp; zhou, pp; chen, xc; liu, z; zhang, x; yu, xh; kong, xw; zhu, qy; zhong, q; xu, m; zhong, ns; zeng, yx; feng, gk; ke, cw; zhao, jc; zeng, ms	acs nano	2021	10.1021/acsnano.0c08379	0
1174	face masks and nanotechnology: keep the blue side up	palmieri, v; de maio, f; de spirito, m; papi, m	nano today	2021	10.1016/j.nantod.2021.101077	0
1175	effectiveness of covid-19 vaccines in preventing hospitalization among adults aged >= 65 years - covid-net, 13 states, february-april 2021	moline, hl; whitaker, m; deng, l; rhodes, jc; milucky, j; pham, h; patel, k; anglin, o; reingold, a; chai, sj; alden, nb; kawasaki, b; meek, j; yousey-hindes, k; anderson, ej; farley, mm; ryan, pa; kim, s; nunez, vt; como-sabetti, k; lynfield, r; sosin, dm; mcmullen, c; muse, a; barney, g; bennett, nm; bushey, s; shiltz, j; sutton, m; abdullah, n; talbot, hk; schaffner, w; chatelain, r; ortega, j; murthy, bp; zell, e; schrag, sj; taylor, c; shang, n; verani, jr; havers, fp	mmwr-morbidity and mortality weekly report	2021		0
1176	clinical evaluation of the abbott alinity sars-cov-2 spike-specific quantitative igg and igm assays among infected, recovered, and vaccinated groups	narasimhan, m; mahimainathan, l; araj, e; clark, ae; markantonis, j; green, a; xu, j; sorelle, ja; alexis, c; fankhauser, k; parikh, h; wilkinson, k; reczek, a; kopplin, n; yekkaluri, s; balani, j; thomas, a; singal, ag; sarode, r; muthukumar, a	journal of clinical microbiology	2021	10.1128/jcm.00388-21	0
1177	use of covid-19 vaccines after reports of adverse events among adult recipients of janssen (johnson & johnson) and mrna covid-19 vaccines (pfizer-biontech and moderna): update from the advisory committee on immunization practices - united states, july 2021	rosenblum, hg; hadler, sc; moulia, d; shimabukuro, tt; su, jr; tepper, nk; ess, kc; woo, ej; mba-jonas, a; alimchandani, m; nair, n; klein, np; hanson, ke; markowitz, le; wharton, m; mcnally, vv; romero, jr; talbot, hk; lee, gm; daley, mf; mbaeyi, sa; oliver, se	mmwr-morbidity and mortality weekly report	2021		1
1178	multicenter interim guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2	chiotos, k; hayes, m; kimberlin, dw; jones, sb; james, sh; pinninti, sg; yarbrough, a; abzug, mj; macbrayne, ce; soma, vl; dulek, de; vora, sb; waghmare, a; wolf, j; olivero, r; grapentine, s; wattier, rl; bio, l; cross, sj; dillman, no; downes, kj; oliveira, cr; timberlake, k; young, j; orscheln, rc; tamma, pd; schwenk, ht; zachariah, p; aldrich, ml; goldman, dl; groves, he; rajapakse, ns; lamb, gs; tribble, ac; hersh, al; thorell, ea; denison, mr; ratner, aj; newland, jg; nakamura, mm	journal of the pediatric infectious diseases society	2021	10.1093/jpids/piaa115	0
1179	sars-cov-2 antibody kinetics eight months from covid-19 onset: persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors	terpos, e; stellas, d; rosati, m; sergentanis, tn; hu, xt; politou, m; pappa, v; ntanasis-stathopoulos, i; karaliota, s; bear, j; donohue, d; pagoni, m; grouzi, e; korompoki, e; pavlakis, gn; felber, bk; dimopoulos, ma	european journal of internal medicine	2021	10.1016/j.ejim.2021.05.010	0
1180	guidelines and safety considerations in the laboratory diagnosis of sars-cov-2 infection: a prerequisite study for health professionals	asrani, p; hussain, a; nasreen, k; alajmi, mf; amir, s; sohal, ss; hassan, mi	risk management and healthcare policy	2021	10.2147/rmhp.s284473	0
1181	sars-cov-2 microbiome dysbiosis linked disorders and possible probiotics role	din, au; mazhar, m; waseem, m; ahmad, w; bibi, a; hassan, a; ali, n; gang, w; qian, g; ullah, r; shah, t; ullah, m; khan, i; nisar, mf; wu, jb	biomedicine & pharmacotherapy	2021	10.1016/j.biopha.2020.110947	0
1182	trust in a covid-19 vaccine in the us: a social-ecological perspective	latkin, ca; dayton, l; yi, g; konstantopoulos, a; boodram, b	social science & medicine	2021	10.1016/j.socscimed.2021.113684	0
1183	fifth-week immunogenicity and safety of anti-sars-cov-2 bnt162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution	pimpinelli, f; marchesi, f; piaggio, g; giannarelli, d; papa, e; falcucci, p; pontone, m; di martino, s; laquintana, v; la malfa, a; di domenico, eg; di bella, o; falzone, g; ensoli, f; vujovic, b; morrone, a; ciliberto, g; mengarelli, a	journal of hematology & oncology	2021	10.1186/s13045-021-01090-6	4
1184	adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia	bourguignon, a; arnold, dm; warkentin, te; smith, jw; pannu, t; shrum, jm; al maqrashi, zaa; shroff, a; lessard, mc; blais, n; kelton, jg; nazy, i	new england journal of medicine	2021	10.1056/nejmoa2107051	0
1185	targeting sars-cov-2 main protease: a computational drug repurposing study	baby, k; maity, s; mehta, ch; suresh, a; nayak, uy; nayak, y	archives of medical research	2021	10.1016/j.arcmed.2020.09.013	1
1186	severe vitamin d deficiency is not related to sars-cov-2 infection but may increase mortality risk in hospitalized adults: a retrospective case-control study in an arab gulf country	alguwaihes, am; sabico, s; hasanato, r; al-sofiani, me; megdad, m; albader, ss; alsari, mh; alelayan, a; alyusuf, ey; alzahrani, sh; al-daghri, nm; jammah, aa	aging clinical and experimental research	2021	10.1007/s40520-021-01831-0	0
1187	why is covid-19 less severe in children? a review of the proposed mechanisms underlying the age-related difference in severity of sars-cov-2 infections	zimmermann, p; curtis, n	archives of disease in childhood	2021	10.1136/archdischild-2020-320338	0
1188	linear epitope landscape of the sars-cov-2 spike protein constructed from 1,051 covid-19 patients	li, y; ma, ml; lei, q; wang, f; hong, w; lai, dy; hou, hy; xu, zw; zhang, b; chen, h; yu, cz; xue, jb; zheng, yx; wang, xn; jiang, hw; zhang, hn; qi, h; guo, sj; zhang, yd; lin, xs; yao, zj; wu, jx; sheng, hm; zhang, yn; wei, hp; sun, zy; fan, xl; tao, sc	cell reports	2021	10.1016/j.celrep.2021.108915	0
1189	genetics and genomics of sars-cov-2: a review of the literature with the special focus on genetic diversity and sars-cov-2 genome detection	rahimi, a; mirzazadeh, a; tavakolpour, s	genomics	2021	10.1016/j.ygeno.2020.09.059	0
1190	initial guidance on use of monoclonal antibody therapy for treatment of coronavirus disease 2019 in children and adolescents	wolf, j; abzug, mj; wattier, rl; sue, pk; vora, sb; zachariah, p; dulek, de; waghmare, a; olivero, r; downes, kj; james, sh; pinninti, sg; yarbrough, a; aldrich, ml; macbrayne, ce; soma, vl; grapentine, sp; oliveira, cr; hayes, m; kimberlin, dw; jones, sb; bio, ll; morton, th; hankins, js; maron, gm; timberlake, k; young, jl; orscheln, rc; schwenk, ht; goldman, dl; groves, he; huskins, wc; rajapakse, ns; lamb, gs; tribble, ac; lloyd, ec; hersh, al; thorell, ea; ratner, aj; chiotos, k; nakamura, mm	journal of the pediatric infectious diseases society	2021	10.1093/jpids/piaa175	0
1191	domains and functions of spike protein in sars-cov-2 in the context of vaccine design	xia, xh	viruses-basel	2021	10.3390/v13010109	0
1192	priming of sars-cov-2 s protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic covid-19 infection	fuentes-prior, p	journal of biological chemistry	2021	10.1074/jbc.rev120.015980	0
1193	genomic mutations and changes in protein secondary structure and solvent accessibility of sars-cov-2 (covid-19 virus)	nguyen, tt; pathirana, pn; nguyen, t; nguyen, qvh; bhatti, a; nguyen, dc; nguyen, dt; nguyen, nd; creighton, d; abdelrazek, m	scientific reports	2021	10.1038/s41598-021-83105-3	0
1194	the neutralizing antibody response post covid-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment	terpos, e; gavriatopoulou, m; ntanasis-stathopoulos, i; briasoulis, a; gumeni, s; malandrakis, p; fotiou, d; papanagnou, ed; migkou, m; theodorakakou, f; roussou, m; eleutherakis-papaiakovou, e; kanellias, n; trougakos, ip; kastritis, e; dimopoulos, ma	blood cancer journal	2021	10.1038/s41408-021-00530-3	1
1195	effect of ivermectin on time to resolution of symptoms among adults with mild covid-19 a randomized clinical trial	lopez-medina, e; lopez, p; hurtado, ic; davalos, dm; ramirez, o; martinez, e; diazgranados, ja; onate, jm; chavarriaga, h; herrera, s; parra, b; libreros, g; jaramillo, r; avendano, ac; toro, df; torres, m; lesmes, mc; rios, ca; caicedo, i	jama-journal of the american medical association	2021	10.1001/jama.2021.3071	0
1196	serum neutralizing activity of mrna-1273 against sars-cov-2 variants	choi, a; koch, m; wu, k; dixon, g; oestreicher, j; legault, h; stewart-jones, gbe; colpitts, t; pajon, r; bennett, h; carfi, a; edwards, dk	journal of virology	2021	10.1128/jvi.01313-21	0
1197	sars-cov-2 vaccine and thrombosis: an expert consensus on vaccine-induced immune thrombotic thrombocytopenia	elalamy, i; gerotziafas, g; alamowitch, s; laroche, jp; van dreden, p; ageno, w; beyer-westendorf, j; cohen, at; jimenez, d; brenner, b; middeldorp, s; cacoub, p	thrombosis and haemostasis	2021	10.1055/a-1499-0119	0
1198	transmission event of sars-cov-2 delta variant reveals multiple vaccine breakthrough infections	farinholt, t; doddapaneni, h; qin, x; menon, v; meng, qc; metcalf, g; chao, h; gingras, mc; ayadhanula, v; farinholt, p; agrawal, c; muzny, dm; piedra, pa; gibbs, ra; petrosino, j	bmc medicine	2021	10.1186/s12916-021-02103-4	1
1199	sars-cov-2 new variants: characteristic features and impact on the efficacy of different vaccines	khan, a; khan, t; ali, s; aftab, s; wang, yj; qiankun, w; khan, m; suleman, m; ali, s; heng, w; ali, ss; wei, dq; mohammad, a	biomedicine & pharmacotherapy	2021	10.1016/j.biopha.2021.112176	0
1200	a meta-analysis on the role of children in severe acute respiratory syndrome coronavirus 2 in household transmission clusters	zhu, ys; bloxham, cj; hulme, kd; sinclair, je; tong, zwm; steele, le; noye, ec; lu, jh; xia, y; chew, ky; pickering, j; gilks, c; bowen, ac; short, kr	clinical infectious diseases	2021	10.1093/cid/ciaa1825	0
1201	analysis of humoral immune responses in patients with severe acute respiratory syndrome coronavirus 2 infection	henss, l; scholz, t; von rhein, c; wieters, i; borgans, f; eberhardt, fj; zacharowski, k; ciesek, s; rohde, g; vehreschild, m; stephan, c; wolf, t; hofmann-winkler, h; scheiblauer, h; schnierle, bs	journal of infectious diseases	2021	10.1093/infdis/jiaa680	0
1202	multiplex assays for the identification of serological signatures of sars-cov-2 infection: an antibody-based diagnostic and machine learning study	rosado, j; pelleau, s; cockram, c; merkling, sh; nekkab, n; demeret, c; meola, a; kerneis, s; terrier, b; fafi-kremer, s; de seze, j; bruel, t; dejardin, f; petres, s; longley, r; fontanet, a; backovic, m; mueller, i; white, mt	lancet microbe	2021	10.1016/s2666-5247(20)30197-x	1
1203	asymptomatic and symptomatic sars-cov-2 infections elicit polyfunctional antibodies	dufloo, j; grzelak, l; staropoli, i; madec, y; tondeur, l; anna, f; pelleau, s; wiedemann, a; planchais, c; buchrieser, j; robinot, r; ungeheuer, mn; mouquet, h; charneau, p; white, m; levy, y; hoen, b; fontanet, a; schwartz, o; bruel, t	cell reports medicine	2021	10.1016/j.xcrm.2021.100275	1
1204	longitudinal analysis of humoral immunity against sars-cov-2 spike in convalescent individuals up to 8 months post-symptom onset	anand, sp; prevost, j; nayrac, m; beaudoin-bussieres, g; benlarbi, m; gasser, r; brassard, n; laumaea, a; gong, sy; bourassa, c; brunet-ratnasingham, e; medjahed, h; gendron-lepage, g; goyette, g; gokool, l; morrisseau, c; begin, p; martel-laferriere, v; tremblay, c; richard, j; bazin, r; duerr, r; kaufmann, de; finzi, a	cell reports medicine	2021	10.1016/j.xcrm.2021.100290	1
1205	evolution of antibody responses up to 13 months after sars-cov-2 infection and risk of reinfection	gallais, f; gantner, p; bruel, t; velay, a; planas, d; wendling, mj; bayer, s; solis, m; laugel, e; reix, n; schneider, a; glady, l; panaget, b; collongues, n; partisani, m; lessinger, jm; fontanet, a; rey, d; hansmann, y; kling-pillitteri, l; schwartz, o; de seze, j; meyer, n; gonzalez, m; schmidt-mutter, c; fafi-kremer, s	ebiomedicine	2021	10.1016/j.ebiom.2021.103561	0
1206	excess mortality associated with the covid-19 pandemic among californians 18-65 years of age, by occupational sector and occupation: march through november 2020	chen, yh; glymour, m; riley, a; balmes, j; duchowny, k; harrison, r; matthay, e; bibbins-domingo, k	plos one	2021	10.1371/journal.pone.0252454	0
1207	the neutralizing antibody, ly-cov555, protects against sars-cov-2 infection in nonhuman primates	jones, be; brown-augsburger, pl; corbett, ks; westendorf, k; davies, j; cujec, tp; wiethoff, cm; blackbourne, jl; heinz, ba; foster, d; higgs, re; balasubramaniam, d; wang, ls; zhang, y; yang, es; bidshahri, r; kraft, l; hwang, y; zentelis, s; jepson, kr; goya, r; smith, ma; collins, dw; hinshaw, sj; tycho, sa; pellacani, d; xiang, p; muthuraman, k; sobhanifar, s; piper, mh; triana, fj; hendle, j; pustilnik, a; adams, ac; berens, sj; baric, rs; martinez, dr; cross, rw; geisbert, tw; borisevich, v; abiona, o; belli, hm; de vries, m; mohamed, a; dittmann, m; samanovic, mi; mulligan, mj; goldsmith, ja; hsieh, cl; johnson, nv; wrapp, d; mclellan, js; barnhart, bc; graham, bs; mascola, jr; hansen, cl; falconer, e	science translational medicine	2021	10.1126/scitranslmed.abf1906	3
1208	effect of bamlanivimab vs placebo on incidence of covid-19 among residents and staff of skilled nursing and assisted living facilities a randomized clinical trial	cohen, ms; nirula, a; mulligan, mj; novak, rm; marovich, m; yen, c; stemer, a; mayer, sm; wohl, d; brengle, b; montague, bt; frank, i; mcculloh, rj; fichtenbaum, cj; lipson, b; gabra, n; ramirez, ja; thai, c; chege, w; lorenzo, mmg; sista, n; farrior, j; clement, me; brown, er; custer, kl; van naarden, j; adams, ac; schade, ae; dabora, mc; knorr, j; price, kl; sabo, j; tuttle, jl; klekotka, p; shen, l; skovronsky, dm	jama-journal of the american medical association	2021	10.1001/jama.2021.88282021.	1
1209	structure-function analyses of new sars-cov-2 variants b.1.1.7, b.1.351 and b.1.1.28.1: clinical, diagnostic, therapeutic and public health implications	singh, j; samal, j; kumar, v; sharma, j; agrawal, u; ehtesham, nz; sundar, d; rahman, sa; hira, s; hasnain, se	viruses-basel	2021	10.3390/v13030439	0
1210	intranasal chadox1 ncov-19/azd1222 vaccination reduces viral shedding after sars-cov-2 d614g challenge in preclinical models	van doremalen, n; purushotham, jn; schulz, je; holbrook, mg; bushmaker, t; carmody, a; port, jr; yinda, ck; okumura, a; saturday, g; amanat, f; krammer, f; hanley, pw; smith, bj; lovaglio, j; anzick, sl; barbian, k; martens, c; gilbert, sc; lambe, t; munster, vj	science translational medicine	2021	10.1126/scitranslmed.abh0755	0
1211	community-level evidence for sars-cov-2 vaccine protection of unvaccinated individuals	milman, o; yelin, i; aharony, n; katz, r; herzel, e; ben-tov, a; kuint, j; gazit, s; chodick, g; patalon, t; kishony, r	nature medicine	2021	10.1038/s41591-021-01407-5	0
1212	magnetic beads combined with carbon black -based screen-printed electrodes for covid-19: a reliable and miniaturized electrochemical immunosensor for sars-cov-2 detection in saliva	fabiani, l; saroglia, m; galata, g; de santis, r; fillo, s; luca, v; faggioni, g; d'amore, n; regalbuto, e; salvatori, p; terova, g; moscone, d; lista, f; arduini, f	biosensors & bioelectronics	2021	10.1016/j.bios.2020.112686	0
1213	antibody response to sars-cov-2 vaccination is extremely vivacious in subjects with previous sars-cov-2 infection	callegaro, a; borleri, d; farina, c; napolitano, g; valenti, d; rizzi, m; maggiolo, f	journal of medical virology	2021	10.1002/jmv.26982	0
1214	sars-cov-2 rna in wastewater settled solids is associated with covid-19 cases in a large urban sewershed	graham, ke; loeb, sk; wolfe, mk; catoe, d; sinnott-armstrong, n; kim, s; yamahara, km; sassoubre, lm; grijalva, lmm; roldan-hernandez, l; langenfeld, k; wigginton, kr; boehm, ab	environmental science & technology	2021	10.1021/acs.est.0c06191	0
1215	outbreak of sars-cov-2 infections, including covid-19 vaccine breakthrough infections, associated with large public gatherings - barnstable county, massachusetts, july 2021	brown, cm; vostok, j; johnson, h; burns, m; gharpure, r; sami, s; sabo, rt; hall, n; foreman, a; schubert, pl; gallagher, gr; fink, t; madoff, lc; gabriel, sb; macinnis, b; park, dj; siddle, kj; harik, v; arvidson, d; brock-fisher, t; dunn, m; kearns, a; laney, as	mmwr-morbidity and mortality weekly report	2021		4
1216	immune responses against sars-cov-2 variants after heterologous and homologous chadox1 ncov-19/bnt162b2 vaccination	barros-martins, j; hammerschmidt, si; cossmann, a; odak, i; stankov, mv; ramos, gm; dopfer-jablonka, a; heidemann, a; ritter, c; friedrichsen, m; schultze-florey, c; ravens, i; willenzon, s; bubke, a; ristenpart, j; janssen, a; ssebyatika, g; bernhardt, g; munch, j; hoffmann, m; pohlmann, s; krey, t; bosnjak, b; forster, r; behrens, gmn	nature medicine	2021	10.1038/s41591-021-01449-9	1
1217	screening for natural and derived bio-active compounds in preclinical and clinical studies: one of the frontlines of fighting the coronaviruses pandemic	khalifa, sam; yosri, n; el-mallah, mf; ghonaim, r; guo, zm; musharraf, sg; du, m; khatib, a; xiao, jb; saeed, a; el-seedi, hhr; zhao, c; efferth, t; el-seedi, hr	phytomedicine	2021	10.1016/j.phymed.2020.153311	0
1218	spontaneous hit syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia	warkentin, te; greinacher, a	thrombosis research	2021	10.1016/j.thromres.2021.05.018	0
1219	humoral and cellular responses to mrna-1273 and bnt162b2 sars-cov-2 vaccines administered to hemodialysis patients	broseta, jj; espinosa, dr; rodriguez, n; mosquera, md; marcos, ma; egri, n; pascal, m; soruco, e; bedini, jl; bayes, b; maduell, f	american journal of kidney diseases	2021	10.1053/j.ajkd.2021.06.002	2
1220	beyond fragmentary: a proposed measure for travel vaccination concerns	adongo, ca; amenumey, ek; kumi-kyereme, a; dube, e	tourism management	2021	10.1016/j.tourman.2020.104180	0
1221	mink, sars-cov-2, and the human-animal interface	fenollar, f; mediannikov, o; maurin, m; devaux, c; colson, p; levasseur, a; fournier, pe; raoult, d	frontiers in microbiology	2021	10.3389/fmicb.2021.663815	0
1222	bats, pangolins, minks and other animals-villains or victims of sars-cov-2?	do vale, b; lopes, ap; fontes, md; silvestre, m; cardoso, l; coelho, ac	veterinary research communications	2021	10.1007/s11259-021-09787-2	0
1223	autoimmune phenomena following sars-cov-2 vaccination	ishay, y; kenig, a; tsemach-toren, t; amer, r; rubin, l; hershkovitz, y; kharouf, f	international immunopharmacology	2021	10.1016/j.intimp.2021.107970	0
1224	in silico t cell epitope identification for sars-cov-2: progress and perspectives	sohail, ms; ahmed, sf; quadeer, aa; mckay, mr	advanced drug delivery reviews	2021	10.1016/j.addr.2021.01.007	0
1225	next generation sequencing of sars-cov-2 genomes: challenges, applications and opportunities	chiara, m; d'erchia, am; gissi, c; manzari, c; parisi, a; resta, n; zambelli, f; picardi, e; pavesi, g; horner, ds; pesole, g	briefings in bioinformatics	2021	10.1093/bib/bbaa297	0
1226	auto-antibodies to type i ifns can underlie adverse reactions to yellow fever live attenuated vaccine	bastard, p; michailidis, e; hoffmann, hh; chbihi, m; le voyer, t; rosain, j; philippot, q; seeleuthner, y; gervais, a; materna, m; de oliveira, pmn; maia, mds; bom, apda; azamor, t; da conceicao, da; goudouris, e; homma, a; slesak, g; schafer, j; pulendran, b; miller, jd; huits, r; yang, r; rosen, lb; bizien, l; lorenzo, l; chrabieh, m; erazo, lv; rozenberg, f; jeljeli, mm; beziat, v; holland, sm; cobat, a; notarangelo, ld; su, hc; ahmed, r; puel, a; zhang, sy; abel, l; seligman, sj; zhang, q; macdonald, mr; jouanguy, e; rice, cm; casanova, jl	journal of experimental medicine	2021	10.1084/jem.20202486	0
1227	antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia	huynh, a; kelton, jg; arnold, dm; daka, m; nazy, i	nature	2021	10.1038/s41586-021-03744-4	1
1228	association of age with sars-cov-2 antibody response	yang, hs; costa, v; racine-brzostek, se; acker, kp; yee, j; chen, zm; karbaschi, m; zuk, r; rand, s; sukhu, a; klasse, pj; cushing, mm; chadburn, a; zhao, z	jama network open	2021	10.1001/jamanetworkopen.2021.4302	1
1229	safety, tolerability, and immunogenicity of an inactivated sars-cov-2 vaccine (coronavac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial	han, bh; song, yf; li, cg; yang, wq; ma, qx; jiang, zw; li, mj; lian, xj; jiao, wb; wang, l; shu, q; wu, zw; zhao, yl; li, q; gao, q	lancet infectious diseases	2021	10.1016/s1473-3099(21)00319-4	0
1230	inactivation of human coronavirus by titania nanoparticle coatings and uvc radiation: throwing light on sars-cov-2	khaiboullina, s; uppal, t; dhabarde, n; subramanian, vr; verma, sc	viruses-basel	2021	10.3390/v13010019	0
1231	immunogenicity of ad26.cov2.s vaccine against sars-cov-2 variants in humans	alter, g; yu, jy; liu, jy; chandrashekar, a; borducchi, en; tostanoski, lh; mcmahan, k; jacob-dolan, c; martinez, dr; chang, aq; anioke, t; lifton, m; nkolola, j; stephenson, ke; atyeo, c; shin, s; fields, p; kaplan, i; robins, h; amanat, f; krammer, f; baric, rs; le gars, m; sadoff, j; de groot, am; heerwegh, d; struyf, f; douoguih, m; van hoof, j; schuitemaker, h; barouch, dh	nature	2021	10.1038/s41586-021-03681-2	0
1232	sars-cov-2 neutralizing antibodies: longevity, breadth, and evasion by emerging viral variants	tea, f; stella, ao; aggarwal, a; darley, dr; pilli, d; vitale, d; merheb, v; lee, fxz; cunningham, p; walker, gj; fichter, c; brown, da; rawlinson, wd; isaacs, sr; mathivanan, v; hoffmann, m; pohlman, s; mazigi, o; christ, d; rockett, rj; sintchenko, v; hoad, vc; irving, do; dore, gj; gosbell, ib; kelleher, ad; matthews, gv; brilot, f; turville, sg	plos medicine	2021	10.1371/journal.pmed.1003656	0
1233	humoral and cellular responses to mrna vaccines against sars-cov-2 in patients with a history of cd20 b-cell-depleting therapy (rituxivac): an investigator-initiated, single-centre, open-label study	moor, mb; suter-riniker, f; horn, mp; aeberli, d; amsler, j; moller, b; njue, lm; medri, c; angelillo-scherrer, a; borradori, l; radonjic-hoesli, s; jafari, sms; chan, a; hoepner, r; bacher, vu; mani, ly; iype, jm; hirzel, c; maurer, b; sidler, d	lancet rheumatology	2021	10.1016/s2665-9913(21)00251-4	0
1234	evaluation of seropositivity following bnt162b2 messenger rna vaccination for sars-cov-2 in patients undergoing treatment for cancer	massarweh, a; eliakim-raz, n; stemmer, a; levy-barda, a; yust-katz, s; zer, a; benouaich-amiel, a; ben-zvi, h; moskovits, n; brenner, b; bishara, j; yahav, d; tadmor, b; zaks, t; stemmer, sm	jama oncology	2021	10.1001/jamaoncol.2021.2155	3
1235	immunogenicity of sars-cov-2 messenger rna vaccines in patients with cancer	addeo, a; shah, pk; bordry, n; hudson, rd; albracht, b; di marco, m; kaklamani, v; dietrich, py; taylor, bs; simand, pf; patel, d; wang, j; labidi-galy, i; fertani, s; leach, rj; sandoval, j; mesa, r; lathrop, k; mach, n; shah, dp	cancer cell	2021	10.1016/j.ccell.2021.06.009	1
1236	antibody and t cell response to sars-cov-2 messenger rna bnt162b2 vaccine in kidney transplant recipients and hemodialysis patients	bertrand, d; hamzaoui, m; lemee, v; lamulle, j; hanoy, m; laurent, c; lebourg, l; etienne, i; lemoine, m; le roy, f; nezam, d; plantier, jc; boyer, o; guerrot, d; candon, s	journal of the american society of nephrology	2021	10.1681/asn.2021040480	2
1237	a novel rapid detection for sars-cov-2 spike 1 antigens using human angiotensin converting enzyme 2 (ace2)	lee, jh; choi, m; jung, y; lee, sk; lee, cs; kim, j; kim, j; kim, nh; kim, bt; kim, hg	biosensors & bioelectronics	2021	10.1016/j.bios.2020.112715	0
1238	hydroxychloroquine with or without azithromycin for treatment of early sars-cov-2 infection among high-risk outpatient adults: a randomized clinical trial	johnston, c; brown, er; stewart, j; karita, hcs; kissinger, pj; dwyer, j; hosek, s; oyedele, t; paasche-orlow, mk; paolino, k; heller, kb; leingang, h; haugen, hs; dong, tq; bershteyn, a; sridhar, ar; poole, j; noseworthy, pa; ackerman, mj; morrison, s; greninger, al; huang, ml; jerome, kr; wener, mh; wald, a; schiffer, jt; celum, c; chu, hy; barnabas, rv; baeten, jm	eclinicalmedicine	2021	10.1016/j.eclinm.2021.100773	0
1239	an in silico deep learning approach to multi-epitope vaccine design: a sars-cov-2 case study	yang, zk; bogdan, p; nazarian, s	scientific reports	2021	10.1038/s41598-021-81749-9	0
1240	structural basis of potential inhibitors targeting sars-cov-2 main protease	mengist, hm; dilnessa, t; jin, tc	frontiers in chemistry	2021	10.3389/fchem.2021.622898	0
1241	b.1.526 sars-cov-2 variants identified in new york city are neutralized by vaccine-elicited and therapeutic monoclonal antibodies	zhou, h; dcosta, bm; samanovic, mi; mulligan, mj; landau, nr; tada, t	mbio	2021	10.1128/mbio.01386-21	0
1242	v367f mutation in sars-cov-2 spike rbd emerging during the early transmission phase enhances viral infectivity through increased human ace2 receptor binding affinity	ou, jx; zhou, zh; dai, rx; zhang, j; zhao, s; wu, xw; lan, wd; ren, y; cui, ll; lan, qs; lu, l; seto, d; chodosh, j; wu, jg; zhang, g; zhang, qw	journal of virology	2021	10.1128/jvi.00617-21	0
1243	effects of the covid-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis	chmielewska, b; barratt, i; townsend, r; kalafat, e; van der meulen, j; gurol-urganci, i; brien, po; morris, e; draycott, t; thangaratinam, s; le doare, k; ladhani, s; von dadelszen, p; magee, l; khalil, a	lancet global health	2021	10.1016/s2214-109x(21)00079-6	2
1244	concerns for others increases the likelihood of vaccination against influenza and covid-19 more in sparsely rather than densely populated areas	jung, h; albarracin, d	proceedings of the national academy of sciences of the united states of	2021	10.1073/pnas.2007538118	0
1245	hispidin and lepidine e: two natural compounds and folic acid as po- tential inhibitors of 2019-novel coronavirus main protease (2019-ncovmpro), molecular docking and sar study	serseg, t; benarous, k; yousfi, m	current computer-aided drug design	2021	10.2174/1573409916666200422075440	0
1246	sars-cov-2 mrna vaccines induce broad cd4(+) t cell responses that recognize sars-cov-2 variants and hcov-nl63	woldemeskel, ba; garliss, cc; blankson, jn	journal of clinical investigation	2021	10.1172/jci149335	0
1247	magnetic bead-based immunoassay allows rapid, inexpensive, and quantitative detection of human sars-cov-2 antibodies	huergo, lf; selim, ka; conzentino, ms; gerhardt, ecm; santos, ars; wagner, b; alford, jt; deobald, n; pedrosa, fo; de souza, em; nogueira, mb; raboni, sm; souto, d; rego, fgm; zanette, dl; aoki, mn; nardin, jm; fornazari, b; morales, hmp; borges, va; nelde, a; walz, js; becker, m; schneiderhan-marra, n; rothbauer, u; reis, ra; forchhammer, k	acs sensors	2021	10.1021/acssensors.0c02544	0
1248	quantitative measurement of anti-sars-cov-2 antibodies: analytical and clinical evaluation	higgins, v; fabros, a; kulasingam, v	journal of clinical microbiology	2021	10.1128/jcm.03149-20	0
1249	age-dependent immune response to the biontech/pfizer bnt162b2 coronavirus disease 2019 vaccination	muller, l; andree, m; moskorz, w; drexler, i; walotka, l; grothmann, r; ptok, j; hillebrandt, j; ritchie, a; rabl, d; ostermann, pn; robitzsch, r; hauka, s; walker, a; menne, c; grutza, r; timm, j; adams, o; schaal, h	clinical infectious diseases	2021	10.1093/cid/ciab381	0
1250	structure of nonstructural protein 1 from sars-cov-2	clark, lk; green, tj; petit, cm	journal of virology	2021	10.1128/jvi.02019-20	0
1251	efficacy and safety of baricitinib for the treatment of hospitalised adults with covid-19 (cov-barrier) : a randomised, double-blind, parallel-group, placebo- controlled phase 3 trial	marconi, vc; ramanan, av; de bono, s; kartman, ce; krishnan, v; liao, r; piruzeli, mlb; goldman, jd; alatorre-alexander, j; pellegrini, rd; estrada, v; som, m; cardoso, a; chakladar, s; crowe, b; reis, p; zhang, x; adams, dh; ely, ew	lancet respiratory medicine	2021	10.1016/s2213-2600(21)00331-3	0
1252	effect of immunosuppression on the immunogenicity of mrna vaccines to sars-cov-2 a prospective cohort study	deepak, p; kim, w; paley, ma; yang, m; carvidi, ab; demissie, eg; el-qunni, aa; haile, a; huang, k; kinnett, b; liebeskind, mj; liu, zm; mcmorrow, le; paez, d; pawar, n; perantie, dc; schriefer, re; sides, se; thapa, m; gergely, m; abushamma, s; akuse, s; klebert, m; mitchell, l; nix, d; graf, j; taylor, ke; chahin, s; ciorba, ma; katz, p; matloubian, m; o'halloran, ja; presti, rm; wu, gf; whelan, spj; buchser, wj; gensler, ls; nakamura, mc; ellebedy, ah; kim, ahj	annals of internal medicine	2021	10.7326/m21-1757	1
1253	repurposing approved drugs as inhibitors of sars-cov-2 s-protein from molecular modeling and virtual screening	de oliveira, ov; rocha, gb; paluch, as; costa, lt	journal of biomolecular structure & dynamics	2021	10.1080/07391102.2020.1772885	0
1254	changes in the incidence of invasive disease due to streptococcus pneumoniae, haemophilus influenzae, and neisseria meningitidis during the covid-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data	brueggemann, ab; van rensburg, mjj; shaw, d; mccarthy, nd; jolley, ka; maiden, mcj; van der linden, mpg; amin-chowdhury, z; bennett, de; borrow, r; brandileone, mcc; broughton, k; campbell, r; cao, b; casanova, c; choi, eh; chu, yw; clark, sa; claus, h; coelho, j; corcoran, m; cottrell, s; cunney, rj; dalby, t; davies, h; de gouveia, l; deghmane, ae; demczuk, w; desmet, s; drew, rj; du plessis, m; erlendsdottir, h; fry, nk; fuursted, k; gray, sj; henriques-normark, b; hale, t; hilty, m; hoffmann, s; humphreys, h; ip, m; jacobsson, s; johnston, j; kozakova, j; kristinsson, kg; krizova, p; kuch, a; ladhani, sn; lam, tt; lebedova, v; lindholm, l; litt, dj; martin, i; martiny, d; mattheus, w; mcelligott, m; meehan, m; meiring, s; molling, p; morfeldt, e; morgan, j; mulhall, rm; munoz-almagro, c; murdoch, dr; murphy, j; musilek, m; mzabi, a; perez-arguello, a; perrin, m; perry, m; redin, a; roberts, r; roberts, m; rokney, a; ron, m; scott, kj; sheppard, cl; siira, l; skoczynska, a; sloan, m; slotved, hc; smith, aj; song, jy; taha, mk; toropainen, m; tsang, d; vainio, a; van sorge, nm; varon, e; vlach, j; vogel, u; vohrnova, s; von gottberg, a; zanella, rc; zhou, f	lancet digital health	2021		0
1255	potential anti-covid-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment	ohashi, h; watashi, k; saso, w; shionoya, k; iwanami, s; hirokawa, t; shirai, t; kanaya, s; ito, y; kim, ks; nomura, t; suzuki, t; nishioka, k; ando, s; ejima, k; koizumi, y; tanaka, t; aoki, s; kuramochi, k; suzuki, t; hashiguchi, t; maenaka, k; matano, t; muramatsu, m; saijo, m; aihara, k; iwami, s; takeda, m; mckeating, ja; wakita, t	iscience	2021	10.1016/j.isci.2021.102367	0
1256	lipid nanoparticles-from liposomes to mrna vaccine delivery, a landscape of research diversity and advancement	tenchov, r; bird, r; curtze, ae; zhou, qq	acs nano	2021	10.1021/acsnano.1c04996	0
1257	identification of new anti-ncov drug chemical compounds from indian spices exploiting sars-cov-2 main protease as target	umesh; kundu, d; selvaraj, c; singh, sk; dubey, vk	journal of biomolecular structure & dynamics	2021	10.1080/07391102.2020.1763202	1
1258	identification of bioactive molecules from tea plant as sars-cov-2 main protease inhibitors	bhardwaj, vk; singh, r; sharma, j; rajendran, v; purohit, r; kumar, s	journal of biomolecular structure & dynamics	2021	10.1080/07391102.2020.1766572	1
1259	correlation of sars-cov-2-breakthrough infections to time-from-vaccine	mizrahi, b; lotan, r; kalkstein, n; peretz, a; perez, g; ben-tov, a; chodick, g; gazit, s; patalon, t	nature communications	2021	10.1038/s41467-021-26672-3	1
1260	modelling optimal vaccination strategy for sars-cov-2 in the uk	moore, s; hill, em; dyson, l; tildesley, mj; keeling, mj	plos computational biology	2021	10.1371/journal.pcbi.1008849	0
1261	development of plant-produced recombinant ace2-fc fusion protein as a potential therapeutic agent against sars-cov-2	siriwattananon, k; manopwisedjaroen, s; kanjanasirirat, p; purwono, pb; rattanapisit, k; shanmugaraj, b; smith, dr; borwornpinyo, s; thitithanyanont, a; phoolcharoen, w	frontiers in plant science	2021	10.3389/fpls.2020.604663	0
1262	therapeutically administered ribonucleoside analogue mk-4482/eidd-2801 blocks sars-cov-2 transmission in ferrets	cox, rm; wolf, jd; plemper, rk	nature microbiology	2021	10.1038/s41564-020-00835-2	1
1263	orally delivered mk-4482 inhibits sars-cov-2 replication in the syrian hamster model	rosenke, k; hansen, f; schwarz, b; feldmann, f; haddock, e; rosenke, r; barbian, k; meade-white, k; okumura, a; leventhal, s; hawman, dw; ricotta, e; bosio, cm; martens, c; saturday, g; feldmann, h; jarvis, ma	nature communications	2021	10.1038/s41467-021-22580-8	0
1264	early-pandemic wastewater surveillance of sars-cov-2 in southern nevada: methodology, occurrence, and incidence/prevalence considerations	gerrity, d; papp, k; stoker, m; sims, a; frehner, w	water research x	2021	10.1016/j.wroa.2020.100086	0
1265	sars-cov-2 specific cd8(+) t cell responses in convalescent covid-19 individuals	kared, h; redd, ad; bloch, em; bonny, ts; sumatoh, h; kairi, f; carbajo, d; abel, b; newell, ew; bettinotti, mp; benner, se; patel, eu; littlefield, k; laeyendecker, o; shoham, s; sullivan, d; casadevall, a; pekosz, a; nardin, a; fehlings, m; tobian, aar; quinn, tc	journal of clinical investigation	2021	10.1172/jci145476	0
1266	rapid and stable mobilization of cd8(+) t cells by sars-cov-2 mrna vaccine	oberhardt, v; luxenburger, h; kemming, j; schulien, i; ciminski, k; giese, s; csernalabics, b; lang-meli, j; janowska, i; staniek, j; wild, k; basho, k; marinescu, ms; fuchs, j; topfstedt, f; janda, a; sogukpinar, o; hilger, h; stete, k; emmerich, f; bengsch, b; waller, cf; rieg, s; sagar; boettler, t; zoldan, k; kochs, g; schwemmle, m; rizzi, m; thimme, r; neumann-haefelin, c; hofmann, m	nature	2021	10.1038/s41586-021-03841-4	0
1267	gess: a database of global evaluation of sars-cov-2/hcov-19 sequences	fang, sy; li, kl; shen, jk; liu, s; liu, jl; yang, l; hu, cd; wan, j	nucleic acids research	2021	10.1093/nar/gkaa808	0
1268	intractable coronavirus disease 2019 (covid-19) and prolonged severe acute respiratory syndrome coronavirus 2 (sars-cov-2) replication in a chimeric antigen receptor-modified t-cell therapy recipient: a case study	hensley, mk; bain, wg; jacobs, j; nambulli, s; parikh, u; cillo, a; staines, b; heaps, a; sobolewski, md; rennick, lj; macatangay, bjc; klamar-blain, c; kitsios, gd; methe, b; somasundaram, a; bruno, tc; cardello, c; shan, f; workman, c; ray, p; ray, a; lee, j; sethi, r; schwarzmann, we; ladinsky, ms; bjorkman, pj; vignali, da; duprex, wp; agha, me; mellors, jw; mccormick, kd; morris, a; haidar, g	clinical infectious diseases	2021	10.1093/cid/ciab072	1
1269	tracing the origins of sars-cov-2 in coronavirus phylogenies: a review	sallard, e; halloy, j; casane, d; decroly, e; van helden, j	environmental chemistry letters	2021	10.1007/s10311-020-01151-1	0
1270	prior sars-cov-2 infection rescues b and t cell responses to variants after first vaccine dose	reynolds, cj; pade, c; gibbons, jm; butler, dk; otter, ad; menacho, k; fontana, m; smit, a; sackville-west, je; cutino-moguel, t; maini, mk; chain, b; noursadeghi, m; brooks, t; semper, a; manisty, c; treibel, ta; moon, jc; valdes, am; mcknight, a; altmann, dm; boyton, r	science	2021	10.1126/science.abh1282	0
1271	reduced neutralisation of the delta (b.1.617.2) sars-cov-2 variant of concern following vaccination	davis, c; logan, n; tyson, g; orton, r; harvey, wt; perkins, js; mollett, g; blacow, rm; peacock, tp; barclay, ws; cherepanov, p; palmarini, m; murcia, pr; patel, ah; robertson, dl; haughney, j; thomson, ec; willett, bj	plos pathogens	2021	10.1371/journal.ppat.1010022	0
1272	spike glycoprotein and host cell determinants of sars-cov-2 entry and cytopathic effects	nguyen, ht; zhang, sj; wang, q; anang, s; wang, j; ding, ht; kappes, jc; sodroski, j	journal of virology	2021	10.1128/jvi.02304-20	0
1273	professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients	chervenak, fa; mccullough, lb; bornstein, e; johnson, l; katz, a; mcleod-sordjan, r; nimaroff, m; rochelson, bl; tekbali, a; warman, a; williams, k; grunebaum, a	american journal of obstetrics and gynecology	2021	10.1016/j.ajog.2021.01.027	0
1274	stability of sars-cov-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: a review	aboubakr, ha; sharafeldin, ta; goyal, sm	transboundary and emerging diseases	2021	10.1111/tbed.13707	1
1275	cold sensitivity of the sars-cov-2 spike ectodomain	edwards, rj; mansouri, k; stalls, v; manne, k; watts, b; parks, r; janowska, k; gobeil, smc; kopp, m; li, dp; lu, xz; mu, zk; deyton, m; oguin, th; sprenz, j; williams, w; saunders, k; montefiori, d; sempowski, gd; henderson, r; alam, m; haynes, bf; acharya, p	nature structural & molecular biology	2021	10.1038/s41594-020-00547-5	1
1276	baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in sars-cov-2-infected rhesus macaques	hoang, tn; pino, m; boddapati, ak; viox, eg; starke, ce; upadhyay, aa; gumber, s; nekorchuk, m; busman-sahay, k; strongin, z; harper, jl; tharp, gk; pellegrini, kl; kirejczyk, s; zandi, k; tao, sj; horton, tr; beagle, en; mahar, ea; lee, myh; cohen, j; jean, sm; wood, js; connor-stroud, f; stammen, rl; delmas, om; wang, s; cooney, ka; sayegh, mn; wang, lf; filev, pd; weiskopf, d; silvestri, g; waggoner, j; piantadosi, a; kasturi, sp; al-shakhshir, h; ribeiro, sp; sekaly, rp; levit, rd; estes, jd; vanderford, th; schinazi, rf; bosinger, se; paiardini, m	cell	2021	10.1016/j.cell.2020.11.007	0
1277	humoral immune responses and neutralizing antibodies against sars-cov-2; implications in pathogenesis and protective immunity	carrillo, j; izquierdo-useros, n; avila-nieto, c; pradenas, e; clotet, b; blanco, j	biochemical and biophysical research communications	2021	10.1016/j.bbrc.2020.10.108	0
1278	glycans of sars-cov-2 spike protein in virus infection and antibody production	zhao, xh; chen, h; wang, hl	frontiers in molecular biosciences	2021	10.3389/fmolb.2021.629873	0
1279	green giant-a tiny chloroplast genome with mighty power to produce high-value proteins: history and phylogeny	daniell, h; jin, sx; zhu, xg; gitzendanner, ma; soltis, de; soltis, ps	plant biotechnology journal	2021	10.1111/pbi.13556	0
1280	replication, pathogenicity, and transmission of sars-cov-2 in minks	shuai, l; zhong, gx; yuan, q; wen, zy; wang, c; he, xj; liu, rq; wang, jl; zhao, qj; liu, yx; huo, nn; deng, jh; bai, jj; wu, hc; guan, yt; shi, jz; tian, kg; xia, ns; chen, hl; bu, zg	national science review	2021	10.1093/nsr/nwaa291	0
1281	preliminary report on severe acute respiratory syndrome coronavirus 2 (sars-cov-2) spike mutation t478k	di giacomo, s; mercatelli, d; rakhimov, a; giorgi, fm	journal of medical virology	2021	10.1002/jmv.27062	1
1282	antibodies elicited by mrna-1273 vaccination bind more broadly to the receptor binding domain than do those from sars-cov-2 infection	greaney, aj; loes, an; gentles, le; crawford, khd; starr, tn; malone, kd; chu, hy; bloom, jd	science translational medicine	2021	10.1126/scitranslmed.abi9915	1
1283	the biological and clinical significance of emerging sars-cov-2 variants	tao, km; tzou, pl; nouhin, j; gupta, rk; de oliveira, t; pond, slk; fera, d; shafer, rw	nature reviews genetics	2021	10.1038/s41576-021-00408-x	1
1284	risk of hospitalisation associated with infection with sars-cov-2 lineage b.1.1.7 in denmark: an observational cohort study	bager, p; wohlfahrt, j; fonager, j; rasmussen, m; albertsen, m; michaelsen, ty; moller, ch; ethelberg, s; legarth, r; button, msf; gubbels, s; voldstedlund, m; molbak, k; skov, rl; fomsgaard, a; krause, tg	lancet infectious diseases	2021	10.1016/s1473-3099(21)00290-5	0
1285	cellular and humoral immune responses following sars-cov-2 mrna vaccination in patients with multiple sclerosis on anti-cd20 therapy	apostolidis, sa; kakara, m; painter, mm; goel, rr; mathew, d; lenzi, k; rezk, a; patterson, kr; espinoza, da; kadri, jc; markowitz, dm; markowitz, ce; mexhitaj, i; jacobs, d; babb, a; betts, mr; prak, etl; weiskopf, d; grifoni, a; lundgreen, ka; gouma, s; sette, a; bates, p; hensley, se; greenplate, ar; wherry, ej; li, r; bar-or, a	nature medicine	2021	10.1038/s41591-021-01507-2	1
1286	immune evasion of sars-cov-2 emerging variants: what have we learnt so far?	lazarevic, i; pravica, v; miljanovic, d; cupic, m	viruses-basel	2021	10.3390/v13071192	0
1287	comparing infectivity and virulence of emerging sars-cov-2 variants in syrian hamsters	abdelnabi, r; boudewijns, r; foo, cs; seldeslachts, l; sanchez-felipe, l; zhang, x; delang, l; maes, p; kaptein, sjf; weynand, b; vande velde, g; neyts, j; dallmeier, k	ebiomedicine	2021	10.1016/j.ebiom.2021.103403	0
1288	asymptomatic sars-cov-2 infection: a systematic review and meta-analysis	sah, p; fitzpatrick, mc; zimmer, cf; abdollahi, e; juden-kelly, l; moghadas, sm; singer, bh; galvani, ap	proceedings of the national academy of sciences of the united states of	2021	10.1073/pnas.2109229118	0
1289	design of a highly thermotolerant, immunogenic sars-cov-2 spike fragment	malladi, sk; singh, r; pandey, s; gayathri, s; kanjo, k; ahmed, s; khan, ms; kalita, p; girish, n; upadhyaya, a; reddy, p; pramanick, i; bhasin, m; mani, s; bhattacharyya, s; joseph, j; thankamani, k; raj, vs; dutta, s; singh, r; nadig, g; varadarajan, r	journal of biological chemistry	2021	10.1074/jbc.ra120.016284	0
1290	sars-cov-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus	dogan, m; kozhaya, l; placek, l; gunter, c; yigit, m; hardy, r; plassmeyer, m; coatney, p; lillard, k; bukhari, z; kleinberg, m; hayes, c; arditi, m; klapper, e; merin, n; liang, btt; gupta, r; alpan, o; unutmaz, d	communications biology	2021	10.1038/s42003-021-01649-6	0
1291	polyphenols as promising biologically active substances for preventing sars-cov-2: a review with research evidence and underlying mechanisms	mehany, t; khalifa, i; barakat, h; althwab, sa; alharbi, ym; el-sohaimy, s	food bioscience	2021	10.1016/j.fbio.2021.100891	0
1292	humoral and t-cell responses to sars-cov-2 vaccination in patients receiving immunosuppression	prendecki, m; clarke, c; edwards, h; mcintyre, s; mortimer, p; gleeson, s; martin, p; thomson, t; randell, p; shah, a; singanayagam, a; lightstone, l; cox, a; kelleher, p; willicombe, m; mcadoo, sp	annals of the rheumatic diseases	2021	10.1136/annrheumdis-2021-220626	2
1293	humoral response after sars-cov-2 mrna vaccination in a cohort of hemodialysis patients and kidney transplant recipients	danthu, c; hantz, s; dahlem, a; duval, m; ba, b; guibbert, m; el ouafi, z; ponsard, s; berrahal, i; achard, jm; bocquentin, f; allot, v; rerolle, jp; alain, s; toure, f	journal of the american society of nephrology	2021	10.1681/asn.2021040490	3
1294	identification of phytochemicals as potential therapeutic agents that binds to nsp15 protein target of coronavirus (sars-cov-2) that are capable of inhibiting virus replication	kumar, s; kashyap, p; chowdhury, s; kumar, s; panwar, a; kumar, a	phytomedicine	2021	10.1016/j.phymed.2020.153317	0
1295	colchicine and sars-cov-2: management of the hyperinflammatory state	vitiello, a; ferrara, f	respiratory medicine	2021	10.1016/j.rmed.2021.106322	0
1296	effectiveness of sars-cov-2 vaccination in a veterans affairs cohort of patients with inflammatory bowel disease with diverse exposure to immunosuppressive medications	khan, n; mahmud, n	gastroenterology	2021	10.1053/j.gastro.2021.05.044	1
1297	bcg vaccination history associates with decreased sars-cov-2 seroprevalence across a diverse cohort of health care workers	rivas, mn; ebinger, je; wu, m; sun, n; braun, j; sobhani, k; van eyk, je; cheng, ss; arditi, m	journal of clinical investigation	2021	10.1172/jci145157	0
1298	high titers and low fucosylation of early human anti-sars-cov-2 igg promote inflammation by alveolar macrophages	hoepel, w; chen, hj; geyer, ce; allahverdiyeva, s; manz, xd; de taeye, sw; aman, j; mes, l; steenhuis, m; griffith, gr; bonta, pi; brouwer, pjm; caniels, tg; van der straten, k; golebski, k; jonkers, re; larsen, md; linty, f; nouta, j; van roomen, cpaa; van baarle, fehp; van drunen, cm; wolbink, g; vlaar, apj; de bree, gj; sanders, rw; willemsen, l; neele, ae; van de beek, d; rispens, t; wuhrer, m; bogaard, hj; van gils, mj; vidarsson, g; de winther, m; den dunnen, j	science translational medicine	2021	10.1126/scitranslmed.abf8654	0
1299	lipid nanoparticles for mrna delivery	hou, xc; zaks, t; langer, r; dong, yz	nature reviews materials	2021	10.1038/s41578-021-00358-0	0
1300	the anti-vaccination infodemic on social media: a behavioral analysis	germani, f; biller-andorno, n	plos one	2021	10.1371/journal.pone.0247642	0
1301	impaired humoral and cellular immunity after sars-cov-2 bnt162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients	sattler, a; schrezenmeier, e; weber, ua; potekhin, a; bachmann, f; straub-hohenbleicher, h; budde, k; storz, e; pross, v; bergmann, y; thole, lml; tizian, c; holsken, o; diefenbach, a; schrezenmeier, h; jahrsdorfer, b; zemojtel, t; jechow, k; conrad, c; lukassen, s; stauch, d; lachmann, n; choi, m; halleck, f; kotsch, k	journal of clinical investigation	2021	10.1172/jci150175	0
1302	the immunodominant and neutralization linear epitopes for sars-cov-2	lu, s; xie, xx; zhao, l; wang, b; zhu, j; yang, tr; yang, gw; ji, m; lv, cp; xue, j; dai, eh; fu, xm; liu, dq; zhang, l; hou, sj; yu, xl; wang, yl; gao, hx; shi, xh; ke, cw; ke, bx; jiang, cg; liu, rt	cell reports	2021	10.1016/j.celrep.2020.108666	0
1303	sars-cov-2 disease adjuvant therapies and supplements breakthrough for the infection prevention	inchingolo, ad; inchingolo, am; bordea, ir; malcangi, g; xhajanka, e; scarano, a; lorusso, f; farronato, m; tartaglia, gm; isacco, cg; marinelli, g; d'oria, mt; hazballa, d; santacroce, l; ballini, a; contaldo, m; inchingolo, f; dipalma, g	microorganisms	2021	10.3390/microorganisms9030525	0
1304	q493k and q498h substitutions in spike promote adaptation of sars-cov-2 in mice	huang, k; zhang, yf; hui, xf; zhao, y; gong, wx; wang, t; zhang, sr; yang, y; deng, f; zhang, q; chen, x; yang, y; sun, xm; chen, hc; tao, yzj; zou, z; jin, ml	ebiomedicine	2021	10.1016/j.ebiom.2021.103381	0
1305	global tuberculosis report 2020-reflections on the global tb burden, treatment and prevention efforts	chakaya, j; khan, m; ntoumi, f; aklillu, e; fatima, r; mwaba, p; kapata, n; mfinanga, s; hasnain, se; katoto, pdmc; bulabula, anh; sam-agudu, na; nachega, jb; tiberi, s; mchugh, td; abubakar, i; zumla, a	international journal of infectious diseases	2021	10.1016/j.ijid.2021.02.107	0
1306	structural basis of sars-cov-2-and sars-cov-receptor binding and small-molecule blockers as potential therapeutics	sivaraman, h; er, sy; choong, yk; gavor, e; sivaraman, j	annual review of pharmacology and toxicology, vol 61, 2021	2021	10.1146/annurev-pharmtox-061220-093932	1
1307	flavonols as potential antiviral drugs targeting sars-cov-2 proteases (3cl(pro) and plpro), spike protein, rna-dependent rna polymerase (rdrp) and angiotensin-converting enzyme ii receptor (ace2)	mouffouk, c; mouffouk, s; mouffouk, s; hambaba, l; haba, h	european journal of pharmacology	2021	10.1016/j.ejphar.2020.173759	0
1308	supply chain management for extreme conditions: research opportunities	sodhi, ms; tang, cs	journal of supply chain management	2021	10.1111/jscm.12255	0
1309	evaluating recovery, cost, and throughput of different concentration methods for sars-cov-2 wastewater-based epidemiology	laturner, zw; zong, dm; kalvapalle, p; gamas, kr; terwilliger, a; crosby, t; ali, p; avadhanula, v; santos, hh; weesner, k; hopkins, l; piedra, pa; maresso, aw; stadler, lb	water research	2021	10.1016/j.watres.2021.117043	0
1310	the sars-cov-2 spike variant d614g favors an open conformational state	mansbach, ra; chakraborty, s; nguyen, k; montefiori, dc; korber, b; gnanakaran, s	science advances	2021	10.1126/sciadv.abf3671	0
1311	isg15-dependent activation of the sensor mda5 is antagonized by the sars-cov-2 papain-like protease to evade host innate immunity	liu, gq; lee, jh; parker, zm; acharya, d; chiang, jj; van gent, m; riedl, w; davis-gardner, me; wies, e; chiang, c; gack, mu	nature microbiology	2021	10.1038/s41564-021-00884-1	0
1312	hydroxychloroquine as postexposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 infection a randomized trial	barnabas, rv; brown, er; bershteyn, a; karita, hcs; johnston, c; thorpe, le; kottkamp, a; neuzil, km; laufer, mk; deming, m; paasche-orlow, mk; kissinger, pj; luk, a; paolino, k; landovitz, rj; hoffman, r; schaafsma, tt; krows, ml; thomas, kk; morrison, s; haugen, hs; kidoguchi, l; wener, m; greninger, al; huang, ml; jerome, kr; wald, a; celum, c; chu, hy; baeten, jm	annals of internal medicine	2021	10.7326/m20-6519	0
1313	rationally designed ace2-derived peptides inhibit sars-cov-2	larue, rc; xing, em; kenney, ad; zhang, yx; tuazon, ja; li, jr; yount, js; li, pk; sharma, a	bioconjugate chemistry	2021	10.1021/acs.bioconjchem.0c00664	0
1314	effective inhibition of sars-cov-2 entry by heparin and enoxaparin derivatives	tandon, r; sharp, js; zhang, fm; pomin, vh; ashpole, nm; mitra, d; jin, wh; liu, h; sharma, p; linhardt, rj; mccandless, mg	journal of virology	2021	10.1128/jvi.01987-20	0
1315	pandemics throughout history	piret, j; boivin, g	frontiers in microbiology	2021	10.3389/fmicb.2020.631736	0
1316	a therapeutic neutralizing antibody targeting receptor binding domain of sars-cov-2 spike protein	kim, c; ryu, dk; lee, j; kim, yi; seo, jm; kim, yg; jeong, jh; kim, m; kim, ji; kim, p; bae, js; shim, ey; lee, ms; kim, ms; noh, h; park, gs; park, js; son, d; an, y; lee, jn; kwon, ks; lee, jy; lee, h; yang, js; kim, kc; kim, ss; woo, hm; kim, jw; park, ms; yu, km; kim, sm; kim, eh; park, sj; jeong, st; yu, ch; song, y; gu, sh; oh, h; koo, bs; hong, jj; ryu, cm; park, wb; oh, md; choi, yk; lee, sy	nature communications	2021	10.1038/s41467-020-20602-5	1
1317	molecular mechanism of interaction between sars-cov-2 and host cells and interventional therapy	zhang, qq; xiang, r; huo, ss; zhou, yj; jiang, sb; wang, q; yu, f	signal transduction and targeted therapy	2021	10.1038/s41392-021-00653-w	0
1318	egcg, a green tea polyphenol, inhibits human coronavirus replication in vitro	jang, m; park, r; park, yi; cha, ye; yamamoto, a; lee, ji; park, j	biochemical and biophysical research communications	2021	10.1016/j.bbrc.2021.02.016	0
1319	guillain-barre syndrome variant occurring after sars-cov-2 vaccination	allen, cm; ramsamy, s; tarr, aw; tighe, pj; irving, wl; tanasescu, r; evans, jr	annals of neurology	2021	10.1002/ana.26144	0
1320	effect of sars-cov-2 mrna vaccination in ms patients treated with disease modifying therapies	sormani, mp; inglese, m; schiavetti, i; carmisciano, l; laroni, a; lapucci, c; da rin, g; serrati, c; gandoglia, i; tassinari, t; perego, g; brichetto, g; gazzola, p; mannironi, a; stromillo, ml; cordioli, c; landi, d; clerico, m; signoriello, e; frau, j; ferro, mt; di sapio, a; pasquali, l; ulivelli, m; marinelli, f; callari, g; iodice, r; liberatore, g; caleri, f; repice, am; cordera, s; battaglia, ma; salvetti, m; franciotta, d; uccelli, a	ebiomedicine	2021	10.1016/j.ebiom.2021.103581	0
1321	computational epitope map of sars-cov-2 spike protein	sikora, m; von bulow, s; blanc, fec; gecht, m; covino, r; hummer, g	plos computational biology	2021	10.1371/journal.pcbi.1008790	0
1322	humoral and t-cell response to sars-cov-2 vaccination in patients with multiple sclerosis treated with ocrelizumab	brill, l; rechtman, a; zveik, o; haham, n; oiknine-djian, e; wolf, dg; levin, n; raposo, c; vaknin-dembinsky, a	jama neurology	2021	10.1001/jamaneurol.2021.3599	0
1323	sars-cov-2 variant prediction and antiviral drug design are enabled by rbd in vitro evolution	zahradnik, j; marciano, s; shemesh, m; zoler, e; harari, d; chiaravalli, j; meyer, b; rudich, y; li, cn; marton, i; dym, o; elad, n; lewis, mg; andersen, h; gagne, m; seder, ra; douek, dc; schreiber, g	nature microbiology	2021	10.1038/s41564-021-00954-4	0
1324	sars-cov-2 infection severity is linked to superior humoral immunity against the spike	guthmiller, jj; stovicek, o; wang, jl; changrob, s; li, l; halfmann, p; zheng, ny; utset, h; stamper, ct; dugan, hl; miller, wd; huang, m; dai, yn; nelson, ca; hall, pd; jansen, m; shanmugarajah, k; donington, js; krammer, f; fremont, dh; joachimiak, a; kawaoka, y; tesic, v; madariaga, ml; wilson, pc	mbio	2021	10.1128/mbio.02940-20	0
1325	overcoming barriers by local drug delivery with liposomes	antimisiaris, sg; marazioti, a; kannavou, m; natsaridis, e; gkartziou, f; kogkos, g; mourtas, s	advanced drug delivery reviews	2021	10.1016/j.addr.2021.01.019	0
1326	transmission of sars-cov-2 in domestic cats imposes a narrow bottleneck	braun, km; moreno, gk; halfmann, pj; hodcroft, eb; baker, da; boehm, ec; weiler, am; haj, ak; hatta, m; chiba, s; maemura, t; kawaoka, y; koelle, k; o'connor, dh; friedrich, tc	plos pathogens	2021	10.1371/journal.ppat.1009373	1
1327	novel sars-cov-2 variants: the pandemics within the pandemic	boehm, e; kronig, i; neher, ra; eckerle, i; vetter, p; kaiser, l	clinical microbiology and infection	2021	10.1016/j.cmi.2021.05.022	1
1328	a new sars-cov-2 dual-purpose serology test: highly accurate infection tracing and neutralizing antibody response detection	taylor, sc; hurst, b; charlton, cl; bailey, a; kanji, jn; mccarthy, mk; morrison, te; huey, l; annen, k; dombourian, mg; knight, v	journal of clinical microbiology	2021	10.1128/jcm.02438-20	0
1329	de novo 3d models of sars-cov-2 rna elements from consensus experimental secondary structures	rangan, r; watkins, am; chacon, j; kretsch, r; kladwang, w; zheludev, in; townley, j; rynge, m; thain, g; das, r	nucleic acids research	2021	10.1093/nar/gkab119	0
1330	global seroprevalence of sars-cov-2 antibodies: a systematic review and meta-analysis	bobrovitz, n; arora, rk; cao, c; boucher, e; liu, m; donnici, c; yanes-lane, m; whelan, m; perlman-arrow, s; chen, j; rahim, h; ilincic, n; segal, m; duarte, n; van wyk, j; yan, tt; atmaja, a; rocco, s; joseph, a; penny, l; clifton, da; williamson, t; yansouni, cp; evans, tg; chevrier, j; papenburg, j; cheng, mp	plos one	2021	10.1371/journal.pone.0252617	0
1331	cryo-em structure of sars-cov-2 orf3a in lipid nanodiscs	kern, dm; sorum, b; mali, ss; hoel, cm; sridharan, s; remis, jp; toso, db; kotecha, a; bautista, dm; brohawn, sg	nature structural & molecular biology	2021	10.1038/s41594-021-00619-0	0
1332	estimation of us sars-cov-2 infections, symptomatic infections, hospitalizations, and deaths using seroprevalence surveys	angulo, fj; finelli, l; swerdlow, dl	jama network open	2021	10.1001/jamanetworkopen.2020.33706	0
1333	human sars cov-2 spike protein mutations	guruprasad, l	proteins-structure function and bioinformatics	2021	10.1002/prot.26042	0
1334	single-cell longitudinal analysis of sars-cov-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes	ravindra, ng; alfajaro, mm; gasque, v; huston, nc; wan, h; szigeti-buck, k; yasumoto, y; greaney, am; habet, v; chow, rd; chen, js; wei, j; filler, rb; wang, b; wang, gl; niklason, le; montgomery, rr; eisenbarth, sc; chen, sd; williams, a; iwasaki, a; horvath, tl; foxman, ef; pierce, rw; pyle, am; van dijk, d; wilen, cb	plos biology	2021	10.1371/journal.pbio.3001143	0
1335	difference in levels of sars-cov-2 s1 and s2 subunits- and nucleocapsid protein-reactive sigm/igm, igg and siga/iga antibodies in human milk	demers-mathieu, v; dung, m; mathijssen, gb; sela, da; seppo, a; jarvinen, km; medo, e	journal of perinatology	2021	10.1038/s41372-020-00805-w	0
1336	n- and o-glycosylation of the sars-cov-2 spike protein	sanda, m; morrison, l; goldman, r	analytical chemistry	2021	10.1021/acs.analchem.0c03173	0
1337	clinical manifestations and impact on daily life of allergy to polyethylene glycol (peg) in ten patients	bruusgaard-mouritsen, ma; johansen, jd; garvey, lh	clinical and experimental allergy	2021	10.1111/cea.13822	1
1338	combining public opinion dissemination with polarization process considering individual heterogeneity	chen, tg; rong, jt; yang, jj; cong, gd; li, gf	healthcare	2021	10.3390/healthcare9020176	0
1339	comparative cost-effectiveness of sars-cov-2 testing strategies in the usa: a modelling study	du, zw; pandey, a; bai, y; fitzpatrick, mc; chinazzi, m; piontti, apy; lachmann, m; vespignani, a; cowling, bj; galvani, ap; meyers, la	lancet public health	2021	10.1016/s2468-2667(21)00002-5	0
1340	possible transmission of viruses from contaminated human feces and sewage: implications for sars-cov-2	elsamadony, m; fujii, m; miura, t; watanabe, t	science of the total environment	2021	10.1016/j.scitotenv.2020.142575	0
1341	in vitro and in vivo functions of sars-cov-2 infection-enhancing and neutralizing antibodies	li, dp; edwards, rj; manne, k; martinez, dr; schafer, a; alam, sm; wiehe, k; lu, xz; parks, r; sutherland, ll; oguin, th; mcdanal, c; perez, lg; mansouri, k; gobeil, smc; janowska, k; stalls, v; kopp, m; cai, fp; lee, e; foulger, a; hernandez, ge; sanzone, a; tilahun, k; jiang, cac; tse, lv; bock, kw; minai, m; nagata, bm; cronin, k; gee-lai, v; deyton, m; barr, m; von holle, t; macintyre, an; stover, e; feldman, j; hauser, bm; caradonna, tm; scobey, td; rountree, w; wang, yf; moody, ma; cain, dw; demarco, ct; denny, tn; woods, cw; petzold, ew; schmidt, ag; teng, it; zhou, tq; kwong, pd; mascola, jr; graham, bs; moore, in; seder, r; andersen, h; lewis, mg; montefiori, dc; sempowski, gd; baric, rs; acharya, p; haynes, bf; saunders, ko	cell	2021	10.1016/j.cell.2021.06.021	1
1342	comparison of symptoms and rna levels in children and adults with sars-cov-2 infection in the community setting	chung, e; chow, ej; wilcox, nc; burstein, r; brandstetter, e; han, pd; fay, k; pfau, b; adler, a; lacombe, k; lockwood, cm; uyeki, tm; shendure, j; duchin, js; rieder, mj; nickerson, da; boeckh, m; famulare, m; hughes, jp; starita, lm; bedford, t; englund, ja; chu, hy	jama pediatrics	2021	10.1001/jamapediatrics.2021.2025	0
1343	nasal delivery of an igm offers broad protection from sars-cov-2 variants	ku, zq; xie, xp; hinton, pr; liu, xl; ye, xh; muruato, ae; ng, dc; biswas, s; zou, j; liu, y; pandya, d; menachery, vd; rahman, s; cao, ya; deng, h; xiong, w; carlin, kb; liu, jq; su, h; haanes, ej; keyt, ba; zhang, ny; carroll, sf; shi, py; an, zq	nature	2021	10.1038/s41586-021-03673-2	0
1344	the flexibility of ace2 in the context of sars-cov-2 infection	barros, ep; casalino, l; gaieb, z; dommer, ac; wang, yz; fallon, l; raguette, l; belfon, k; simmerling, c; amaro, re	biophysical journal	2021	10.1016/j.bpj.2020.10.036	0
1345	identification of existing pharmaceuticals and herbal medicines as inhibitors of sars-cov-2 infection	jan, jt; cheng, tjr; juang, yp; ma, hh; wu, yt; yang, wb; cheng, cw; chen, xr; chou, th; shie, jj; cheng, wc; chein, rj; mao, ss; liang, ph; ma, c; hung, sc; wong, ch	proceedings of the national academy of sciences of the united states of	2021	10.1073/pnas.2021579118	0
1346	a comprehensive review on antimicrobial face masks: an emerging weapon in fighting pandemics	pullangott, g; kannan, u; gayathri, s; kiran, dv; maliyekkal, sm	rsc advances	2021	10.1039/d0ra10009a	0
1347	immune response to sars-cov-2 variants of concern in vaccinated individuals	becker, m; dulovic, a; junker, d; ruetalo, n; kaiser, pd; pinilla, yt; heinzel, c; haering, j; traenkle, b; wagner, tr; layer, m; mehrlaender, m; mirakaj, v; held, j; planatscher, h; schenke-layland, k; krause, g; strengert, m; bakchoul, t; althaus, k; fendel, r; kreidenweiss, a; koeppen, m; rothbauer, u; schindler, m; schneiderhan-marra, n	nature communications	2021	10.1038/s41467-021-23473-6	0
1348	plitidepsin has potent preclinical efficacy against sars-cov-2 by targeting the host protein eef1a	white, km; rosales, r; yildiz, s; kehrer, t; miorin, l; moreno, e; jangra, s; uccellini, mb; rathnasinghe, r; coughlan, l; martinez-romero, c; batra, j; rojc, a; bouhaddou, m; fabius, jm; obernier, k; dejosez, m; guillen, mj; losada, a; aviles, p; schotsaert, m; zwaka, t; vignuzzi, m; shokat, km; krogan, nj; garcia-sastre, a	science	2021	10.1126/science.abf4058	0
1349	integrated analysis of multimodal single-cell data	hao, yh; hao, s; andersen-nissen, e; mauck, wm; zheng, sw; butler, a; lee, mj; wilk, aj; darby, c; zager, m; hoffman, p; stoeckius, m; papalexi, e; mimitou, ep; jain, j; srivastava, a; stuart, t; fleming, lm; yeung, b; rogers, aj; mcelrath, jm; blish, ca; gottardo, r; smibert, p; satija, r	cell	2021	10.1016/j.cell.2021.04.048	0
1350	comprehensive analysis of genomic diversity of sars-cov-2 in different geographic regions of india: an endeavour to classify indian sars-cov-2 strains on the basis of co-existing mutations	sarkar, r; mitra, s; chandra, p; saha, p; banerjee, a; dutta, s; chawla-sarkar, m	archives of virology	2021	10.1007/s00705-020-04911-0	0
1351	sustained cellular immune dysregulation in individuals recovering from sars-cov-2 infection	files, jk; boppana, s; perez, md; sarkar, s; lowman, ke; qin, k; sterrett, s; carlin, e; bansal, a; sabbaj, s; long, dm; kutsch, o; kobie, j; goepfert, pa; erdmann, n	journal of clinical investigation	2021	10.1172/jci140491	0
1352	global, regional, and national progress towards sustainable development goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the global burden of disease study 2019	paulson, kr; kamath, am; alam, t; bienhoff, k; abady, gg; abbas, j; abbasi-kangevari, m; abbastabar, h; abd-allah, f; abd-elsalam, sm; abdoli, a; abedi, a; abolhassani, h; abreu, lg; abu-gharbieh, e; abu-rmeileh, nme; abushouk, ai; adamu, al; adebayo, om; adegbosin, ae; adekanmbi, v; adetokunboh, oo; adeyinka, da; adsuar, jc; afshari, k; aghaali, m; agudelo-botero, m; ahinkorah, bo; ahmad, t; ahmadi, k; ahmed, mb; aji, b; akalu, y; akinyemi, oo; aklilu, a; al-aly, z; alam, k; alanezi, fm; alanzi, tm; alcalde-rabanal, je; al-eyadhy, a; ali, t; alicandro, g; alif, sm; alipour, v; alizade, h; aljunid, sm; almasi-hashiani, a; almasri, na; al-mekhlafi, hm; alonso, j; al-raddadi, rm; altirkawi, ka; alumran, ak; alvis-guzman, n; alvis-zakzuk, nj; ameyaw, ek; amini, s; amini-rarani, m; amit, aml; amugsi, da; ancuceanu, r; anderlini, d; andrei, cl; ansari, f; ansari-moghaddam, a; antonio, cat; antriyandarti, e; anvari, d; anwer, r; aqeel, m; arabloo, j; arab-zozani, m; aripov, t; arnlov, j; artanti, kd; arzani, a; asaad, m; asadi-aliabadi, m; asadi-pooya, aa; jafarabadi, ma; athari, ss; athari, sm; atnafu, dd; atreya, a; atteraya, ms; ausloos, m; awan, at; quintanilla, bpa; ayano, g; ayanore, ma; aynalem, ya; azari, s; azarian, g; azene, zn; darshan, bb; babaee, e; badiye, ad; baig, aa; banach, m; banik, pc; barker-collo, sl; barqawi, hj; bassat, q; basu, s; baune, bt; bayati, m; bedi, n; beghi, e; beghi, m; bell, ml; bendak, s; bennett, da; bensenor, im; berhe, k; berman, ae; bezabih, ym; bhagavathula, as; bhandari, d; bhardwaj, n; bhardwaj, p; bhattacharyya, k; bhattarai, s; bhutta, za; bikbov, b; biondi, a; birihane, bm; biswas, rk; bohlouli, s; bragazzi, nl; breusov, av; brunoni, ar; burkart, k; nagaraja, sb; busse, r; butt, za; dos santos, flc; cahuana-hurtado, l; camargos, p; camera, la; cardenas, r; carreras, g; carrero, jj; carvalho, f; castaldelli-maia, jm; castaneda-orjuela, ca; castelpietra, g; cerin, e; chang, jc; chanie, wf; charan, j; chatterjee, s; chattu, sk; chattu, vk; chaturvedi, s; chen, s; cho, dy; choi, jyj; chu, dt; ciobanu, lg; cirillo, m; conde, j; costa, vm; couto, ras; dachew, ba; dahlawi, sma; dai, hc; dai, xc; dandona, l; dandona, r; daneshpajouhnejad, p; darmstadt, gl; das, jk; davila-cervantes, ca; davis, ac; davletov, k; de la hoz, fp; de leo, d; deeba, f; denova-gutierrez, e; dervenis, n; desalew, a; deuba, k; dey, s; dharmaratne, sd; dhingra, s; dhungana, gp; da silva, dd; diaz, d; dorostkar, f; doshmangir, l; dubljanin, e; duraes, ar; eagan, aw; edinur, ha; efendi, f; eftekharzadeh, s; el sayed, i; el tantawi, m; elbarazi, i; elgendy, iy; el-jaafary, si; emami, a; enany, s; eyawo, o; ezzikouri, s; faris, ps; farzadfar, f; fattahi, n; fauk, nk; fazlzadeh, m; feigin, vl; ferede, ty; fereshtehnejad, sm; fernandes, e; ferrara, p; filip, i; fischer, f; fisher, jl; foigt, na; folayan, mo; foroutan, m; franklin, rc; freitas, m; friedman, sd; fukumoto, t; gad, mm; gaidhane, am; gaidhane, s; gaihre, s; gallus, s; garcia-basteiro, al; garcia-gordillo, m; gardner, wm; fonseca, mg; gebremedhin, kb; getacher, l; ghashghaee, a; gholamian, a; gilani, sa; gill, tk; giussani, g; gnedovskaya, ev; godinho, ma; goel, a; golechha, m; gona, pn; gopalani, sv; goudarzi, h; grivna, m; gugnani, hc; guido, d; guimaraes, ra; das gupta, r; gupta, r; hafezi-nejad, n; haider, mr; haj-mirzaian, a; hamidi, s; hanif, a; hankey, gj; hargono, a; hasaballah, ai; hasan, mm; hasan, ss; hassan, a; hassanipour, s; hassankhani, h; havmoeller, rj; hayat, k; heidari-soureshjani, r; henry, nj; herteliu, c; hole, mk; holla, r; hossain, n; hosseini, m; hosseinzadeh, m; hostiuc, m; hostiuc, s; househ, m; huang, j; humayun, a; hwang, bf; iavicoli, i; ibitoye, se; ikuta, ks; ilesanmi, os; ilic, im; ilic, md; inamdar, s; inbaraj, lr; iqbal, k; iqbal, u; islam, mm; islam, sms; iso, h; iwagami, m; iwu, ccd; jaafari, j; jacobsen, kh; jagnoor, j; jain, v; janodia, md; javaheri, t; javanmardi, f; jayaram, s; jayatilleke, au; jenabi, e; jha, rp; ji, js; john, o; jonas, jb; joo, t; joseph, n; joukar, f; jozwiak, jj; jurisson, m; kabir, a; kabir, z; kalankesh, lr; kamyari, n; kanchan, t; kapoor, n; matin, bk; karch, a; karimi, se; kassahun, g; kayode, ga; karyani, ak; kemmer, l; khalid, n; khalilov, r; khammarnia, m; khan, ea; khan, g; khan, m; khan, mn; khang, yh; khatab, k; khater, am; khater, mm; khayamzadeh, m; khosravi, a; kim, d; kim, ye; kim, yj; kimokoti, rw; kisa, a; kisa, s; kissoon, n; kopec, ja; kosen, s; koul, pa; laxminarayana, slk; koyanagi, a; krishan, k; krishnamoorthy, v; defo, bk; bicer, bk; kulkarni, v; kumar, ga; kumar, m; kumar, n; kurmi, op; kusuma, d; la vecchia, c; lacey, b; lalloo, r; lami, fh; landires, i; larsson, ao; lasrado, s; lassi, zs; lauriola, p; lee, ph; lee, swh; lee, yh; leigh, j; leonardi, m; lewycka, s; li, by; li, ss; liang, j; lim, ll; limenih, ma; lin, rt; liu, xf; lodha, r; lopez, ad; lozano, r; lugo, a; lunevicius, r; mackay, mt; kunjathur, sm; magnani, fg; prasad, drm; maheri, m; mahmoudi, m; majeed, a; maled, v; maleki, a; maleki, s; malekzadeh, r; malik, aa; malta, dc; mamun, aa; mansouri, b; mansournia, ma; martinez, g; martini, s; martins-melo, fr; masoumi, sz; maulik, pk; mcalinden, c; mcgrath, jj; medina-solis, ce; nasab, em; mejia-rodriguez, f; memish, za; mendoza, w; menezes, rg; mengesha, ew; mensah, ga; meretoja, a; meretoja, tj; mersha, am; mestrovic, t; miazgowski, b; miazgowski, t; michalek, im; miller, tr; mini, gk; miri, m; mirica, a; mirrakhimov, em; mirzaei, h; mirzaei, m; moazen, b; moghadaszadeh, m; mohajer, b; mohamad, o; mohammad, y; mohammadi, sm; mohammadian-hafshejani, a; mohammed, s; mokdad, ah; molokhia, m; monasta, l; mondello, s; moni, ma; moore, ce; moradi, g; moradi, m; moradzadeh, r; moraga, p; morawska, l; morrison, sd; mosser, jf; khaneghah, am; mustafa, g; naderi, m; nagarajan, aj; nagaraju, sp; naghavi, m; naghshtabrizi, b; naimzada, md; nangia, v; swamy, sn; nascimento, br; naveed, m; nazari, j; ndejjo, r; negoi, i; negoi, ri; nena, e; nepal, s; netsere, hb; nguefack-tsague, g; ngunjiri, jw; nguyen, cty; nguyen, ct; nguyen, hlt; nigatu, yt; nigussie, sn; nixon, mr; nnaji, ca; nomura, s; noor, nm; noubiap, jj; nunez-samudio, v; nwatah, ve; oancea, b; odukoya, oo; ogbo, fa; olusanya, bo; olusanya, jo; bali, ao; onwujekwe, oe; ortiz, a; otoiu, a; otstavnov, n; otstavnov, ss; owolabi, mo; mahesh, pa; padubidri, jr; pakhale, s; pakshir, k; pal, pk; palladino, r; pana, a; panda-jonas, s; pandey, a; pandey, a; pandi-perumal, sr; pangaribuan, hu; pardo-montano, am; park, ek; patel, sk; patton, gc; pawar, s; toroudi, hp; peden, ae; pepito, vcf; peprah, ek; pereira, j; perez-gomez, j; perico, n; pesudovs, k; pilgrim, t; pinheiro, m; piradov, ma; pirsaheb, m; platts-mills, ja; pokhrel, kn; postma, mj; pourjafar, h; prada, si; prakash, s; pupillo, e; syed, zq; rabiee, n; radfar, a; rafiee, a; rafiei, a; raggi, a; rahimzadeh, s; rahman, mhu; rahmani, am; ramezanzadeh, k; rana, j; ranabhat, cl; rao, sj; rasella, d; rastogi, p; rathi, p; rawaf, dl; rawaf, s; rawasia, wf; rawassizadeh, r; reiner, rc; remuzzi, g; renzaho, amn; reshmi, b; resnikoff, s; rezaei, n; rezaei, n; rezapour, a; riahi, sm; ribeiro, d; rickard, j; roever, l; ronfani, l; rothenbacher, d; rubagotti, e; rumisha, sf; ryan, pm; saddik, b; sadeghi, e; moghaddam, ss; sagar, r; sahebkar, a; salahshoor, mr; salehi, s; salem, mr; salimzadeh, h; salomon, ja; samodra, yl; samy, am; sanabria, j; santric-milicevic, mm; saraswathy, syi; sarker, ar; sarrafzadegan, n; sarveazad, a; sathian, b; sathish, t; sattin, d; saxena, s; saya, gk; saylan, m; schiavolin, s; schlaich, mp; schwebel, dc; schwendicke, f; senthilkumaran, s; sepanlou, sg; servan-mori, e; sha, f; shafaat, o; shahabi, s; shahbaz, m; shaheen, aa; shahid, i; shaikh, ma; shakiba, s; shalash, as; shams-beyranvand, m; shannawaz, m; sharafi, k; sheikh, a; sheikhbahaei, s; shiferaw, ws; shigematsu, m; shin, ji; shiri, r; shiue, i; shuval, k; siddiqi, tj; sidemo, nb; sigfusdottir, id; sigurvinsdottir, r; silva, jp; silverberg, jis; simonetti, b; singh, bb; singh, ja; singhal, d; sinha, dn; skiadaresi, e; skryabin, vy; skryabina, aa; sleet, da; sobaih, bh; sobhiyeh, mr; soltani, s; soriano, jb; spurlock, ee; sreeramareddy, ct; steiropoulos, p; stokes, ma; stortecky, s; sufiyan, mb; abdulkader, rs; sulo, g; swope, cb; sykes, bl; szeto, md; szocska, m; tabares-seisdedos, r; tadesse, eg; taherkhani, a; tamiru, at; tareque, mi; tehrani-banihashemi, a; temsah, mh; tesfay, fh; tessema, ga; tessema, zt; thankappan, kr; thapar, r; tolani, ma; tovani-palone, mr; traini, e; tran, bx; tripathy, jp; tsapparellas, g; tsatsakis, a; car, lt; uddin, r; ullah, a; umeokonkwo, cd; unim, b; unnikrishnan, b; upadhyay, e; usman, ms; vacante, m; vaezi, m; tahbaz, sv; valdez, pr; vasankari, tj; venketasubramanian, n; verma, m; violante, fs; vlassov, v; vo, b; vu, gt; wado, yd; waheed, y; wamai, rg; wang, yp; wang, yz; wang, yp; ward, p; werdecker, a; westerman, r; wickramasinghe, nd; wilner, lb; wiysonge, cs; wu, am; wu, ck; xie, y; jabbari, shy; yamagishi, k; yandrapalli, s; yaya, s; yazdi-feyzabadi, v; yip, p; yonemoto, n; yoon, sj; younis, mz; yousefi, z; yousefinezhadi, t; yu, ch; yusuf, ss; zaidi, ss; bin zaman, s; zamani, m; zamanian, m; zastrozhin, ms; zastrozhina, a; zhang, yq; zhang, zj; zhao, xjg; ziapour, a; hay, si; murray, cjl; wang, hd; kassebaum, nj	lancet	2021	10.1016/s0140-6736(21)01207-1	0
1353	antiviral drug discovery: preparing for the next pandemic	adamson, cs; chibale, k; goss, rjm; jaspars, m; newman, dj; dorrington, ra	chemical society reviews	2021	10.1039/d0cs01118e	0
1354	potent sars-cov-2 neutralizing antibodies directed against spike n-terminal domain target a single supersite	cerutti, g; guo, yc; zhou, tq; gorman, j; lee, m; rapp, m; reddem, er; yu, j; bahna, f; bimela, j; huang, yx; katsamba, ps; liu, lh; nair, ms; rawi, r; olia, as; wang, pf; zhang, bs; chuang, gy; ho, dd; sheng, zz; kwong, pd; shapiro, l	cell host & microbe	2021	10.1016/j.chom.2021.03.005	0
1355	advisory committee on immunization practices recommended immunization schedule for children and adolescents aged 18 years or younger - united states, 2021	wodi, ap; ault, k; hunter, p; mcnally, v; szilagyi, pg; bernstein, h	mmwr-morbidity and mortality weekly report	2021	10.15585/mmwr.mm7006a1	0
1356	viral load and contact heterogeneity predict sars-cov-2 transmission and super-spreading events	goyal, a; reeves, db; cardozo-ojeda, ef; schiffer, jt; mayer, bt	elife	2021	10.7554/elife.63537	0
1357	in vivo monoclonal antibody efficacy against sars-cov-2 variant strains	chen, re; winkler, es; case, jb; aziati, id; bricker, tl; joshi, a; darling, tl; ying, bl; errico, jm; shrihari, s; vanblargan, la; xie, xp; gilchuk, p; zost, sj; droit, l; liu, zm; stumpf, s; wang, d; handley, sa; stine, wb; shi, py; davis-gardner, me; suthar, ms; knight, mg; andino, r; chiu, cy; ellebedy, ah; fremont, dh; whelan, spj; crowe, je; purcell, l; corti, d; boon, acm; diamond, ms	nature	2021	10.1038/s41586-021-03720-y	0
1358	masitinib is a broad coronavirus 3cl inhibitor that blocks replication of sars-cov-2	drayman, n; demarco, jk; jones, ka; azizi, sa; froggatt, hm; tan, k; maltseva, ni; chen, s; nicolaescu, v; dvorkin, s; furlong, k; kathayat, rs; firpo, mr; mastrodomenico, v; bruce, ea; schmidt, mm; jedrzejczak, r; munoz-alia, ma; schuster, b; nair, v; han, ky; o'brien, a; tomatsidou, a; meyer, b; vignuzzi, m; missiakas, d; botten, jw; brooke, cb; lee, h; baker, sc; mounce, bc; heaton, ns; severson, we; palmer, ke; dickinson, bc; joachimiak, a; randall, g; tay, s	science	2021	10.1126/science.abg5827	0
1359	genetic and structural basis for sars-cov-2 variant neutralization by a two-antibody cocktail	dong, jh; zost, sj; greaney, aj; starr, tn; dingens, as; chen, ec; chen, re; case, jb; sutton, re; gilchuk, p; rodriguez, j; armstrong, e; gainza, c; nargi, rs; binshtein, e; xie, xp; zhang, xw; shi, py; logue, j; weston, s; mcgrath, me; frieman, mb; brady, t; tuffy, km; bright, h; loo, ym; mctamney, pm; esser, mt; carnahan, rh; diamond, ms; bloom, jd; crowe, je	nature microbiology	2021	10.1038/s41564-021-00972-2	0
1360	review of covid-19 vaccine clinical trials ? a puzzle with missing pieces	kwok, hf	international journal of biological sciences	2021	10.7150/ijbs.59170	0
1361	covid-19 vaccines: frequently asked questions and updated answers	lefebvre, m; vignier, n; pitard, b; botelho-nevers, e; wyplosz, b; cohen, r; epaulard, o	infectious diseases now	2021	10.1016/j.idnow.2021.02.007	0
1362	playing vaccine roulette: why the current strategy of staking everything on covid-19 vaccines is a high-stakes wager	paul, e; brown, gw; kalk, a; ridde, v	vaccine	2021	10.1016/j.vaccine.2021.07.045	0
1363	are some covid-19 vaccines better than others? interpreting and comparing estimates of efficacy in vaccine trials	rapaka, rr; hammershaimb, ea; neuzil, km	clinical infectious diseases	2022	10.1093/cid/ciab213	0
1364	correlates of covid-19 vaccine hesitancy in austria: trust and the government	schernhammer, e; weitzer, j; laubichler, md; birmann, bm; bertau, m; zenk, l; caniglia, g; jager, cc; steiner, g	journal of public health	2022	10.1093/pubmed/fdab122	0
1365	the effectiveness of the two-dose bnt162b2 vaccine: analysis of real-world data	chodick, g; tene, l; rotem, rs; patalon, t; gazit, s; ben-tov, a; weil, c; goldshtein, i; twig, g; cohen, d; muhsen, k	clinical infectious diseases	2022	10.1093/cid/ciab438	2
1366	immunogenicity and safety of the bnt162b2 mrna covid-19 vaccine among actively treated cancer patients	ligumsky, h; safadi, e; etan, t; vaknin, n; waller, m; croll, a; nikolaevski-berlin, a; greenberg, i; halperin, t; wasserman, a; galazan, l; arber, n; wolf, i	jnci-journal of the national cancer institute	2022	10.1093/jnci/djab174	2
1367	immunological and clinical efficacy of covid-19 vaccines in immunocompromised populations: a systematic review	galmiche, s; nguyen, lbl; tartour, e; de lamballerie, x; wittkop, l; loubet, p; launay, o	clinical microbiology and infection	2022	10.1016/j.cmi.2021.09.036	0
1368	covid-19 vaccination intention in the first year of the pandemic: a systematic review	al-amer, r; della maneze; everett, b; montayre, j; villarosa, ar; dwekat, e; salamonson, y	journal of clinical nursing	2022	10.1111/jocn.15951	0
1369	willingness to get a covid-19 vaccine and reasons for hesitancy among medicare beneficiaries: results from a national survey	luo, hb; qu, hy; basu, r; rafferty, ap; patil, sp; cummings, dm	journal of public health management and practice	2022	10.1097/phh.0000000000001394	0
1370	effectiveness of bnt162b2 vaccine against critical covid-19 in adolescents	olson, sm; newhams, mm; halasa, nb; price, am; boom, ja; sahni, lc; pannaraj, ps; irby, k; walker, tc; schwartz, sp; maddux, ab; mack, eh; bradford, tt; schuster, je; nofziger, ra; cameron, ma; chiotos, k; cullimore, ml; gertz, sj; levy, er; kong, m; cvijanovich, nz; staat, ma; kamidani, s; chatani, bm; bhumbra, ss; bline, ke; gaspers, mg; hobbs, cv; heidemann, sm; maamari, m; flori, hr; hume, jr; zinter, ms; michelson, kn; zambrano, ld; campbell, ap; patel, mm; randolph, g	new england journal of medicine	2022	10.1056/nejmoa2117995	0
1371	covid-19 vaccination during pregnancy: coverage and safety	blakeway, h; prasad, s; kalafat, e; heath, pt; ladhani, sn; le doare, k; magee, la; o'brien, p; rezvani, a; von dadelszen, p; khalil, a	american journal of obstetrics and gynecology	2022	10.1016/j.ajog.2021.08.007	1
1372	postmarketing studies: can they provide a safety net for covid-19 vaccines in the uk?	dhanda, s; osborne, v; lynn, e; shakir, s	bmj evidence-based medicine	2022	10.1136/bmjebm-2020-111507	0
1373	immune correlates analysis of the mrna-1273 covid-19 vaccine efficacy clinical trial	gilbert, pb; montefiori, dc; mcdermott, a; fong, yy; benkeser, d; deng, wp; zhou, hh; houchens, cr; martins, k; jayashankar, l; castellino, f; flach, b; lin, bc; o'connell, s; mcdanal, c; eaton, a; sarzotti-kelsoe, m; lu, yw; yu, cc; borate, b; van der laan, lwp; hejazi, n; huynh, c; miller, j; el sahly, hm; baden, lr; baron, m; de la cruz, l; gay, c; kalams, s; kelley, cf; andrasik, mp; kublin, jg; corey, l; neuzil, km; carpp, ln; pajon, r; follmann, d; donis, ro; koup, ra	science	2022	10.1126/science.abm3425	0
1374	in-line treatments and clinical initiatives to fight against covid-19 outbreak	agrawal, m; saraf, s; saraf, s; murty, us; kurundkar, sb; roy, d; joshi, p; sable, d; choudhary, yk; kesharwani, p; alexander, a	respiratory medicine	2022	10.1016/j.rmed.2020.106192	0
1375	review and evolution of guidelines for diagnosis of covid-19 vaccine induced thrombotic thrombocytopenia (vitt)	favaloro, ej; pasalic, l; lippi, g	clinical chemistry and laboratory medicine	2022	10.1515/cclm-2021-1039	0
1376	duration of protection against mild and severe disease by covid-19 vaccines	andrews, n; tessier, e; stowe, j; gower, c; kirsebom, f; simmons, r; gallagher, e; thelwall, s; groves, n; dabrera, g; myers, r; campbell, cnj; amirthalingam, g; edmunds, m; zambon, m; brown, k; hopkins, s; chand, m; ladhani, sn; ramsay, m; bernal, jl	new england journal of medicine	2022	10.1056/nejmoa2115481	0
1377	covid-19 mrna vaccination: age and immune status and its association with axillary lymph node pet/ct uptake	eifer, m; tau, n; alhoubani, y; kanana, n; domachevsky, l; shams, j; keret, n; gorfine, m; eshet, y	journal of nuclear medicine	2022	10.2967/jnumed.121.262194	0
1378	covid-19 in children: where do we stand?	nikolopoulou, gb; maltezou, hc	archives of medical research	2022	10.1016/j.arcmed.2021.07.002	0
1379	evaluation of the bnt162b2 covid-19 vaccine in children 5 to 11 years of age	walter, eb; talaat, kr; sabharwal, c; gurtman, a; lockhart, s; paulsen, gc; barnett, ed; munoz, fm; maldonado, y; pahud, ba; domachowske, jb; simoes, eaf; sarwar, un; kitchin, n; cunliffe, l; rojo, p; kuchar, e; ramet, m; munjal, i; perez, jl; frenck, rw; lagkadinou, e; swanson, ka; ma, h; xu, x; koury, k; mather, s; belanger, tj; cooper, d; tureci, o; dormitzer, pr; jansen, ku; gruber, wc	new england journal of medicine	2022	10.1056/nejmoa2116298	0
1380	an update on covid-19 and pregnancy	jamieson, dj; rasmussen, sa	american journal of obstetrics and gynecology	2022	10.1016/j.ajog.2021.08.054	0
1381	adverse effects and antibody titers in response to the bnt162b2 mrna covid-19 vaccine in a prospective study of healthcare workers	coggins, sa; laing, ed; olsen, ch; goguet, e; moser, m; jackson-thompson, bm; samuels, ec; pollett, sd; tribble, dr; davies, j; illinik, l; hollis-perry, m; maiolatesi, se; duplessis, ca; ramsey, kf; reyes, ae; alcorta, y; wong, ma; wang, g; ortega, o; parmelee, e; lindrose, ar; snow, al; malloy, amw; letizia, ag; ewing, d; powers, jh; schully, kl; burgess, th; broder, cc; mitre, e	open forum infectious diseases	2022	10.1093/ofid/ofab575	0
1382	a prospective observational study for justification, safety, and efficacy of a third dose of mrna vaccine in patients receiving maintenance hemodialysis	espi, m; charmetant, x; barba, t; mathieu, c; pelletier, c; koppe, l; chalencon, e; kalbacher, e; mathias, v; ovize, a; cart-tanneur, e; bouz, c; pellegrina, l; morelon, e; juillard, l; fouque, d; couchoud, c; thaunat, o	kidney international	2022	10.1016/j.kint.2021.10.040	0
1383	fear of covid-19 in madrid. will patients avoid dental care?	gonzalez-olmo, mj; delgado-ramos, b; ortega-martinez, ar; romero-maroto, m; carrillo-diaz, m	international dental journal	2022	10.1016/j.identj.2021.01.013	0
1384	delta variants of sars-cov-2 cause significantly increased vaccine breakthrough covid-19 cases in houston, texas	christensen, pa; olsen, rj; long, sw; subedi, s; davis, jj; hodjat, p; walley, dr; kinskey, jc; saavedra, mo; pruitt, l; reppond, k; shyer, mn; cambric, j; gadd, r; thakur, rm; batajoo, a; mangham, r; pena, s; trinh, t; yerramilli, p; nguyen, m; olson, r; snehal, r; gollihar, j; musser, jm	american journal of pathology	2022	10.1016/j.ajpath.2021.10.019	0
1385	seroconversion rate after vaccination against covid-19 in patients with cancer-a systematic review	corti, c; antonarelli, g; scotte, f; spano, jp; barriere, j; michot, jm; andre, f; curigliano, g	annals of oncology	2022	10.1016/j.annonc.2021.10.014	0
1386	the effect of mandatory covid-19 certificates on vaccine uptake: synthetic-control modelling of six countries	mills, mc; ruttenauer, t	lancet public health	2022	10.1016/s2468-2667(21)00273-5	0
1387	central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to covid-19 mrna vaccine	watanabe, m; balena, a; tuccinardi, d; tozzi, r; risi, r; masi, d; caputi, a; rossetti, r; spoltore, me; filippi, v; gangitano, e; manfrini, s; mariani, s; lubrano, c; lenzi, a; mastroianni, c; gnessi, l	diabetes-metabolism research and reviews	2022	10.1002/dmrr.3465	0
1388	covid-19/sars-cov-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment	munavalli, gg; guthridge, r; knutsen-larson, s; brodsky, a; matthew, e; landau, m	archives of dermatological research	2022	10.1007/s00403-021-02190-6	1
1389	preparedness of countries to face covid-19 pandemic crisis: strategic positioning and factors supporting effective strategies of prevention of pandemic threats	coccia, m	environmental research	2022	10.1016/j.envres.2021.111678	0
1390	estimating the early impact of the us covid-19 vaccination programme on covid-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data	mcnamara, la; wiegand, re; burke, rm; sharma, aj; sheppard, m; adjemian, j; ahmad, fb; anderson, rn; barbour, ke; binder, am; dasgupta, s; dee, dl; jones, es; kriss, jl; lyons, bc; mcmorrow, m; payne, dc; reses, he; rodgers, le; walker, d; verani, jr; schrag, sj	lancet	2022	10.1016/s0140-6736(21)02226-1	0
1391	a survey on mathematical, machine learning and deep learning models for covid-19 transmission and diagnosis	john, cc; ponnusamy, v; chandrasekaran, sk; nandakumar, r	ieee reviews in biomedical engineering	2022	10.1109/rbme.2021.3069213	0
1392	exhausted nk cells and cytokine storms in covid-19: whether nk cell therapy could be a therapeutic choice	ghasemzadeh, m; ghasemzadeh, a; hosseini, e	human immunology	2022	10.1016/j.humimm.2021.09.004	0
1393	covid-evax, an electroporated dna vaccine candidate encoding the sars-cov-2 rbd, elicits protective responses in animal models	conforti, a; marra, e; palombo, f; roscilli, g; rava, m; fumagalli, v; muzi, a; maffei, m; luberto, l; lione, l; salvatori, e; compagnone, m; pinto, e; pavoni, e; bucci, f; vitagliano, g; stoppoloni, d; pacello, ml; cappelletti, m; ferrara, ff; d'acunto, e; chiarini, v; arriga, r; nyska, a; di lucia, p; marotta, d; bono, e; giustini, l; sala, e; perucchini, c; paterson, j; ryan, ka; challis, ar; matusali, g; colavita, f; caselli, g; criscuolo, e; clementi, n; mancini, n; gross, r; seidel, a; wettstein, l; munch, j; donnici, l; conti, m; de francesco, r; kuka, m; ciliberto, g; castilletti, c; capobianchi, mr; ippolito, g; guidotti, lg; rovati, l; iannacone, m; aurisicchio, l	molecular therapy	2022	10.1016/j.ymthe.2021.09.011	0
1394	association between 3 doses of mrna covid-19 vaccine and symptomatic infection caused by the sars-cov-2 omicron and delta variants	accorsi, ek; britton, a; fleming-dutra, ke; smith, zr; shang, n; derado, g; miller, j; schrag, sj; verani, jr	jama-journal of the american medical association	2022	10.1001/jama.2022.0470	0
1395	preventing, mitigating, and managing future pandemics for people with an intellectual and developmental disability - learnings from covid-19: a scoping review	taggart, l; mulhall, p; kelly, r; trip, h; sullivan, b; wallen, ef	journal of policy and practice in intellectual disabilities	2022	10.1111/jppi.12408	0
1396	increased peripheral blood neutrophil activation phenotypes and neutrophil extracellular trap formation in critically ill coronavirus disease 2019 (covid-19) patients: a case series and review of the literature	masso-silva, ja; moshensky, a; lam, mty; odish, mf; patel, a; xu, l; hansen, e; trescott, s; nguyen, c; kim, r; perofsky, k; perera, s; ma, l; pham, j; rolfsen, m; olay, j; shin, j; dan, jm; abbott, rk; ramirez, s; alexander, th; lin, gy; fuentes, al; advani, i; gunge, d; pretorius, v; malhotra, a; sun, x; duran, j; hepokoski, m; crotty, s; coufal, ng; meier, a; alexander, lec	clinical infectious diseases	2022	10.1093/cid/ciab437	0
1397	third dose of the bnt162b2 vaccine in heart transplant recipients: immunogenicity and clinical experience	peled, y; ram, e; lavee, j; segev, a; matezki, s; wieder-finesod, a; halperin, r; mandelboim, m; indenbaum, v; levy, i; sternik, l; raanani, e; afek, a; kreiss, y; lustig, y; rahav, g	journal of heart and lung transplantation	2022	10.1016/j.healun.2021.08.010	1
1398	heterologous versus homologous covid-19 booster vaccination in previous recipients of two doses of coronavac covid-19 vaccine in brazil (rhh-001): a phase 4, non-inferiority, single blind, randomised study	clemens, sac; weckx, l; clemens, r; mendes, ava; souza, ar; silveira, mbv; da guarda, snf; de nobrega, mm; pinto, mid; gonzalez, igs; salvador, n; franco, mm; mendonca, rnd; oliveira, isq; souza, bsd; fraga, m; aley, p; bibi, s; cantrell, l; dejnirattisai, w; liu, xx; mongkolsapaya, j; supasa, p; screaton, gr; lambe, t; voysey, m; pollard, aj	lancet	2022	10.1016/s0140-6736(22)00094-0	0
1399	persistence of sars cov-2 s1 protein in cd16+monocytes in post-acute sequelae of covid-19 (pasc) up to 15 months post-infection	patterson, bk; francisco, eb; yogendra, r; long, emy; pise, a; rodrigues, h; hall, e; herrera, m; parikh, p; guevara-coto, j; triche, tj; scott, p; hekmati, s; maglinte, d; chang, xoa; mora-rodriguez, ra; mora, j	frontiers in immunology	2022	10.3389/fimmu.2021.746021	0
1400	safety and immunogenicity of an inactivated covid-19 vaccine, bbibp-corv, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial	xia, sl; zhang, yt; wang, yx; wang, h; yang, yk; gao, gf; tan, wj; wu, gz; xu, m; lou, zy; huang, wj; xu, wb; huang, by; wang, w; zhang, w; li, n; xie, zq; zhu, xj; ding, l; you, wy; zhao, yx; zhao, j; huang, ll; shi, xz; yang, yl; xu, gx; wang, wl; liu, pp; ma, m; qiao, yl; zhao, sh; chai, jj; li, qq; fu, h; xu, y; zheng, xt; guo, ws; yang, xm	lancet infectious diseases	2022	10.1016/s1473-3099(21)00462-x	0
1401	multisociety statement on coronavirus disease 2019 (covid-19) vaccination as a condition of employment for healthcare personnel	weber, dj; al-tawfiq, ja; babcock, hm; bryant, k; drees, m; elshaboury, r; essick, k; fakih, m; henderson, dk; javaid, w; juffras, d; jump, rlp; lee, f; malani, an; mathew, ta; murthy, rk; nace, d; o'shea, t; pettigrew, e; pettis, am; schaffzin, jk; shenoy, es; vaishampayan, j; wiley, z; wright, sb; yokoe, d; young, h	infection control and hospital epidemiology	2022	10.1017/ice.2021.322	0
1402	recognizing vaccine-induced immune thrombotic thrombocytopenia	iba, t; levy, jh; warkentin, te	critical care medicine	2022	10.1097/ccm.0000000000005211	0
1403	community transmission and viral load kinetics of the sars-cov-2 delta (b.1.617.2) variant in vaccinated and unvaccinated individuals in the uk: a prospective, longitudinal, cohort study	singanayagam, a; hakki, s; dunning, j; madon, kj; crone, ma; koycheva, a; derqui-fernandez, n; barnett, jl; whitfield, mg; varro, r; charlett, a; kundu, r; fenn, j; cutajar, j; quinn, v; conibear, e; barclay, w; freemont, ps; taylor, gp; ahmad, s; zambon, m; ferguson, nm; lalvani, a	lancet infectious diseases	2022	10.1016/s1473-3099(21)00648-4	1
1404	effect of covid-19 vaccination on transmission of alpha and delta variants	eyre, dw; taylor, d; purver, m; chapman, d; fowler, t; pouwels, kb; walker, as; peto, tea	new england journal of medicine	2022	10.1056/nejmoa2116597	0
1405	large-scale study of antibody titer decay following bnt162b2 mrna vaccine or sars-cov-2 infection	israel, a; shenhar, y; green, i; merzon, e; golan-cohen, a; schaeffer, aa; ruppin, e; vinker, s; magen, e	vaccines	2022	10.3390/vaccines10010064	0
1406	sars-cov-2 vaccine protection and deaths among us veterans during 2021	cohn, ba; cirillo, pm; murphy, cc; krigbaum, ny; wallace, aw	science	2022	10.1126/science.abm0620	0
1407	neutralization of sars-cov-2 omicron by bnt162b2 mrna vaccine-elicited human sera	muik, a; lui, bg; wallisch, ak; bacher, m; muhl, j; reinholz, j; ozhelvaci, o; beckmann, n; garcia, rdg; poran, a; shpyro, s; finlayson, a; cai, h; yang, q; swanson, ka; tureci, o; sahin, u	science	2022	10.1126/science.abn7591	0
1408	risk factors and disease profile of post-vaccination sars-cov-2 infection in uk users of the covid symptom study app: a prospective, community-based, nested, case-control study	antonelli, m; penfold, rs; merino, j; sudre, ch; molteni, e; berry, s; canas, ls; graham, ms; klaser, k; modat, m; murray, b; kerfoot, e; chen, ly; deng, j; osterdahl, mf; cheetham, nj; drew, da; nguyen, lh; pujol, jc; hu, c; selvachandran, s; polidori, l; may, a; wolf, j; chan, at; hammers, a; duncan, el; spector, td; ourselin, s; steves, cj	lancet infectious diseases	2022	10.1016/s1473-3099(21)00460-6	0
1409	immunity to sars-cov-2 up to 15 months after infection	marcotte, h; piralla, a; zuo, fl; du, lk; cassaniti, i; wan, h; kumagai-braesh, m; andrell, j; percivalle, e; sammartino, jc; wang, yt; vlachiotis, s; attevall, j; bergami, f; ferrari, a; colaneri, m; vecchia, m; sambo, m; zuccaro, v; asperges, e; bruno, r; oggionni, t; meloni, f; abolhassani, h; bertoglio, f; schubert, m; calzolai, l; varani, l; hust, m; xue, yt; hammarstrom, l; baldanti, f; pan-hammarstrom, q	iscience	2022	10.1016/j.isci.2022.103743	0
1410	are the healthy vulnerable? cytomegalovirus seropositivity in healthy adults is associated with accelerated epigenetic age and immune dysregulation	poloni, c; szyf, m; cheishvili, d; tsoukas, cm	journal of infectious diseases	2022	10.1093/infdis/jiab365	0
1411	final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial	halperin, sa; ye, ly; mackinnon-cameron, d; smith, b; cahn, pe; ruiz-palacios, gm; ikram, a; lanas, f; guerrero, ml; navarro, srm; sued, o; lioznov, da; dzutseva, v; parveen, g; zhu, fc; leppan, l; langley, jm; barreto, l; gou, jb; zhu, t	lancet	2022	10.1016/s0140-6736(21)02753-7	0
1412	sars-cov-2 antibody response after a third dose of the bnt162b2 vaccine in patients receiving maintenance hemodialysis or peritoneal dialysis	bensouna, i; caudwell, v; kubab, s; acquaviva, s; pardon, a; vittoz, n; bozman, df; hanafi, l; faucon, al; housset, p	american journal of kidney diseases	2022	10.1053/j.ajkd.2021.08.005	0
1413	cutaneous reactions after sars-cov-2 vaccination: a cross-sectional spanish nationwide study of 405 cases	catala, a; munoz-santos, c; galvan-casas, c; riesco, mr; nebreda, dr; sola-truyols, a; giavedoni, p; llamas-velasco, m; gonzalez-cruz, c; cubiro, x; ruiz-villaverde, r; gomez-armayones, s; mateo, mpg; pesque, d; marcantonio, o; fernandez-nieto, d; romani, j; pena, ni; gonzalez, lc; tercedor-sanchez, j; carretero, g; masat-tico, t; rodriguez-jimenez, p; gimenez-arnau, am; utrera-busquets, m; laguna, ev; menendez, aga; lasser, es; iglesias-sancho, m; naranjo, la; hiltun, i; marco, ec; olabarrieta, ip; escobedo, sm; garcia-navarro, x; gutierrez, mjc; baeza-hernandez, g; camps, lb; toledo-pastrana, t; guilabert, a	british journal of dermatology	2022	10.1111/bjd.20639	0
1414	mechanisms of sars-cov-2 entry into cells	jackson, cb; farzan, m; chen, b; choe, h	nature reviews molecular cell biology	2022	10.1038/s41580-021-00418-x	0
1415	optimizing investigation of suspected allergy to polyethylene glycols	bruusgaard-mouritsen, ma; jensen, bm; poulsen, lk; johansen, jd; garvey, lh	journal of allergy and clinical immunology	2022	10.1016/j.jaci.2021.05.020	0
1416	enhanced fusogenicity and pathogenicity of sars-cov-2 delta p681r mutation	saito, a; irie, t; suzuki, r; maemura, t; nasser, h; uriu, k; kosugi, y; shirakawa, k; sadamasu, k; kimura, i; ito, j; wu, jq; iwatsuki-horimoto, k; ito, m; yamayoshi, s; loeber, s; tsuda, m; wang, l; ozono, s; butlertanaka, ep; tanaka, yl; shimizu, r; shimizu, k; yoshimatsu, k; kawabata, r; sakaguchi, t; tokunaga, k; yoshida, i; asakura, h; nagashima, m; kazuma, y; nomura, r; horisawa, y; yoshimura, k; takaori-kondo, a; imai, m; tanaka, s; nakagawa, s; ikeda, t; fukuhara, t; kawaoka, y; sato, k	nature	2022	10.1038/s41586-021-04266-9	1
1417	altered tmprss2 usage by sars-cov-2 omicron impacts infectivity and fusogenicity	meng, b; abdullahi, a; ferreira, iatm; goonawardane, n; saito, a; kimura, i; yamasoba, d; gerber, pp; fatihi, s; rathore, s; zepeda, sk; papa, g; kemp, sa; ikeda, t; toyoda, m; tan, ts; kuramochi, j; mitsunaga, s; ueno, t; shirakawa, k; takaori-kondo, a; brevini, t; mallery, dl; charles, oj; bowen, je; joshi, a; walls, ac; jackson, l; martin, d; smith, kgc; bradley, j; briggs, jag; choi, j; madissoon, e; meyer, kb; mlcochova, p; ceron-gutierrez, l; doffinger, r; teichmann, sa; fisher, aj; pizzuto, ms; de marco, a; corti, d; hosmillo, m; lee, jh; james, lc; thukral, l; veesler, d; sigal, a; sampaziotis, f; goodfellow, ig; matheson, nj; sato, k; gupta, rk	nature	2022	10.1038/s41586-022-04474-x	0
1418	multimorbidity and adverse events of special interest associated with covid-19 vaccines in hong kong	lai, ftt; huang, l; chui, csl; wan, eyf; li, x; wong, ckh; chan, eww; ma, tt; lum, dh; leung, jcn; luo, h; chan, ewy; wong, ick	nature communications	2022	10.1038/s41467-022-28068-3	0
1419	environmental friendly micro cold storage for last-mile covid-19 vaccine logistics	nadimuthu, lpr; victor, k	environmental science and pollution research	2022	10.1007/s11356-021-17584-2	0
1420	mrna covid-19 vaccines in pregnancy: a systematic review	pratama, nr; wafa, ia; budi, ds; putra, m; wardhana, mp; wungu, cdk	plos one	2022	10.1371/journal.pone.0261350	0
1421	covid-19 vaccine acceptance and associated factors among pregnant women in pennsylvania 2020	sznajder, kk; kjerulff, kh; wang, m; hwang, w; ramirez, si; gandhi, ck	preventive medicine reports	2022	10.1016/j.pmedr.2022.101713	0
